#BEGIN_DRUGCARD DB03431

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
20398-34-9

# ChEBI_ID:
16761

# Chemical_Formula:
C10H15N5O10P2

# Chemical_IUPAC_Name:
[({[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Adenosine 5&#39;-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5&#39;-position. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Adenosine-5'-Diphosphate

# HET_ID:
ADP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7+,10+/m0/s1

# InChI_Key:
InChIKey=XTWYTFMLZFPYCI-FCIPNVEPSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00008

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3431

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
427.2011

# Molecular_Weight_Mono:
427.029414749

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1UC9

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.6

# Predicted_LogS:
-2.1

# Predicted_Water_Solubility:
3.27e+00 g/l

# Primary_Accession_No:
DB03431

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5702665

# PubChem_Substance_ID:
46508887

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00436

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC=NC2=C1N=CN2[C@@H]1O[C@@H](CO[P@](O)(=O)OP(O)(O)=O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:15 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Phase_1_Metabolizing_Enzyme_1_Gene_Name:
DCK

# Phase_1_Metabolizing_Enzyme_1_ID:
4773

# Phase_1_Metabolizing_Enzyme_1_Name:
Deoxycytidine kinase

# Phase_1_Metabolizing_Enzyme_1_Protein_Sequence:
>Deoxycytidine kinase
MATPPKRSCPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLCEDWEVVPEPVARWCN
VQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAE
KPVLFFERSVYSDRYIFASNLYESECMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQA
TPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNE
DFKDKYESLVEKVKEFLSTL

# Phase_1_Metabolizing_Enzyme_1_SwissProt_ID:
P27707

# Phase_1_Metabolizing_Enzyme_2_Gene_Name:
NME1

# Phase_1_Metabolizing_Enzyme_2_ID:
5294

# Phase_1_Metabolizing_Enzyme_2_Name:
Nucleoside diphosphate kinase A

# Phase_1_Metabolizing_Enzyme_2_Protein_Sequence:
>Nucleoside diphosphate kinase A
MANCERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVGLKFMQASEDLLKEHYVDLKDRPF
FAGLVKYMHSGPVVAMVWEGLNVVKTGRVMLGETNPADSKPGTIRGDFCIQVGRNIIHGS
DSVESAEKEIGLWFHPEELVDYTSCAQNWIYE

# Phase_1_Metabolizing_Enzyme_2_SwissProt_ID:
P15531

# Drug_Target_100_Cellular_Location:
Not Available

# Drug_Target_100_Chromosome_Location:
Not Available

# Drug_Target_100_Drug_References:
Not Available

# Drug_Target_100_Essentiality:
Non-Essential

# Drug_Target_100_GenAtlas_ID:
Not Available

# Drug_Target_100_GenBank_ID_Gene:
AE017222

# Drug_Target_100_GenBank_ID_Protein:
Not Available

# Drug_Target_100_GeneCard_ID:
Not Available

# Drug_Target_100_Gene_Name:
TT_P0036

# Drug_Target_100_Gene_Sequence:
>930 bp
ATGCTTGAGGTGGTGACGGCGGGGGAGCCCCTGGTGGCCCTGGTGCCCCAGGAGCCCGGA
CACCTTCGGGGGAAGCGCCTTCTGGAGGTGTACGTGGGCGGGGCCGAGGTGAACGTGGCC
GTGGCCCTGGCCCGGCTTGGGGTCAAGGTGGGCTTCGTGGGCCGGGTGGGAGAGGACGAG
CTTGGGGCCATGGTGGAGGAAAGGCTCCGGGCCGAGGGGGTGGACCTCACCCACTTTCGC
AGGGCGCCGGGGTTCACGGGGCTTTACCTGCGGGAGTACTTGCCTTTGGGACAGGGAAGG
GTCTTCTACTACCGGAAGGGCTCGGCGGGAAGCGCCCTCGCCCCCGGGGCCTTTGACCCC
GACTACCTGGAGGGGGTCCGCTTCCTTCACCTAAGCGGCATCACCCCGGCCCTCTCCCCC
GAGGCCCGGGCCTTCAGCCTGTGGGCCATGGAGGAGGCGAAGCGGCGGGGGGTCCGGGTG
AGCCTGGACGTGAACTACCGCCAGACCCTCTGGCCCCCCGAGGAGGCCCGGGGCTTCCTG
GAGAGGGCCCTTCCCGGGGTGGACCTCCTCTTCTTGAGCGAGGAGGAGGCGGAGCTCCTC
TTCGGCCGGGTGGAGGAGGCGTTGCGGGCGCTTTCCGCCCCCGAGGTGGTCCTGAAGCGG
GGGGCCAAGGGGGCCTGGGCCTTCGTGGACGGGAGGCGGGCGGAGGGGAGCGCCTTCGTC
GTGGAGGCGGTGGACCCCGTGGGCGCGGGGGACGCCTTCGCTGCCGGTTACCTGGCGGGG
GCGGTGTGGGGGCTACCGGTGGAGGAAAGGCTTCGCCTCGCCAACCTCCTCGGGGCCTCG
GTGGCGGCGTCCCGGGGAGACCACGAGGGGGCGCCTTACCGGGAGGACCTCGAGGTCCTC
CTGAAGGCAACCCAGACCTTCATGCGTTAG

# Drug_Target_100_General_Function:
Involved in ribokinase activity

# Drug_Target_100_General_References:
Not Available

# Drug_Target_100_HGNC_ID:
Not Available

# Drug_Target_100_HPRD_ID:
Not Available

# Drug_Target_100_ID:
5295

# Drug_Target_100_Locus:
Not Available

# Drug_Target_100_Molecular_Weight:
33441

# Drug_Target_100_Name:
2-keto-3-deoxy-gluconate kinase

# Drug_Target_100_Number_of_Residues:
309

# Drug_Target_100_PDB_ID:
1V1S

# Drug_Target_100_Pathway:
Not Available

# Drug_Target_100_Pfam_Domain_Function:
PF00294	PfkB

# Drug_Target_100_Protein_Sequence:
>2-keto-3-deoxy-gluconate kinase
MLEVVTAGEPLVALVPQEPGHLRGKRLLEVYVGGAEVNVAVALARLGVKVGFVGRVGEDE
LGAMVEERLRAEGVDLTHFRRAPGFTGLYLREYLPLGQGRVFYYRKGSAGSALAPGAFDP
DYLEGVRFLHLSGITPALSPEARAFSLWAMEEAKRRGVRVSLDVNYRQTLWPPEEARGFL
ERALPGVDLLFLSEEEAELLFGRVEEALRALSAPEVVLKRGAKGAWAFVDGRRAEGSAFV
VEAVDPVGAGDAFAAGYLAGAVWGLPVEERLRLANLLGASVAASRGDHEGAPYREDLEVL
LKATQTFMR

# Drug_Target_100_Reaction:
Not Available

# Drug_Target_100_Signals:
None

# Drug_Target_100_Specific_Function:
Not Available

# Drug_Target_100_SwissProt_ID:
Q746L7

# Drug_Target_100_SwissProt_Name:
Q746L7_THET2

# Drug_Target_100_Synonyms:
Not Available

# Drug_Target_100_Theoretical_pI:
5.16

# Drug_Target_100_Transmembrane_Regions:
None

# Drug_Target_101_Cellular_Location:
Not Available

# Drug_Target_101_Chromosome_Location:
Not Available

# Drug_Target_101_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_101_Essentiality:
Non-Essential

# Drug_Target_101_GenAtlas_ID:
Not Available

# Drug_Target_101_GenBank_ID_Gene:
Not Available

# Drug_Target_101_GenBank_ID_Protein:
Not Available

# Drug_Target_101_GeneCard_ID:
Not Available

# Drug_Target_101_Gene_Name:
KIFC1

# Drug_Target_101_Gene_Sequence:
Not Available

# Drug_Target_101_General_Function:
Not Available

# Drug_Target_101_General_References:
Not Available

# Drug_Target_101_HGNC_ID:
Not Available

# Drug_Target_101_HPRD_ID:
Not Available

# Drug_Target_101_ID:
7015

# Drug_Target_101_Locus:
Not Available

# Drug_Target_101_Molecular_Weight:
Not Available

# Drug_Target_101_Name:
Kinesin-like protein KIFC1

# Drug_Target_101_Number_of_Residues:
0

# Drug_Target_101_PDB_ID:
Not Available

# Drug_Target_101_Pathway:
Not Available

# Drug_Target_101_Pfam_Domain_Function:
Not Available

# Drug_Target_101_Protein_Sequence:
Not Available

# Drug_Target_101_Reaction:
Not Available

# Drug_Target_101_Signals:
Not Available

# Drug_Target_101_Specific_Function:
Not Available

# Drug_Target_101_SwissProt_ID:
Q9BW19

# Drug_Target_101_SwissProt_Name:
KIFC1_HUMAN

# Drug_Target_101_Synonyms:
Not Available

# Drug_Target_101_Theoretical_pI:
Not Available

# Drug_Target_101_Transmembrane_Regions:
Not Available

# Drug_Target_102_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_102_Chromosome_Location:
Not Available

# Drug_Target_102_Drug_References:
Not Available

# Drug_Target_102_Essentiality:
Non-Essential

# Drug_Target_102_GenAtlas_ID:
Not Available

# Drug_Target_102_GenBank_ID_Gene:
U08909

# Drug_Target_102_GenBank_ID_Protein:
Not Available

# Drug_Target_102_GeneCard_ID:
Not Available

# Drug_Target_102_Gene_Name:
ddl

# Drug_Target_102_Gene_Sequence:
>1134 bp
ATGACTAAAAAAAGAGTAGCGCTTATTTTTGGAGGTAATTCCTCTGAGCACGACGTATCA
AAGCGTTCAGCGCAAAATTTCTATAATGCAATCGAAGCAACTGATAAATATGAAATTATT
GTTTTTGCAATTGCCCAAAATGGTTTCTTTTTAGATACGGAAAGTTCTAAGAAAATACTT
GCGTTAGAAGATGAACAGCCCATTGTGGATGCCTTCATGAAAACTGTCGATACTAGTGAT
CCATTGGCGCGCATTCATGCTTTAAAGAGTGCGGGTGACTTTGATATTTTCTTCCCTGTA
GTTCATGGTAACTTAGGAGAAGATGGTACACTGCAAGGTTTATTTAAACTATTAGATAAA
CCATATGTGGGGGCACCGTTACGTGGCCATGCGGTAAGCTTTGACAAAGCTTTGACTAAA
GAACTATTGACGGTAAATGGTATTCGCAATACTAAATACATTGTGGTGGACCCTGAGTCA
GCAAACAATTGGTCGTGGGATAAGATTGTGGCTGAATTAGGCAACATTGTGTTTGTTAAA
GCTGCTAATCAAGGATCTTCAGTGGGAATTTCACGTGTAACCAATGCCGAAGAATATACT
GAAGCATTATCAGATTCATTCCAATATGATTATAAAGTTTTGATAGAAGAAGCAGTCAAC
GGTGCCCGAGAGTTGGAAGTTGGTGTGATTGGTAACGATCAGCCGCTTGTCTCTGAGATT
GGCGCACATACAGTGCCAAATCAGGGTAGTGGGGACGGTTGGTATGATTATAATAATAAG
TTCGTTGATAATTCCGCTGTTCACTTTGAAATTCCTGCTCAGTTATCCCCAGAAGTAACA
AAAGAAGTTAAACAAATGGCTTTAGATGCTTATAAAGTATTGAATTTACGTGGCGAAGCG
CGAATGGATTTTTTGTTAGATGAAAATAATGTTCCCTACTTAGGTGAACCAAACACGTTA
CCAGGGTTCACGAATATGTCGTTATTTAAACGTTTGTGGGATTATTCTGATATTAACAAC
GCCAAGCTAGTTGATATGTTGATTGACTACGGGTTTGAAGATTTTGCACAAAATAAAAAA
TTGAGTTACTCATTTGTGTCACTTGGAGAAGAAAAGATAGGGAAGTTTAACTAA

# Drug_Target_102_General_Function:
Involved in catalytic activity

# Drug_Target_102_General_References:
7828933	Elisha BG, Courvalin P: Analysis of genes encoding D-alanine:D-alanine ligase-related enzymes in Leuconostoc mesenteroides and Lactobacillus spp. Gene. 1995 Jan 11;152(1):79-83.

# Drug_Target_102_HGNC_ID:
Not Available

# Drug_Target_102_HPRD_ID:
Not Available

# Drug_Target_102_ID:
5299

# Drug_Target_102_Locus:
Not Available

# Drug_Target_102_Molecular_Weight:
41914

# Drug_Target_102_Name:
D-alanine--D-alanine ligase

# Drug_Target_102_Number_of_Residues:
377

# Drug_Target_102_PDB_ID:
1EHI

# Drug_Target_102_Pathway:
Not Available

# Drug_Target_102_Pfam_Domain_Function:
PF01820	Dala_Dala_lig_N
PF07478	Dala_Dala_lig_C

# Drug_Target_102_Protein_Sequence:
>D-alanine--D-alanine ligase
MTKKRVALIFGGNSSEHDVSKRSAQNFYNAIEATDKYEIIVFAIAQNGFFLDTESSKKIL
ALEDEQPIVDAFMKTVDTSDPLARIHALKSAGDFDIFFPVVHGNLGEDGTLQGLFKLLDK
PYVGAPLRGHAVSFDKALTKELLTVNGIRNTKYIVVDPESANNWSWDKIVAELGNIVFVK
AANQGSSVGISRVTNAEEYTEALSDSFQYDYKVLIEEAVNGARELEVGVIGNDQPLVSEI
GAHTVPNQGSGDGWYDYNNKFVDNSAVHFEIPAQLSPEVTKEVKQMALDAYKVLNLRGEA
RMDFLLDENNVPYLGEPNTLPGFTNMSLFKRLWDYSDINNAKLVDMLIDYGFEDFAQNKK
LSYSFVSLGEEKIGKFN

# Drug_Target_102_Reaction:
Not Available

# Drug_Target_102_Signals:
None

# Drug_Target_102_Specific_Function:
Cell wall formation (By similarity)

# Drug_Target_102_SwissProt_ID:
Q48745

# Drug_Target_102_SwissProt_Name:
DDL_LEUME

# Drug_Target_102_Synonyms:
D-Ala-D-Ala ligase
D-alanylalanine synthetase
EC 6.3.2.4

# Drug_Target_102_Theoretical_pI:
4.52

# Drug_Target_102_Transmembrane_Regions:
None

# Drug_Target_103_Cellular_Location:
Endoplasmic reticulum

# Drug_Target_103_Chromosome_Location:
Not Available

# Drug_Target_103_Drug_References:
Not Available

# Drug_Target_103_Essentiality:
Non-Essential

# Drug_Target_103_GenAtlas_ID:
TAP1

# Drug_Target_103_GenBank_ID_Gene:
X66401

# Drug_Target_103_GenBank_ID_Protein:
Not Available

# Drug_Target_103_GeneCard_ID:
Not Available

# Drug_Target_103_Gene_Name:
TAP1

# Drug_Target_103_Gene_Sequence:
>2247 bp
ATGGCTAGCTCTAGGTGTCCCGCTCCCCGCGGGTGCCGCTGCCTCCCCGGAGCTTCTCTC
GCATGGCTGGGGACAGTACTGCTACTTCTCGCCGACTGGGTGCTGCTCCGGACCGCGCTG
CCCCGCATATTCTCCCTGCTGGTGCCCACCGCGCTGCCACTGCTCCGGGTCTGGGCGGTG
GGCCTGAGCCGCTGGGCCGTGCTCTGGCTGGGGGCCTGCGGGGTCCTCAGGGCAACGGTT
GGCTCCAAGAGCGAAAACGCAGGTGCCCAGGGCTGGCTGGCTGCTTTGAAGCCATTAGCT
GCGGCACTGGGCTTGGCCCTGCCGGGACTTGCCTTGTTCCGAGAGCTGATCTCATGGGGA
GCCCCCGGGTCCGCGGATAGCACCAGGCTACTGCACTGGGGAAGTCACCCTACCGCCTTC
GTTGTCAGTTATGCAGCGGCACTGCCCGCAGCAGCCCTGTGGCACAAACTCGGGAGCCTC
TGGGTGCCCGGCGGTCAGGGCGGCTCTGGAAACCCTGTGCGTCGGCTTCTAGGCTGCCTG
GGCTCGGAGACGCGCCGCCTCTCGCTGTTCCTGGTCCTGGTGGTCCTCTCCTCTCTTGGG
GAGATGGCCATTCCATTCTTTACGGGCCGCCTCACTGACTGGATTCTACAAGATGGCTCA
GCCGATACCTTCACTCGAAACTTAACTCTCATGTCCATTCTCACCATAGCCAGTGCAGTG
CTGGAGTTCGTGGGTGACGGGATCTATAACAACACCATGGGCCACGTGCACAGCCACTTG
CAGGGAGAGGTGTTTGGGGCTGTCCTGCGCCAGGAGACGGAGTTTTTCCAACAGAACCAG
ACAGGTAACATCATGTCTCGGGTAACAGAGGACACGTCCACCCTGAGTGATTCTCTGAGT
GAGAATCTGAGCTTATTTCTGTGGTACCTGGTGCGAGGCCTATGTCTCTTGGGGATCATG
CTCTGGGGATCAGTGTCCCTCACCATGGTCACCCTGATCACCCTGCCTCTGCTTTTCCTT
CTGCCCAAGAAGGTGGGAAAATGGTACCAGTTGCTGGAAGTGCAGGTGCGGGAATCTCTG
GCAAAGTCCAGCCAGGTGGCCATTGAGGCTCTGTCGGCCATGCCTACAGTTCGAAGCTTT
GCCAACGAGGAGGGCGAAGCCCAGAAGTTTAGGGAAAAGCTGCAAGAAATAAAGACACTC
AACCAGAAGGAGGCTGTGGCCTATGCAGTCAACTCCTGGACCACTAGTATTTCAGGTATG
CTGCTGAAAGTGGGAATCCTCTACATTGGTGGGCAGCTGGTGACCAGTGGGGCTGTAAGC
AGTGGGAACCTTGTCACATTTGTTCTCTACCAGATGCAGTTCACCCAGGCTGTGGAGGTA
CTGCTCTCCATCTACCCCAGAGTACAGAAGGCTGTGGGCTCCTCAGAGAAAATATTTGAG
TACCTGGACCGCACCCCTCGCTGCCCACCCAGTGGTCTGTTGACTCCCTTACACTTGGAG
GGCCTTGTCCAGTTCCAAGATGTCTCCTTTGCCTACCCAAACCGCCCAGATGTCTTAGTG
CTACAGGGGCTGACATTCACCCTACGCCCTGGCGAGGTGACGGCGCTGGTGGGACCCAAT
GGGTCTGGGAAGAGCACAGTGGCTGCCCTGCTGCAGAATCTGTACCAGCCCACCGGGGGA
CAGCTGCTGTTGGATGGGAAGCCCCTTCCCCAATATGAGCACCGCTACCTGCACAGGCAG
GTGGCTGCAGTGGGACAAGAGCCACAGGTATTTGGAAGAAGTCTTCAAGAAAATATTGCC
TATGGCCTGACCCAGAAGCCAACTATGGAGGAAATCACAGCTGCTGCAGTAAAGTCTGGG
GCCCATAGTTTCATCTCTGGACTCCCTCAGGGCTATGACACAGAGGTAGACGAGGCTGGG
AGCCAGCTGTCAGGGGGTCAGCGACAGGCAGTGGCGTTGGCCCGAGCATTGATCCGGAAA
CCGTGTGTACTTATCCTGGATGATGCCACCAGTGCCCTGGATGCAAACAGCCAGTTACAG
GTGGAGCAGCTCCTGTACGAAAGCCCTGAGCGGTACTCCCGCTCAGTGCTTCTCATCACC
CAGCACCTCAGCCTGGTGGAGCAGGCTGACCACATCCTCTTTCTGGAAGGAGGCGCTATC
CGGGAGGGGGGAACCCACCAGCAGCTCATGGAGAAAAAGGGGTGCTACTGGGCCATGGTG
CAGGCTCCTGCAGATGCTCCAGAATGA

# Drug_Target_103_General_Function:
Involved in nucleotide binding

# Drug_Target_103_General_References:
1453454	Beck S, Kelly A, Radley E, Khurshid F, Alderton RP, Trowsdale J: DNA sequence analysis of 66 kb of the human MHC class II region encoding a cluster of genes for antigen processing. J Mol Biol. 1992 Nov 20;228(2):433-41.
1946428	Bahram S, Arnold D, Bresnahan M, Strominger JL, Spies T: Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10094-8.
2259383	Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A: Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature. 1990 Dec 20-27;348(6303):741-4.
2259384	Spies T, Bresnahan M, Bahram S, Arnold D, Blanck G, Mellins E, Pious D, DeMars R: A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature. 1990 Dec 20-27;348(6303):744-7.
8168860	Szafer F, Oksenberg JR, Steinman L: New allelic polymorphisms in TAP genes. Immunogenetics. 1994;39(5):374.
8248212	Jackson DG, Capra JD: TAP1 alleles in insulin-dependent diabetes mellitus: a newly defined centromeric boundary of disease susceptibility. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11079-83.
8568858	Beck S, Abdulla S, Alderton RP, Glynne RJ, Gut IG, Hosking LK, Jackson A, Kelly A, Newell WR, Sanseau P, Radley E, Thorpe KL, Trowsdale J: Evolutionary dynamics of non-coding sequences within the class II region of the human MHC. J Mol Biol. 1996 Jan 12;255(1):1-13.
8670825	Ahn K, Meyer TH, Uebel S, Sempe P, Djaballah H, Yang Y, Peterson PA, Fruh K, Tampe R: Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 1996 Jul 1;15(13):3247-55.
9175839	Ahn K, Gruhler A, Galocha B, Jones TR, Wiertz EJ, Ploegh HL, Peterson PA, Yang Y, Fruh K: The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity. 1997 May;6(5):613-21.

# Drug_Target_103_HGNC_ID:
HGNC:43

# Drug_Target_103_HPRD_ID:
Not Available

# Drug_Target_103_ID:
5300

# Drug_Target_103_Locus:
6p21.3

# Drug_Target_103_Molecular_Weight:
80966

# Drug_Target_103_Name:
Antigen peptide transporter 1

# Drug_Target_103_Number_of_Residues:
748

# Drug_Target_103_PDB_ID:
1JJ7

# Drug_Target_103_Pathway:
Not Available

# Drug_Target_103_Pfam_Domain_Function:
PF00005	ABC_tran
PF00664	ABC_membrane

# Drug_Target_103_Protein_Sequence:
>Antigen peptide transporter 1
MASSRCPAPRGCRCLPGASLAWLGTVLLLLADWVLLRTALPRIFSLLVPTALPLLRVWAV
GLSRWAVLWLGACGVLRATVGSKSENAGAQGWLAALKPLAAALGLALPGLALFRELISWG
APGSADSTRLLHWGSHPTAFVVSYAAALPAAALWHKLGSLWVPGGQGGSGNPVRRLLGCL
GSETRRLSLFLVLVVLSSLGEMAIPFFTGRLTDWILQDGSADTFTRNLTLMSILTIASAV
LEFVGDGIYNNTMGHVHSHLQGEVFGAVLRQETEFFQQNQTGNIMSRVTEDTSTLSDSLS
ENLSLFLWYLVRGLCLLGIMLWGSVSLTMVTLITLPLLFLLPKKVGKWYQLLEVQVRESL
AKSSQVAIEALSAMPTVRSFANEEGEAQKFREKLQEIKTLNQKEAVAYAVNSWTTSISGM
LLKVGILYIGGQLVTSGAVSSGNLVTFVLYQMQFTQAVEVLLSIYPRVQKAVGSSEKIFE
YLDRTPRCPPSGLLTPLHLEGLVQFQDVSFAYPNRPDVLVLQGLTFTLRPGEVTALVGPN
GSGKSTVAALLQNLYQPTGGQLLLDGKPLPQYEHRYLHRQVAAVGQEPQVFGRSLQENIA
YGLTQKPTMEEITAAAVKSGAHSFISGLPQGYDTEVDEAGSQLSGGQRQAVALARALIRK
PCVLILDDATSALDANSQLQVEQLLYESPERYSRSVLLITQHLSLVEQADHILFLEGGAI
REGGTHQQLMEKKGCYWAMVQAPADAPE

# Drug_Target_103_Reaction:
Not Available

# Drug_Target_103_Signals:
None

# Drug_Target_103_Specific_Function:
Involved in the transport of antigens from the cytoplasm to the endoplasmic reticulum for association with MHC class I molecules. Also acts as a molecular scaffold for the final stage of MHC class I folding, namely the binding of peptide. Nascent MHC class I molecules associate with TAP via tapasin. Inhibited by the covalent attachment of herpes simplex virus ICP47 protein, which blocks the peptide-binding site of TAP. Inhibited by human cytomegalovirus US6 glycoprotein, which binds to the lumenal side of the TAP complex and inhibits peptide translocation by specifically blocking ATP-binding to TAP1 and prevents the conformational rearrangement of TAP induced by peptide binding. Inhibited by human adenovirus E3-19K glycoprotein, which binds the TAP complex and acts as a tapasin inhibitor, preventing MHC class I/TAP association. Expression of TAP1 is down-regulated by human Epstein-Barr virus vIL-10 protein, thereby affecting the transport of peptides into the endoplasmic reticulum and subsequent peptide loading by MHC class I molecules

# Drug_Target_103_SwissProt_ID:
Q03518

# Drug_Target_103_SwissProt_Name:
TAP1_HUMAN

# Drug_Target_103_Synonyms:
APT1
ATP- binding cassette sub-family B member 2
PSF-1
Peptide supply factor 1
Peptide transporter PSF1
Peptide transporter TAP1
Peptide transporter involved in antigen processing 1

# Drug_Target_103_Theoretical_pI:
7.34

# Drug_Target_103_Transmembrane_Regions:
16-36
54-76
93-113
134-154
187-207
228-248
299-319
329-349
419-439
444-464

# Drug_Target_104_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_104_Chromosome_Location:
Not Available

# Drug_Target_104_Drug_References:
Not Available

# Drug_Target_104_Essentiality:
Non-Essential

# Drug_Target_104_GenAtlas_ID:
Not Available

# Drug_Target_104_GenBank_ID_Gene:
AE001437

# Drug_Target_104_GenBank_ID_Protein:
Not Available

# Drug_Target_104_GeneCard_ID:
Not Available

# Drug_Target_104_Gene_Name:
tdk

# Drug_Target_104_Gene_Sequence:
>588 bp
TTACACCTCTTTTTTTTGTGGAACAACATGGCATTTCCTACATCTTGCTTCATAAGACTC
CATTGCTCCTATCAAAACCACCGGATCATCATAAAACGCTGGCTTTCCATTTATTAACCT
CTGCGTTCTAGTTGCTGGATTTCCACATACAACGCATATTGCCTGAATCTTGTCTACAAA
TTCTGCAATAGCCATAAGCTCTGGTATAGGTCCAAATGGCTTACCTCTAAAATCCATATC
AAGTCCAGCGCAAATTACTCTTCTACCACTCTCCGCAATTTTATTTACAATTTCTACTAT
TTCATCGTCAAAAAACTGTACCTCATCGATTGCAATTACCTCTGTATCCTCCTCAAAATA
TTTTAATATTTCTCTACTATTTTTAATTGCAACTGCCTGTTCCTTCTCTCCCATATGAGA
AACTACATCTTCTTTACTATATCTGTTATCTATTTCAGGTTTAAAAACTTGAATTTTTTG
TTTTGCAATTTTAGCTCTTCTTATTCTTCTTATAAGTTCTTCTGATTTCCCACTATACAT
TGGTCCTACAATAACCTCAACCCATCCGTGGTCCTTTGGTCTGTACAT

# Drug_Target_104_General_Function:
Involved in thymidine kinase activity

# Drug_Target_104_General_References:
11466286	Nolling J, Breton G, Omelchenko MV, Makarova KS, Zeng Q, Gibson R, Lee HM, Dubois J, Qiu D, Hitti J, Wolf YI, Tatusov RL, Sabathe F, Doucette-Stamm L, Soucaille P, Daly MJ, Bennett GN, Koonin EV, Smith DR: Genome sequence and comparative analysis of the solvent-producing bacterium Clostridium acetobutylicum. J Bacteriol. 2001 Aug;183(16):4823-38.

# Drug_Target_104_HGNC_ID:
Not Available

# Drug_Target_104_HPRD_ID:
Not Available

# Drug_Target_104_ID:
5301

# Drug_Target_104_Locus:
Not Available

# Drug_Target_104_Molecular_Weight:
22303

# Drug_Target_104_Name:
Thymidine kinase

# Drug_Target_104_Number_of_Residues:
195

# Drug_Target_104_PDB_ID:
1XX6

# Drug_Target_104_Pathway:
Not Available

# Drug_Target_104_Pfam_Domain_Function:
PF00265	TK

# Drug_Target_104_Protein_Sequence:
>Thymidine kinase
MYRPKDHGWVEVIVGPMYSGKSEELIRRIRRAKIAKQKIQVFKPEIDNRYSKEDVVSHMG
EKEQAVAIKNSREILKYFEEDTEVIAIDEVQFFDDEIVEIVNKIAESGRRVICAGLDMDF
RGKPFGPIPELMAIAEFVDKIQAICVVCGNPATRTQRLINGKPAFYDDPVVLIGAMESYE
ARCRKCHVVPQKKEV

# Drug_Target_104_Reaction:
Not Available

# Drug_Target_104_Signals:
None

# Drug_Target_104_Specific_Function:
ATP + thymidine = ADP + thymidine 5'- phosphate

# Drug_Target_104_SwissProt_ID:
Q97F65

# Drug_Target_104_SwissProt_Name:
KITH_CLOAB

# Drug_Target_104_Synonyms:
EC 2.7.1.21

# Drug_Target_104_Theoretical_pI:
6.77

# Drug_Target_104_Transmembrane_Regions:
None

# Drug_Target_105_Cellular_Location:
Not Available

# Drug_Target_105_Chromosome_Location:
Not Available

# Drug_Target_105_Drug_References:
Not Available

# Drug_Target_105_Essentiality:
Non-Essential

# Drug_Target_105_GenAtlas_ID:
Not Available

# Drug_Target_105_GenBank_ID_Gene:
X63150

# Drug_Target_105_GenBank_ID_Protein:
Not Available

# Drug_Target_105_GeneCard_ID:
Not Available

# Drug_Target_105_Gene_Name:
trwB

# Drug_Target_105_Gene_Sequence:
>1524 bp
ATGCATCCAGACGATCAAAGAAAGGTCAGCGCCGGAATCGTTATTGTCCTGCCGCTTATC
TTTTGGATTACCGCCGTTCAGAAAACGGAGGTACTCGGTTCGCCGAAACTTTTGGCGCTT
TGGGAGCTAATGAAGCTCACCCCACAGAAGCCAATTTTGTTGCTTTCTGCGCTTGGAGGT
TTGGCCGTTGGAGTGTTGTTTGTCTGGCTATTGAATAGCGTCGGACAAGGCGAATTTGGC
GGCGCTCCATTCAAGCGATTTTTGCGCGGAACTCGCATCGTCAGTGGGGGAAAACTCAAA
CGCATGACACGCGAAAAAGCCAAGCAAGTTACCGTTGCTGGTGTACCAATGCCGCGTGAT
GCAGAGCCGCGCCATTTGCTGGTAAATGGTGCCACTGGTACGGGTAAATCGGTGTTGCTT
CGTGAGCTTGCTTATACCGGACTTTTGCGCGGCGACCGCATGGTAATTGTTGACCCGAAT
GGCGATATGTTGTCGAAATTCGGCAGGGATAAAGACATTATCTTGAACCCCTACGATCAG
CGTACAAAGGGTTGGTCTTTCTTCAACGAAATCCGAAATGACTACGACTGGCAGCGTTAT
GCGTTGTCGGTTGTTCCACGCGGAAAGACAGATGAGGCCGAGGAATGGGCCAGCTACGGG
CGCTTGCTGTTACGTGAAACAGCTAAAAAATTGGCGCTTATTGGTACGCCTTCCATGCGC
GAATTGTTCCACTGGACAACCATCGCCACGTTTGACGATTTGCGGGGGTTTCTGGAAGGA
ACTTTGGCCGAATCTTTGTTTGCTGGGTCGAATGAAGCGAGCAAGGCGCTGACCTCAGCG
CGCTTTGTTCTTTCCGACAAATTACCGGAGCATGTCACCATGCCGGACGGTGATTTCAGC
ATTCGTAGTTGGCTGGAAGACCCGAACGGCGGCAATCTGTTCATTACGTGGCGCGAGGAC
ATGGGGCCAGCCTTGCGTCCGTTGATCTCCGCATGGGTTGACGTGGTGTGCACGTCTATT
CTGTCACTACCGGAAGAACCCAAGCGCCGCTTGTGGCTGTTCATCGACGAGTTGGCTTCG
CTGGAAAAGCTGGCGAGCTTGGCCGACGCACTCACCAAAGGCCGAAAGGCAGGGCTTCGG
GTTGTGGCGGGCCTGCAATCGACCTCGCAGCTTGATGACGTGTACGGCGTGAAAGAGGCG
CAGACCCTGCGGGCCAGCTTCCGCTCGCTTGTTGTCCTGGGCGGCTCGCGCACCGACCCG
AAAACCAATGAGGACATGAGTTTGAGCTTGGGCGAGCATGAAGTCGAACGCGACCGCTAC
AGCAAGAACACAGGCAAACACCACAGCACCGGGCGGGCGCTTGAGCGCGTGCGCGAGCGC
GTCGTGATGCCGGCGGAAATCGCCAACTTGCCCGACCTCACCGCCTATGTCGGCTTTGCC
GGTAATCGGCCAATTGCCAAGGTTCCGCTTGAAATCAAGCAGTTTGCAAACCGGCAACCG
GCCTTTGTTGAGGGGACTATCTAA

# Drug_Target_105_General_Function:
Intracellular trafficking, secretion, and vesicular transport

# Drug_Target_105_General_References:
11959558	Partridge SR, Brown HJ, Hall RM: Characterization and movement of the class 1 integron known as Tn2521 and Tn1405. Antimicrob Agents Chemother. 2002 May;46(5):1288-94.
12533481	Rabel C, Grahn AM, Lurz R, Lanka E: The VirB4 family of proposed traffic nucleoside triphosphatases: common motifs in plasmid RP4 TrbE are essential for conjugation and phage adsorption. J Bacteriol. 2003 Feb;185(3):1045-58.
2038309	Llosa M, Bolland S, de la Cruz F: Structural and functional analysis of the origin of conjugal transfer of the broad-host-range IncW plasmid R388 and comparison with the related IncN plasmid R46. Mol Gen Genet. 1991 May;226(3):473-83.
3054482	Sundstrom L, Radstrom P, Swedberg G, Skold O: Site-specific recombination promotes linkage between trimethoprim- and sulfonamide resistance genes. Sequence characterization of dhfrV and sulI and a recombination active locus of Tn21. Mol Gen Genet. 1988 Aug;213(2-3):191-201.
7022127	Swift G, McCarthy BJ, Heffron F: DNA sequence of a plasmid-encoded dihydrofolate reductase. Mol Gen Genet. 1981;181(4):441-7.
7929000	Hall RM, Brown HJ, Brookes DE, Stokes HW: Integrons found in different locations have identical 5' ends but variable 3' ends. J Bacteriol. 1994 Oct;176(20):6286-94.
8289274	Llosa M, Bolland S, de la Cruz F: Genetic organization of the conjugal DNA processing region of the IncW plasmid R388. J Mol Biol. 1994 Jan 14;235(2):448-64.
9325277	Rivas S, Bolland S, Cabezon E, Goni FM, de la Cruz F: TrwD, a protein encoded by the IncW plasmid R388, displays an ATP hydrolase activity essential for bacterial conjugation. J Biol Chem. 1997 Oct 10;272(41):25583-90.

# Drug_Target_105_HGNC_ID:
Not Available

# Drug_Target_105_HPRD_ID:
Not Available

# Drug_Target_105_ID:
5302

# Drug_Target_105_Locus:
Not Available

# Drug_Target_105_Molecular_Weight:
56274

# Drug_Target_105_Name:
TrwB

# Drug_Target_105_Number_of_Residues:
507

# Drug_Target_105_PDB_ID:
1GL7

# Drug_Target_105_Pathway:
Not Available

# Drug_Target_105_Pfam_Domain_Function:
Not Available

# Drug_Target_105_Protein_Sequence:
>TrwB
MHPDDQRKVSAGIVIVLPLIFWITAVQKTEVLGSPKLLALWELMKLTPQKPILLLSALGG
LAVGVLFVWLLNSVGQGEFGGAPFKRFLRGTRIVSGGKLKRMTREKAKQVTVAGVPMPRD
AEPRHLLVNGATGTGKSVLLRELAYTGLLRGDRMVIVDPNGDMLSKFGRDKDIILNPYDQ
RTKGWSFFNEIRNDYDWQRYALSVVPRGKTDEAEEWASYGRLLLRETAKKLALIGTPSMR
ELFHWTTIATFDDLRGFLEGTLAESLFAGSNEASKALTSARFVLSDKLPEHVTMPDGDFS
IRSWLEDPNGGNLFITWREDMGPALRPLISAWVDVVCTSILSLPEEPKRRLWLFIDELAS
LEKLASLADALTKGRKAGLRVVAGLQSTSQLDDVYGVKEAQTLRASFRSLVVLGGSRTDP
KTNEDMSLSLGEHEVERDRYSKNTGKHHSTGRALERVRERVVMPAEIANLPDLTAYVGFA
GNRPIAKVPLEIKQFANRQPAFVEGTI

# Drug_Target_105_Reaction:
Not Available

# Drug_Target_105_Signals:
None

# Drug_Target_105_Specific_Function:
Not Available

# Drug_Target_105_SwissProt_ID:
Q04230

# Drug_Target_105_SwissProt_Name:
Q04230_ECOLX

# Drug_Target_105_Synonyms:
Not Available

# Drug_Target_105_Theoretical_pI:
9.87

# Drug_Target_105_Transmembrane_Regions:
None

# Drug_Target_106_Cellular_Location:
Not Available

# Drug_Target_106_Chromosome_Location:
Not Available

# Drug_Target_106_Drug_References:
Not Available

# Drug_Target_106_Essentiality:
Non-Essential

# Drug_Target_106_GenAtlas_ID:
Not Available

# Drug_Target_106_GenBank_ID_Gene:
AE000512

# Drug_Target_106_GenBank_ID_Protein:
Not Available

# Drug_Target_106_GeneCard_ID:
Not Available

# Drug_Target_106_Gene_Name:
TM_0021

# Drug_Target_106_Gene_Sequence:
>309 bp
ATGAAGCTTCTCAAGATCTACCTCGGAGAAAAAGACAAGCACAGCGGAAAGCCTCTTTTC
GAGTATCTTGTGAAGCGCGCTTACGAACTCGGTATGAAAGGAGTCACCGTCTACAGAGGT
ATCATGGGTTTCGGTCACAAGAGACACATGCACAGAAGTGATTTTTTCAGTCTTTCACCG
GATCTTCCTATCGTTCTTGAGATCGTCGATGAAGAAGAGAGAATAAACCTTTTTTTGAAG
GAAATCGACAACATAGACTTCGATGGCCTGGTTTTCACCGCTGACGTCAACGTGGTGAAA
ATGGGTTAA

# Drug_Target_106_General_Function:
Involved in enzyme regulator activity

# Drug_Target_106_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_106_HGNC_ID:
Not Available

# Drug_Target_106_HPRD_ID:
Not Available

# Drug_Target_106_ID:
5304

# Drug_Target_106_Locus:
Not Available

# Drug_Target_106_Molecular_Weight:
11804

# Drug_Target_106_Name:
UPF0166 protein TM_0021

# Drug_Target_106_Number_of_Residues:
102

# Drug_Target_106_PDB_ID:
1O51

# Drug_Target_106_Pathway:
Not Available

# Drug_Target_106_Pfam_Domain_Function:
PF02641	DUF190

# Drug_Target_106_Protein_Sequence:
>UPF0166 protein TM_0021
MKLLKIYLGEKDKHSGKPLFEYLVKRAYELGMKGVTVYRGIMGFGHKRHMHRSDFFSLSP
DLPIVLEIVDEEERINLFLKEIDNIDFDGLVFTADVNVVKMG

# Drug_Target_106_Reaction:
Not Available

# Drug_Target_106_Signals:
None

# Drug_Target_106_Specific_Function:
Not Available

# Drug_Target_106_SwissProt_ID:
Q9WXM9

# Drug_Target_106_SwissProt_Name:
Y021_THEMA

# Drug_Target_106_Synonyms:
Not Available

# Drug_Target_106_Theoretical_pI:
6.97

# Drug_Target_106_Transmembrane_Regions:
None

# Drug_Target_107_Cellular_Location:
Membrane
multi-pass membrane protein

# Drug_Target_107_Chromosome_Location:
Not Available

# Drug_Target_107_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_107_Essentiality:
Non-Essential

# Drug_Target_107_GenAtlas_ID:
CFTR

# Drug_Target_107_GenBank_ID_Gene:
M28668

# Drug_Target_107_GenBank_ID_Protein:
180332

# Drug_Target_107_GeneCard_ID:
CFTR

# Drug_Target_107_Gene_Name:
CFTR

# Drug_Target_107_Gene_Sequence:
>4443 bp
ATGCAGAGGTCGCCTCTGGAAAAGGCCAGCGTTGTCTCCAAACTTTTTTTCAGCTGGACC
AGACCAATTTTGAGGAAAGGATACAGACAGCGCCTGGAATTGTCAGACATATACCAAATC
CCTTCTGTTGATTCTGCTGACAATCTATCTGAAAAATTGGAAAGAGAATGGGATAGAGAG
CTGGCTTCAAAGAAAAATCCTAAACTCATTAATGCCCTTCGGCGATGTTTTTTCTGGAGA
TTTATGTTCTATGGAATCTTTTTATATTTAGGGGAAGTCACCAAAGCAGTACAGCCTCTC
TTACTGGGAAGAATCATAGCTTCCTATGACCCGGATAACAAGGAGGAACGCTCTATCGCG
ATTTATCTAGGCATAGGCTTATGCCTTCTCTTTATTGTGAGGACACTGCTCCTACACCCA
GCCATTTTTGGCCTTCATCACATTGGAATGCAGATGAGAATAGCTATGTTTAGTTTGATT
TATAAGAAGACTTTAAAGCTGTCAAGCCGTGTTCTAGATAAAATAAGTATTGGACAACTT
GTTAGTCTCCTTTCCAACAACCTGAACAAATTTGATGAAGGACTTGCATTGGCACATTTC
GTGTGGATCGCTCCTTTGCAAGTGGCACTCCTCATGGGGCTAATCTGGGAGTTGTTACAG
GCGTCTGCCTTCTGTGGACTTGGTTTCCTGATAGTCCTTGCCCTTTTTCAGGCTGGGCTA
GGGAGAATGATGATGAAGTACAGAGATCAGAGAGCTGGGAAGATCAGTGAAAGACTTGTG
ATTACCTCAGAAATGATTGAAAATATCCAATCTGTTAAGGCATACTGCTGGGAAGAAGCA
ATGGAAAAAATGATTGAAAACTTAAGACAAACAGAACTGAAACTGACTCGGAAGGCAGCC
TATGTGAGATACTTCAATAGCTCAGCCTTCTTCTTCTCAGGGTTCTTTGTGGTGTTTTTA
TCTGTGCTTCCCTATGCACTAATCAAAGGAATCATCCTCCGGAAAATATTCACCACCATC
TCATTCTGCATTGTTCTGCGCATGGCGGTCACTCGGCAATTTCCCTGGGCTGTACAAACA
TGGTATGACTCTCTTGGAGCAATAAACAAAATACAGGATTTCTTACAAAAGCAAGAATAT
AAGACATTGGAATATAACTTAACGACTACAGAAGTAGTGATGGAGAATGTAACAGCCTTC
TGGGAGGAGGGATTTGGGGAATTATTTGAGAAAGCAAAACAAAACAATAACAATAGAAAA
ACTTCTAATGGTGATGACAGCCTCTTCTTCAGTAATTTCTCACTTCTTGGTACTCCTGTC
CTGAAAGATATTAATTTCAAGATAGAAAGAGGACAGTTGTTGGCGGTTGCTGGATCCACT
GGAGCAGGCAAGACTTCACTTCTAATGATGATTATGGGAGAACTGGAGCCTTCAGAGGGT
AAAATTAAGCACAGTGGAAGAATTTCATTCTGTTCTCAGTTTTCCTGGATTATGCCTGGC
ACCATTAAAGAAAATATCATCTTTGGTGTTTCCTATGATGAATATAGATACAGAAGCGTC
ATCAAAGCATGCCAACTAGAAGAGGACATCTCCAAGTTTGCAGAGAAAGACAATATAGTT
CTTGGAGAAGGTGGAATCACACTGAGTGGAGGTCAACGAGCAAGAATTTCTTTAGCAAGA
GCAGTATACAAAGATGCTGATTTGTATTTATTAGACTCTCCTTTTGGATACCTAGATGTT
TTAACAGAAAAAGAAATATTTGAAAGCTGTGTCTGTAAACTGATGGCTAACAAAACTAGG
ATTTTGGTCACTTCTAAAATGGAACATTTAAAGAAAGCTGACAAAATATTAATTTTGAAT
GAAGGTAGCAGCTATTTTTATGGGACATTTTCAGAACTCCAAAATCTACAGCCAGACTTT
AGCTCAAAACTCATGGGATGTGATTCTTTCGACCAATTTAGTGCAGAAAGAAGAAATTCA
ATCCTAACTGAGACCTTACACCGTTTCTCATTAGAAGGAGATGCTCCTGTCTCCTGGACA
GAAACAAAAAAACAATCTTTTAAACAGACTGGAGAGTTTGGGGAAAAAAGGAAGAATTCT
ATTCTCAATCCAATCAACTCTATACGAAAATTTTCCATTGTGCAAAAGACTCCCTTACAA
ATGAATGGCATCGAAGAGGATTCTGATGAGCCTTTAGAGAGAAGGCTGTCCTTAGTACCA
GATTCTGAGCAGGGAGAGGCGATACTGCCTCGCATCAGCGTGATCAGCACTGGCCCCACG
CTTCAGGCACGAAGGAGGCAGTCTGTCCTGAACCTGATGACACACTCAGTTAACCAAGGT
CAGAACATTCACCGAAAGACAACAGCATCCACACGAAAAGTGTCACTGGCCCCTCAGGCA
AACTTGACTGAACTGGATATATATTCAAGAAGGTTATCTCAAGAAACTGGCTTGGAAATA
AGTGAAGAAATTAACGAAGAAGACTTAAAGGAGTGCCTTTTTGATGATATGGAGAGCATA
CCAGCAGTGACTACATGGAACACATACCTTCGATATATTACTGTCCACAAGAGCTTAATT
TTTGTGCTAATTTGGTGCTTAGTAATTTTTCTGGCAGAGGTGGCTGCTTCTTTGGTTGTG
CTGTGGCTCCTTGGAAACACTCCTCTTCAAGACAAAGGGAATAGTACTCATAGTAGAAAT
AACAGCTATGCAGTGATTATCACCAGCACCAGTTCGTATTATGTGTTTTACATTTACGTG
GGAGTAGCCGACACTTTGCTTGCTATGGGATTCTTCAGAGGTCTACCACTGGTGCATACT
CTAATCACAGTGTCGAAAATTTTACACCACAAAATGTTACATTCTGTTCTTCAAGCACCT
ATGTCAACCCTCAACACGTTGAAAGCAGGTGGGATTCTTAATAGATTCTCCAAAGATATA
GCAATTTTGGATGACCTTCTGCCTCTTACCATATTTGACTTCATCCAGTTGTTATTAATT
GTGATTGGAGCTATAGCAGTTGTCGCAGTTTTACAACCCTACATCTTTGTTGCAACAGTG
CCAGTGATAGTGGCTTTTATTATGTTGAGAGCATATTTCCTCCAAACCTCACAGCAACTC
AAACAACTGGAATCTGAAGGCAGGAGTCCAATTTTCACTCATCTTGTTACAAGCTTAAAA
GGACTATGGACACTTCGTGCCTTCGGACGGCAGCCTTACTTTGAAACTCTGTTCCACAAA
GCTCTGAATTTACATACTGCCAACTGGTTCTTGTACCTGTCAACACTGCGCTGGTTCCAA
ATGAGAATAGAAATGATTTTTGTCATCTTCTTCATTGCTGTTACCTTCATTTCCATTTTA
ACAACAGGAGAAGGAGAAGGAAGAGTTGGTATTATCCTGACTTTAGCCATGAATATCATG
AGTACATTGCAGTGGGCTGTAAACTCCAGCATAGATGTGGATAGCTTGATGCGATCTGTG
AGCCGAGTCTTTAAGTTCATTGACATGCCAACAGAAGGTAAACCTACCAAGTCAACCAAA
CCATACAAGAATGGCCAACTCTCGAAAGTTATGATTATTGAGAATTCACACGTGAAGAAA
GATGACATCTGGCCCTCAGGGGGCCAAATGACTGTCAAAGATCTCACAGCAAAATACACA
GAAGGTGGAAATGCCATATTAGAGAACATTTCCTTCTCAATAAGTCCTGGCCAGAGGGTG
GGCCTCTTGGGAAGAACTGGATCAGGGAAGAGTACTTTGTTATCAGCTTTTTTGAGACTA
CTGAACACTGAAGGAGAAATCCAGATCGATGGTGTGTCTTGGGATTCAATAACTTTGCAA
CAGTGGAGGAAAGCCTTTGGAGTGATACCACAGAAAGTATTTATTTTTTCTGGAACATTT
AGAAAAAACTTGGATCCCTATGAACAGTGGAGTGATCAAGAAATATGGAAAGTTGCAGAT
GAGGTTGGGCTCAGATCTGTGATAGAACAGTTTCCTGGGAAGCTTGACTTTGTCCTTGTG
GATGGGGGCTGTGTCCTAAGCCATGGCCACAAGCAGTTGATGTGCTTGGCTAGATCTGTT
CTCAGTAAGGCGAAGATCTTGCTGCTTGATGAACCCAGTGCTCATTTGGATCCAGTAACA
TACCAAATAATTAGAAGAACTCTAAAACAAGCATTTGCTGATTGCACAGTAATTCTCTGT
GAACACAGGATAGAAGCAATGCTGGAATGCCAACAATTTTTGGTCATAGAAGAGAACAAA
GTGCGGCAGTACGATTCCATCCAGAAACTGCTGAACGAGAGGAGCCTCTTCCGGCAAGCC
ATCAGCCCCTCCGACAGGGTGAAGCTCTTTCCCCACCGGAACTCAAGCAAGTGCAAGTCT
AAGCCCCAGATTGCTGCTCTGAAAGAGGAGACAGAAGAAGAGGTGCAAGATACAAGGCTT
TAG

# Drug_Target_107_General_Function:
Involved in chloride ion transport

# Drug_Target_107_General_References:
10094564	Picci L, Cameran M, Olante P, Zacchello F, Scarpa M: Identification of a D579G homozygote cystic fibrosis patient with pancreatic sufficiency and minor lung involvement. Mutations in brief no. 221. Online. Hum Mutat. 1999;13(2):173.
11304524	Karthikeyan S, Leung T, Ladias JA: Structural basis of the Na+/H+ exchanger regulatory factor PDZ1 interaction with the carboxyl-terminal region of the cystic fibrosis transmembrane conductance regulator. J Biol Chem. 2001 Jun 8;276(23):19683-6. Epub 2001 Apr 13.
11707463	Cheng J, Moyer BD, Milewski M, Loffing J, Ikeda M, Mickle JE, Cutting GR, Li M, Stanton BA, Guggino WB: A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression. J Biol Chem. 2002 Feb 1;277(5):3520-9. Epub 2001 Nov 13.
12690205	Scherer SW, Cheung J, MacDonald JR, Osborne LR, Nakabayashi K, Herbrick JA, Carson AR, Parker-Katiraee L, Skaug J, Khaja R, Zhang J, Hudek AK, Li M, Haddad M, Duggan GE, Fernandez BA, Kanematsu E, Gentles S, Christopoulos CC, Choufani S, Kwasnicka D, Zheng XH, Lai Z, Nusskern D, Zhang Q, Gu Z, Lu F, Zeesman S, Nowaczyk MJ, Teshima I, Chitayat D, Shuman C, Weksberg R, Zackai EH, Grebe TA, Cox SR, Kirkpatrick SJ, Rahman N, Friedman JM, Heng HH, Pelicci PG, Lo-Coco F, Belloni E, Shaffer LG, Pober B, Morton CC, Gusella JF, Bruns GA, Korf BR, Quade BJ, Ligon AH, Ferguson H, Higgins AW, Leach NT, Herrick SR, Lemyre E, Farra CG, Kim HG, Summers AM, Gripp KW, Roberts W, Szatmari P, Winsor EJ, Grzeschik KH, Teebi A, Minassian BA, Kere J, Armengol L, Pujana MA, Estivill X, Wilson MD, Koop BF, Tosi S, Moore GE, Boright AP, Zlotorynski E, Kerem B, Kroisel PM, Petek E, Oscier DG, Mould SJ, Dohner H, Dohner K, Rommens JM, Vincent JB, Venter JC, Li PW, Mural RJ, Adams MD, Tsui LC: Human chromosome 7: DNA sequence and biology. Science. 2003 May 2;300(5620):767-72. Epub 2003 Apr 10.
1284466	Jones CT, McIntosh I, Keston M, Ferguson A, Brock DJ: Three novel mutations in the cystic fibrosis gene detected by chemical cleavage: analysis of variant splicing and a nonsense mutation. Hum Mol Genet. 1992 Apr;1(1):11-7.
1284468	Cheadle JP, Meredith AL, al-Jader LN: A new missense mutation (R1283M) in exon 20 of the cystic fibrosis transmembrane conductance regulator gene. Hum Mol Genet. 1992 May;1(2):123-5.
1284529	Shackleton S, Beards F, Harris A: Detection of novel and rare mutations in exon 4 of the cystic fibrosis gene by SSCP. Hum Mol Genet. 1992 Sep;1(6):439-40.
1284530	Lissens W, Bonduelle M, Malfroot A, Dab I, Liebaers I: A serine to proline substitution (S1255P) in the second nucleotide binding fold of the cystic fibrosis gene. Hum Mol Genet. 1992 Sep;1(6):441-2.
1284534	Tsui LC: Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: a report from the Cystic Fibrosis Genetic Analysis Consortium. Hum Mutat. 1992;1(3):197-203.
12853948	Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64.
1377674	Picciotto MR, Cohn JA, Bertuzzi G, Greengard P, Nairn AC: Phosphorylation of the cystic fibrosis transmembrane conductance regulator. J Biol Chem. 1992 Jun 25;267(18):12742-52.
1378801	McIntosh I, Cutting GR: Cystic fibrosis transmembrane conductance regulator and the etiology and pathogenesis of cystic fibrosis. FASEB J. 1992 Jul;6(10):2775-82.
1695717	Cutting GR, Kasch LM, Rosenstein BJ, Zielenski J, Tsui LC, Antonarakis SE, Kazazian HH Jr: A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein. Nature. 1990 Jul 26;346(6282):366-9.
1710598	Zielenski J, Rozmahel R, Bozon D, Kerem B, Grzelczak Z, Riordan JR, Rommens J, Tsui LC: Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics. 1991 May;10(1):214-28.
1710600	White MB, Krueger LJ, Holsclaw DS Jr, Gerrard BC, Stewart C, Quittell L, Dolganov G, Baranov V, Ivaschenko T, Kapronov NI, et al.: Detection of three rare frameshift mutations in the cystic fibrosis gene in an African-American (CF444delA), an Italian (CF2522insC), and a Soviet (CF3821delT). Genomics. 1991 May;10(1):266-9.
2236053	Kerem BS, Zielenski J, Markiewicz D, Bozon D, Gazit E, Yahav J, Kennedy D, Riordan JR, Collins FS, Rommens JM, et al.: Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8447-51.
2475911	Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et al.: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 Sep 8;245(4922):1066-73.
7504969	Gasparini P, Marigo C, Bisceglia G, Nicolis E, Zelante L, Bombieri C, Borgo G, Pignatti PF, Cabrini G: Screening of 62 mutations in a cohort of cystic fibrosis patients from north eastern Italy: their incidence and clinical features of defined genotypes. Hum Mutat. 1993;2(5):389-94.
7505694	Chillon M, Casals T, Nunes V, Gimenez J, Perez Ruiz E, Estivill X: Identification of a new missense mutation (P205S) in the first transmembrane domain of the CFTR gene associated with a mild cystic fibrosis phenotype. Hum Mol Genet. 1993 Oct;2(10):1741-2.
7513296	Boteva K, Papageorgiou E, Georgiou C, Angastiniotis M, Middleton LT, Constantinou-Deltas CD: Novel cystic fibrosis mutation associated with mild disease in Cypriot patients. Hum Genet. 1994 May;93(5):529-32.
7517264	Chillon M, Casals T, Gimenez J, Nunes V, Estivill X: Analysis of the CFTR gene in the Spanish population: SSCP-screening for 60 known mutations and identification of four new mutations (Q30X, A120T, 1812-1 G-->A, and 3667del4). Hum Mutat. 1994;3(3):223-30.
7520022	Greil I, Wagner K, Rosenkranz W: A new missense mutation G1249E in exon 20 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Hum Hered. 1994 Jul-Aug;44(4):238-40.
7522211	Ghanem N, Costes B, Girodon E, Martin J, Fanen P, Goossens M: Identification of eight mutations and three sequence variations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics. 1994 May 15;21(2):434-6.
7524909	Schaedel C, Kristoffersson AC, Kornfalt R, Holmberg L: A novel cystic fibrosis mutation, Y109C, in the first transmembrane domain of CFTR. Hum Mol Genet. 1994 Jun;3(6):1001-2.
7524913	Petreska L, Koceva S, Gordova-Muratovska A, Nestorov R, Efremov GD: Identification of two new mutations (711 +3A-->G and V1397E) in CF chromosomes of Albanian and Macedonian origin. Hum Mol Genet. 1994 Jun;3(6):999-1000.
7525450	Dork T, Mekus F, Schmidt K, Bosshammer J, Fislage R, Heuer T, Dziadek V, Neumann T, Kalin N, Wulbrand U, et al.: Detection of more than 50 different CFTR mutations in a large group of German cystic fibrosis patients. Hum Genet. 1994 Nov;94(5):533-42.
7529962	Mercier B, Verlingue C, Lissens W, Silber SJ, Novelli G, Bonduelle M, Audrezet MP, Ferec C: Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients. Am J Hum Genet. 1995 Jan;56(1):272-7.
7537150	Zielenski J, Markiewicz D, Chen HS, Schappert K, Seller A, Durie P, Corey M, Tsui LC: Identification of six mutations (R31L, 441delA, 681delC, 1461ins4, W1089R, E1104X) in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Hum Mutat. 1995;5(1):43-7.
7539342	Jezequel P, Dorval I, Fergelot P, Chauvel B, Le Treut A, Le Gall JY, Le Lannou D, Blayau M: Structural analysis of CFTR gene in congenital bilateral absence of vas deferens. Clin Chem. 1995 Jun;41(6 Pt 1):833-5.
7541273	Verlingue C, Kapranov NI, Mercier B, Ginter EK, Petrova NV, Audrezet MP, Ferec C: Complete screening of mutations in the coding sequence of the CFTR gene in a sample of CF patients from Russia: identification of three novel alleles. Hum Mutat. 1995;5(3):205-9.
7541510	Ferec C, Novelli G, Verlingue C, Quere I, Dallapiccola B, Audrezet MP, Mercier B: Identification of six novel CFTR mutations in a sample of Italian cystic fibrosis patients. Mol Cell Probes. 1995 Apr;9(2):135-7.
7543567	Leoni GB, Pitzalis S, Podda R, Zanda M, Silvetti M, Caocci L, Cao A, Rosatelli MC: A specific cystic fibrosis mutation (T3381) associated with the phenotype of isolated hypotonic dehydration. J Pediatr. 1995 Aug;127(2):281-3.
7544319	Brancolini V, Cremonesi L, Belloni E, Pappalardo E, Bordoni R, Seia M, Russo S, Padoan R, Giunta A, Ferrari M: Search for mutations in pancreatic sufficient cystic fibrosis Italian patients: detection of 90% of molecular defects and identification of three novel mutations. Hum Genet. 1995 Sep;96(3):312-8.
7581407	Romey MC, Desgeorges M, Ray P, Godard P, Demaille J, Claustres M: Novel missense mutation in the first transmembrane segment of the CFTR gene (Q98R) identified in a male adult. Hum Mutat. 1995;6(2):190-1.
7680525	Zielenski J, Fujiwara TM, Markiewicz D, Paradis AJ, Anacleto AI, Richards B, Schwartz RH, Klinger KW, Tsui LC, Morgan K: Identification of the M1101K mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and complete detection of cystic fibrosis mutations in the Hutterite population. Am J Hum Genet. 1993 Mar;52(3):609-15.
7683628	Mercier B, Lissens W, Novelli G, Kalaydjieva L, De Arce M, Kapranov N, Klain NC, Lenoir G, Chauveau P, Lenaerts C, et al.: Identification of eight novel mutations in a collaborative analysis of a part of the second transmembrane domain of the CFTR gene. Genomics. 1993 Apr;16(1):296-7.
7683954	Nunes V, Chillon M, Dork T, Tummler B, Casals T, Estivill X: A new missense mutation (E92K) in the first transmembrane domain of the CFTR gene causes a benign cystic fibrosis phenotype. Hum Mol Genet. 1993 Jan;2(1):79-80.
8081395	Bienvenu T, Petitpretz P, Beldjord C, Kaplan JC: A missense mutation (F87L) in exon 3 of the cystic fibrosis transmembrane conductance regulator gene. Hum Mutat. 1994;3(4):395-6.
8522333	Desgeorges M, Rodier M, Piot M, Demaille J, Claustres M: Four adult patients with the missense mutation L206W and a mild cystic fibrosis phenotype. Hum Genet. 1995 Dec;96(6):717-20.
8723693	Petreska L, Plaseska D, Koceva S, Stavljenic-Rukavina A, Efremov GD: A novel mutation in exon 12 (Y569C) of the CFTR gene identified in a patient of Croatian origin. Hum Mutat. 1996;7(4):374-5.
8723695	Bienvenu T, Chertkoff L, Beldjord C, Segal E, Carniglia L, Barreiro C, Kaplan JC: Identification of three novel mutations in the cystic fibrosis transmembrane conductance regulator gene in Argentinian CF patients. Hum Mutat. 1996;7(4):376-7.
8800923	Messaoud T, Verlingue C, Denamur E, Pascaud O, Quere I, Fattoum S, Elion J, Ferec C: Distribution of CFTR mutations in cystic fibrosis patients of Tunisian origin: identification of two novel mutations. Eur J Hum Genet. 1996;4(1):20-4.
8829633	Nasr SZ, Strong TV, Mansoura MK, Dawson DC, Collins FS: Novel missense mutation (G314R) in a cystic fibrosis patient with hepatic failure. Hum Mutat. 1996;7(2):151-4.
8956039	Hughes DJ, Hill AJ, Macek M Jr, Redmond AO, Nevin NC, Graham CA: Mutation characterization of CFTR gene in 206 Northern Irish CF families: thirty mutations, including two novel, account for approximately 94% of CF chromosomes. Hum Mutat. 1996;8(4):340-7.
9067761	Zielenski J, Patrizio P, Markiewicz D, Asch RH, Tsui LC: Identification of two mutations (S50Y and 4173delC) in the CFTR gene from patients with congenital bilateral absence of vas deferens (CBAVD). Hum Mutat. 1997;9(2):183-4.
9101301	Clavel C, Pennaforte F, Pigeon F, Verlingue C, Birembaut P, Ferec C: Identification of four novel mutations in the cystic fibrosis transmembrane conductance regulator gene: E664X, 2113delA, 306delTAGA, and delta M1140. Hum Mutat. 1997;9(4):368-9.
9222768	Gouya L, Pascaud O, Munck A, Elion J, Denamur E: Novel mutation (A141D) in exon 4 of the CFTR gene identified in an Algerian patient. Hum Mutat. 1997;10(1):86-7.
9375855	Casals T, Pacheco P, Barreto C, Gimenez J, Ramos MD, Pereira S, Pinheiro JA, Cobos N, Curvelo A, Vazquez C, Rocha H, Seculi JL, Perez E, Dapena J, Carrilho E, Duarte A, Palacio AM, Nunes V, Lavinha J, Estivill X: Missense mutation R1066C in the second transmembrane domain of CFTR causes a severe cystic fibrosis phenotype: study of 19 heterozygous and 2 homozygous patients. Hum Mutat. 1997;10(5):387-92.
9385646	Neville DC, Rozanas CR, Price EM, Gruis DB, Verkman AS, Townsend RR: Evidence for phosphorylation of serine 753 in CFTR using a novel metal-ion affinity resin and matrix-assisted laser desorption mass spectrometry. Protein Sci. 1997 Nov;6(11):2436-45.
9401006	Shrimpton AE, Borowitz D, Swender P: Cystic fibrosis mutation frequencies in upstate New York. Hum Mutat. 1997;10(6):436-42.
9443874	Friedman KJ, Leigh MW, Czarnecki P, Feldman GL: Cystic fibrosis transmembrane-conductance regulator mutations among African Americans. Am J Hum Genet. 1998 Jan;62(1):195-6.
9452048	Feldmann D, Sardet A, Cougoureux E, Plouvier E, Fontaine JL, Tournier G, Aymard P: Identification of three novel mutations in the CFTR gene, R117P, deltaD192, and 3121-1G-->A in four French patients. Hum Mutat. 1998;Suppl 1:S78-80.
9452054	Casals T, Ramos MD, Gimenez J, Nadal M, Nunes V, Estivill X: Paternal origin of a de novo novel CFTR mutation (L1065R) causing cystic fibrosis. Hum Mutat. 1998;Suppl 1:S99-102.
9452073	Shackleton S, Harris A: A 2-amino acid insertion mutation (1243insACAAAA) in exon 7 of the CFTR gene. Hum Mutat. 1998;Suppl 1:S156-7.
9482579	Malone G, Haworth A, Schwarz MJ, Cuppens H, Super M: Detection of five novel mutations of the cystic fibrosis transmembrane regulator (CFTR) gene in Pakistani patients with cystic fibrosis: Y569D, Q98X, 296+12(T>C), 1161delC and 621+2(T>C). Hum Mutat. 1998;11(2):152-7.
9517543	Hoedemaeker FJ, Davidson AR, Rose DR: A model for the nucleotide-binding domains of ABC transporters based on the large domain of aspartate aminotransferase. Proteins. 1998 Feb 15;30(3):275-86.
9521595	Onay T, Topaloglu O, Zielenski J, Gokgoz N, Kayserili H, Camcioglu Y, Cokugras H, Akcakaya N, Apak M, Tsui LC, Kirdar B: Analysis of the CFTR gene in Turkish cystic fibrosis patients: identification of three novel mutations (3172delAC, P1013L and M1028I). Hum Genet. 1998 Feb;102(2):224-30.
9554753	Leoni GB, Pitzalis S, Tonelli R, Cao A: Identification of a novel mutation (S13F) in the CFTR gene in a CF patient of Sardinian origin. Hum Mutat. 1998;11(4):337.
9736778	Vankeerberghen A, Wei L, Jaspers M, Cassiman JJ, Nilius B, Cuppens H: Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator. Hum Mol Genet. 1998 Oct;7(11):1761-9.
9921909	Bombieri C, Benetazzo M, Saccomani A, Belpinati F, Gile LS, Luisetti M, Pignatti PF: Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease. Hum Genet. 1998 Dec;103(6):718-22.

# Drug_Target_107_HGNC_ID:
HGNC:1884

# Drug_Target_107_HPRD_ID:
03883

# Drug_Target_107_ID:
2184

# Drug_Target_107_Locus:
7q31.2

# Drug_Target_107_Molecular_Weight:
168144

# Drug_Target_107_Name:
Cystic fibrosis transmembrane conductance regulator

# Drug_Target_107_Number_of_Residues:
1480

# Drug_Target_107_PDB_ID:
1XMI

# Drug_Target_107_Pathway:
Not Available

# Drug_Target_107_Pfam_Domain_Function:
PF00005	ABC_tran
PF00664	ABC_membrane

# Drug_Target_107_Protein_Sequence:
>Cystic fibrosis transmembrane conductance regulator
MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRE
LASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIA
IYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQL
VSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGL
GRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAA
YVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQT
WYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRK
TSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEG
KIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIV
LGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTR
ILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNS
ILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQ
MNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQG
QNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESI
PAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRN
NSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAP
MSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATV
PVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHK
ALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIM
STLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKK
DDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRL
LNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVAD
EVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVT
YQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQA
ISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL

# Drug_Target_107_Reaction:
Not Available

# Drug_Target_107_Signals:
None

# Drug_Target_107_Specific_Function:
Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter

# Drug_Target_107_SwissProt_ID:
P13569

# Drug_Target_107_SwissProt_Name:
CFTR_HUMAN

# Drug_Target_107_Synonyms:
ATP-binding cassette transporter sub- family C member 7
CFTR
cAMP- dependent chloride channel

# Drug_Target_107_Theoretical_pI:
9.02

# Drug_Target_107_Transmembrane_Regions:
81-103
118-138
195-215
221-241
308-328
331-350
860-880
912-932
991-1011
1014-1034
1103-1123
1129-1149

# Drug_Target_108_Cellular_Location:
Not Available

# Drug_Target_108_Chromosome_Location:
Not Available

# Drug_Target_108_Drug_References:
Not Available

# Drug_Target_108_Essentiality:
Non-Essential

# Drug_Target_108_GenAtlas_ID:
Not Available

# Drug_Target_108_GenBank_ID_Gene:
X12982

# Drug_Target_108_GenBank_ID_Protein:
Not Available

# Drug_Target_108_GeneCard_ID:
Not Available

# Drug_Target_108_Gene_Name:
purK

# Drug_Target_108_Gene_Sequence:
>1068 bp
ATGAAACAGGTTTGCGTCCTCGGTAACGGGCAGTTAGGCCGTATGCTGCGTCAGGCAGGC
GAACCGTTAGGCATTGCTGTCTGGCCAGTCGGGCTGGACGCTGAACCGGCGGCGGTGCCT
TTTCAACAAAGCGTGATTACCGCTGAGATAGAACGCTGGCCGGAAACCGCATTAACCCGC
GAGCTGGCGCCCGATCCGGCCTTTGTGAACCGCGATGTGTTCCCGATTATTGCTGACCGT
CTGACTCAGAAGCAGCTTTTCGATAAGCTCCACCTGCCGACTGCACCGTGGCAGTTACTT
GCCGAACGCAGCGAGTGGCCTGCGGTGTTTGATCGTTTAGGTGAGCTGGCGATTGTTAAG
CGTCGCACTGGTGGTTATGACGGTCGCGGTCAATGGCGTTTACGCGCAAATGAAACCGAA
CAGTTACCGGCAGAGTGTTACGGCGAATGTATTGTCGAGCAGGGCATTAACTTCTCTGGT
GAAGTGTCGCTGGTTGGCGCGCGCGGCTTTGATGGCAGCACCGTGTTTTATCCGCTGACG
CATAACCTGCATCAGGACGGTATTTTGCGCACCAGCGTCGCTTTTCCGCAGGCCAACGCA
CAGCAGCAGGCGCAAGCCGAAGAGATGCTGTCGGCGATTATGCAGGAGCTGGGCTATGTG
GGCGTGATGGCGATGGAGTGTTTTGTCACCCCGCAAGGTCTGTTGATCAACGAACTGGCA
CCGCGTGTGCATAACAGCGGTCACTGGACACAAAACGGTGCCAGCATCAGCCAGTTTGAG
CTGCATCTGCGGGCGATTACCGATCTGCCGTTACCGCAACCAGTGGTGAATAATCCGTCG
GTGATGATCAATCTGATTGGTAGCGATGTGAATTATGACTGGCTGAAACTGCCGCTGGTG
CATCTGCACTGGTACGACAAAGAAGTCCGTCCGGGGCGTAAAGTGGGGCATCTGAATTTG
ACCGACAGCGACACATCGCGTCTGACTGCGACGCTGGAAGCCTTAATCCCGCTGCTGCCG
CCGGAATATGCCAGCGGCGTGATTTGGGCGCAGAGTAAGTTCGGTTAA

# Drug_Target_108_General_Function:
Involved in catalytic activity

# Drug_Target_108_General_References:
10569930	Thoden JB, Kappock TJ, Stubbe J, Holden HM: Three-dimensional structure of N5-carboxyaminoimidazole ribonucleotide synthetase: a member of the ATP grasp protein superfamily. Biochemistry. 1999 Nov 23;38(47):15480-92.
1534690	Meyer E, Leonard NJ, Bhat B, Stubbe J, Smith JM: Purification and characterization of the purE, purK, and purC gene products: identification of a previously unrecognized energy requirement in the purine biosynthetic pathway. Biochemistry. 1992 Jun 2;31(21):5022-32.
2464576	Tiedeman AA, Keyhani J, Kamholz J, Daum HA 3rd, Gots JS, Smith JM: Nucleotide sequence analysis of the purEK operon encoding 5'-phosphoribosyl-5-aminoimidazole carboxylase of Escherichia coli K-12. J Bacteriol. 1989 Jan;171(1):205-12.
2644189	Watanabe W, Sampei G, Aiba A, Mizobuchi K: Identification and sequence analysis of Escherichia coli purE and purK genes encoding 5'-phosphoribosyl-5-amino-4-imidazole carboxylase for de novo purine biosynthesis. J Bacteriol. 1989 Jan;171(1):198-204.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_108_HGNC_ID:
Not Available

# Drug_Target_108_HPRD_ID:
Not Available

# Drug_Target_108_ID:
5305

# Drug_Target_108_Locus:
Not Available

# Drug_Target_108_Molecular_Weight:
39462

# Drug_Target_108_Name:
Phosphoribosylaminoimidazole carboxylase ATPase subunit

# Drug_Target_108_Number_of_Residues:
355

# Drug_Target_108_PDB_ID:
1B6S

# Drug_Target_108_Pathway:
Not Available

# Drug_Target_108_Pfam_Domain_Function:
PF02222	ATP-grasp

# Drug_Target_108_Protein_Sequence:
>Phosphoribosylaminoimidazole carboxylase ATPase subunit
MKQVCVLGNGQLGRMLRQAGEPLGIAVWPVGLDAEPAAVPFQQSVITAEIERWPETALTR
ELARHPAFVNRDVFPIIADRLTQKQLFDKLHLPTAPWQLLAERSEWPAVFDRLGELAIVK
RRTGGYDGRGQWRLRANETEQLPAECYGECIVEQGINFSGEVSLVGARGFDGSTVFYPLT
HNLHQDGILRTSVAFPQANAQQQAQAEEMLSAIMQELGYVGVMAMECFVTPQGLLINELA
PRVHNSGHWTQNGASISQFELHLRAITDLPLPQPVVNNPSVMINLIGSDVNYDWLKLPLV
HLHWYDKEVRPGRKVGHLNLTDSDTSRLTATLEALIPLLPPEYASGVIWAQSKFG

# Drug_Target_108_Reaction:
Not Available

# Drug_Target_108_Signals:
None

# Drug_Target_108_Specific_Function:
Possesses an ATPase activity that is dependent on the presence of AIR (aminoimidazole ribonucleotide). The association of purK and purE produces an enzyme complex capable of converting AIR to CAIR efficiently under physiological condition

# Drug_Target_108_SwissProt_ID:
P09029

# Drug_Target_108_SwissProt_Name:
PURK_ECOLI

# Drug_Target_108_Synonyms:
AIR carboxylase
AIRC
EC 4.1.1.21

# Drug_Target_108_Theoretical_pI:
5.79

# Drug_Target_108_Transmembrane_Regions:
None

# Drug_Target_109_Cellular_Location:
Not Available

# Drug_Target_109_Chromosome_Location:
Not Available

# Drug_Target_109_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_109_Essentiality:
Non-Essential

# Drug_Target_109_GenAtlas_ID:
Not Available

# Drug_Target_109_GenBank_ID_Gene:
Not Available

# Drug_Target_109_GenBank_ID_Protein:
Not Available

# Drug_Target_109_GeneCard_ID:
Not Available

# Drug_Target_109_Gene_Name:
RFC5

# Drug_Target_109_Gene_Sequence:
Not Available

# Drug_Target_109_General_Function:
Not Available

# Drug_Target_109_General_References:
Not Available

# Drug_Target_109_HGNC_ID:
Not Available

# Drug_Target_109_HPRD_ID:
Not Available

# Drug_Target_109_ID:
7127

# Drug_Target_109_Locus:
Not Available

# Drug_Target_109_Molecular_Weight:
Not Available

# Drug_Target_109_Name:
Replication factor C subunit 5

# Drug_Target_109_Number_of_Residues:
0

# Drug_Target_109_PDB_ID:
Not Available

# Drug_Target_109_Pathway:
Not Available

# Drug_Target_109_Pfam_Domain_Function:
Not Available

# Drug_Target_109_Protein_Sequence:
Not Available

# Drug_Target_109_Reaction:
Not Available

# Drug_Target_109_Signals:
Not Available

# Drug_Target_109_Specific_Function:
Not Available

# Drug_Target_109_SwissProt_ID:
P40937

# Drug_Target_109_SwissProt_Name:
RFC5_HUMAN

# Drug_Target_109_Synonyms:
Not Available

# Drug_Target_109_Theoretical_pI:
Not Available

# Drug_Target_109_Transmembrane_Regions:
Not Available

# Drug_Target_10_Cellular_Location:
Not Available

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
D14486

# Drug_Target_10_GenBank_ID_Protein:
221822

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
TK

# Drug_Target_10_Gene_Sequence:
>1059 bp
ATGGCTGCTTGCGTACCCCCGGGAGAAGCTCCACGAAGCGCCAGCGGAACGCCCACCCGG
CGGCAAGTAACAATAGTTAGAATTTACCTCGATGGAGTTTATGGCATCGGTAAGAGCACG
ACGGGACGAGTTATGGCATCGGCTGCTAGCGGAGGAAGTCCAACTCTATACTTTCCAGAG
CCTATGGCGTACTGGCGGACTCTTTTTGAAACGGACGTAATTAGTGGTATTTACGACACC
CAAAACCGGAAACAGCAGGGAAATTTGGCCGTTGATGACGCGGCATTAATAACTGCGCAT
TACCAAAGCCGCTTTACCACGCCCTACCTGATACTCCACGATCACACTTGTACGTTGTTT
GGGGGAAACAGCCTACAGCGTGGAACACAACCGGACCTGACCCTTGTGTTTGACCGCCAC
CCGGTCGCCTCTACCGTATGCTTTCCAGCAGCCCGCTACCTACTCGGTGACATGTCAATG
TGCGCGCTAATGGCTATGGTTGCTACTCTACCAAGAGAACCCCAGGGTGGTAACATTGTG
GTTACCACCCTAAATGTAGAGGAGCATATACGGAGACTGCGTACGCGGGCTAGAATAGGA
GAACAAATTGACATTACGCTGATTGCTACATTGCGAAATGTGTACTTTATGCTAGTTAAT
ACATGTCACTTTTTGCGCTCTGGGCGAGTTTGGCGCGACGGTTGGGGTGAGCTACCCACT
TCCTGTGGGGCTTATAAGCATCGCGCCACACAGATGGACGCCTTCCAAGAGCGCGTTTCA
CCGGAGCTGGGCGACACTCTGTTTGCCCTGTTTAAAACTCAAGAACTGCTAGACGATCGC
GGTGTAATATTGGAAGTTCACGCTTGGGCGTTGGACGCGCTTATGCTAAAACTGCGTAAC
CTGAATGTTTTCAGTGCCGATTTAAGTGGTACACCGCGACAATGTGCAGCTGTTGTAGAG
TCTTTGCTGCCACTTATGAGCAGCACCTTATCAGATTTTGATTCCGCCTCTGCTTTAGAG
CGGGCGGCACGCACCTTTAACGCGGAGATGGGCGTCTGA

# Drug_Target_10_General_Function:
Involved in thymidine kinase activity

# Drug_Target_10_General_References:
2391500	Nicolson L, Cullinane AA, Onions DE: The nucleotide sequence of the equine herpesvirus 4 thymidine kinase gene. J Gen Virol. 1990 Aug;71 ( Pt 8):1801-5.

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
3518

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
38785

# Drug_Target_10_Name:
Thymidine kinase

# Drug_Target_10_Number_of_Residues:
352

# Drug_Target_10_PDB_ID:
1P75

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF00693	Herpes_TK

# Drug_Target_10_Protein_Sequence:
>Thymidine kinase
MAACVPPGEAPRSASGTPTRRQVTIVRIYLDGVYGIGKSTTGRVMASAASGGSPTLYFPE
PMAYWRTLFETDVISGIYDTQNRKQQGNLAVDDAALITAHYQSRFTTPYLILHDHTCTLF
GGNSLQRGTQPDLTLVFDRHPVASTVCFPAARYLLGDMSMCALMAMVATLPREPQGGNIV
VTTLNVEEHIRRLRTRARIGEQIDITLIATLRNVYFMLVNTCHFLRSGRVWRDGWGELPT
SCGAYKHRATQMDAFQERVSPELGDTLFALFKTQELLDDRGVILEVHAWALDALMLKLRN
LNVFSADLSGTPRQCAAVVESLLPLMSSTLSDFDSASALERAARTFNAEMGV

# Drug_Target_10_Reaction:
ATP + thymidine = ADP + thymidine 5'-phosphate

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
ATP + thymidine = ADP + thymidine 5'- phosphate

# Drug_Target_10_SwissProt_ID:
P24425

# Drug_Target_10_SwissProt_Name:
KITH_EHV4

# Drug_Target_10_Synonyms:
EC 2.7.1.21

# Drug_Target_10_Theoretical_pI:
7.19

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_110_Cellular_Location:
Cell membrane

# Drug_Target_110_Chromosome_Location:
Not Available

# Drug_Target_110_Drug_References:
Not Available

# Drug_Target_110_Essentiality:
Non-Essential

# Drug_Target_110_GenAtlas_ID:
Not Available

# Drug_Target_110_GenBank_ID_Gene:
BX842582

# Drug_Target_110_GenBank_ID_Protein:
Not Available

# Drug_Target_110_GeneCard_ID:
Not Available

# Drug_Target_110_Gene_Name:
secA1

# Drug_Target_110_Gene_Sequence:
>2850 bp
CTAACGCTTCTTGACCGATTTCGGCGGCTTGGCGCCGCGGCCTTGTCGGCGGGCGGCTTC
GCGCCGCTCGCGCCGGCTAGCACCGGCCGGCACTCCGGCCGGCGTCTTGTGGGCTCCACC
GCCGTTGCGCTGCACCTGAGCCGAGCCATCCTCCGCGGGACCGGAATAGGTCAAAGCGGG
CGACTCGCTGGCAACACCCTTGGCGCGTAATGCACTTGGAGCTCTTTCGCGCGCGCCACC
ATCGACCGCGCTGCGTTGCTGCGCGGCGGCTGCGGCCGCGGCGGCGAATTCGGCAAGCTC
TGCGGGTTCGGCAGCCGGGGCAACCGGCGGGGCGGGGACCGCCTCCACGGTGACGTTGAA
CAGGAAGCCGACCGATTCCTCTTTCATGCCGTCGAGCATGGCCATGAACATGTCGTAGCC
CTCACGCTGGTACTCGACCAACGGATCGCGCTGCGCCATCGCGCGCAGCCCGATACCCTC
CTTGAGGTAGTCCATCTCGTAGAGGTGTTCACGCCACTTACGGTCTATGACGTTGAGCAG
CACGTTGCGTTCCAGCTGGCGCATCGCACCCTCGCCGGCGATTTCCTCGAGTTCGGCTTC
CCGTGCGGCATAGGCACGTTCGGCGTCCTTGAGTAGTGCCTCCAGCAACTCCTCGCGGGT
GAGATCGTCGCGCTCGAATTCGTGGTCCTTGCGGGTCAGCGAGTCGGCGGTGATCCCCAC
CGGATAGAGGGTTTTGAGTGCCGTCCACAACGCGTCCAGATCCCAATCTTCGGCATAGCC
TTCGCCGGTCGCGCCGTCGACGTAGGCGGTGATGACATCGCGGACCATGTCCAGCGCCTG
GTCCTTGAGGTTTTCGCCTTCGAGGATGCGCCGGCGCTCGGCGTAGATGACCTTGCGCTG
CTGGTTCATCACCTCGTCGTATTTGAGGACGTTCTTGCGGACCTCAAAGTTCTGCTGCTC
GACCTGGGTCTGGGCGCTCTTGATGGCCCGGGTGACCATCTTGGCTTCGATCGGCACGTC
GTCGGGCAGGTTCAGCCTGGTCAACAAGGTCTCCAAGGCCGCGCCATTGAAGCGGCGCAT
CAGCTCGTCACCCAGCGACAAATAGAAGCGCGACTCCCCGGGGTCCCCCTGGCGGCCGGA
CCGGCCACGCAACTGGTTGTCGATCCGCCGCGACTCGTGGCGCTCGGTGCCCAGCACGTA
CAGGCCGCCGGCCTCGATTACTTCCTTGGCCTCCTTGCTGGCTTCCTCTTTGACGATGGG
CAGTTCGGAGTGCCAGGCCGCCTCGTACTCCTCGGGCGTCTCCACCGGATCCAGGCCGCG
TTCGCGCAGCCGCTGATCGGTGAGAAAGTCGACGTTGCCGCCCAGCACAATGTCGGTGCC
GCGACCGGCCATGTTGGTGGCGACGGTGACGCCGCCGCGGCGGCCCGCCACCGCGATGAT
GGTCGCCTCTTGCTCGTGGTACTTGGCGTTGAGCACATTGTGCGGGATGCGCCGCTTGGT
GAACTGCCGCGACAGATACTCCGAGCGCTCCACGCTGGTGGTGCCGATCAGCACCGGCTG
TCCCTTCGCGTAGCGCTCGGCGACGTCGTCGACCACCGCGATGTACTTGGCCTCCTCGGT
CTTGTAGATCAGGTCGGACTGGTCTTCACGGATCATCGGCATGTTGGTCGGGATGCTGAC
CACGCCCAGCTTGTAGATCTCGTGCAGCTCGGCCGCCTCCGTCTGGGCGGTGCCGGTCAT
GCCGGCGAGCTTGTCGTAGAGCCGGAAGTAGTTCTGCAGCGTGATGGTGGCCAGCGTCTG
GTTCTCGGCCTTGATCTCGACGTGCTCCTTGGCCTCGATGGCCTGGTGCATGCCCTCGTT
GTAGCGGCGGCCGATCAGCACCCGGCCGGTGAACTCGTCGACGATGAGCACCTCACCATC
GCGGACGATGTAGTCCTTGTCGCGGCTGAACAGCTCTTTGGCCTTCAGAGCGTTGTTGAG
ATAGCTGACCAACGGCGAGTTGGCGGCCTCGTACAGGTTGTCGATGCCGAGCTGGTCTTC
GACGAATTCCACACCCTTCTCGTGCACGCCGACGGTGCGTTTGCGTAGATCGACCTCGTA
GTGGACGTCCTTTTCCATCAGCGGCGCCAACCGGGCGAACTCGGTGTACCAGTTGGAGGC
GCCGTCGGCGGGACCGGAGATGATCAGCGGGGTGCGGGCCTCGTCGATCAGGATGGAATC
GACCTCGTCGACAATGGCGTAATGGTGCCCGCGCTGCACCAGATCATCCAGTGAGTGCGC
CATGTTGTCGCGCAGGTAGTCGAACCCAAACTCGTTATTGGTGCCGTAGGTGATGTCGGC
GTTATAGGCCACCCGGCGTTCATCGGGTGTCATGGTGGCCAAAATCACCCCGACCTGAAG
CCCGAGGAAGCGGTGCACGCGGCCCATCCACTCACTGTCGCGTTTAGCCAGGTAGTCGTT
GACGGTGACGATGTGCACGCCGTTGCCGGCCAGCGCATTGAGGTAAGCGGGCAACACACA
GGTCAGGGTCTTGCCTTCACCGGTCTTCATCTCGGCAACGTTGCCCAGGTGCAGGGCGGC
CGCACCCATCACCTGCACGTCGAACGGCCGCTGGTCCAGCACCCGCCAGGCGGCCTCGCG
GGCCACGGCGAAGGCCTCGGGCAACAGGTCGTCGAGGGTTTCTGGGTTTTTCTGGTCGGC
CAGCCGCCGCTTGAACTCGTCGGTTTTCGCCCTCAGCTCGGCGTCGGTGAGTTTCTCGAC
ATCGTCGGACAAAGTGCCGACATAGTCGGCCACCTTCTTGAGGCGCTTGACCATGCGACC
TTCGCCAAGGCGCAGCAACTTCGACAGCAC

# Drug_Target_110_General_Function:
Involved in nucleic acid binding

# Drug_Target_110_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_110_HGNC_ID:
Not Available

# Drug_Target_110_HPRD_ID:
Not Available

# Drug_Target_110_ID:
5308

# Drug_Target_110_Locus:
Not Available

# Drug_Target_110_Molecular_Weight:
106023

# Drug_Target_110_Name:
Preprotein translocase secA 1 subunit

# Drug_Target_110_Number_of_Residues:
949

# Drug_Target_110_PDB_ID:
1NL3

# Drug_Target_110_Pathway:
Not Available

# Drug_Target_110_Pfam_Domain_Function:
PF01043	SecA_PP_bind
PF07516	SecA_SW
PF07517	SecA_DEAD

# Drug_Target_110_Protein_Sequence:
>Preprotein translocase secA 1 subunit
MLSKLLRLGEGRMVKRLKKVADYVGTLSDDVEKLTDAELRAKTDEFKRRLADQKNPETLD
DLLPEAFAVAREAAWRVLDQRPFDVQVMGAAALHLGNVAEMKTGEGKTLTCVLPAYLNAL
AGNGVHIVTVNDYLAKRDSEWMGRVHRFLGLQVGVILATMTPDERRVAYNADITYGTNNE
FGFDYLRDNMAHSLDDLVQRGHHYAIVDEVDSILIDEARTPLIISGPADGASNWYTEFAR
LAPLMEKDVHYEVDLRKRTVGVHEKGVEFVEDQLGIDNLYEAANSPLVSYLNNALKAKEL
FSRDKDYIVRDGEVLIVDEFTGRVLIGRRYNEGMHQAIEAKEHVEIKAENQTLATITLQN
YFRLYDKLAGMTGTAQTEAAELHEIYKLGVVSIPTNMPMIREDQSDLIYKTEEAKYIAVV
DDVAERYAKGQPVLIGTTSVERSEYLSRQFTKRRIPHNVLNAKYHEQEATIIAVAGRRGG
VTVATNMAGRGTDIVLGGNVDFLTDQRLRERGLDPVETPEEYEAAWHSELPIVKEEASKE
AKEVIEAGGLYVLGTERHESRRIDNQLRGRSGRQGDPGESRFYLSLGDELMRRFNGAALE
TLLTRLNLPDDVPIEAKMVTRAIKSAQTQVEQQNFEVRKNVLKYDEVMNQQRKVIYAERR
RILEGENLKDQALDMVRDVITAYVDGATGEGYAEDWDLDALWTALKTLYPVGITADSLTR
KDHEFERDDLTREELLEALLKDAERAYAAREAELEEIAGEGAMRQLERNVLLNVIDRKWR
EHLYEMDYLKEGIGLRAMAQRDPLVEYQREGYDMFMAMLDGMKEESVGFLFNVTVEAVPA
PPVAPAAEPAELAEFAAAAAAAAQQRSAVDGGARERAPSALRAKGVASESPALTYSGPAE
DGSAQVQRNGGGAHKTPAGVPAGASRRERREAARRQGRGAKPPKSVKKR

# Drug_Target_110_Reaction:
Not Available

# Drug_Target_110_Signals:
None

# Drug_Target_110_Specific_Function:
Involved in protein export. Interacts with the secY/secE subunits. SecA has a central role in coupling the hydrolysis of ATP to the transfer of pre-secretory proteins across the membrane (By similarity)

# Drug_Target_110_SwissProt_ID:
P0A5Y8

# Drug_Target_110_SwissProt_Name:
SECA1_MYCTU

# Drug_Target_110_Synonyms:
Not Available

# Drug_Target_110_Theoretical_pI:
5.09

# Drug_Target_110_Transmembrane_Regions:
None

# Drug_Target_111_Cellular_Location:
Not Available

# Drug_Target_111_Chromosome_Location:
Not Available

# Drug_Target_111_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_111_Essentiality:
Non-Essential

# Drug_Target_111_GenAtlas_ID:
Not Available

# Drug_Target_111_GenBank_ID_Gene:
Not Available

# Drug_Target_111_GenBank_ID_Protein:
Not Available

# Drug_Target_111_GeneCard_ID:
Not Available

# Drug_Target_111_Gene_Name:
CCT3

# Drug_Target_111_Gene_Sequence:
Not Available

# Drug_Target_111_General_Function:
Not Available

# Drug_Target_111_General_References:
Not Available

# Drug_Target_111_HGNC_ID:
Not Available

# Drug_Target_111_HPRD_ID:
Not Available

# Drug_Target_111_ID:
7064

# Drug_Target_111_Locus:
Not Available

# Drug_Target_111_Molecular_Weight:
Not Available

# Drug_Target_111_Name:
T-complex protein 1 subunit gamma

# Drug_Target_111_Number_of_Residues:
0

# Drug_Target_111_PDB_ID:
Not Available

# Drug_Target_111_Pathway:
Not Available

# Drug_Target_111_Pfam_Domain_Function:
Not Available

# Drug_Target_111_Protein_Sequence:
Not Available

# Drug_Target_111_Reaction:
Not Available

# Drug_Target_111_Signals:
Not Available

# Drug_Target_111_Specific_Function:
Not Available

# Drug_Target_111_SwissProt_ID:
P49368

# Drug_Target_111_SwissProt_Name:
TCPG_HUMAN

# Drug_Target_111_Synonyms:
Not Available

# Drug_Target_111_Theoretical_pI:
Not Available

# Drug_Target_111_Transmembrane_Regions:
Not Available

# Drug_Target_112_Cellular_Location:
Not Available

# Drug_Target_112_Chromosome_Location:
Not Available

# Drug_Target_112_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_112_Essentiality:
Non-Essential

# Drug_Target_112_GenAtlas_ID:
Not Available

# Drug_Target_112_GenBank_ID_Gene:
Not Available

# Drug_Target_112_GenBank_ID_Protein:
Not Available

# Drug_Target_112_GeneCard_ID:
Not Available

# Drug_Target_112_Gene_Name:
MYO1D

# Drug_Target_112_Gene_Sequence:
Not Available

# Drug_Target_112_General_Function:
Not Available

# Drug_Target_112_General_References:
Not Available

# Drug_Target_112_HGNC_ID:
Not Available

# Drug_Target_112_HPRD_ID:
Not Available

# Drug_Target_112_ID:
7085

# Drug_Target_112_Locus:
Not Available

# Drug_Target_112_Molecular_Weight:
Not Available

# Drug_Target_112_Name:
Myosin-Id

# Drug_Target_112_Number_of_Residues:
0

# Drug_Target_112_PDB_ID:
Not Available

# Drug_Target_112_Pathway:
Not Available

# Drug_Target_112_Pfam_Domain_Function:
Not Available

# Drug_Target_112_Protein_Sequence:
Not Available

# Drug_Target_112_Reaction:
Not Available

# Drug_Target_112_Signals:
Not Available

# Drug_Target_112_Specific_Function:
Not Available

# Drug_Target_112_SwissProt_ID:
O94832

# Drug_Target_112_SwissProt_Name:
MYO1D_HUMAN

# Drug_Target_112_Synonyms:
Not Available

# Drug_Target_112_Theoretical_pI:
Not Available

# Drug_Target_112_Transmembrane_Regions:
Not Available

# Drug_Target_113_Cellular_Location:
Not Available

# Drug_Target_113_Chromosome_Location:
Not Available

# Drug_Target_113_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_113_Essentiality:
Non-Essential

# Drug_Target_113_GenAtlas_ID:
KIF1A

# Drug_Target_113_GenBank_ID_Gene:
X90840

# Drug_Target_113_GenBank_ID_Protein:
Not Available

# Drug_Target_113_GeneCard_ID:
Not Available

# Drug_Target_113_Gene_Name:
KIF1A

# Drug_Target_113_Gene_Sequence:
>5073 bp
ATGGCCGGGGCTTCGGTGAAGGTGGCGGTGCGGGTCCGCCCCTTCAATTCCCGGGAAATG
AGCCGTGACTCCAAGTGCATCATTCAGATGTCTGGAAGCACCACCACCATTGTTAACCCC
AAACAGCCCAAGGAGACGCCCAAAAGCTTCAGCTTTGACTACTCCTACTGGTCGCACACC
TCACCTGAGGACATCAACTACGCGTCGCAGAAGCAGGTGTACCGGGACATCGGCGAGGAG
ATGCTGCAGCATGCCTTTGAGGGATACAACGTGTGCATCTTCGCCTATGGGCAGACGGGT
GCCGGCAAGTCCTACACCATGATGGGCAAGCAGGAGAAGGACCAGCAGGGCATCATCCCA
CAGCTCTGCGAGGACCTCTTCTCTCGGATCAACGACACGACCAACGACAACATGTCCTAC
TCCGTGGAGGTCAGCTACATGGAGATTTACTGTGAGCGCGTCCGTGACCTCCTGAACCCC
AAGAACAAGGGCAACCTTCGCGTGAGGGAGCACCCACTGCTGGGGCCCTACGTGGAGGAC
CTCTCCAAGCTGGCTGTCACCTCCTACAATGACATCCAGGACCTCATGGACTCAGGGAAC
AAGGCCAGGACCGTGGCGGCCACCAACATGAATGAGACCAGCAGTCGCTCCCACGCCGTC
TTCAACATCATCTTCACCCAGAAGCGCCATGACGCAGAGACCAATATCACCACGGAGAAG
GTGAGCAAAATCAGCCTGGTGGACCTGGCTGGGAGCGAGCGGGCTGACTCCACGGGAGCC
AAGGGCACGCGCCTCAAGGAGGGGGCCAACATCAACAAGTCGCTGACCACCCTGGGCAAG
GTCATCTCCGCCCTGGCTGAAATGGACTCCGGACCCAACAAGAACAAGAAAAAGAAGAAG
ACAGATTTCATTCCGTACCGAGATTCCGTGTTGACCTGGCTCCTCCGGGAAAACCTGGGC
GGTAACTCAAGGACAGCTATGGTGGCAGCCCTGAGTCCTGCAGACATCAACTACGATGAG
ACCCTTAGCACGCTGAGGTATGCTGACCGGGCCAAGCAGATCCGCTGCAATGCTGTCATC
AATGAGGACCCCAACAACAAGCTGATCCGCGAGCTGAAGGATGAGGTGACCCGGCTGCGG
GACCTTCTGTACGCCCAGGGTCTTGGCGACATCACTGACATGACCAATGCCCTGGTGGGT
ATGAGCCCCTCATCCTCGCTCTCAGCCCTGTCCAGCCGCGCGGCCTCCGTGTCCAGCCTC
CACGAGCGCATCTTGTTTGCCCCGGGCAGCGAGGAGGCCATTGAAAGACTGAAGGAAACA
GAGAAGATCATAGCTGAGCTCAATGAGACCTGGGAGGAGAAGCTGCGGCGGACAGAAGCC
ATCCGGATGGAGAGGGAAGCCCTGCTGGCCGAGATGGGTGTGGCCATGAGGGAGGATGGC
GGCACCTTGGGCGTATTCTCTCCCAAAAAGACACCACACCTCGTCAACCTGAACGAGGAC
CCGCTGATGTCTGAGTGCCTGCTCTACTACATCAAGGATGGGATCACCAGAGTGGGCAGG
GAGGATGGCGAGAGGCGGCAGGACATTGTTCTGAGTGGGCACTTCATCAAGGAGGAGCAC
TGCGTCTTCCGGAGCGACTCCAGGGGAGGCAGCGAAGCTGTGGTGACCTTGGAGCCCTGT
GAGGGGGCAGACACCTACGTCAATGGCAAGAAAGTCACAGAGCCCAGCATCCTGCGTTCA
GGAAACCGCATCATCATGGGTAAGAGCCATGTGTTCCGGTTCACCCACCCCGAGCAGGCC
CGGCAGGAGCGTGAGCGCACGCCTTGTGCGGAGACGCCAGCTGAGCCTGTGGACTGGGCC
TTCGCCCAGCGTGAGCTGCTGGAGAAGCAGGGCATCGACATGAAGCAGGAGATGGAGCAG
AGGCTCCAGGAACTGGAGGACCAGTACCGCCGCGAGCGGGAGGAGGCCACCTACCTGCTG
GAGCAGCAGCGGCTGGACTATGAGAGCAAGCTGGAGGCTCTGCAGAAGCAGATGGACTCC
AGGTACTACCCGGAGGTGAACGAGGAGGAGGAGGAGCCCGAGGATGAAGTCCAGTGGACA
GAGCGGGAGTGTGAGCTGGCGCTCTGGGCCTTCCGGAAGTGGAAGTGGTACCAGTTCACG
TCTCTGCGGGACCTGCTGTGGGGCAACGCCATCTTCCTCAAGGAGGCCAATGCCATCAGC
GTGGAGCTGAAAAAGAAGGTACAATTCCAGTTTGTCCTCCTGACGGACACACTCTACTCC
CCTCTGCCACCCGACCTGCTGCCCCCAGAGGCCGCCAAAGACCGAGAGAAGCGGCCCTTC
CCCCGCACCATTGTGGCCGTGGAGGTCCAGGACCAGAAGAACGGGGCCACCCACTACTGG
ACGCTGGAGAAGCTCAGGCAGCGTCTGGACCTGATGCGGGAGATGTACGACCGCGCTGCA
GAGGTGCCCTCCAGTGTCATCGAGGACTGTGACAACGTGGTGACCGGCGGAGACCCCTTC
TATGACCGCTTCCCCTGGTTCCGGCTGGTGGGCAGGGCCTTCGTGTACCTGAGCAACCTG
CTGTACCCCGTTCCCCTGGTACACCGTGTGGCAATCGTCAGCGAGAAGGGCGAGGTGAAG
GGCTTCCTCCGCGTGGCCGTCCAGGCCATCTCAGCCGATGAAGAGGCCCCTGATTATGGC
TCTGGCGTCCGCCAGTCGGGAACTGCTAAAATCTCCTTTGATGACCAGCATTTTGAAAAG
TTCCAGTCCGAGTCTTGCCCCGTGGTGGGGATGTCCCGCTCGGGAACCTCCCAGGAAGAG
CTTCGCATCGTGGAGGGCCAGGGCCAGGGTGCAGACGTGGGGCCCTCAGCCGATGAAGTC
AACAACAACACCTGTTCAGCAGTGCCCCCAGAAGGCCTCCTCCTAGACAGCTCTGAGAAA
GCCGCCCTGGATGGGCCCCTGGATGCTGCCCTGGACCACCTCCGCCTGGGCAACACCTTC
ACCTTCCGTGTGACAGTCCTGCAGGCGTCCAGCATCTCTGCCGAATATGCCGACATCTTC
TGCCAGTTCAACTTCATCCACCGCCACGACGAGGCCTTCTCCACAGAGCCCCTGAAGAAC
ACAGGCAGAGGCCCCCCACTTGGCTTCTACCACGTCCAGAACATCGCAGTGGAGGTGACC
AAGTCCTTCATTGAGTACATCAAGAGCCAGCCCATTGTTTTCGAGGTCTTTGGCCACTAC
CAGCAGCACCCGTTCCCGCCCCTCTGCAAGGACGTGCTCAGCCCCCTGAGGCCCTCGCGC
CGCCACTTCCCTCGGGTCATGCCACTGTCCAAGCCAGTGCCCGCCACCAAGCTCAGCACA
CTGACGCGGCCCTGTCCGGGACCCTGCCACTGCAAGTACGACCTGCTGGTCTACTTCGAG
ATCTGTGAGCTGGAGGCCAACGGCGATTACATCCCGGCCGTGGTGGACCACCGTGGGGGC
ATGCCATGCATGGGGACCTTCCTCCTCCACCAGGGCATCCAGCGACGGATTACGGTGACA
CTACTGCATGAGACAGGCAGCCATATCCGCTGGAAGGAAGTGCGCGAGCTGGTCGTGGGC
CGCATCCGAAACACTCCAGAGACCGACGAGTCCCTGATCGACCCCAACATCTTGTCTCTC
AACATCCTCTCTGCCGGATACATCCACCCAGCCCATGATGACCGGACCTTTTACCAATTT
GAGGCTGCGTGGAACAGCTCCATGCACAACTCTCTCCTGCTGAACCGGATCACCCCTTAT
CGAGAGAAAATCTACATGACACTCTCCGCTTATATCGAGATGGAGAACTGCACCCAGCCG
GCTGTTGTCACCAAGGACTTCTGCATGGTCTTCTATTCCCGTGATGCCAAGCTGCCAGCC
TCGCGCTCCATCCGCAACCTCTTTGGCAGTGGGAGCCTTCGGGCCTCAGAGAGTAACCGT
GTGACTGGTGTGTACGAGCTCAGCCTGTGCCACGTGGCTGACGCGGGCAGCCCAGGGATG
CAGCGCCGGCGCCGACGAGTCCTGGACACATCTGTGGCCTATGTCCGGGGCGAGGAGAAC
CTGGCAGGCTGGAGGCCCCGGAGTGACAGTCTCATTCTGGACCACCAGTGGGAGCTGGAG
AAGCTGAGCCTCCTGCAGGAGGTGGAGAAGACTAGGCACTACCTGCTCCTGCGGGAGAAG
CTGGAGACCGCCCAGCGGCCTGTCCCGGAGGCACTGTCCCCGGCCTTCAGCGAGGACTCT
GAGTCCCATGGCTCCTCCAGCGCCTCCTCCCCGCTCTCGGCTGAGGGCCGCCCATCACCC
CTGGAGGCTCCCAACGAGAGGCAGCGGGAGCTGGCCGTCAAGTGCTTGCGCCTGCTCACG
CACACATTCAACAGAGAGTACACACACAGCCACGTCTGCGTCAGTGCCAGCGAGAGCAAG
CTCTCCGAGATGTCTGTCACCCTGCTCCGGGACCCGTCGATGTCCCCTCTAGGGGTGGCC
ACTCTCACCCCCTCCTCCACTTGCCCCTCTCTGGTTGAAGGGCGGTACGGTGCCACTGAC
CTGAGGACCCCGCAGCCCTGCTCCCGGCCAGCCAGCCCAGAGCCCGAGCTGCTGCCAGAG
GCCGACTCCAAGAAGCTCCCTTCCCCTGCCCGGGCAACAGAGACAGACAAGGAGCCCCAG
CGCCTGCTGGTCCCTGACATCCAGGAGATCCGAGTCAGCCCGATCGTTTCCAAGAAGGGG
TACCTGCACTTCCTGGAGCCGCACACGTCAGGCTGGGCCAGGCGCTTCGTGGTGGTGCGG
CGCCCCTATGCCTACATGTACAACAGCGACAAGGACACCGTGGAGCGGTTCGTGCTCAAC
CTGGCCACTGCCCAGGTGGAGTACAGTGAGGACCAGCAGGCTATGCTCAAGACACCCAAC
ACATTCGCGGTGTGCACGGAACACCGCGGCATCCTGCTGCAGGCCGCCAGCGACAAGGAC
ATGCATGACTGGCTGTACGCCTTCAACCCCCTCCTGGCCGGGACCATACGGTCCAAGCTC
TCCAGAAGGAGGTCTGCCCAGATGCGGGTCTGA

# Drug_Target_113_General_Function:
Involved in microtubule motor activity

# Drug_Target_113_General_References:
8661001	Furlong RA, Zhou CY, Ferguson-Smith MA, Affara NA: Characterization of a kinesin-related gene ATSV, within the tuberous sclerosis locus (TSC1) candidate region on chromosome 9Q34. Genomics. 1996 May 1;33(3):421-9.

# Drug_Target_113_HGNC_ID:
HGNC:888

# Drug_Target_113_HPRD_ID:
Not Available

# Drug_Target_113_ID:
5312

# Drug_Target_113_Locus:
2q37.3

# Drug_Target_113_Molecular_Weight:
191066

# Drug_Target_113_Name:
Kinesin-like protein KIF1A

# Drug_Target_113_Number_of_Residues:
1690

# Drug_Target_113_PDB_ID:
1I6I

# Drug_Target_113_Pathway:
Not Available

# Drug_Target_113_Pfam_Domain_Function:
PF00169	PH
PF00225	Kinesin
PF00498	FHA

# Drug_Target_113_Protein_Sequence:
>Kinesin-like protein KIF1A
MAGASVKVAVRVRPFNSREMSRDSKCIIQMSGSTTTIVNPKQPKETPKSFSFDYSYWSHT
SPEDINYASQKQVYRDIGEEMLQHAFEGYNVCIFAYGQTGAGKSYTMMGKQEKDQQGIIP
QLCEDLFSRINDTTNDNMSYSVEVSYMEIYCERVRDLLNPKNKGNLRVREHPLLGPYVED
LSKLAVTSYNDIQDLMDSGNKARTVAATNMNETSSRSHAVFNIIFTQKRHDAETNITTEK
VSKISLVDLAGSERADSTGAKGTRLKEGANINKSLTTLGKVISALAEMDSGPNKNKKKKK
TDFIPYRDSVLTWLLRENLGGNSRTAMVAALSPADINYDETLSTLRYADRAKQIRCNAVI
NEDPNNKLIRELKDEVTRLRDLLYAQGLGDITDMTNALVGMSPSSSLSALSSRAASVSSL
HERILFAPGSEEAIERLKETEKIIAELNETWEEKLRRTEAIRMEREALLAEMGVAMREDG
GTLGVFSPKKTPHLVNLNEDPLMSECLLYYIKDGITRVGREDGERRQDIVLSGHFIKEEH
CVFRSDSRGGSEAVVTLEPCEGADTYVNGKKVTEPSILRSGNRIIMGKSHVFRFNHPEQA
RQERERTPCAETPAEPVDWAFAQRELLEKQGIDMKQEMEQRLQELEDQYRREREEATYLL
EQQRLDYESKLEALQKQMDSRYYPEVNEEEEEPEDEVQWTERECELALWAFRKWKWYQFT
SLRDLLWGNAIFLKEANAISVELKKKVQFQFVLLTDTLYSPLPPDLLPPEAAKDRETRPF
PRTIVAVEVQDQKNGATHYWTLEKLRQRLDLMREMYDRAAEVPSSVIEDCDNVVTGGDPF
YDRFPWFRLVGRAFVYLSNLLYPVPLVHRVAIVSEKGEVKGFLRVAVQAISADEEAPDYG
SGVRQSGTAKISFDDQHFEKFQSESCPVVGMSRSGTSQEELRIVEGQGQGADVGPSADEV
NNNTCSAVPPEGLLLDSSEKAALDGPLDAALDHLRLGNTFTFRVTVLQASSISAEYADIF
CQFNFIHRHDEAFSTEPLKNTGRGPPLGFYHVQNIAVEVTKSFIEYIKSQPIVFEVFGHY
QQHPFPPLCKDVLSPLRPSRRHFPRVMPLSKPVPATKLSTLTRPCPGPCHCKYDLLVYFE
ICELEANGDYIPAVVDHRGGMPCMGTFLLHQGIQRRITVTLLHETGSHIRWKEVRELVVG
RIRNTPETDESLIDPNILSLNILSSGYIHPAQDDRTFYQFEAAWDSSMHNSLLLNRVTPY
REKIYMTLSAYIEMENCTQPAVVTKDFCMVFYSRDAKLPASRSIRNLFGSGSLRASESNR
VTGVYELSLCHVADAGSPGMQRRRRRVLDTSVAYVRGEENLAGWRPRSDSLILDHQWELE
KLSLLQEVEKTRHYLLLREKLETAQRPVPEALSPAFSEDSESHGSSSASSPLSAEGRPSP
LEAPNERQRELAVKCLRLLTHTFNREYTHSHVCVSASESKLSEMSVTLLRDPSMSPLGVA
TLTPSSTCPSLVEGRYGATDLRTPQPCSRPASPEPELLPEADSKKLPSPARATETDKEPQ
RLLVPDIQEIRVSPIVSKKGYLHFLEPHTSGWARRFVVVRRPYAYMYNSDKDTVERFVLN
LATAQVEYSEDQQAMLKTPNTFAVCTEHRGILLQAASDKDMHDWLYAFNPLLAGTIRSKL
SRRRSAQMRV

# Drug_Target_113_Reaction:
Not Available

# Drug_Target_113_Signals:
None

# Drug_Target_113_Specific_Function:
Motor for anterograde axonal transport of synaptic vesicle precursors (By similarity)

# Drug_Target_113_SwissProt_ID:
Q12756

# Drug_Target_113_SwissProt_Name:
KIF1A_HUMAN

# Drug_Target_113_Synonyms:
Axonal transporter of synaptic vesicles
Microtubule-based motor KIF1A
UNC-104-and KIF1A-related protein
hUNC-104

# Drug_Target_113_Theoretical_pI:
6.13

# Drug_Target_113_Transmembrane_Regions:
None

# Drug_Target_114_Cellular_Location:
Not Available

# Drug_Target_114_Chromosome_Location:
Not Available

# Drug_Target_114_Drug_References:
Not Available

# Drug_Target_114_Essentiality:
Non-Essential

# Drug_Target_114_GenAtlas_ID:
Not Available

# Drug_Target_114_GenBank_ID_Gene:
X68079

# Drug_Target_114_GenBank_ID_Protein:
Not Available

# Drug_Target_114_GeneCard_ID:
Not Available

# Drug_Target_114_Gene_Name:
tmd

# Drug_Target_114_Gene_Sequence:
>2193 bp
ATGGCACGAGATCCGAAGCATGATATTTTGTTTGAGCCAATACAAATTGGCCCCAAAACA
TTACGCAATCGCTTTTACCAGGTACCGCATTGTATCGGTGCTGGATCCGATAAGCCTGGC
TTTCAATCTGCACACCGTTCGGTTAAAGCTGAAGGCGGTTGGGCGGCTTTAAACACTGAA
TATTGCTCCATTAACCCTGAGTCAGATGATACACATCGTTTGTCCGCACGTATCTGGGAC
GAAGGTGATGTGCGTAACTTGAAAGCCATGACCGACGAAGTTCATAAGTACGGTGCATTA
GCCGGGGTCGAGTTATGGTACGGCGGTGCACACGCACCTAACATGGAGTCACGCGCGACC
CCACGTGGTCCAAGCCAATATGCGTCAGAGTTTGAGACGCTGTCCTACTGTAAAGAAATG
GATCTAAGCGATATCGCTCAGGTACAGCAGTTCTATGTTGATGCAGCGAAGCGCTCTCGT
GACGCTGGTTTTGACATTGTCTACGTATACGGTGCGCACTCTTATTTGCCGCTGCAATTC
CTGAATCCATACTACAACAAGCGTACAGACAAATACGGTGGCTCATTGGAGAACCGTGCG
CGCTTCTGGCTGGAAACACTAGAAAAAGTGAAGCATGCCGTGGGTTCAGATTGTGCGATT
GCGACACGTTTCGGCGTGGATACTGTGTATGGTCCAGGTCAAATCGAAGCAGAAGTGGAT
GGTCAGAAGTTTGTTGAAATGGCTGACTCACTGGTCGATATGTGGGATATCACAATTGGT
GATATTGCCGAGTGGGGCGAAGATGCGGGGCCGTCACGTTTCTACCAGCAAGGTCACACC
ATCCCTTGGGTTAAATTGGTCAAACAGGTTTCCAAAAAACCAGTATTAGGCGTTGGCCGT
TATACCGACCCTGAGAAAATGATCGAAATCGTCACCAAAGGCTATGCCGACATTATTGGT
TGTGCACGCCCTTCTATTGCTGATCCGTTCTTGCCACAAAAGGTTGAGCAGGGTCGCTAC
GACGATATCCGTGTATGTATTGGTTGTAACGTGTGTATTTCCCGCTGGGAAATCGGTGGT
CCTCCAATGATTTGTACCCAGAATGCGACAGCAGGTGAAGAGTACCGTCGTGGTTGGCAT
CCAGAGAAATTCCGTCAAACCAAGAACAAGGATTCTGTATTGATCGTTGGTGCAGGCCCA
TCCGGTTCTGAAGCAGCCCGCGTATTGATGGAAAGCGGTTATACCGTGCACTTGACCGAT
ACCGCAGAGAAAATCGGTGGTCACTTGAACCAGGTGGCAGCGTTGCCTGGCTTGGGTGAG
TGGAGCTATCACCGCGATTATCGTGAAACACAAATCACCAAGTTGCTGAAGAAGAACAAA
GAAAGCCAATTGGCATTGGGTCAAAAACCAATGACGGCTGACGACGTGCTGCAATATGGT
GCTGACAAAGTCATCATCGCTACCGGTGCGCGCTGGAATACCGATGGTACCAACTGCCTG
ACGCATGACCCAATTCCAGGGGCAGATGCTTCCTTGCCAGATCAACTGACACCAGAGCAA
GTCATGGATGGTAAGAAGAAGATTGGTAAGCGCGTGGTGATTCTGAATGCGGATACTTAT
TTCATGGCGCCTAGCCTGGCTGAGAAGCTTGCGACGGCTGGTCACGAAGTAACCATCGTT
TCTGGCGTGCACCTGGCTAACTACATGCACTTCACGCTGGAATATCCAAACATGATGCGT
CGTTTGCACGAACTGCATGTTGAAGAGTTGGGCGATCACTTCTGCTCACGTATCGAACCA
GGCCGTATGGAAATCTACAACATCTGGGGCGATGGTTCCAAACGTACTTACCGTGGCCCA
GGCGTTTCTCCGCGTGATGCCAATACCTCGCATCGTTGGATTGAGTTTGACTCCCTGGTG
CTGGTGACAGGCCGTCATTCAGAGTGCACGCTGTGGAATGAGTTAAAAGCCCGTGAATCT
GAGTGGGCTGAGAACGACATTAAAGGTATCTACCTGATTGGTGATGCTGAGGCGCCTCGT
TTGATTGCTGATGCCACATTTACGGGTCACCGTGTGGCCCGTGAAATTGAAGAAGCAAAC
CCACAAATTGCCATCCCATACAAGCGTGAAACCATCGCATGGGGCACGCCGCATATGCCA
GGTGGTAATTTCAAAATTGAGTACAAAGTTTAA

# Drug_Target_114_General_Function:
Involved in catalytic activity

# Drug_Target_114_General_References:
12567183	Leys D, Basran J, Talfournier F, Sutcliffe MJ, Scrutton NS: Extensive conformational sampling in a ternary electron transfer complex. Nat Struct Biol. 2003 Mar;10(3):219-25.
1505666	Boyd G, Mathews FS, Packman LC, Scrutton NS: Trimethylamine dehydrogenase of bacterium W3A1. Molecular cloning, sequence determination and over-expression of the gene. FEBS Lett. 1992 Aug 24;308(3):271-6.
1551870	Barber MJ, Neame PJ, Lim LW, White S, Matthews FS: Correlation of x-ray deduced and experimental amino acid sequences of trimethylamine dehydrogenase. J Biol Chem. 1992 Apr 5;267(10):6611-9.
620783	Kenney WC, McIntire W, Steenkamp DJ: Amino acid sequence of a cofactor peptide from trimethylamine dehydrogenase. FEBS Lett. 1978 Jan 1;85(1):137-40.

# Drug_Target_114_HGNC_ID:
Not Available

# Drug_Target_114_HPRD_ID:
Not Available

# Drug_Target_114_ID:
5189

# Drug_Target_114_Locus:
Not Available

# Drug_Target_114_Molecular_Weight:
81630

# Drug_Target_114_Name:
Trimethylamine dehydrogenase

# Drug_Target_114_Number_of_Residues:
730

# Drug_Target_114_PDB_ID:
1O95

# Drug_Target_114_Pathway:
Not Available

# Drug_Target_114_Pfam_Domain_Function:
PF00724	Oxidored_FMN
PF07992	Pyr_redox_2

# Drug_Target_114_Protein_Sequence:
>Trimethylamine dehydrogenase
MARDPKHDILFEPIQIGPKTLRNRFYQVPHCIGAGSDKPGFQSAHRSVKAEGGWAALNTE
YCSINPESDDTHRLSARIWDEGDVRNLKAMTDEVHKYGALAGVELWYGGAHAPNMESRAT
PRGPSQYASEFETLSYCKEMDLSDIAQVQQFYVDAAKRSRDAGFDIVYVYGAHSYLPLQF
LNPYYNKRTDKYGGSLENRARFWLETLEKVKHAVGSDCAIATRFGVDTVYGPGQIEAEVD
GQKFVEMADSLVDMWDITIGDIAEWGEDAGPSRFYQQGHTIPWVKLVKQVSKKPVLGVGR
YTDPEKMIEIVTKGYADIIGCARPSIADPFLPQKVEQGRYDDIRVCIGCNVCISRWEIGG
PPMICTQNATAGEEYRRGWHPEKFRQTKNKDSVLIVGAGPSGSEAARVLMESGYTVHLTD
TAEKIGGHLNQVAALPGLGEWSYHRDYRETQITKLLKKNKESQLALGQKPMTADDVLQYG
ADKVIIATGARWNTDGTNCLTHDPIPGADASLPDQLTPEQVMDGKKKIGKRVVILNADTY
FMAPSLAEKLATAGHEVTIVSGVHLANYMHFTLEYPNMMRRLHELHVEELGDHFCSRIEP
GRMEIYNIWGDGSKRTYRGPGVSPRDANTSHRWIEFDSLVLVTGRHSECTLWNELKARES
EWAENDIKGIYLIGDAEAPRLIADATFTGHRVAREIEEANPQIAIPYKRETIAWGTPHMP
GGNFKIEYKV

# Drug_Target_114_Reaction:
Not Available

# Drug_Target_114_Signals:
None

# Drug_Target_114_Specific_Function:
Trimethylamine + H(2)O + electron-transferring flavoprotein = dimethylamine + formaldehyde + reduced electron- transferring flavoprotein

# Drug_Target_114_SwissProt_ID:
P16099

# Drug_Target_114_SwissProt_Name:
DHTM_METME

# Drug_Target_114_Synonyms:
EC 1.5.8.2
TMADh

# Drug_Target_114_Theoretical_pI:
6.31

# Drug_Target_114_Transmembrane_Regions:
None

# Drug_Target_115_Cellular_Location:
Cytoplasm

# Drug_Target_115_Chromosome_Location:
Not Available

# Drug_Target_115_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_115_Essentiality:
Non-Essential

# Drug_Target_115_GenAtlas_ID:
Not Available

# Drug_Target_115_GenBank_ID_Gene:
M13169

# Drug_Target_115_GenBank_ID_Protein:
Not Available

# Drug_Target_115_GeneCard_ID:
Not Available

# Drug_Target_115_Gene_Name:
rbsK

# Drug_Target_115_Gene_Sequence:
Not Available

# Drug_Target_115_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_115_General_References:
10438599	Sigrell JA, Cameron AD, Mowbray SL: Induced fit on sugar binding activates ribokinase. J Mol Biol. 1999 Jul 30;290(5):1009-18.
3011794	Hope JN, Bell AW, Hermodson MA, Groarke JM: Ribokinase from Escherichia coli K12. Nucleotide sequence and overexpression of the rbsK gene and purification of ribokinase. J Biol Chem. 1986 Jun 15;261(17):7663-8.
7686882	Burland V, Plunkett G 3rd, Daniels DL, Blattner FR: DNA sequence and analysis of 136 kilobases of the Escherichia coli genome: organizational symmetry around the origin of replication. Genomics. 1993 Jun;16(3):551-61.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9385653	Sigrell JA, Cameron AD, Jones TA, Mowbray SL: Purification, characterization, and crystallization of Escherichia coli ribokinase. Protein Sci. 1997 Nov;6(11):2474-6.
9519409	Sigrell JA, Cameron AD, Jones TA, Mowbray SL: Structure of Escherichia coli ribokinase in complex with ribose and dinucleotide determined to 1.8 A resolution: insights into a new family of kinase structures. Structure. 1998 Feb 15;6(2):183-93.

# Drug_Target_115_HGNC_ID:
Not Available

# Drug_Target_115_HPRD_ID:
Not Available

# Drug_Target_115_ID:
3669

# Drug_Target_115_Locus:
Not Available

# Drug_Target_115_Molecular_Weight:
32291

# Drug_Target_115_Name:
Ribokinase

# Drug_Target_115_Number_of_Residues:
309

# Drug_Target_115_PDB_ID:
1GQT

# Drug_Target_115_Pathway:
Not Available

# Drug_Target_115_Pfam_Domain_Function:
PF00294	PfkB

# Drug_Target_115_Protein_Sequence:
>Ribokinase
MQNAGSLVVLGSINADHILNLQSFPTPGETVTGNHYQVAFGGKGANQAVAAGRSGANIAF
IACTGDDSIGESVRQQLATDNIDITPVSVIKGESTGVALIFVNGEGENVIGIHAGANAAL
SPALVEAQRERIANASALLMQLESPLESVMAAAKIAHQNKTIVALNPAPARELPDELLAL
VDIITPNETEAEKLTGIRVENDEDAAKAAQVLHEKGIRTVLITLGSRGVWASVNGEGQRV
PGFRVQAVDTIAAGDTFNGALITALLEEKPLPEAIRFAHAAAAIAVTRKGAQPSVPWREE
IDAFLDRQR

# Drug_Target_115_Reaction:
ATP + D-ribose = ADP + D-ribose 5-phosphate

# Drug_Target_115_Signals:
None

# Drug_Target_115_Specific_Function:
ATP + D-ribose = ADP + D-ribose 5-phosphate

# Drug_Target_115_SwissProt_ID:
P0A9J6

# Drug_Target_115_SwissProt_Name:
RBSK_ECOLI

# Drug_Target_115_Synonyms:
EC 2.7.1.15

# Drug_Target_115_Theoretical_pI:
4.73

# Drug_Target_115_Transmembrane_Regions:
None

# Drug_Target_116_Cellular_Location:
Not Available

# Drug_Target_116_Chromosome_Location:
Not Available

# Drug_Target_116_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_116_Essentiality:
Non-Essential

# Drug_Target_116_GenAtlas_ID:
Not Available

# Drug_Target_116_GenBank_ID_Gene:
Not Available

# Drug_Target_116_GenBank_ID_Protein:
Not Available

# Drug_Target_116_GeneCard_ID:
Not Available

# Drug_Target_116_Gene_Name:
TRPM7

# Drug_Target_116_Gene_Sequence:
Not Available

# Drug_Target_116_General_Function:
Not Available

# Drug_Target_116_General_References:
Not Available

# Drug_Target_116_HGNC_ID:
Not Available

# Drug_Target_116_HPRD_ID:
Not Available

# Drug_Target_116_ID:
7134

# Drug_Target_116_Locus:
Not Available

# Drug_Target_116_Molecular_Weight:
Not Available

# Drug_Target_116_Name:
Transient receptor potential cation channel subfamily M member 7

# Drug_Target_116_Number_of_Residues:
0

# Drug_Target_116_PDB_ID:
Not Available

# Drug_Target_116_Pathway:
Not Available

# Drug_Target_116_Pfam_Domain_Function:
Not Available

# Drug_Target_116_Protein_Sequence:
Not Available

# Drug_Target_116_Reaction:
Not Available

# Drug_Target_116_Signals:
Not Available

# Drug_Target_116_Specific_Function:
Not Available

# Drug_Target_116_SwissProt_ID:
Q96QT4

# Drug_Target_116_SwissProt_Name:
TRPM7_HUMAN

# Drug_Target_116_Synonyms:
Not Available

# Drug_Target_116_Theoretical_pI:
Not Available

# Drug_Target_116_Transmembrane_Regions:
Not Available

# Drug_Target_117_Cellular_Location:
Not Available

# Drug_Target_117_Chromosome_Location:
Not Available

# Drug_Target_117_Drug_References:
Not Available

# Drug_Target_117_Essentiality:
Non-Essential

# Drug_Target_117_GenAtlas_ID:
Not Available

# Drug_Target_117_GenBank_ID_Gene:
L42023

# Drug_Target_117_GenBank_ID_Protein:
Not Available

# Drug_Target_117_GeneCard_ID:
Not Available

# Drug_Target_117_Gene_Name:
HI_0065

# Drug_Target_117_Gene_Sequence:
>477 bp
ATGGAAAGTTTGACTCAATATATCCCTGATGAATTTTCTATGCTCCGCTTCGGCAAAAAA
TTTGCCGAAATTCTTTTAAAATTGCATACAGAAAAAGCAATTATGGTTTATCTTAACGGT
GATCTTGGGGCAGGAAAAACAACGCTAACGCGCGGAATGTTGCAAGGTATCGGTCATCAA
GGTAATGTAAAAAGCCCAACTTATACGCTGGTTGAAGAATACAATATTGCAGGCAAAATG
ATTTATCATTTTGATTTATATCGTTTAGCAGATCCTGAAGAGCTCGAATTTATGGGCATT
AGAGATTATTTTAATACGGATAGCATCTGCTTAATTGAATGGTCTGAAAAAGGTCAAGGC
ATATTGCCAGAAGCGGATATTTTAGTGAATATTGATTATTACGATGATGCACGAAATATT
GAATTAATCGCACAAACAAATTTGGGTAAAAATATTATAAGCGCATTTTCTAATTAA

# Drug_Target_117_General_Function:
Not Available

# Drug_Target_117_General_References:
10675023	Langen H, Takacs B, Evers S, Berndt P, Lahm HW, Wipf B, Gray C, Fountoulakis M: Two-dimensional map of the proteome of Haemophilus influenzae. Electrophoresis. 2000 Jan;21(2):411-29.
7542800	Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, et al.: Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science. 1995 Jul 28;269(5223):496-512.

# Drug_Target_117_HGNC_ID:
Not Available

# Drug_Target_117_HPRD_ID:
Not Available

# Drug_Target_117_ID:
5314

# Drug_Target_117_Locus:
Not Available

# Drug_Target_117_Molecular_Weight:
17970

# Drug_Target_117_Name:
UPF0079 ATP-binding protein HI0065

# Drug_Target_117_Number_of_Residues:
158

# Drug_Target_117_PDB_ID:
1HTW

# Drug_Target_117_Pathway:
Not Available

# Drug_Target_117_Pfam_Domain_Function:
PF02367	UPF0079

# Drug_Target_117_Protein_Sequence:
>UPF0079 ATP-binding protein HI0065
MESLTQYIPDEFSMLRFGKKFAEILLKLHTEKAIMVYLNGDLGAGKTTLTRGMLQGIGHQ
GNVKSPTYTLVEEYNIAGKMIYHFDLYRLADPEELEFMGIRDYFNTDSICLIEWSEKGQG
ILPEADILVNIDYYDDARNIELIAQTNLGKNIISAFSN

# Drug_Target_117_Reaction:
Not Available

# Drug_Target_117_Signals:
None

# Drug_Target_117_Specific_Function:
Not Available

# Drug_Target_117_SwissProt_ID:
P44492

# Drug_Target_117_SwissProt_Name:
Y065_HAEIN

# Drug_Target_117_Synonyms:
Not Available

# Drug_Target_117_Theoretical_pI:
4.48

# Drug_Target_117_Transmembrane_Regions:
None

# Drug_Target_118_Cellular_Location:
Cytoplasm. Cell inner membrane

# Drug_Target_118_Chromosome_Location:
Not Available

# Drug_Target_118_Drug_References:
Not Available

# Drug_Target_118_Essentiality:
Non-Essential

# Drug_Target_118_GenAtlas_ID:
Not Available

# Drug_Target_118_GenBank_ID_Gene:
M38777

# Drug_Target_118_GenBank_ID_Protein:
Not Available

# Drug_Target_118_GeneCard_ID:
Not Available

# Drug_Target_118_Gene_Name:
htpG

# Drug_Target_118_Gene_Sequence:
>1875 bp
ATGAAAGGACAAGAAACTCGTGGTTTTCAGTCAGAAGTGAAACAGCTTCTGCACCTGATG
ATCCATTCTCTCTATTCCAATAAAGAAATCTTCCTGCGTGAGCTTATCTCTAACGCCTCC
GATGCGGCGGACAAGCTGCGTTTCCGTGCGCTCTCTAACCCGGACCTGTACGAAGGTGAT
GGCGAACTACGCGTTCGTGTCTCTTTCGATAAAGACAAGCGTACGCTGACCATCTCCGAT
AACGGCGTGGGGATGACCCGCGACGAAGTGATTGACCATCTGGGGACTATCGCTAAATCC
GGTACCAAATCATTCCTCGAATCCCTGGGTTCTGACCAGGCGAAAGACAGCCAGCTGATC
GGTCAGTTTGGTGTTGGTTTCTACTCTGCGTTTATCGTGGCCGACAAAGTGACCGTGCGT
ACTCGCGCGGCAGGCGAAAAACCAGAAAATGGCGTCTTCTGGGAATCGGCTGGCGAAGGT
GAATACACCGTTGCCGACATCACCAAAGAAGATCGTGGTACTGAAATCACCCTGCATCTG
CGTGAAGGCGAAGACGAGTTCCTCGATGACTGGCGCGTGCGTTCCATCATCAGCAAATAC
TCCGACCATATCGCGCTGCCGGTAGAGATCGAAAAACGCGAAGAGAAAGACGGCGAAACC
GTTATCTCCTGGGAGAAAATCAACAAAGCGCAGGCGCTGTGGACTCGTAACAAGTCGGAA
ATCACCGATGAAGAGTACAAAGAGTTCTACAAACACATCGCCCACGACTTTAATGATCCG
CTGACCTGGAGCCACAACCGTGTTGAAGGTAAGCAGGAGTACACCAGCCTGCTGTACATC
CCGTCCCAGGCTCCGTGGGATATGTGGAACCGCGATCATAAACACGGCCTGAAACTGTAT
GTTCAGCGTGTGTTCATCATGGACGACGCAGAACAGTTCATGCCGAACTATCTGCGCTTC
GTGCGTGGTCTGATTGACTCCAGCGATCTGCCGCTGAACGTTTCCCGTGAAATCCTCCAG
GACAGCACGGTAACGCGTAACCTGCGCAATGCGCTGACCAAGCGTGTGCTGCAAATGCTG
GAAAAACTGGCGAAAGACGACGCGGAAAAATACCAGACCTTCTGGCAACAGTTTGGCCTG
GTACTGAAAGAAGGTCCGGCGGAAGATTTCGCTAACCAGGAAGCGATCGCCAAACTGCTG
CGTTTTGCTTCTACCCATACCGATTCTTCTGCGCAGACCGTATCTCTGGAAGACTACGTT
TCCCGCATGAAAGAAGGGCAGGAGAAAATCTACTACATCACCGCAGACAGCTATGCGGCA
GCGAAGAGCAGCCCGCACCTGGAACTGCTGCGTAAGAAAGGCATCGAAGTTCTGCTGCTT
TCCGACCGCATCGATGAGTGGATGATGAACTATCTGACTGAGTTCGACGGTAAACCGTTC
CAGTCGGTGTCTAAAGTTGACGAGTCGCTTGAAAAACTGGCTGACGAAGTTGATGAGAGC
GCGAAAGAAGCGGAGAAAGCACTGACTCCGTTCATCGACCGTGTGAAAGCCCTGCTCGGC
GAGCGCGTGAAAGATGTCCGTCTGACTCACCGTCTGACCGATACGCCAGCGATCGTTTCG
ACCGACGCGGACGAAATGAGCACTCAGATGGCGAAACTGTTCGCTGCGGCGGGCCAGAAA
GTGCCAGAAGTGAAATACATCTTCGAACTGAACCCGGATCACGTACTGGTGAAACGTGCG
GCAGATACTGAAGATGAAGCGAAGTTCAGCGAGTGGGTAGAACTGCTGCTGGATCAGGCG
CTGCTGGCAGAACGCGGCACGCTGGAAGATCCGAACCTGTTTATTCGTCGTATGAACCAG
CTGCTGGTTTCCTGA

# Drug_Target_118_General_Function:
Involved in ATP binding

# Drug_Target_118_General_References:
11237871	Nemoto TK, Ono T, Tanaka K: Substrate-binding characteristics of proteins in the 90 kDa heat shock protein family. Biochem J. 2001 Mar 15;354(Pt 3):663-70.
11606187	Nemoto TK, Ono T, Kobayakawa T, Tanaka E, Baba TT, Tanaka K, Takagi T, Gotoh T: Domain-domain interactions of HtpG, an Escherichia coli homologue of eukaryotic HSP90 molecular chaperone. Eur J Biochem. 2001 Oct;268(20):5258-69.
2647735	Spence J, Georgopoulos C: Purification and properties of the Escherichia coli heat shock protein, HtpG. J Biol Chem. 1989 Mar 15;264(8):4398-403.
3299380	Bardwell JC, Craig EA: Eukaryotic Mr 83,000 heat shock protein has a homologue in Escherichia coli. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5177-81.
8419347	Nadeau K, Das A, Walsh CT: Hsp90 chaperonins possess ATPase activity and bind heat shock transcription factors and peptidyl prolyl isomerases. J Biol Chem. 1993 Jan 15;268(2):1479-87.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_118_HGNC_ID:
Not Available

# Drug_Target_118_HPRD_ID:
Not Available

# Drug_Target_118_ID:
5315

# Drug_Target_118_Locus:
Not Available

# Drug_Target_118_Molecular_Weight:
71423

# Drug_Target_118_Name:
Chaperone protein htpG

# Drug_Target_118_Number_of_Residues:
624

# Drug_Target_118_PDB_ID:
1Y4U

# Drug_Target_118_Pathway:
Not Available

# Drug_Target_118_Pfam_Domain_Function:
PF00183	HSP90
PF02518	HATPase_c

# Drug_Target_118_Protein_Sequence:
>Chaperone protein htpG
MKGQETRGFQSEVKQLLHLMIHSLYSNKEIFLRELISNASDAADKLRFRALSNPDLYEGD
GELRVRVSFDKDKRTLTISDNGVGMTRDEVIDHLGTIAKSGTKSFLESLGSDQAKDSQLI
GQFGVGFYSAFIVADKVTVRTRAAGEKPENGVFWESAGEGEYTVADITKEDRGTEITLHL
REGEDEFLDDWRVRSIISKYSDHIALPVEIEKREEKDGETVISWEKINKAQALWTRNKSE
ITDEEYKEFYKHIAHDFNDPLTWSHNRVEGKQEYTSLLYIPSQAPWDMWNRDHKHGLKLY
VQRVFIMDDAEQFMPNYLRFVRGLIDSSDLPLNVSREILQDSTVTRNLRNALTKRVLQML
EKLAKDDAEKYQTFWQQFGLVLKEGPAEDFANQEAIAKLLRFASTHTDSSAQTVSLEDYV
SRMKEGQEKIYYITADSYAAAKSSPHLELLRKKGIEVLLLSDRIDEWMMNYLTEFDGKPF
QSVSKVDESLEKLADEVDESAKEAEKALTPFIDRVKALLGERVKDVRLTHRLTDTPAIVS
TDADEMSTQMAKLFAAAGQKVPEVKYIFELNPDHVLVKRAADTEDEAKFSEWVELLLDQA
LLAERGTLEDPNLFIRRMNQLLVS

# Drug_Target_118_Reaction:
Not Available

# Drug_Target_118_Signals:
None

# Drug_Target_118_Specific_Function:
Molecular chaperone. Has ATPase activity

# Drug_Target_118_SwissProt_ID:
P0A6Z3

# Drug_Target_118_SwissProt_Name:
HTPG_ECOLI

# Drug_Target_118_Synonyms:
Heat shock protein C62.5
Heat shock protein htpG
High temperature protein G

# Drug_Target_118_Theoretical_pI:
4.85

# Drug_Target_118_Transmembrane_Regions:
None

# Drug_Target_119_Cellular_Location:
Not Available

# Drug_Target_119_Chromosome_Location:
Not Available

# Drug_Target_119_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_119_Essentiality:
Non-Essential

# Drug_Target_119_GenAtlas_ID:
Not Available

# Drug_Target_119_GenBank_ID_Gene:
Not Available

# Drug_Target_119_GenBank_ID_Protein:
Not Available

# Drug_Target_119_GeneCard_ID:
Not Available

# Drug_Target_119_Gene_Name:
KIF3B

# Drug_Target_119_Gene_Sequence:
Not Available

# Drug_Target_119_General_Function:
Not Available

# Drug_Target_119_General_References:
Not Available

# Drug_Target_119_HGNC_ID:
Not Available

# Drug_Target_119_HPRD_ID:
Not Available

# Drug_Target_119_ID:
7097

# Drug_Target_119_Locus:
Not Available

# Drug_Target_119_Molecular_Weight:
Not Available

# Drug_Target_119_Name:
Kinesin-like protein KIF3B

# Drug_Target_119_Number_of_Residues:
0

# Drug_Target_119_PDB_ID:
Not Available

# Drug_Target_119_Pathway:
Not Available

# Drug_Target_119_Pfam_Domain_Function:
Not Available

# Drug_Target_119_Protein_Sequence:
Not Available

# Drug_Target_119_Reaction:
Not Available

# Drug_Target_119_Signals:
Not Available

# Drug_Target_119_Specific_Function:
Not Available

# Drug_Target_119_SwissProt_ID:
O15066

# Drug_Target_119_SwissProt_Name:
KIF3B_HUMAN

# Drug_Target_119_Synonyms:
Not Available

# Drug_Target_119_Theoretical_pI:
Not Available

# Drug_Target_119_Transmembrane_Regions:
Not Available

# Drug_Target_11_Cellular_Location:
Not Available

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_11_Essentiality:
Non-Essential

# Drug_Target_11_GenAtlas_ID:
Not Available

# Drug_Target_11_GenBank_ID_Gene:
X03954

# Drug_Target_11_GenBank_ID_Protein:
581100

# Drug_Target_11_GeneCard_ID:
Not Available

# Drug_Target_11_Gene_Name:
gshA

# Drug_Target_11_Gene_Sequence:
>1557 bp
TTGATCCCGGACGTATCACAGGCGCTGGCCTGGCTGGAAAAACATCCTCAGGCGTTAAAG
GGGATACAGCGTGGGCTGGAGCGCGAAACTTTGCGTGTTAATGCTGATGGCACACTGGCA
ACAACAGGTCATCCTGAAGCATTAGGTTCCGCACTGACGCACAAATGGATTACTACCGAT
TTTGCGGAAGCATTGCTGGAATTCATTACACCAGTGGATGGTGATATTGAACATATGCTG
ACCTTTATGCGCGATCTGCATCGTTATACGGCGCGCAATATGGGCGATGAGCGGATGTTG
CCGTTAAGTATGCCATGCTACATCGCAGAAGGTCAGGACATCGAACTGGCACAGTACGGC
ACTTCTAACACCGGACGCTTTAAAACGCTGTATCGTGAAGGGCTGAAAAATCGCTACGGC
GCGCTGATGCAAACCATTTCCGGCGTGCACTACAATTTCTCTTTGCCAATGGCATTCTGG
CAAGCGAAGTGCGGTGATATCTCGGGCGCTGATGCCAAAGAGAAAATTTCTGCGGGCTAT
TTCCGCGTTATCCGCAATTACTATCGTTTCGGTTGGGTCATTCCTTATCTGTTTGGTGCA
TCTCCGGCGATTTGTTCTTCTTTCCTGCAAGGAAAACCAACGTCGCTGCCGTTTGAGAAA
ACCGAGTGCGGTATGTATTACCTGCCGTATGCGACCTCTCTTCGTTTGAGCGATCTCGGC
TATACCAATAAATCGCAAAGCAATCTTGGTATTACCTTCAACGATCTTTACGAATACGTA
GCGGGCCTTAAACAGGCAATCAAAACGCCATCGGAAGAGTACGCGAAGATTGGTATTGAG
AAAGACGGTAAGAGGCTGCAAATCAACAGCAACGTGTTGCAGATTGAAAACGAACTGTAC
GCGCCGATTCGTCCAAAACGCGTTACCCGCAGCGGCGAGTCGCCTTCTGATGCGCTGTTA
CGTGGCGGCATTGAATATATTGAAGTGCGTTCGCTGGACATCAACCCGTTCTCGCCGATT
GGTGTAGATGAACAGCAGGTGCGATTCCTCGACCTGTTTATGGTCTGGTGTGCGCTGGCT
GATGCACCGGAAATGAGCAGTAGCGAACTTGCCTGTACACGCGTTAACTGGAACCGGGTG
ATCCTCGAAGGTCGCAAACCGGGTCTGACGCTGGGTATCGGCTGCGAAACCGCACAGTTC
CCGTTACCGCAGGTGGGTAAAGATCTGTTCCGCGATCTGAAACGCGTCGCGCAAACGCTG
GATAGTATTAACGGCGGCGAAGCGTATCAGAAAGTGTGTGATGAACTGGTTGCCTGCTTC
GATAATCCCGATCTGACTTTCTCTGCCCGTATCTTAAGGTCTATGATTGATACTGGTATT
GGCGGAACAGGCAAAGCATTTGCAGAAGCCTACCGTAATCTGCTGCGTGAAGAGCCGCTG
GAAATTCTGCGCGAAGAGGATTTTGTAGCCGAGCGCGAGGGCTTCGAACGCCGTCAGCAG
GAAATGGAAGCCGCTGATACCGAACCGTTTGCGGTGTGGCTGGAAAAACACGCCTGA

# Drug_Target_11_General_Function:
Coenzyme transport and metabolism

# Drug_Target_11_General_References:
2872655	Watanabe K, Yamano Y, Murata K, Kimura A: The nucleotide sequence of the gene for gamma-glutamylcysteine synthetase of Escherichia coli. Nucleic Acids Res. 1986 Jun 11;14(11):4393-400.
9205837	Yamamoto Y, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kimura S, Kitagawa M, Makino K, Miki T, Mitsuhashi N, Mizobuchi K, Mori H, Nakade S, Nakamura Y, Nashimoto H, Oshima T, Oyama S, Saito N, Sampei G, Satoh Y, Sivasundaram S, Tagami H, Horiuchi T, et al.: Construction of a contiguous 874-kb sequence of the Escherichia coli -K12 genome corresponding to 50.0-68.8 min on the linkage map and analysis of its sequence features. DNA Res. 1997 Apr 28;4(2):91-113.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_11_HGNC_ID:
Not Available

# Drug_Target_11_HPRD_ID:
Not Available

# Drug_Target_11_ID:
3175

# Drug_Target_11_Locus:
Not Available

# Drug_Target_11_Molecular_Weight:
58270

# Drug_Target_11_Name:
Glutamate--cysteine ligase

# Drug_Target_11_Number_of_Residues:
518

# Drug_Target_11_PDB_ID:
1VA6

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
PF04262	Glu_cys_ligase

# Drug_Target_11_Protein_Sequence:
>Glutamate--cysteine ligase
MIPDVSQALAWLEKHPQALKGIQRGLERETLRVNADGTLATTGHPEALGSALTHKWITTD
FAEALLEFITPVDGDIEHMLTFMRDLHRYTARNMGDERMWPLSMPCYIAEGQDIELAQYG
TSNTGRFKTLYREGLKNRYGALMQTISGVHYNFSLPMAFWQAKCGDISGADAKEKISAGY
FRVIRNYYRFGWVIPYLFGASPAICSSFLQGKPTSLPFEKTECGMYYLPYATSLRLSDLG
YTNKSQSNLGITFNDLYEYVAGLKQAIKTPSEEYAKIGIEKDGKRLQINSNVLQIENELY
APIRPKRVTRSGESPSDALLRGGIEYIEVRSLDINPFSPIGVDEQQVRFLDLFMVWCALA
DAPEMSSSELACTRVNWNRVILEGRKPGLTLGIGCETAQFPLPQVGKDLFRDLKRVAQTL
DSINGGEAYQKVCDELVACFDNPDLTFSARILRSMIDTGIGGTGKAFAEAYRNLLREEPL
EILREEDFVAEREASERRQQEMEAADTEPFAVWLEKHA

# Drug_Target_11_Reaction:
ATP + L-glutamate + L-cysteine = ADP + phosphate + gamma-L-glutamyl-L-cysteine

# Drug_Target_11_Signals:
None

# Drug_Target_11_Specific_Function:
ATP + L-glutamate + L-cysteine = ADP + phosphate + gamma-L-glutamyl-L-cysteine

# Drug_Target_11_SwissProt_ID:
P0A6W9

# Drug_Target_11_SwissProt_Name:
GSH1_ECOLI

# Drug_Target_11_Synonyms:
EC 6.3.2.2
GCS
Gamma-ECS
Gamma-glutamylcysteine synthetase

# Drug_Target_11_Theoretical_pI:
5.04

# Drug_Target_11_Transmembrane_Regions:
None

# Drug_Target_120_Cellular_Location:
Mitochondrion matrix

# Drug_Target_120_Chromosome_Location:
1

# Drug_Target_120_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_120_Essentiality:
Non-Essential

# Drug_Target_120_GenAtlas_ID:
Not Available

# Drug_Target_120_GenBank_ID_Gene:
L42451

# Drug_Target_120_GenBank_ID_Protein:
1088283

# Drug_Target_120_GeneCard_ID:
PDK2

# Drug_Target_120_Gene_Name:
PDK2

# Drug_Target_120_Gene_Sequence:
>1224 bp
ATGCGCTGGGTGTGGGCGCTGCTGAAGAATGCGTCCCTGGCAGGGGCGCCCAAGTACATA
GAGCACTTCAGCAAGTTCTCCCCGTCCCCGCTGTCCATGAAGCAGTTTCTGGACTTCGGA
TCCAGCAATGCCTGTGAGAAAACCTCCTTCACCTTCCTCAGGCAGGAGCTGCCTGTGCGC
CTGGCCAACATCATGAAAGAGATCAACCTGCTTCCCGACCGAGTGCTGAGCACACCCACC
GTGCAGCTGGTGCAGAGCTGGTATGTCCAGAGCCTCCTGGACATCATGGAGTTCCTGGAC
AAGGATCCTGAGGACCATCGCACCCTGAGCCAGTTCACTGACGCCCTGGTCACCATCCGG
AACCGGCACAACGACGTGGTGCCCACCATGGCACAAGGCGTGCTCGAGTACAAGGACACC
TACGGCGATGACCCCGTCTCCAACCAGAACATCCAGTACTTCCTGGACCGCTTCTACCTC
AGCCGCATCTCCATCCGCATGCTCATCAACCAGCACACCCTCATCTTTGATGGCAGCACC
AACCCAGCCCATCCCAAACACATCGGCAGCATCGACCCCAACTGCAACGTCTCTGAGGTG
GTCAAAGATGCCTACGACATGGCTAAGCTCCTGTGTGACAAGTATTACATGGCCTCACCT
GACCTGGAGATCCAGGAGATCAATGCAGCCAACTCCAAACAGCCGATTCACATGGTCTAC
GTCCCCTCCCACCTCTACCACATGCTCTTTGAGCTCTTCAAGAATGCCATGAGGGCGACT
GTGGAAAGCCATGAGTCCAGCCTCATTCTCCCACCCATCAAGGTCATGGTGGCCTTGGGT
GAGGAAGATCTGTCCATCAAGATGAGTGACCGAGGTGGGGGTGTTCCCTTGAGGAAGATT
GAGCGACTCTTCAGCTATATGTACTCCACAGCACCCACCCCCCAGCCTGGCACCGGGGGA
ACGCCGCTGGCTGGCTTTGGTTATGGGCTCCCCATTTCCCGCCTCTACGCCAAGTACTTC
CAGGGAGACCTGCAGCTCTTCTCCATGGAAGGCTTTGGGACCGATGCTGTCATCTATCTC
AAGGCCCTGTCCACGGACTCGGTGGAGCGCCTGCCTGTCTACAACAAGTCAGCCTGGCGC
CACTACCAGACCATCCAGGAGGCCGGCGACTGGTGTGTGCCCAGCACGGAGCCCAAGAAC
ACGTCCACGTACCGCGTCACGTAA

# Drug_Target_120_General_Function:
Signal transduction mechanisms

# Drug_Target_120_General_References:
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
17344846	Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O'Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew YE, DeFazio A, Greaves MF, Green AR, Campbell P, Birney E, Easton DF, Chenevix-Trench G, Tan MH, Khoo SK, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR: Patterns of somatic mutation in human cancer genomes. Nature. 2007 Mar 8;446(7132):153-8.
7499431	Gudi R, Bowker-Kinley MM, Kedishvili NY, Zhao Y, Popov KM: Diversity of the pyruvate dehydrogenase kinase gene family in humans. J Biol Chem. 1995 Dec 1;270(48):28989-94.

# Drug_Target_120_HGNC_ID:
GNC:8810

# Drug_Target_120_HPRD_ID:
Not Available

# Drug_Target_120_ID:
6857

# Drug_Target_120_Locus:
17q21.33

# Drug_Target_120_Molecular_Weight:
46153.4

# Drug_Target_120_Name:
[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial

# Drug_Target_120_Number_of_Residues:
407

# Drug_Target_120_PDB_ID:
1JM6

# Drug_Target_120_Pathway:
Not Available

# Drug_Target_120_Pfam_Domain_Function:
PF02518	HATPase_c
PF10436	BCDHK_Adom3

# Drug_Target_120_Protein_Sequence:
>[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial
MRWVWALLKNASLAGAPKYIEHFSKFSPSPLSMKQFLDFGSSNACEKTSFTFLRQELPVR
LANIMKEINLLPDRVLSTPSVQLVQSWYVQSLLDIMEFLDKDPEDHRTLSQFTDALVTIR
NRHNDVVPTMAQGVLEYKDTYGDDPVSNQNIQYFLDRFYLSRISIRMLINQHTLIFDGST
NPAHPKHIGSIDPNCNVSEVVKDAYDMAKLLCDKYYMASPDLEIQEINAANSKQPIHMVY
VPSHLYHMLFELFKNAMRATVESHESSLILPPIKVMVALGEEDLSIKMSDRGGGVPLRKI
ERLFSYMYSTAPTPQPGTGGTPLAGFGYGLPISRLYAKYFQGDLQLFSMEGFGTDAVIYL
KALSTDSVERLPVYNKSAWRHYQTIQEAGDWCVPSTEPKNTSTYRVS

# Drug_Target_120_Reaction:
Not Available

# Drug_Target_120_Signals:
None

# Drug_Target_120_Specific_Function:
Inhibits the mitochondrial pyruvate dehydrogenase complex by phosphorylation of the E1 alpha subunit, thus contributing to the regulation of glucose metabolism

# Drug_Target_120_SwissProt_ID:
Q15119

# Drug_Target_120_SwissProt_Name:
PDK2_HUMAN

# Drug_Target_120_Synonyms:
Pyruvate dehydrogenase kinase isoform 2

# Drug_Target_120_Theoretical_pI:
6.59

# Drug_Target_120_Transmembrane_Regions:
None

# Drug_Target_121_Cellular_Location:
Not Available

# Drug_Target_121_Chromosome_Location:
Not Available

# Drug_Target_121_Drug_References:
Not Available

# Drug_Target_121_Essentiality:
Non-Essential

# Drug_Target_121_GenAtlas_ID:
Not Available

# Drug_Target_121_GenBank_ID_Gene:
AF282852

# Drug_Target_121_GenBank_ID_Protein:
Not Available

# Drug_Target_121_GeneCard_ID:
Not Available

# Drug_Target_121_Gene_Name:
cag-alfa

# Drug_Target_121_Gene_Sequence:
>993 bp
CTACCTATGTTTGATATAAAATTCATCACACTGTTTGTGGTGGTTGATATGGACAATCAT
ATCAATCAAATCTTTAAAGCCCTCAATGAGACTTTCAAACTTGATATTCCTTGCTGCGCT
ATTAGATGAACTCATGTTGGCTAAACGAATAAACGCTTCTTCACTGCTCCCTGCATGCAG
AGTGGTTAGCGTGCCTTTATGACCGCTACAAAGCACATTATAAAAATCGTATGCCTCACT
GCTTCTGAGTTCCCCTAAAATGATTCTATCAGGCCGCATTCTCAGACATGACTTTAAGCA
ATCAGCAGAGGTGATATTCCCGCCAAAAAAAAGCTGTGTGTAGTTTTTGTGGTGTTTGAA
TACAATCTCTTCGGTGTCTTCAATGGATATGATCCTTTCTTCTTTAGGGATAAACTCCAT
GATGCTTTTGATATAAGTCGTTTTACCGCTTCCTGTGCCACCACAAACAATCACATTTTT
ACCAATAGCAATACCATCTTTAATCGCACTGATCGCTTGTTCTTTGTTGTCTAGTAGATT
ATAAAAACCTTGCTCTTCAAAGAAGCTATGAGGATAGGTTGTTTTGCTAGGTATCCTTAT
GGATATGGAAATGGTTTCATCATTAACTGTAACAGGGGAAAGGACAATCTGCACCCTTTC
ACCATTCGCTAAATTGCTGCTCAAAATAGGATTTTCATAGTTGTCTATTGTTTTTTTCTT
AAAACTTGCACAGCACCGAGCAAAATGCATTAAACGAGACAGGCTAAAGGCTTTCCTGTC
TCTCACATCAAATGGTTGCCATTCGCCATTATTTTTTAAAACCCATACAACCTTGTTCCC
ATTGTAACAAATCTCAGTGATATTTTCCATTTTTAAAAAATCGCCAAAAAGTTCTTCAGT
AGCATGCCTTAGAGGATTTAATGCTGCTTCTTTTAAAGCTCTTTCTACTTCTAGAAATTT
TTTATCTTCTGCACTCAATCTGTCTTCAGTCAT

# Drug_Target_121_General_Function:
Involved in ATP binding

# Drug_Target_121_General_References:
10684850	Covacci A, Rappuoli R: Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell. J Exp Med. 2000 Feb 21;191(4):587-92.
8962108	Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A: cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14648-53.
9252185	Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzegerald LM, Lee N, Adams MD, Hickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM, Cotton MD, Weidman JM, Fujii C, Bowman C, Watthey L, Wallin E, Hayes WS, Borodovsky M, Karp PD, Smith HO, Fraser CM, Venter JC: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997 Aug 7;388(6642):539-47.

# Drug_Target_121_HGNC_ID:
Not Available

# Drug_Target_121_HPRD_ID:
Not Available

# Drug_Target_121_ID:
4837

# Drug_Target_121_Locus:
Not Available

# Drug_Target_121_Molecular_Weight:
37580

# Drug_Target_121_Name:
Cag-alfa

# Drug_Target_121_Number_of_Residues:
330

# Drug_Target_121_PDB_ID:
1OPX

# Drug_Target_121_Pathway:
Not Available

# Drug_Target_121_Pfam_Domain_Function:
PF00437	GSPII_E

# Drug_Target_121_Protein_Sequence:
>Cag-alfa
MTEDRLSAEDKKFLEVERALKEAALNPLRHATEELFGDFLKMENITEICYNGNKVVWVLK
NNGEWQPFDVRDRKAFSLSRLMHFARCCASFKKKTIDNYENPILSSNLANGERVQIVLSP
VTVNDETISISIRIPSKTTYPHSFFEEQGFYNLLDNKEQAISAIKDGIAIGKNVIVCGGT
GSGKTTYIKSIMEFIPKEERIISIEDTEEIVFKHHKNYTQLFFGGNITSADCLKSCLRMR
PDRIILGELRSSEAYDFYNVLCSGHKGTLTTLHAGSSEEAFIRLANMSSSNSAARNIKFE
SLIEGFKDLIDMIVHINHHKQCDEFYIKHR

# Drug_Target_121_Reaction:
Not Available

# Drug_Target_121_Signals:
None

# Drug_Target_121_Specific_Function:
Not Available

# Drug_Target_121_SwissProt_ID:
Q7BK04

# Drug_Target_121_SwissProt_Name:
Q7BK04_HELPY

# Drug_Target_121_Synonyms:
Cag pathogenicity island protein
VirB11 homolog

# Drug_Target_121_Theoretical_pI:
6.89

# Drug_Target_121_Transmembrane_Regions:
None

# Drug_Target_12_Cellular_Location:
Cytoplasm

# Drug_Target_12_Chromosome_Location:
Not Available

# Drug_Target_12_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_12_Essentiality:
Non-Essential

# Drug_Target_12_GenAtlas_ID:
CKM

# Drug_Target_12_GenBank_ID_Gene:
M14780

# Drug_Target_12_GenBank_ID_Protein:
180576

# Drug_Target_12_GeneCard_ID:
CKM

# Drug_Target_12_Gene_Name:
CKM

# Drug_Target_12_Gene_Sequence:
>1146 bp
ATGCCATTCGGTAACACCCACAACAAGTTCAAGCTGAATTACAAGCCTGAGGAGGAGTAC
CCCGACCTCAGCAAACATAACAACCACATGGCCAAGGTACTGACCCTTGAACTCTACAAG
AAGCTGCGGGACAAGGAGATCCCATCTGGCTTCACTGTAGACGATGTCATCCAGACAGGA
GTGGACAACCCAGGTCACCCCTTCATCATGACCGTGGGCTGCGTGGCTGGTGATGAGGAG
TCCTACGAAGTTTTCAAGGAACTCTTTGACCCCATCATCTCGGATCGCCACGGGGGCTAC
AAACCCACTGACAAGCACAAGACTGACCTCAACCATGAAAACCTCAAGGGTGGAGACGAC
CTGGACCCCAACTACGTGCTCAGCAGCCCGGTCCGCACTGGCCGCAGCATCAAGGGCTAC
ACGTTGCCCCCACACTGCTCCCGTGGCGAGCGCCGGGCGGTGGAGAAGCTCTCTGTGGAA
GCTCTCAACAGCCTGACGGGCGAGTTCAAAGGGAAGTACTACCCTCTGAAGAGCATGACG
GAGAAGGAGCAGCAGCAGCTCATCGATGACCACTTCCAGTTCGACAAGCCCGTGTCCCCG
CTGCTGCTGGCCTCAGGCATGGCCCGCCACTGGCCCGACGCCCCTGGCATCTGGCACAAT
GACAACAAGAGCTTCCTGGTGTGGGTGAACGAGGAGGATCACCTCCGGGTCATCTCCATG
GAGAAGGGGGGCAACATGAAGGAGGTTTTCCGCCGCTTCTGCGTAGGGCTGCAGAAGATT
GAGGAGATCTTTAAGAAAGCTGGCCACCCCTTCATGTGGAACCAGCACCTGGGCTACGTG
CTCACCTGCCCATCCAACCTGGGCACTGGGCTGCGTGGAGGCGTGCATGTGAAGCTGGCG
CACCTGAGCAAGCACCCCAAGTTCGAGGAGATCCTCACCCGCCTGCGTCTGCAGAAGAGG
GGTACAGGTGCGGTGGACACAGCTGCCGTGGGCTCAGTATTTGACGTGTCCAACGCTGAT
CGGCTGGGCTCGTCCGAAGTAGAACAGGTGCAGCTGGTGGTGGATGGTGTGAAGCTCATG
GTGGAAATGGAGAAGAAGTTGGAGAAAGGCCAGTCCATCGACGACATGATCCCCGCCCAG
AAGTAG

# Drug_Target_12_General_Function:
Involved in kinase activity

# Drug_Target_12_General_References:
10089465	Tang L, Zhou HM, Lin ZJ: Crystallization and preliminary X-ray analysis of human muscle creatine kinase. Acta Crystallogr D Biol Crystallogr. 1999 Mar;55(Pt 3):669-70.
1690725	Hamburg RJ, Friedman DL, Olson EN, Ma TS, Cortez MD, Goodman C, Puleo PR, Perryman MB: Muscle creatine kinase isoenzyme expression in adult human brain. J Biol Chem. 1990 Apr 15;265(11):6403-9.
2903158	Trask RV, Strauss AW, Billadello JJ: Developmental regulation and tissue-specific expression of the human muscle creatine kinase gene. J Biol Chem. 1988 Nov 15;263(32):17142-9.
3031982	Nigro JM, Schweinfest CW, Rajkovic A, Pavlovic J, Jamal S, Dottin RP, Hart JT, Kamarck ME, Rae PM, Carty MD, et al.: cDNA cloning and mapping of the human creatine kinase M gene to 19q13. Am J Hum Genet. 1987 Feb;40(2):115-25.
3778496	Perryman MB, Kerner SA, Bohlmeyer TJ, Roberts R: Isolation and sequence analysis of a full-length cDNA for human M creatine kinase. Biochem Biophys Res Commun. 1986 Nov 14;140(3):981-9.

# Drug_Target_12_HGNC_ID:
HGNC:1994

# Drug_Target_12_HPRD_ID:
00426

# Drug_Target_12_ID:
788

# Drug_Target_12_Locus:
19q13.2-q13.3

# Drug_Target_12_Molecular_Weight:
43102

# Drug_Target_12_Name:
Creatine kinase M-type

# Drug_Target_12_Number_of_Residues:
381

# Drug_Target_12_PDB_ID:
1I0E

# Drug_Target_12_Pathway:
Not Available

# Drug_Target_12_Pfam_Domain_Function:
PF00217	ATP-gua_Ptrans
PF02807	ATP-gua_PtransN

# Drug_Target_12_Protein_Sequence:
>Creatine kinase M-type
MPFGNTHNKFKLNYKPEEEYPDLSKHNNHMAKVLTLELYKKLRDKETPSGFTVDDVIQTG
VDNPGHPFIMTVGCVAGDEESYEVFKELFDPIISDRHGGYKPTDKHKTDLNHENLKGGDD
LDPNYVLSSRVRTGRSIKGYTLPPHCSRGERRAVEKLSVEALNSLTGEFKGKYYPLKSMT
EKEQQQLIDDHFLFDKPVSPLLLASGMARDWPDARGIWHNDNKSFLVWVNEEDHLRVISM
EKGGNMKEVFRRFCVGLQKIEEIFKKAGHPFMWNQHLGYVLTCPSNLGTGLRGGVHVKLA
HLSKHPKFEEILTRLRLQKRGTGGVDTAAVGSVFDVSNADRLGSSEVEQVQLVVDGVKLM
VEMEKKLEKGQSIDDMIPAQK

# Drug_Target_12_Reaction:
ATP + creatine = ADP + phosphocreatine

# Drug_Target_12_Signals:
None

# Drug_Target_12_Specific_Function:
Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa

# Drug_Target_12_SwissProt_ID:
P06732

# Drug_Target_12_SwissProt_Name:
KCRM_HUMAN

# Drug_Target_12_Synonyms:
Creatine kinase M chain
EC 2.7.3.2
M-CK

# Drug_Target_12_Theoretical_pI:
7.28

# Drug_Target_12_Transmembrane_Regions:
None

# Drug_Target_13_Cellular_Location:
Cytoplasm. Melanosome. Note=Identified by mass spectrometry in melanosome fractions from stage I to

# Drug_Target_13_Chromosome_Location:
Not Available

# Drug_Target_13_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_13_Essentiality:
Non-Essential

# Drug_Target_13_GenAtlas_ID:
HSP90AB1

# Drug_Target_13_GenBank_ID_Gene:
M16660

# Drug_Target_13_GenBank_ID_Protein:
306891

# Drug_Target_13_GeneCard_ID:
HSP90AB1

# Drug_Target_13_Gene_Name:
HSP90AB1

# Drug_Target_13_Gene_Sequence:
>2175 bp
ATGCCTGAGGAAGTGCACCATGGAGAGGAGGAGGTGGAGACTTTTGCCTTTCAGGCAGAA
ATTGCCCAACTCATGTCCCTCATCATCAATACCTTCTATTCCAACAAGGAGATTTTCCTT
CGGGAGTTGATCTCTAATGCTTCTGATGCCTTGGACAAGATTCGCTATGAGAGCCTGACA
GACCCTTCGAAGTTGGACAGTGGTAAAGAGCTGAAAATTGACATCATCCCCAACCCTCAG
GAACGTACCCTGACTTTGGTAGACACAGGCATTGGCATGACCAAAGCTGATCTCATAAAT
AATTTGGGAACCATTGCCAAGTCTGGTACTAAAGCATTCATGGAGGCTCTTCAGGCTGGT
GCAGACATCTCCATGATTGGGCAGTTTGGTGTTGGCTTTTATTCTGCCTACTTGGTGGCA
GAGAAAGTGGTTGTGATCAGAAAGCACAACGATGATGAACAGTATGCTTGGGAGTCTTCT
GCTGGAGGTTCCTTCACTGTGCGTGCTGACCATGGTGAGCCCATTGGCATGGGTACCAAA
GTGATCCTCCATCTTAAAGAAGATCAGACAGAGTACCTAGAAGAGAGGCGGGTCAAAGAA
GTAGTGAAGAAGCATTCTCAGTTCATAGGCTATCCCATCACCCTTTATTTGGAGAAGGAA
CGAGAGAAGGAAATTAGTGATGATGAGGCAGAGGAAGAGAAAGGTGAGAAAGAAGAGGAA
GATAAAGATGATGAAGAAAAGCCCAAGATCGAAGATGTGGGTTCAGATGAGGAGGATGAC
AGCGGTAAGGATAAGAAGAAGAAAACTAAGAAGATCAAAGAGAAATACATTGATCAGGAA
GAACTAAACAAGACCAAGCCTATTTGGACCAGAAACCCTGATGACATCACCCAAGAGGAG
TATGGAGAATTCTACAAGAGCCTCACTAATGACTGGGAAGACCACTTGGCAGTCAAGCAC
TTTTCTGTAGAAGGTCAGTTGGAATTCAGGGCATTGCTATTTATTCCTCGTCGGGCTCCC
TTTGACCTTTTTGAGAACAAGAAGAAAAAGAACAACATCAAACTCTATGTCCGCCGTGTG
TTCATCATGGACAGCTGTGATGAGTTGATACCAGAGTATCTCAATTTTATCCGTGGTGTG
GTTGACTCTGAGGATCTGCCCCTGAACATCTCCCGAGAAATGCTCCAGCAGAGCAAAATC
TTGAAAGTCATTCGCAAAAACATTGTTAAGAAGTGCCTTGAGCTCTTCTCTGAGCTGGCA
GAAGACAAGGAGAATTACAAGAAATTCTATGAGGCATTCTCTAAAAATCTCAAGCTTGGA
ATCCACGAAGACTCCACTAACCGCCGCCGCCTGTCTGAGCTGCTGCGCTATCATACCTCC
CAGTCTGGAGATGAGATGACATCTCTGTCAGAGTATGTTTCTCGCATGAAGGAGACACAG
AAGTCCATCTATTACATCACTGGTGAGAGCAAAGAGCAGGTGGCCAACTCAGCTTTTGTG
GAGCGAGTGCGGAAACGGGGCTTCGAGGTGGTATATATGACCGAGCCCATTGACGAGTAC
TGTGTGCAGCAGCTCAAGGAATTTGATGGGAAGAGCCTGGTCTCAGTTACCAAGGAGGGT
CTGGAGCTGCCTGAGGATGAGGAGGAGAAGAAGAAGATGGAAGAGAGCAAGGCAAAGTTT
GAGAACCTCTGCAAGCTCATGAAAGAAATCTTAGATAAGAAGGTTGAGAAGGTGACAATC
TCCAATAGACTTGTGTCTTCACCTTGCTGCATTGTGACCAGCACCTACGGCTGGACAGCC
AATATGGAGCGGATCATGAAAGCCCAGGCACTTCGGGACAACTCCACCATGGGCTATATG
ATGGCCAAAAAGCACCTGGAGATCAACCCTGACCACCCCATTGTGGAGACGCTGCGGCAG
AAGGCTGAGGCCGACAAGAATGATAAGGCAGTTAAGGACCTGGTGGTGCTGCTGTTTGAA
ACCGCCCTGCTATCTTCTGGCTTTTCCCTTGAGGATCCCCAGACCCACTCCAACCGCATC
TATCGCATGATCAAGCTAGGTCTAGGTATTGATGAAGATGAAGTGGCAGCAGAGGAACCC
AATGCTGCAGTTCCTGATGAGATCCCCCCTCTCGAGGGCGATGAGGATGCGTCTCGCATG
GAAGAAGTCGATTAG

# Drug_Target_13_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_13_General_References:
14574404	Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, Wilming L, Jones MC, Horton R, Hunt SE, Scott CE, Gilbert JG, Clamp ME, Bethel G, Milne S, Ainscough R, Almeida JP, Ambrose KD, Andrews TD, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beare DM, Beasley H, Beasley O, Bird CP, Blakey S, Bray-Allen S, Brook J, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Clark SY, Clark G, Clee CM, Clegg S, Cobley V, Collier RE, Collins JE, Colman LK, Corby NR, Coville GJ, Culley KM, Dhami P, Davies J, Dunn M, Earthrowl ME, Ellington AE, Evans KA, Faulkner L, Francis MD, Frankish A, Frankland J, French L, Garner P, Garnett J, Ghori MJ, Gilby LM, Gillson CJ, Glithero RJ, Grafham DV, Grant M, Gribble S, Griffiths C, Griffiths M, Hall R, Halls KS, Hammond S, Harley JL, Hart EA, Heath PD, Heathcott R, Holmes SJ, Howden PJ, Howe KL, Howell GR, Huckle E, Humphray SJ, Humphries MD, Hunt AR, Johnson CM, Joy AA, Kay M, Keenan SJ, Kimberley AM, King A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd CR, Lloyd DM, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, Maslen GL, Matthews L, McCann OT, McLaren SJ, McLay K, McMurray A, Moore MJ, Mullikin JC, Niblett D, Nickerson T, Novik KL, Oliver K, Overton-Larty EK, Parker A, Patel R, Pearce AV, Peck AI, Phillimore B, Phillips S, Plumb RW, Porter KM, Ramsey Y, Ranby SA, Rice CM, Ross MT, Searle SM, Sehra HK, Sheridan E, Skuce CD, Smith S, Smith M, Spraggon L, Squares SL, Steward CA, Sycamore N, Tamlyn-Hall G, Tester J, Theaker AJ, Thomas DW, Thorpe A, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, White SS, Whitehead SL, Whittaker H, Wild A, Willey DJ, Wilmer TE, Wood JM, Wray PW, Wyatt JC, Young L, Younger RM, Bentley DR, Coulson A, Durbin R, Hubbard T, Sulston JE, Dunham I, Rogers J, Beck S: The DNA sequence and analysis of human chromosome 6. Nature. 2003 Oct 23;425(6960):805-11.
2469626	Hoffmann T, Hovemann B: Heat-shock proteins, Hsp84 and Hsp86, of mice and men: two related genes encode formerly identified tumour-specific transplantation antigens. Gene. 1988 Dec 30;74(2):491-501.
2492519	Lees-Miller SP, Anderson CW: Two human 90-kDa heat shock proteins are phosphorylated in vivo at conserved serines that are phosphorylated in vitro by casein kinase II. J Biol Chem. 1989 Feb 15;264(5):2431-7.
2768249	Rebbe NF, Hickman WS, Ley TJ, Stafford DW, Hickman S: Nucleotide sequence and regulation of a human 90-kDa heat shock protein gene. J Biol Chem. 1989 Sep 5;264(25):15006-11.
3301534	Rebbe NF, Ware J, Bertina RM, Modrich P, Stafford DW: Nucleotide sequence of a cDNA for a member of the human 90-kDa heat-shock protein family. Gene. 1987;53(2-3):235-45.
8180474	Takahashi I, Tanuma R, Hirata M, Hashimoto K: A cosmid clone at the D6S182 locus on human chromosome 6p12 contains the 90-kDa heat shock protein beta gene (HSP90 beta). Mamm Genome. 1994 Feb;5(2):121-2.
9150948	Ji H, Reid GE, Moritz RL, Eddes JS, Burgess AW, Simpson RJ: A two-dimensional gel database of human colon carcinoma proteins. Electrophoresis. 1997 Mar-Apr;18(3-4):605-13.

# Drug_Target_13_HGNC_ID:
HGNC:5258

# Drug_Target_13_HPRD_ID:
06763

# Drug_Target_13_ID:
3456

# Drug_Target_13_Locus:
6p12

# Drug_Target_13_Molecular_Weight:
83265

# Drug_Target_13_Name:
Heat shock protein HSP 90-beta

# Drug_Target_13_Number_of_Residues:
724

# Drug_Target_13_PDB_ID:
1UYM

# Drug_Target_13_Pathway:
Not Available

# Drug_Target_13_Pfam_Domain_Function:
PF00183	HSP90
PF02518	HATPase_c

# Drug_Target_13_Protein_Sequence:
>Heat shock protein HSP 90-beta
MPEEVHHGEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESLT
DPSKLDSGKELKIDIIPNPQERTLTLVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAG
ADISMIGQFGVGFYSAYLVAEKVVVITKHNDDEQYAWESSAGGSFTVRADHGEPIGRGTK
VILHLKEDQTEYLEERRVKEVVKKHSQFIGYPITLYLEKEREKEISDDEAEEEKGEKEEE
DKDDEEKPKIEDVGSDEEDDSGKDKKKKTKKIKEKYIDQEELNKTKPIWTRNPDDITQEE
YGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFIPRRAPFDLFENKKKKNNIKLYVRRV
FIMDSCDELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNIVKKCLELFSELA
EDKENYKKFYEAFSKNLKLGIHEDSTNRRRLSELLRYHTSQSGDEMTSLSEYVSRMKETQ
KSIYYITGESKEQVANSAFVERVRKRGFEVVYMTEPIDEYCVQQLKEFDGKSLVSVTKEG
LELPEDEEEKKKMEESKAKFENLCKLMKEILDKKVEKVTISNRLVSSPCCIVTSTYGWTA
NMERIMKAQALRDNSTMGYMMAKKHLEINPDHPIVETLRQKAEADKNDKAVKDLVVLLFE
TALLSSGFSLEDPQTHSNRIYRMIKLGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASRM
EEVD

# Drug_Target_13_Reaction:
Not Available

# Drug_Target_13_Signals:
None

# Drug_Target_13_Specific_Function:
Molecular chaperone. Has ATPase activity

# Drug_Target_13_SwissProt_ID:
P08238

# Drug_Target_13_SwissProt_Name:
HS90B_HUMAN

# Drug_Target_13_Synonyms:
HSP 84
HSP 90

# Drug_Target_13_Theoretical_pI:
4.68

# Drug_Target_13_Transmembrane_Regions:
None

# Drug_Target_14_Cellular_Location:
Not Available

# Drug_Target_14_Chromosome_Location:
Not Available

# Drug_Target_14_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_14_Essentiality:
Non-Essential

# Drug_Target_14_GenAtlas_ID:
MAT1A

# Drug_Target_14_GenBank_ID_Gene:
D49357

# Drug_Target_14_GenBank_ID_Protein:
220066

# Drug_Target_14_GeneCard_ID:
MAT1A

# Drug_Target_14_Gene_Name:
MAT1A

# Drug_Target_14_Gene_Sequence:
>1188 bp
ATGAATGGACCGGTGGATGGCTTGTGTGACCACTCTCTAAGTGAAGGAGTCTTCATGTTC
ACATCGGAGTCTGTGGGAGAGGGACACCCGGATAAGATCTGTGACCAGATCAGTGATGCA
GTGCTGGATGCCCATCTCAAGCAAGACCCCAATGCCAAGGTGGCCTGTGAGACAGTGTGC
AAGACCGGCATGGTGCTGCTGTGTGGTGAGATCACCTCAATGGCCATGGTGGACTACCAG
CGGGTGGTGAGGGACACCATCAAGCACATCGGCTACGATGACTCAGCCAAGGGCTTTGAC
TTCAAGACTTGCAACGTGCTGGTGGCTTTGGAGCAGCAATCCCCAGATATTGCCCAGTGC
GTCCATCTGGACAGAAATGAGGAGGATGTGGGGGCAGGAGATCAGGGTTTGATGTTCGGC
TATGCCACCGACGAGACAGAGGAGTGCATGCCCCTCACCATCATCCTTGCTCACAAGCTC
AACGCCCGGATGGCAGACCTCAGGCGCTCCGGCCTCCTCCCCTGGCTGCGGCCTGACTCT
AAGACTCAGGTGACAGTTCAGTACATGCAGGACAATGGCGCAGTCATCCCTGTGCGCATC
CACACCATCGTCATCTCTGTGCAGCACAACGAAGACATCACGCTGGAGGAGATGCGCAGG
GCCCTGAAGGAGCAAGTCATCAGGGCCGTGGTGCCGGCCAAGTACCTGGACGAAGACACC
GTCTACCACCTGCAGCCCAGTGGGCGGTTTGTCATCGGAGGTCCCCAGGGGGATGCGGGT
GTCACTGGCCGTAAGATTATTGTGGACACCTATGCGGCCTGGGGGGCTCATGGTGGTGGG
GCCTTCTCTGGGAAGGACTACACCAAGGTGGACCGCTCAGCCGCATATGCTGCCCGCTGG
GTGGCCAAGTCTCTGGTGAAAGCAGGGCTCTGCCGGAGAGTGCTTGTCCAGGTTTCCTAT
GCCATTGGTGTGGCCGAGCCGCTGTCCATTTCCATCTTCACCTACGGAACCTCTCAGAAG
ACAGAGCGAGAGCTGCTGGATGTGGTGCATAAGAACTTCGACCTCCGGCCGGGCGTCATT
GTCAGGGACTTGGATTTGAAGAAGCCCATCTACCAGAAGACAGCATGCTACGGCCATTTC
GGAAGAAGCGAGTTCCCATGGGAGGTTCCCAGGAAGCTTGTATTTTAG

# Drug_Target_14_General_Function:
Coenzyme transport and metabolism

# Drug_Target_14_General_References:
10677294	Chamberlin ME, Ubagai T, Mudd SH, Thomas J, Pao VY, Nguyen TK, Levy HL, Greene C, Freehauf C, Chou JY: Methionine adenosyltransferase I/III deficiency: novel mutations and clinical variations. Am J Hum Genet. 2000 Feb;66(2):347-55.
1772450	Horikawa S, Tsukada K: Molecular cloning and nucleotide sequence of cDNA encoding the human liver S-adenosylmethionine synthetase. Biochem Int. 1991 Sep;25(1):81-90.
7560086	Ubagai T, Lei KJ, Huang S, Mudd SH, Levy HL, Chou JY: Molecular mechanisms of an inborn error of methionine pathway. Methionine adenosyltransferase deficiency. J Clin Invest. 1995 Oct;96(4):1943-7.
8393662	Alvarez L, Corrales F, Martin-Duce A, Mato JM: Characterization of a full-length cDNA encoding human liver S-adenosylmethionine synthetase: tissue-specific gene expression and mRNA levels in hepatopathies. Biochem J. 1993 Jul 15;293 ( Pt 2):481-6.
8770875	Chamberlin ME, Ubagai T, Mudd SH, Wilson WG, Leonard JV, Chou JY: Demyelination of the brain is associated with methionine adenosyltransferase I/III deficiency. J Clin Invest. 1996 Aug 15;98(4):1021-7.
9042912	Chamberlin ME, Ubagai T, Mudd SH, Levy HL, Chou JY: Dominant inheritance of isolated hypermethioninemia is associated with a mutation in the human methionine adenosyltransferase 1A gene. Am J Hum Genet. 1997 Mar;60(3):540-6.

# Drug_Target_14_HGNC_ID:
HGNC:6903

# Drug_Target_14_HPRD_ID:
02013

# Drug_Target_14_ID:
453

# Drug_Target_14_Locus:
10q22

# Drug_Target_14_Molecular_Weight:
43648

# Drug_Target_14_Name:
S-adenosylmethionine synthetase isoform type-1

# Drug_Target_14_Number_of_Residues:
395

# Drug_Target_14_PDB_ID:
1O9T

# Drug_Target_14_Pathway:
Not Available

# Drug_Target_14_Pfam_Domain_Function:
PF00438	S-AdoMet_synt_N
PF02772	S-AdoMet_synt_M
PF02773	S-AdoMet_synt_C

# Drug_Target_14_Protein_Sequence:
>S-adenosylmethionine synthetase isoform type-1
MNGPVDGLCDHSLSEGVFMFTSESVGEGHPDKICDQISDAVLDAHLKQDPNAKVACETVC
KTGMVLLCGEITSMAMVDYQRVVRDTIKHIGYDDSAKGFDFKTCNVLVALEQQSPDIAQC
VHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIILAHKLNARMADLRRSGLLPWLRPDS
KTQVTVQYMQDNGAVIPVRIHTIVISVQHNEDITLEEMRRALKEQVIRAVVPAKYLDEDT
VYHLQPSGRFVIGGPQGDAGVTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARW
VAKSLVKAGLCRRVLVQVSYAIGVAEPLSISIFTYGTSQKTERELLDVVHKNFDLRPGVI
VRDLDLKKPIYQKTACYGHFGRSEFPWEVPRKLVF

# Drug_Target_14_Reaction:
ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine

# Drug_Target_14_Signals:
None

# Drug_Target_14_Specific_Function:
Catalyzes the formation of S-adenosylmethionine from methionine and ATP

# Drug_Target_14_SwissProt_ID:
Q00266

# Drug_Target_14_SwissProt_Name:
METK1_HUMAN

# Drug_Target_14_Synonyms:
AdoMet synthetase 1
EC 2.5.1.6
MAT-I/III
Methionine adenosyltransferase 1
Methionine adenosyltransferase I/III

# Drug_Target_14_Theoretical_pI:
6.24

# Drug_Target_14_Transmembrane_Regions:
None

# Drug_Target_15_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_15_Chromosome_Location:
Not Available

# Drug_Target_15_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_15_Essentiality:
Non-Essential

# Drug_Target_15_GenAtlas_ID:
Not Available

# Drug_Target_15_GenBank_ID_Gene:
AE004091

# Drug_Target_15_GenBank_ID_Protein:
9951641

# Drug_Target_15_GeneCard_ID:
Not Available

# Drug_Target_15_Gene_Name:
argB

# Drug_Target_15_Gene_Sequence:
>906 bp
ATGACCCTGAGTCGCGATGACGCCGCCCAGGTTGCCAAGGTCCTTTCCGAGGCCCTGCCC
TACATCCGCCGCTTCGTCGGCAAGACGCTGGTGATCAAGTACGGCGGCAACGCCATGGAG
AGCGAGGAGCTGAAGGCCGGCTTCGCCCGCGACGTGGTGCTGATGAAAGCGGTCGGCATC
AACCCGGTGGTGGTGCATGGCGGCGGCCCGCAGATCGGAGACCTGCTCAAGCGCCTGTCG
ATCGAGAGCCACTTCATCGACGGCATGCGCGTCACCGACGCGGCGACCATGGACGTGGTG
GAGATGGTCCTCGGCGGCCAGGTGAACAAGGACATCGTCAACCTGATCAACCGCCACGGC
GGCAGCGCCATCGGCCTGACCGGCAAGGACGCCGAGCTGATCCGCGCGAAGAAGCTCACC
GTGACCCGCCAGACCCCGGAGATGACCAAGCCGGAGATCATCGACATCGGCCACGTGGGC
GAAGTCACCGGGGTCAACGTCGGGCTGCTGAACATGCTGGTCAAGGGCGACTTCATTCCG
GTGATCGCGCCGATCGGCGTGGGCAGCAACGGCGAGTCCTACAACATCAATGCCGACCTG
GTGGCCGGCAAGGTGGCGGAAGCGCTGAAGGCCGAGAAACTGATGCTGCTGACCAACATC
GCCGGCCTGATGGACAAGCAGGGCCAGGTGCTGACCGGGCTGTCCACCGAACAGGTCAAC
GAGCTGATCGCCGACGGCACCATCTACGGCGGCATGCTGCCGAAGATCCGCTGCGCCCTG
GAAGCGGTGCAGGGCGGCGTGACCAGCGCGCACATCATCGATGGCCGGGTACCGAATGCC
GTGCTGCTGGAAATCTTCACCGACAGCGGCGTCGGCACCCTGATCAGCAACCGCAAGCGT
CACTGA

# Drug_Target_15_General_Function:
Amino acid transport and metabolism

# Drug_Target_15_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
12037312	Fernandez-Murga ML, Ramon-Maiques S, Gil-Ortiz F, Fita I, Rubio V: Towards structural understanding of feedback control of arginine biosynthesis: cloning and expression of the gene for the arginine-inhibited N-acetyl-L-glutamate kinase from Pseudomonas aeruginosa, purification and crystallization of the recombinant enzyme and preliminary X-ray studies. Acta Crystallogr D Biol Crystallogr. 2002 Jun;58(Pt 6 Pt 2):1045-7. Epub 2002 May 29.

# Drug_Target_15_HGNC_ID:
Not Available

# Drug_Target_15_HPRD_ID:
Not Available

# Drug_Target_15_ID:
3550

# Drug_Target_15_Locus:
Not Available

# Drug_Target_15_Molecular_Weight:
31850

# Drug_Target_15_Name:
Acetylglutamate kinase

# Drug_Target_15_Number_of_Residues:
301

# Drug_Target_15_PDB_ID:
1UVD

# Drug_Target_15_Pathway:
Not Available

# Drug_Target_15_Pfam_Domain_Function:
PF00696	AA_kinase

# Drug_Target_15_Protein_Sequence:
>Acetylglutamate kinase
MTLSRDDAAQVAKVLSEALPYIRRFVGKTLVIKYGGNAMESEELKAGFARDVVLMKAVGI
NPVVVHGGGPQIGDLLKRLSIESHFIDGMRVTDAATMDVVEMVLGGQVNKDIVNLINRHG
GSAIGLTGKDAELIRAKKLTVTRQTPEMTKPEIIDIGHVGEVTGVNVGLLNMLVKGDFIP
VIAPIGVGSNGESYNINADLVAGKVAEALKAEKLMLLTNIAGLMDKQGQVLTGLSTEQVN
ELIADGTIYGGMLPKIRCALEAVQGGVTSAHIIDGRVPNAVLLEIFTDSGVGTLISNRKR
H

# Drug_Target_15_Reaction:
ATP + N-acetyl-L-glutamate = ADP + N-acetyl-L-glutamyl 5-phosphate

# Drug_Target_15_Signals:
None

# Drug_Target_15_Specific_Function:
ATP + N-acetyl-L-glutamate = ADP + N-acetyl-L- glutamate 5-phosphate

# Drug_Target_15_SwissProt_ID:
Q9HTN2

# Drug_Target_15_SwissProt_Name:
ARGB_PSEAE

# Drug_Target_15_Synonyms:
AGK
EC 2.7.2.8
N-acetyl-L- glutamate 5-phosphotransferase
NAG kinase

# Drug_Target_15_Theoretical_pI:
6.81

# Drug_Target_15_Transmembrane_Regions:
None

# Drug_Target_16_Cellular_Location:
Not Available

# Drug_Target_16_Chromosome_Location:
Not Available

# Drug_Target_16_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_16_Essentiality:
Non-Essential

# Drug_Target_16_GenAtlas_ID:
Not Available

# Drug_Target_16_GenBank_ID_Gene:
Not Available

# Drug_Target_16_GenBank_ID_Protein:
Not Available

# Drug_Target_16_GeneCard_ID:
Not Available

# Drug_Target_16_Gene_Name:
DDX39B

# Drug_Target_16_Gene_Sequence:
Not Available

# Drug_Target_16_General_Function:
Not Available

# Drug_Target_16_General_References:
Not Available

# Drug_Target_16_HGNC_ID:
Not Available

# Drug_Target_16_HPRD_ID:
Not Available

# Drug_Target_16_ID:
7108

# Drug_Target_16_Locus:
Not Available

# Drug_Target_16_Molecular_Weight:
Not Available

# Drug_Target_16_Name:
Spliceosome RNA helicase BAT1

# Drug_Target_16_Number_of_Residues:
0

# Drug_Target_16_PDB_ID:
Not Available

# Drug_Target_16_Pathway:
Not Available

# Drug_Target_16_Pfam_Domain_Function:
Not Available

# Drug_Target_16_Protein_Sequence:
Not Available

# Drug_Target_16_Reaction:
Not Available

# Drug_Target_16_Signals:
Not Available

# Drug_Target_16_Specific_Function:
Not Available

# Drug_Target_16_SwissProt_ID:
Q13838

# Drug_Target_16_SwissProt_Name:
DX39B_HUMAN

# Drug_Target_16_Synonyms:
Not Available

# Drug_Target_16_Theoretical_pI:
Not Available

# Drug_Target_16_Transmembrane_Regions:
Not Available

# Drug_Target_17_Cellular_Location:
Nucleus. Mainly nuclear. Cytoplasm

# Drug_Target_17_Chromosome_Location:
Not Available

# Drug_Target_17_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_17_Essentiality:
Non-Essential

# Drug_Target_17_GenAtlas_ID:
CMPK

# Drug_Target_17_GenBank_ID_Gene:
AF070416

# Drug_Target_17_GenBank_ID_Protein:
6578133

# Drug_Target_17_GeneCard_ID:
CMPK

# Drug_Target_17_Gene_Name:
CMPK1

# Drug_Target_17_Gene_Sequence:
>687 bp
ATGCTGAGCCGCTGCCGCAGCGGGCTGCTCCACGTCCTGGGCCTTAGCTTCCTGCTGCAG
ACCCGCCGGCCGATTCTCCTCTGCTCTCCACGTCTCATGAAGCCGCTGGTCGTGTTCGTC
CTCGGCGGCCCCGGCGCCGGCAAGGGGACCCAGTGCGCCCGCATCGTCGAGAAATATGGC
TACACACACCTTTCTGCAGGAGAGCTGCTTCGTGATGAAAGGAAGAACCCAGATTCACAG
TATGGTGAACTTATTGAAAAGTACATTAAAGAAGGAAAGATTGTACCAGTTGAGATAACC
ATCAGTTTATTAAAGAGGGAAATGGATCAGACAATGGCTGCCAATGCTCAGAAGAATAAA
TTCTTGATTGATGGGTTTCCAAGAAATCAAGACAACCTTCAAGGATGGAACAAGACCATG
GATGGGAAGGCAGATGTATCTTTCGTTCTCTTTTTTGACTGTAATAATGAGATTTGTATT
GAACGATGTCTTGAGAGGGGAAAGAGTAGTGGTAGGAGTGATGACAACAGAGAGAGCTTG
GAAAAGAGAATTCAGACCTACCTTCAGTCAACAAAGCCAATTATTGACTTATATGAAGAA
ATGGGGAAAGTCAAGAAAATAGATGCTTCTAAATCTGTTGATGAAGTTTTTGATGAAGTT
GTGCAGATTTTTGACAAGGAAGGCTAA

# Drug_Target_17_General_Function:
Nucleotide transport and metabolism

# Drug_Target_17_General_References:
10931946	Hu RM, Han ZG, Song HD, Peng YD, Huang QH, Ren SX, Gu YJ, Huang CH, Li YB, Jiang CL, Fu G, Zhang QH, Gu BW, Dai M, Mao YF, Gao GF, Rong R, Ye M, Zhou J, Xu SH, Gu J, Shi JX, Jin WR, Zhang CK, Wu TM, Huang GY, Chen Z, Chen MD, Chen JL: Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning. Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9543-8.
1286669	Hochstrasser DF, Frutiger S, Paquet N, Bairoch A, Ravier F, Pasquali C, Sanchez JC, Tissot JD, Bjellqvist B, Vargas R, et al.: Human liver protein map: a reference database established by microsequencing and gel comparison. Electrophoresis. 1992 Dec;13(12):992-1001.
8313870	Hughes GJ, Frutiger S, Paquet N, Pasquali C, Sanchez JC, Tissot JD, Bairoch A, Appel RD, Hochstrasser DF: Human liver protein map: update 1993. Electrophoresis. 1993 Nov;14(11):1216-22.

# Drug_Target_17_HGNC_ID:
HGNC:18170

# Drug_Target_17_HPRD_ID:
18258

# Drug_Target_17_ID:
702

# Drug_Target_17_Locus:
1p32

# Drug_Target_17_Molecular_Weight:
22223

# Drug_Target_17_Name:
UMP-CMP kinase

# Drug_Target_17_Number_of_Residues:
196

# Drug_Target_17_PDB_ID:
1TEV

# Drug_Target_17_Pathway:
Gemcitabine Pathway	SMP00446

# Drug_Target_17_Pfam_Domain_Function:
PF00406	ADK

# Drug_Target_17_Protein_Sequence:
>UMP-CMP kinase
MKPLVVFVLGGPGAGKGTQCARIVEKYGYTHLSAGELLRDERKNPDSQYGELIEKYIKEG
KIVPVEITISLLKREMDQTMAANAQKNKFLIDGFPRNQDNLQGWNKTMDGKADVSFVLFF
DCNNEICIERCLERGKSSGRSDDNRESLEKRIQTYLQSTKPIIDLYEEMGKVKKIDASKS
VDEVFDEVVQIFDKEG

# Drug_Target_17_Reaction:
ATP + (d)CMP = ADP + (d)CDP

# Drug_Target_17_Signals:
None

# Drug_Target_17_Specific_Function:
Catalyzes specific phosphoryl transfer from ATP to UMP and CMP

# Drug_Target_17_SwissProt_ID:
P30085

# Drug_Target_17_SwissProt_Name:
KCY_HUMAN

# Drug_Target_17_Synonyms:
Cytidine monophosphate kinase
Cytidylate kinase
Deoxycytidylate kinase
EC 2.7.4.14
UMP/CMP kinase
UMP/CMPK
Uridine monophosphate kinase
Uridine monophosphate/cytidine monophosphate kinase

# Drug_Target_17_Theoretical_pI:
5.20

# Drug_Target_17_Transmembrane_Regions:
None

# Drug_Target_18_Cellular_Location:
Not Available

# Drug_Target_18_Chromosome_Location:
Not Available

# Drug_Target_18_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_18_Essentiality:
Non-Essential

# Drug_Target_18_GenAtlas_ID:
Not Available

# Drug_Target_18_GenBank_ID_Gene:
Not Available

# Drug_Target_18_GenBank_ID_Protein:
Not Available

# Drug_Target_18_GeneCard_ID:
Not Available

# Drug_Target_18_Gene_Name:
ABCA6

# Drug_Target_18_Gene_Sequence:
Not Available

# Drug_Target_18_General_Function:
Not Available

# Drug_Target_18_General_References:
Not Available

# Drug_Target_18_HGNC_ID:
Not Available

# Drug_Target_18_HPRD_ID:
Not Available

# Drug_Target_18_ID:
7099

# Drug_Target_18_Locus:
Not Available

# Drug_Target_18_Molecular_Weight:
Not Available

# Drug_Target_18_Name:
ATP-binding cassette sub-family A member 6

# Drug_Target_18_Number_of_Residues:
0

# Drug_Target_18_PDB_ID:
Not Available

# Drug_Target_18_Pathway:
Not Available

# Drug_Target_18_Pfam_Domain_Function:
Not Available

# Drug_Target_18_Protein_Sequence:
Not Available

# Drug_Target_18_Reaction:
Not Available

# Drug_Target_18_Signals:
Not Available

# Drug_Target_18_Specific_Function:
Not Available

# Drug_Target_18_SwissProt_ID:
Q8N139

# Drug_Target_18_SwissProt_Name:
ABCA6_HUMAN

# Drug_Target_18_Synonyms:
Not Available

# Drug_Target_18_Theoretical_pI:
Not Available

# Drug_Target_18_Transmembrane_Regions:
Not Available

# Drug_Target_19_Cellular_Location:
Cytoplasm

# Drug_Target_19_Chromosome_Location:
Not Available

# Drug_Target_19_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_19_Essentiality:
Non-Essential

# Drug_Target_19_GenAtlas_ID:
Not Available

# Drug_Target_19_GenBank_ID_Gene:
M14536

# Drug_Target_19_GenBank_ID_Protein:
154090

# Drug_Target_19_GeneCard_ID:
Not Available

# Drug_Target_19_Gene_Name:
glnA

# Drug_Target_19_Gene_Sequence:
>1407 bp
ATGTCCGCTGAACACGTTTTGACGATGCTGAACGAGCACGAAGTGAAGTTTGTCGATCTG
CGCTTCACCGATACCAAAGGCAAAGAACAGCACGTCACGATTCCTGCTCATCAGGTAAAT
GCCGAATTCTTTGAAGAAGGCAAAATGTTTGACGGCTCCTCTATCGGCGGCTGGAAAGGC
ATTAACGAATCCGACATGGTGCTGATGCCCGATGCGTCCACTGCGGTTATCGACCCGTTC
TTCGCGGACTCCACCCTGATTATCCGTTGTGACATCCTGGAGCCTGGCACTCTGCAAGGT
TATGACCGTGACCCACGTTCCATCGCAAAACGTGCGGAAGACTACCTGCGCGCGACCGGT
ATCGCCGATACCGTCCTGTTTGGGCCGGAACCTGAATTCTTCCTGTTCGACGACATCCGC
TTCGGCGCATCTATCTCCGGCTCACATGTGGCGATTGACGATATTGAAGGCGCCTGGAAC
TCCTCTACCAAGTACGAAGGCGGCAACAAAGGCCATCGTCCGGGCGTGAAAGGCGGTTAT
TTCCCGGTTCCGCCAGTTGACTCCGCGCAGGATATCCGTTCTGAAATGTGTCTGGTCATG
GAGCAGATGGGCCTGGTCGTTGAAGCGCACCACCACGAAGTAGCGACCGCAGGTCAGAAC
GAAGTCGCGACCCGCTTTAACACCATGACCAAAAAAGCCGACGAAATTCAGATTTACAAA
TATGTCGTGCATAACGTGGCTCACCGCTTCGGTAAGACCGCGACCTTTATGCCAAAACCG
ATGTTCGGCGATAACGGTTCCGGTATGCACTGCCACATGTCTCTGGCGAAGAACGGCACC
AACCTGTTCTCTGGCGACAAATATGCCGGCCTGTCTGAACAAGCGCTGTACTACATCGGC
GGCGTCATCAAACACGCCAAAGCCATCAACGCCCTGGCGAACCCGACCACCAACTCCTAC
AAGCGTCTGGTCCCGGGTTACGAAGCGCCGGTGATGCTGGCCTACTCCGCCCGTAACCGT
TCCGCCTCCATCCGTATTCCGGTGGTGGCGTCTCCGAAAGCGCGCCGTATCGAAGTTCGC
TTCCCGGACCCGGCGGCTAACCCGTATCTGTGCTTTGCCGCCCTGCTGATGGCCGGTCTG
GACGGGATTAAGAATAAGATTCACCCGGGCGAACCGATGGACAAAAACCTGTATGACCTG
CCGCCGGAAGAAGCGAAAGAGATCCCACAGGTAGCGGGTTCTCTGGAAGAAGCGCTGAAC
GCGCTGGACCTGGACCGCGAGTTCCTGAAAGCAGGCGGCGTGTTCACTGATGAAGCGATC
GATGCGTATATTGCGCTGCGTCCGGAAGAAGATGACCGCGTGCGTATGACCCCGCACCCG
GTAGAGTTTGAGCTGTACTACAGCGTT

# Drug_Target_19_General_Function:
Amino acid transport and metabolism

# Drug_Target_19_General_References:
11329256	Gill HS, Eisenberg D: The crystal structure of phosphinothricin in the active site of glutamine synthetase illuminates the mechanism of enzymatic inhibition. Biochemistry. 2001 Feb 20;40(7):1903-12.
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
2572586	Yamashita MM, Almassy RJ, Janson CA, Cascio D, Eisenberg D: Refined atomic model of glutamine synthetase at 3.5 A resolution. J Biol Chem. 1989 Oct 25;264(30):17681-90.
2879772	Janson CA, Kayne PS, Almassy RJ, Grunstein M, Eisenberg D: Sequence of glutamine synthetase from Salmonella typhimurium and implications for the protein structure. Gene. 1986;46(2-3):297-300.

# Drug_Target_19_HGNC_ID:
Not Available

# Drug_Target_19_HPRD_ID:
Not Available

# Drug_Target_19_ID:
3426

# Drug_Target_19_Locus:
Not Available

# Drug_Target_19_Molecular_Weight:
51786

# Drug_Target_19_Name:
Glutamine synthetase

# Drug_Target_19_Number_of_Residues:
469

# Drug_Target_19_PDB_ID:
2GLS

# Drug_Target_19_Pathway:
Not Available

# Drug_Target_19_Pfam_Domain_Function:
PF00120	Gln-synt_C
PF03951	Gln-synt_N

# Drug_Target_19_Protein_Sequence:
>Glutamine synthetase
MSAEHVLTMLNEHEVKFVDLRFTDTKGKEQHVTIPAHQVNAEFFEEGKMFDGSSIGGWKG
INESDMVLMPDASTAVIDPFFADSTLIIRCDILEPGTLQGYDRDPRSIAKRAEDYLRATG
IADTVLFGPEPEFFLFDDIRFGASISGSHVAIDDIEGAWNSSTKYEGGNKGHRPGVKGGY
FPVPPVDSAQDIRSEMCLVMEQMGLVVEAHHHEVATAGQNEVATRFNTMTKKADEIQIYK
YVVHNVAHRFGKTATFMPKPMFGDNGSGMHCHMSLAKNGTNLFSGDKYAGLSEQALYYIG
GVIKHAKAINALANPTTNSYKRLVPGYEAPVMLAYSARNRSASIRIPVVASPKARRIEVR
FPDPAANPYLCFAALLMAGLDGIKNKIHPGEAMDKNLYDLPPEEAKEIPQVAGSLEEALN
ALDLDREFLKAGGVFTDEAIDAYIALRREEDDRVRMTPHPVEFELYYSV

# Drug_Target_19_Reaction:
ATP + L-glutamate + NH3 = ADP + phosphate + L-glutamine

# Drug_Target_19_Signals:
None

# Drug_Target_19_Specific_Function:
ATP + L-glutamate + NH(3) = ADP + phosphate + L-glutamine

# Drug_Target_19_SwissProt_ID:
P0A1P6

# Drug_Target_19_SwissProt_Name:
GLNA_SALTY

# Drug_Target_19_Synonyms:
EC 6.3.1.2
Glutamate--ammonia ligase

# Drug_Target_19_Theoretical_pI:
5.34

# Drug_Target_19_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
GUK1

# Drug_Target_1_GenBank_ID_Gene:
L76200

# Drug_Target_1_GenBank_ID_Protein:
1196436

# Drug_Target_1_GeneCard_ID:
GUK1

# Drug_Target_1_Gene_Name:
GUK1

# Drug_Target_1_Gene_Sequence:
>594 bp
ATGTCGGGCCCCAGGCCTGTGGTGCTGAGCGGGCCTTCGGGAGCTGGGAAGAGCACCCTG
CTGAAGAGGCTGCTCCAGGAGCACAGCGGCATCTTTGGCTTCAGCGTGTCCCATACCACG
AGGAACCCGAGGCCCGGCGAGGAGAACGGCAAAGATTACTACTTTGTAACCAGGGAGGTG
ATGCAGCGTGACATAGCAGCCGGCGACTTCATCGAGCATGCCGAGTTCTCGGGGAACCTG
TATGGCACGAGCAAGGTGGCGGTGCAGGCCGTGCAGGCCATGAACCGCATCTGTGTGCTG
GACGTGGACCTGCAGGGTGTGCGGAACATCAAGGCCACCGATCTGCGGCCCATCTACATC
TCTGTGCAGCCGCCTTCACTGCACGTGCTGGAGCAGCGGCTGCGGCAGCGCAACACTGAA
ACCGAGGAGAGCCTGGTGAAGCGGCTGGCTGCTGCCCAGGCCGACATGGAGAGCAGCAAG
GAGCCCGGCCTGTTTGATGTGGTCATCATTAACGACAGCCTGGACCAGGCCTACGCAGAG
CTGAAGGAGGCGCTCTCTGAGGAAATCAAGAAAGCTCAAAGGACCGGCGCCTGA

# Drug_Target_1_General_Function:
Nucleotide transport and metabolism

# Drug_Target_1_General_References:
8647247	Fitzgibbon J, Katsanis N, Wells D, Delhanty J, Vallins W, Hunt DM: Human guanylate kinase (GUK1): cDNA sequence, expression and chromosomal localisation. FEBS Lett. 1996 May 6;385(3):185-8.
8663313	Brady WA, Kokoris MS, Fitzgibbon M, Black ME: Cloning, characterization, and modeling of mouse and human guanylate kinases. J Biol Chem. 1996 Jul 12;271(28):16734-40.

# Drug_Target_1_HGNC_ID:
HGNC:4693

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
4106

# Drug_Target_1_Locus:
1q32-q41

# Drug_Target_1_Molecular_Weight:
21726

# Drug_Target_1_Name:
Guanylate kinase

# Drug_Target_1_Number_of_Residues:
197

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00625	Guanylate_kin

# Drug_Target_1_Protein_Sequence:
>Guanylate kinase
MSGPRPVVLSGPSGAGKSTLLKRLLQEHSGIFGFSVSHTTRNPRPGEENGKDYYFVTREV
MQRDIAAGDFIEHAEFSGNLYGTSKVAVQAVQAMNRICVLDVDLQGVRNIKATDLRPIYI
SVQPPSLHVLEQRLRQRNTETEESLVKRLAAAQADMESSKEPGLFDVVIINDSLDQAYAE
LKEALSEEIKKAQRTGA

# Drug_Target_1_Reaction:
ATP + GMP = ADP + GDP

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Essential for recycling GMP and indirectly, cGMP

# Drug_Target_1_SwissProt_ID:
Q16774

# Drug_Target_1_SwissProt_Name:
KGUA_HUMAN

# Drug_Target_1_Synonyms:
EC 2.7.4.8
GMP kinase

# Drug_Target_1_Theoretical_pI:
6.53

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_20_Cellular_Location:
Not Available

# Drug_Target_20_Chromosome_Location:
Not Available

# Drug_Target_20_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_20_Essentiality:
Non-Essential

# Drug_Target_20_GenAtlas_ID:
Not Available

# Drug_Target_20_GenBank_ID_Gene:
U00089

# Drug_Target_20_GenBank_ID_Protein:
1674179

# Drug_Target_20_GeneCard_ID:
Not Available

# Drug_Target_20_Gene_Name:
MPN_348

# Drug_Target_20_Gene_Sequence:
>495 bp
ATGGACAAAAATGCCTTAAGAAAACAAATTCTGCAAAAAAGAATGGCATTAAGTACCATT
GAAAAAAGTCACTTAGATCAAAAGATTAATCAAAAATTAGTTGCTTTTTTAACTCCTAAG
CCATGCATTAAAACAATTGCACTTTATGAACCCATTAAAAATGAGGTTACTTTTGTTGAC
TTCTTCTTTGAGTTTTTAAAGATTAACCAAATAAGAGCTGTTTACCCCAAGGTAATAAGT
GATACCGAAATTATCTTTATTGATCAGGAGACAAATACATTCGAACCTAATCAAATAGAC
TGCTTCCTAATACCATTGGTAGGCTTTAATAAAGACAATTACCGTCTAGGCTTTGGCAAG
GGCTATTATGACCGTTATTTAATGCAATTAACTAGACAACAACCTAAAATAGGAATAGCG
TACAGTTTCCAAAAAGGTGATTTTTTAGCCGATCCTTGGGATGTACAACTAGACTTAATT
ATTAATGATGAATAG

# Drug_Target_20_General_Function:
Coenzyme transport and metabolism

# Drug_Target_20_General_References:
8948633	Himmelreich R, Hilbert H, Plagens H, Pirkl E, Li BC, Herrmann R: Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res. 1996 Nov 15;24(22):4420-49.

# Drug_Target_20_HGNC_ID:
Not Available

# Drug_Target_20_HPRD_ID:
Not Available

# Drug_Target_20_ID:
3470

# Drug_Target_20_Locus:
Not Available

# Drug_Target_20_Molecular_Weight:
19266

# Drug_Target_20_Name:
Hypothetical protein MG245 homolog

# Drug_Target_20_Number_of_Residues:
164

# Drug_Target_20_PDB_ID:
1SBQ

# Drug_Target_20_Pathway:
Not Available

# Drug_Target_20_Pfam_Domain_Function:
PF01812	5-FTHF_cyc-lig

# Drug_Target_20_Protein_Sequence:
>Hypothetical protein MG245 homolog
MDKNALRKQILQKRMALSTIEKSHLDQKINQKLVAFLTPKPCIKTIALYEPIKNEVTFVD
FFFEFLKINQIRAVYPKVISDTEIIFIDQETNTFEPNQIDCFLIPLVGFNKDNYRLGFGK
GYYDRYLMQLTRQQPKIGIAYSFQKGDFLADPWDVQLDLIINDE

# Drug_Target_20_Reaction:
Not Available

# Drug_Target_20_Signals:
None

# Drug_Target_20_Specific_Function:
Not Available

# Drug_Target_20_SwissProt_ID:
P75430

# Drug_Target_20_SwissProt_Name:
MTHFS_MYCPN

# Drug_Target_20_Synonyms:
H91_orf164

# Drug_Target_20_Theoretical_pI:
7.25

# Drug_Target_20_Transmembrane_Regions:
None

# Drug_Target_21_Cellular_Location:
Not Available

# Drug_Target_21_Chromosome_Location:
Not Available

# Drug_Target_21_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_21_Essentiality:
Non-Essential

# Drug_Target_21_GenAtlas_ID:
KIF11

# Drug_Target_21_GenBank_ID_Gene:
X85137

# Drug_Target_21_GenBank_ID_Protein:
1155084

# Drug_Target_21_GeneCard_ID:
KIF11

# Drug_Target_21_Gene_Name:
KIF11

# Drug_Target_21_Gene_Sequence:
>3174 bp
ATGGCGTCGCAGCCAAATTCGTCTGCGAAGAAGAAAGAGGAGAAGGGGAAGAACATCCAG
GTGGTGGTGAGATGCAGACCATTTAATTTGGCAGAGCGGAAAGCTAGCGCCCATTCAATA
GTAGAATGTGATCCTGTACGAAAAGAAGTTAGTGTACGAACTGGAGGATTGGCTGACAAG
AGCTCAAGGAAAACATACACTTTTGATATGGTGTTTGGAGCATCTACTAAACAGATTGAT
GTTTACCGAAGTGTTGTTTGTCCAATTCTGGATGAAGTTATTATGGGCTATAATTGCACT
ATCTTTGCGTATGGCCAAACTGGCACTGGAAAAACTTTTACAATGGAAGGTGAAAGGTCA
CCTAATGAAGAGTATACCTGGGAAGAGGATCCCTTGGCTGGTATAATTCCACGTACCCTT
CATCAAATTTTTGAGAAACTTACTGATAATGGTACTGAATTTTCAGTCAAAGTGTCTCTG
TTGGAGATCTATAATGAAGAGCTTTTTGATCTTCTTAATCCATCATCTGATGTTTCTGAG
AGACTACAGATGTTTGATGATCCCCGTAACAAGAGAGGAGTGATAATTAAAGGTTTAGAA
GAAATTACAGTACACAACAAGGATGAAGTCTATCAAATTTTAGAAAAGGGGGCAGCAAAA
AGGACAACTGCAGCTACTCTGATGAATGCATACTCTAGTCGTTCCCACTCAGTTTTCTCT
GTTACAATACATATGAAAGAAACTACGATTGATGGAGAAGAGCTTGTTAAAATCGGAAAG
TTGAACTTGGTTGATCTTGCAGGAAGTGAAAACATTGGCCGTTCTGGAGCTGTTGATAAG
AGAGCTCGGGAAGCTGGAAATATAAATCAATCCCTGTTGACTTTGGGAAGGGTCATTACT
GCCCTTGTAGAAAGAACACCTCATGTTCCTTATCGAGAATCTAAACTAACTAGAATCCTC
CAGGATTCTCTTGGAGGGCGTACAAGAACATCTATAATTGCAACAATTTCTCCTGCATCT
CTCAATCTTGAGGAAACTCTGAGTACATTGGAATATGCTCATAGAGCAAAGAACATATTG
AATAAGCCTGAAGTGAATCAGAAACTCACCAAAAAAGCTCTTATTAAGGAGTATACGGAG
GAGATAGAACGTTTAAAACGAGATCTTGCTGCAGCCCGTGAGAAAAATGGAGTGTATATT
TCTGAAGAAAATTTTAGAGTCATGAGTGGAAAATTAACTGTTCAAGAAGAGCAGATTGTA
GAATTGATTGAAAAAATTGGTGCTGTTGAGGAGGAGCTGAATAGGGTTACAGAGTTGTTT
ATGGATAATAAAAATGAACTTGACCAGTGTAAATCTGACCTGCAAAATAAAACACAAGAA
CTTGAAACCACTCAAAAACATTTGCAAGAAACTAAATTACAACTTGTTAAAGAAGAATAT
ATCACATCAGCTTTGGAAAGTACTGAGGAGAAACTTCATGATGCTGCCAGCAAGCTGCTT
AACACAGTTGAAGAAACTACAAAAGATGTATCTGGTCTCCATTCCAAACTGGATCGTAAG
AAGGCAGTTGACCAACACAATGCAGAAGCTCAGGATATTTTTGGCAAAAACCTGAATAGT
CTGTTTAATAATATGGAAGAATTAATTAAGGATGGCAGCTCAAAGCAAAAGGCCATGCTA
GAAGTACATAAGACCTTATTTGGTAATCTGCTGTCTTCCAGTGTCTCTGCATTAGATACC
ATTACTACAGTAGCACTTGGATCTCTCACATCTATTCCAGAAAATGTGTCTACTCATGTT
TCTCAGATTTTTAATATGATACTAAAAGAACAATCATTAGCAGCAGAAAGTAAAACTGTA
CTACAGGAATTGATTAATGTACTCAAGACTGATCTTCTAAGTTCACTGGAAATGATTTTA
TCCCCAACTGTGGTGTCTATACTGAAAATCAATAGTCAACTAAAGCATATTTTCAAGACT
TCATTGACAGTGGCCGATAAGATAGAAGATCAAAAAAAAAGGAACTCAGATGGCTTTCTC
AGTATACTGTGTAACAATCTACATGAACTACAAGAAAATACCATTTGTTCCTTGGTTGAG
TCACAAAAGCAATGTGGAAACCTAACTGAAGACCTGAAGACAATAAAGCAGACCCATTCC
CAGGAACTTTGCAAGTTAATGAATCTTTGGACAGAGAGATTCTGTGCTTTGGAGGAAAAG
TGTGAAAATATACAGAAACCACTTAGTAGTGTCCAGGAAAATATACAGCAGAAATCTAAG
GATATAGTCAACAAAATGACTTTTCACAGTCAAAAATTTTGTGCTGATTCTGATGGCTTC
TCACAGGAACTCAGAAATTTTAACCAAGAAGGTACAAAATTGGTTGAAGAATCTGTGAAA
CACTCTGATAAACTCAATGGCAACCTGGAAAAAATATCTCAAGAGACTGAACAGAGATGT
GAATCTCTGAACACAAGAACAGTTTATTTTTCTGAACAGTGGGTATCTTCCTTAAATGAA
AGGGAACAGGAACTTCACAACTTATTGGAGGTTGTAAGCCAATGTTGTGAGGCTTCAAGT
TCAGACATCACTGAGAAATCAGATGGACGTAAGGCAGCTCATGAGAAACAGCATAACATT
TTTCTTGATCAGATGACTATTGATGAAGATAAATTGATAGCACAAAATCTAGAACTTAAT
GAAACCATAAAAATTGGTTTGACTAAGCTTAATTGCTTTCTGGAACAGGATCTGAAACTG
GATATCCCAACAGGTACGACACCACAGAGGAAAAGTTATTTATACCCATCAACACTGGTA
AGAACTGAACCACGTGAACATCTCCTTGATCAGCTGAAAAGGAAACAGCCTGAGCTGTTA
ATGATGCTAAACTGTTCAGAAAACAACAAAGAAGAGACAATTCCGGATGTGGATGTAGAA
GAGGCAGTTCTGGGGCAGTATACTGAAGAACCTCTAAGTCAAGAGCCATCTGTAGATGCT
GGTGTGGATTGTTCATCAATTGGCGGGGTTCCATTTTTCCAGCATAAAAAATCACATGGA
AAAGACAAAGAAAACAGAGGCATTAACACACTGGAGAGGTCTAAAGTGGAAGAAACTACA
GAGCACTTGGTTACAAAGAGCAGATTACCTCTGCGAGCCCAGATCAACCTTTAA

# Drug_Target_21_General_Function:
Replication, recombination and repair

# Drug_Target_21_General_References:
7776974	Lee JW, Choi HS, Gyuris J, Brent R, Moore DD: Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol Endocrinol. 1995 Feb;9(2):243-54.
8548803	Blangy A, Lane HA, d'Herin P, Harper M, Kress M, Nigg EA: Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo. Cell. 1995 Dec 29;83(7):1159-69.
9701554	Whitehead CM, Rattner JB: Expanding the role of HsEg5 within the mitotic and post-mitotic phases of the cell cycle. J Cell Sci. 1998 Sep;111 ( Pt 17):2551-61.

# Drug_Target_21_HGNC_ID:
HGNC:6388

# Drug_Target_21_HPRD_ID:
01023

# Drug_Target_21_ID:
3379

# Drug_Target_21_Locus:
10q24.1

# Drug_Target_21_Molecular_Weight:
119160

# Drug_Target_21_Name:
Kinesin-like protein KIF11

# Drug_Target_21_Number_of_Residues:
1056

# Drug_Target_21_PDB_ID:
1YRS

# Drug_Target_21_Pathway:
Not Available

# Drug_Target_21_Pfam_Domain_Function:
PF00225	Kinesin

# Drug_Target_21_Protein_Sequence:
>Kinesin-like protein KIF11
MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADK
SSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERS
PNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSE
RLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFS
VTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVIT
ALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNIL
NKPEVNQKLTKKALIKEYTEEIERLKRDLAAAREKNGVYISEENFRVMSGKLTVQEEQIV
ELIEKIGAVEEELNRVTELFMDNKNELDQCKSDLQNKTQELETTQKHLQETKLQLVKEEY
ITSALESTEEKLHDAASKLLNTVEETTKDVSGLHSKLDRKKAVDQHNAEAQDIFGKNLNS
LFNNMEELIKDGSSKQKAMLEVHKTLFGNLLSSSVSALDTITTVALGSLTSIPENVSTHV
SQIFNMILKEQSLAAESKTVLQELINVLKTDLLSSLEMILSPTVVSILKINSQLKHIFKT
SLTVADKIEDQKKELDGFLSILCNNLHELQENTICSLVESQKQCGNLTEDLKTIKQTHSQ
ELCKLMNLWTERFCALEEKCENIQKPLSSVQENIQQKSKDIVNKMTFHSQKFCADSDGFS
QELRNFNQEGTKLVEESVKHSDKLNGNLEKISQETEQRCESLNTRTVYFSEQWVSSLNER
EQELHNLLEVVSQCCEASSSDITEKSDGRKAAHEKQHNIFLDQMTIDEDKLIAQNLELNE
TIKIGLTKLNCFLEQDLKLDIPTGTTPQRKSYLYPSTLVRTEPREHLLDQLKRKQPELLM
MLNCSENNKEETIPDVDVEEAVLGQYTEEPLSQEPSVDAGVDCSSIGGVPFFQHKKSHGK
DKENRGINTLERSKVEETTEHLVTKSRLPLRAQINL

# Drug_Target_21_Reaction:
Not Available

# Drug_Target_21_Signals:
None

# Drug_Target_21_Specific_Function:
Motor protein required for establishing a bipolar spindle. Blocking of KIF11 prevents centrosome migration and arrest cells in mitosis with monoastral microtubule arrays

# Drug_Target_21_SwissProt_ID:
P52732

# Drug_Target_21_SwissProt_Name:
KIF11_HUMAN

# Drug_Target_21_Synonyms:
Kinesin-like protein 1
Kinesin-like spindle protein HKSP
Kinesin-related motor protein Eg5
TRIP-5
Thyroid receptor-interacting protein 5

# Drug_Target_21_Theoretical_pI:
5.36

# Drug_Target_21_Transmembrane_Regions:
None

# Drug_Target_22_Cellular_Location:
Cytoplasm

# Drug_Target_22_Chromosome_Location:
Not Available

# Drug_Target_22_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_22_Essentiality:
Non-Essential

# Drug_Target_22_GenAtlas_ID:
ACTA1

# Drug_Target_22_GenBank_ID_Gene:
J00068

# Drug_Target_22_GenBank_ID_Protein:
178029

# Drug_Target_22_GeneCard_ID:
ACTA1

# Drug_Target_22_Gene_Name:
ACTA1

# Drug_Target_22_Gene_Sequence:
>1134 bp
ATGTGCGACGAAGACGAGACCACCGCCCTCGTGTGCGACAATGGCTCCGGCCTGGTGAAA
GCCGGCTTCGCCGGGGATGACGCCCCTAGGGCCGTGTTCCCGTCCATCGTGGGCCGCCCC
CGACACCAGGGCGTCATGGTCGGTATGGGTCAGAAAGATTCCTACGTGGGCGACGAGGCT
CAGAGCAAGAGAGGTATCCTGACCCTGAAGTACCCTATCGAGCACGGCATCATCACCAAC
TGGGATGACATGGAGAAGATCTGGCACCACACCTTCTACAACGAGCTTCGCGTGGCTCCC
GAGGAGCACCCCACCCTGCTCACCGAAGCCCCCCTCAATCCCAAGGCCAACCGCGAGAAG
ATGACCCAGATCATGTTTGAGACCTTCAACGTGCCCGCCATGTACGTGGCCATCCAGGCC
GTGCTGTCCCTCTACGCCTCCGGCAGGACCACCGGCATCGTGCTGGACTCCGGCGACGGC
GTCACCCACAACGTGCCCATTTATGAGGGCTACGCGCTGCCGCACGCCATCATGCGCCTG
GACCTGGCGGGCCGCGATCTTACCGACTACCTGATGAAGATCCTCACTGAGCGTGGCTAC
TCCTTCGTGACCACAGCTGAGCGCGAGATCGTGCGCGACATCAAGGAGAAGCTGTGCTAC
GTGGCCCTGGACTTCGAGAACGAGATGGCGACGGCCGCCTCCTCCTCCTCCCTGGAAAAG
AGCTACGAGCTGCCAGACGGGCAGGTCATCACCATCGGCAACGAGCGCTTCCGCTGCCCG
GAGACGCTCTTCCAGCCCTCCTTCATCGGTATGGAGTCGGCGGGCATTCACGAGACCACC
TACAACAGCATCATGAAGTGTGACATCGACATCAGGAAGGACCTGTATGCCAACAACGTC
ATGTCGGGGGGCACCACGATGTACCCTGGGATCGCTGACCGCATGCAGAAAGAGATCACC
GCGCTGGCACCCAGCACCATGAAGATCAAGATCATCGCCCCGCCGGAGCGCAAATACTCG
GTGTGGATCGGCGGCTCCATCCTGGCCTCGCTGTCCACCTTCCAGCAGATGTGGATCACC
AAGCAGGAGTACGACGAGGCCGGCCCTTCCATCGTCCACCGCAAATGCTTCTAG

# Drug_Target_22_General_Function:
Cytoskeleton

# Drug_Target_22_General_References:
10508519	Nowak KJ, Wattanasirichaigoon D, Goebel HH, Wilce M, Pelin K, Donner K, Jacob RL, Hubner C, Oexle K, Anderson JR, Verity CM, North KN, Iannaccone ST, Muller CR, Nurnberg P, Muntoni F, Sewry C, Hughes I, Sutphen R, Lacson AG, Swoboda KJ, Vigneron J, Wallgren-Pettersson C, Beggs AH, Laing NG: Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nat Genet. 1999 Oct;23(2):208-12.
11166164	Jungbluth H, Sewry CA, Brown SC, Nowak KJ, Laing NG, Wallgren-Pettersson C, Pelin K, Manzur AY, Mercuri E, Dubowitz V, Muntoni F: Mild phenotype of nemaline myopathy with sleep hypoventilation due to a mutation in the skeletal muscle alpha-actin (ACTA1) gene. Neuromuscul Disord. 2001 Jan;11(1):35-40.
11333380	Ilkovski B, Cooper ST, Nowak K, Ryan MM, Yang N, Schnell C, Durling HJ, Roddick LG, Wilkinson I, Kornberg AJ, Collins KJ, Wallace G, Gunning P, Hardeman EC, Laing NG, North KN: Nemaline myopathy caused by mutations in the muscle alpha-skeletal-actin gene. Am J Hum Genet. 2001 Jun;68(6):1333-43. Epub 2001 Apr 27.
2907503	Taylor A, Erba HP, Muscat GE, Kedes L: Nucleotide sequence and expression of the human skeletal alpha-actin gene: evolution of functional regulatory domains. Genomics. 1988 Nov;3(4):323-36.
6190133	Hanauer A, Levin M, Heilig R, Daegelen D, Kahn A, Mandel JL: Isolation and characterization of cDNA clones for human skeletal muscle alpha actin. Nucleic Acids Res. 1983 Jun 11;11(11):3503-16.

# Drug_Target_22_HGNC_ID:
HGNC:129

# Drug_Target_22_HPRD_ID:
Not Available

# Drug_Target_22_ID:
3822

# Drug_Target_22_Locus:
1q42.13-q42.2

# Drug_Target_22_Molecular_Weight:
42052

# Drug_Target_22_Name:
Actin, alpha skeletal muscle

# Drug_Target_22_Number_of_Residues:
377

# Drug_Target_22_PDB_ID:
1IJJ

# Drug_Target_22_Pathway:
Not Available

# Drug_Target_22_Pfam_Domain_Function:
PF00022	Actin

# Drug_Target_22_Protein_Sequence:
>Actin, alpha skeletal muscle
MCDEDETTALVCDNGSGLVKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDEA
QSKRGILTLKYPIEHGIITNWDDMEKIWHHTFYNELRVAPEEHPTLLTEAPLNPKANREK
MTQIMFETFNVPAMYVAIQAVLSLYASGRTTGIVLDSGDGVTHNVPIYEGYALPHAIMRL
DLAGRDLTDYLMKILTERGYSFVTTAEREIVRDIKEKLCYVALDFENEMATAASSSSLEK
SYELPDGQVITIGNERFRCPETLFQPSFIGMESAGIHETTYNSIMKCDIDIRKDLYANNV
MSGGTTMYPGIADRMQKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWIT
KQEYDEAGPSIVHRKCF

# Drug_Target_22_Reaction:
Not Available

# Drug_Target_22_Signals:
None

# Drug_Target_22_Specific_Function:
Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells

# Drug_Target_22_SwissProt_ID:
P68133

# Drug_Target_22_SwissProt_Name:
ACTS_HUMAN

# Drug_Target_22_Synonyms:
Alpha-actin-1

# Drug_Target_22_Theoretical_pI:
5.05

# Drug_Target_22_Transmembrane_Regions:
None

# Drug_Target_23_Cellular_Location:
Not Available

# Drug_Target_23_Chromosome_Location:
Not Available

# Drug_Target_23_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_23_Essentiality:
Non-Essential

# Drug_Target_23_GenAtlas_ID:
Not Available

# Drug_Target_23_GenBank_ID_Gene:
Not Available

# Drug_Target_23_GenBank_ID_Protein:
Not Available

# Drug_Target_23_GeneCard_ID:
Not Available

# Drug_Target_23_Gene_Name:
PGK1

# Drug_Target_23_Gene_Sequence:
Not Available

# Drug_Target_23_General_Function:
Not Available

# Drug_Target_23_General_References:
Not Available

# Drug_Target_23_HGNC_ID:
Not Available

# Drug_Target_23_HPRD_ID:
Not Available

# Drug_Target_23_ID:
6964

# Drug_Target_23_Locus:
Not Available

# Drug_Target_23_Molecular_Weight:
Not Available

# Drug_Target_23_Name:
Phosphoglycerate kinase 1

# Drug_Target_23_Number_of_Residues:
0

# Drug_Target_23_PDB_ID:
Not Available

# Drug_Target_23_Pathway:
Not Available

# Drug_Target_23_Pfam_Domain_Function:
Not Available

# Drug_Target_23_Protein_Sequence:
Not Available

# Drug_Target_23_Reaction:
Not Available

# Drug_Target_23_Signals:
Not Available

# Drug_Target_23_Specific_Function:
Not Available

# Drug_Target_23_SwissProt_ID:
P00558

# Drug_Target_23_SwissProt_Name:
PGK1_HUMAN

# Drug_Target_23_Synonyms:
Not Available

# Drug_Target_23_Theoretical_pI:
Not Available

# Drug_Target_23_Transmembrane_Regions:
Not Available

# Drug_Target_24_Cellular_Location:
Cytoplasm

# Drug_Target_24_Chromosome_Location:
Not Available

# Drug_Target_24_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_24_Essentiality:
Non-Essential

# Drug_Target_24_GenAtlas_ID:
PDXK

# Drug_Target_24_GenBank_ID_Gene:
U89606

# Drug_Target_24_GenBank_ID_Protein:
1946349

# Drug_Target_24_GeneCard_ID:
PDXK

# Drug_Target_24_Gene_Name:
PDXK

# Drug_Target_24_Gene_Sequence:
>939 bp
ATGGAGGAGGAGTGCCGGGTGCTCTCCATACAGAGCCACGTCATCCGCGGCTACGTGGGC
AACCGGGCGGCCACGTTCCCGCTGCAGGTTTTGGGATTTGAGATTGACGCGGTGAACTCT
GTCCAGTTTTCAAACCACACAGGCTATGCCCACTGGAAGGGCCAAGTGCTGAATTCAGAT
GAGCTCCAGGAGTTGTACGAAGGCCTGAGGCTGAACAACATGAATAAATATGACTACGTG
CTCACAGGTTATACGAGGGACAAGTCGTTCCTGGCCATGGTGGTGGACATTGTGCAGGAG
CTGAAGCAGCAGAACCCCAGGCTGGTGTACGTGTGTGATCCAGTCTTGGGTGACAAGTGG
GACGGCGAAGGCTCGATGTACGTCCCGGAGGACCTCCTTCCCGTCTACAAAGAAAAAGTG
GTGCCGCTTGCAGACATTATCACGCCCAACCAGTTTGAGGCCGAGTTACTGAGTGGCCGG
AAGATCCACAGCCAGGAGGAAGCCTTGCGGGTGATGGACATGCTGCACTCTATGGGCCCC
GACACCGTGGTCATCACCAGCTCCGACCTGCCCTCCCCGCAGGGCAGCAACTACCTGATT
GTGCTGGGGAGTCAGAGGAGGAGGAATCCCGCTGGCTCCGTGGTGATGGAACGCATCCGG
ATGGACATTCGCAAAGTGGACGCCGTCTTTGTGGGCACTGGGGACCTGTTTGCTGCCATG
CTCCTGGCGTGGACACACAAGCACCCCAATAACCTCAAGGTGGCCTGTGAGAAGACCGTG
TCTACCTTGCACCACGTTCTGCAGAGGACCATCCAGTGTGCAAAAGCCCAGGCCGGGGAA
GGAGTGAGGCCCAGCCCCATGCAGCTGGAGCTGCGGATGGTGCAGAGCAAAAGGGACATC
GAGGACCCAGAGATCGTCGTCCAGGCCACGGTGCTGTGA

# Drug_Target_24_General_Function:
Coenzyme transport and metabolism

# Drug_Target_24_General_References:
10830953	Hattori M, Fujiyama A, Taylor TD, Watanabe H, Yada T, Park HS, Toyoda A, Ishii K, Totoki Y, Choi DK, Groner Y, Soeda E, Ohki M, Takagi T, Sakaki Y, Taudien S, Blechschmidt K, Polley A, Menzel U, Delabar J, Kumpf K, Lehmann R, Patterson D, Reichwald K, Rump A, Schillhabel M, Schudy A, Zimmermann W, Rosenthal A, Kudoh J, Schibuya K, Kawasaki K, Asakawa S, Shintani A, Sasaki T, Nagamine K, Mitsuyama S, Antonarakis SE, Minoshima S, Shimizu N, Nordsiek G, Hornischer K, Brant P, Scharfe M, Schon O, Desario A, Reichelt J, Kauer G, Blocker H, Ramser J, Beck A, Klages S, Hennig S, Riesselmann L, Dagand E, Haaf T, Wehrmeyer S, Borzym K, Gardiner K, Nizetic D, Francis F, Lehrach H, Reinhardt R, Yaspo ML: The DNA sequence of human chromosome 21. Nature. 2000 May 18;405(6784):311-9.
10987144	Lee HS, Moon BJ, Choi SY, Kwon OS: Human pyridoxal kinase: overexpression and properties of the recombinant enzyme. Mol Cells. 2000 Aug 31;10(4):452-9.
9099727	Hanna MC, Turner AJ, Kirkness EF: Human pyridoxal kinase. cDNA cloning, expression, and modulation by ligands of the benzodiazepine receptor. J Biol Chem. 1997 Apr 18;272(16):10756-60.

# Drug_Target_24_HGNC_ID:
HGNC:8819

# Drug_Target_24_HPRD_ID:
01526

# Drug_Target_24_ID:
48

# Drug_Target_24_Locus:
Not Available

# Drug_Target_24_Molecular_Weight:
35103

# Drug_Target_24_Name:
Pyridoxal kinase

# Drug_Target_24_Number_of_Residues:
312

# Drug_Target_24_PDB_ID:
1RFV

# Drug_Target_24_Pathway:
Not Available

# Drug_Target_24_Pfam_Domain_Function:
PF00294	PfkB

# Drug_Target_24_Protein_Sequence:
>Pyridoxal kinase
MEEECRVLSIQSHVIRGYVGNRAATFPLQVLGFEIDAVNSVQFSNHTGYAHWKGQVLNSD
ELQELYEGLRLNNMNKYDYVLTGYTRDKSFLAMVVDIVQELKQQNPRLVYVCDPVLGDKW
DGEGSMYVPEDLLPVYKEKVVPLADIITPNQFEAELLSGRKIHSQEEALRVMDMLHSMGP
DTVVITSSDLPSPQGSNYLIVLGSQRRRNPAGSVVMERIRMDIRKVDAVFVGTGDLFAAM
LLAWTHKHPNNLKVACEKTVSTLHHVLQRTIQCAKAQAGEGVRPSPMQLELRMVQSKRDI
EDPEIVVQATVL

# Drug_Target_24_Reaction:
ATP + pyridoxal = ADP + pyridoxal 5'-phosphate

# Drug_Target_24_Signals:
None

# Drug_Target_24_Specific_Function:
Required for synthesis of pyridoxal-5-phosphate from vitamin B6

# Drug_Target_24_SwissProt_ID:
O00764

# Drug_Target_24_SwissProt_Name:
PDXK_HUMAN

# Drug_Target_24_Synonyms:
EC 2.7.1.35
Pyridoxine kinase

# Drug_Target_24_Theoretical_pI:
6.05

# Drug_Target_24_Transmembrane_Regions:
None

# Drug_Target_25_Cellular_Location:
Cytoplasmic

# Drug_Target_25_Chromosome_Location:
Not Available

# Drug_Target_25_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_25_Essentiality:
Non-Essential

# Drug_Target_25_GenAtlas_ID:
Not Available

# Drug_Target_25_GenBank_ID_Gene:
J02591

# Drug_Target_25_GenBank_ID_Protein:
151857

# Drug_Target_25_GeneCard_ID:
Not Available

# Drug_Target_25_Gene_Name:
arsA

# Drug_Target_25_Gene_Sequence:
>1752 bp
ATGCAATTCTTACAGAATATCCCCCCTTATCTGTTTTTTACGGGTAAAGGAGGCGTGGGT
AAAACCTCTATTTCCTGCGCCACGGCGATCCGTCTGGCAGAACAGGGGAAACGGGTGCTG
CTGGTCAGTACCGATCCGGCCTCAAACGTAGGCCAGGTGTTTAGCCAGACGATTGGCATT
ACCATTCAGGCAATAGCCTCTGTTCCTGGATTGTCGGCTCTTGAGATTGATCCTCAGGCT
GCTGCACAACAGTACCGGGCCAGAATCGTTGACCCTATTAAAGGCGTCCTGCCTGATGAC
GTTGTTTCCAGCATCAACGAACAACTGTCAGGTGCATGCACAACAGAGATTGCGGCTTTT
GATGAATTTACCGGATTACTGACAGATGCCTCTCTGCTGACGCGGTTTGACCATATCATT
TTTGATACCGCGCCGACGGGTCACACCATTCGCCTTCTGCAGTTGCCGGGCGCCTGGAGT
AGCTTTATTGACAGCAATCCCGAGGGCGCGTCCTGTCTCGGCCCAATGGCGGGGCTGGAA
AAGCAGCGTGAACAGTATGCCTATGCTGTTGAAGCGTTGTCTGATCCAAAGCGTACCCGA
CTGGTATTAGTTGCTCGTCTGCAAAAATCCACGTTGCAGGAAGTCGCCCGGACTCATCTG
GAACTTGCCGCCATCGGCCTTAAAAATCAGTACCTGGTTATTAATGGCGTTCTGCCCAAA
ACTGAAGCGGCAAACGATACACTGGCTGCTGCAATATGGGAGCGTGAACAGGAGGCGCTG
GCCAATCTTCCCGCTGATCTTGCAGGTTTGCCAACTGACACATTATTTCTCCAGCCGGTC
AATATGGTCGGTGTGTCTGCGCTCAGCAGGCTTCTCTCCACTCAGCCTGTAGCGTCGCCA
TCCTCGGATGAATACCTGCAACAGCGGCCTGATATTCCGTCACTTTCTGCGTTGGTTGAT
GATATTGCCCGTAATGAACATGGCCTGATTATGCTGATGGGTAAAGGTGGCGTGGGGAAA
ACCACGATGGCTGCTGCCATTGCTGTCAGGCTGGCCGACATGGGATTTGATGTCCATCTG
ACAACATCTGATCCTGCGGCGCATCTCAGCATGACCCTGAACGGTAGCCTTAACAACCTG
CAGGTCAGCAGGATCGATCCTCACGAGGAAACGGAACGCTATCGTCAGCATGTTCTTGAA
ACAAAGGGAAAAGAACTGGACGAAGCGGGAAAACGCCTGCTGGAAGAGGACTTACGCTCA
CCTTGCACTGAGGAAATTGCTGTTTTCCAGGCCTTTTCACGGGTGATTCGTGAAGCGGGT
AAACGTTTCGTGGTGATGGATACGGCTCCGACCGGACACACGCTGTTGCTGCTGGATGCT
ACAGGCGCGTACCACCGCGAAATTGCGAAGAAAATGGGAGAAAAAGGCCATTTCACCACA
CCGATGATGCTGCTTCAGGATCCGGAGCGCACTAAAGTGTTACTGGTCACGCTGCCGGAA
ACCACGCCCGTGCTTGAAGCGGCAAATTTACAGGCCGACCTTGAGCGTGCAGGCATTCAC
CCCTGGGGCTGGATTATCAATAACAGCCTTTCCATTGCGGATACCCGTTCGCCACTGCTT
CGTATGCGGGCACAACAGGAACTTCCGCAGATAGAGAGCGTTAAACGCCAGCACGCCAGC
CGTGTCGCTCTTGTTCCCGTACTGGCGTCAGAACCAACCGGCATCGACAAACTCAAACAA
CTTGCTGGGTAA

# Drug_Target_25_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_25_General_References:
1704144	Rosen BP: The plasmid-encoded arsenical resistance pump: an anion-translocating ATPase. Res Microbiol. 1990 Mar-Apr;141(3):336-41.
3021763	Chen CM, Misra TK, Silver S, Rosen BP: Nucleotide sequence of the structural genes for an anion pump. The plasmid-encoded arsenical resistance operon. J Biol Chem. 1986 Nov 15;261(32):15030-8.

# Drug_Target_25_HGNC_ID:
Not Available

# Drug_Target_25_HPRD_ID:
Not Available

# Drug_Target_25_ID:
3435

# Drug_Target_25_Locus:
Not Available

# Drug_Target_25_Molecular_Weight:
63189

# Drug_Target_25_Name:
Arsenical pump-driving ATPase

# Drug_Target_25_Number_of_Residues:
583

# Drug_Target_25_PDB_ID:
1II9

# Drug_Target_25_Pathway:
Not Available

# Drug_Target_25_Pfam_Domain_Function:
PF02374	ArsA_ATPase

# Drug_Target_25_Protein_Sequence:
>Arsenical pump-driving ATPase
MQFLQNIPPYLFFTGKGGVGKTSISCATAIRLAEQGKRVLLVSTDPASNVGQVFSQTIGI
TIQAIASVPGLSALEIDPQAAAQQYRARIVDPIKGVLPDDVVSSINEQLSGACTTEIAAF
DEFTGLLTDASLLTRFDHIIFDTAPTGHTIRLLQLPGAWSSFIDSNPEGASCLGPMAGLE
KQREQYAYAVEALSDPKRTRLVLVARLQKSTLQEVARTHLELAAIGLKNQYLVINGVLPK
TEAANDTLAAAIWEREQEALANLPADLAGLPTDTLFLQPVNMVGVSALSRLLSTQPVASP
SSDEYLQQRPDIPSLSALVDDIARNEHGLIMLMGKGGVGKTTMAAAIAVRLADMGFDVHL
TTSDPAAHLSMTLNGSLNNLQVSRIDPHEETERYRQHVLETKGKELDEAGKRLLEEDLRS
PCTEEIAVFQAFSRVIREAGKRFVVMDTAPTGHTLLLLDATGAYHREIAKKMGEKGHFTT
PMMLLQDPERTKVLLVTLPETTPVLEAANLQADLERAGIHPWGWIINNSLSIADTRSPLL
RMRAQQELPQIESVKRQHASRVALVPVLASEPTGIDKLKQLAG

# Drug_Target_25_Reaction:
ATP + H2O + arsenitein = ADP + phosphate + arseniteout

# Drug_Target_25_Signals:
None

# Drug_Target_25_Specific_Function:
Anion-transporting ATPase. Catalyzes the extrusion of the oxyanions arsenite, antimonite and arsenate. Maintenance of a low intracellular concentration of oxyanion produces resistance to the toxic agents

# Drug_Target_25_SwissProt_ID:
P08690

# Drug_Target_25_SwissProt_Name:
ARSA1_ECOLX

# Drug_Target_25_Synonyms:
Arsenical resistance ATPase
Arsenite-translocating ATPase
Arsenite-transporting ATPase
EC 3.6.3.16

# Drug_Target_25_Theoretical_pI:
5.64

# Drug_Target_25_Transmembrane_Regions:
None

# Drug_Target_26_Cellular_Location:
Membrane
single-pass type I membrane protein

# Drug_Target_26_Chromosome_Location:
Not Available

# Drug_Target_26_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_26_Essentiality:
Non-Essential

# Drug_Target_26_GenAtlas_ID:
KIT

# Drug_Target_26_GenBank_ID_Gene:
X06182

# Drug_Target_26_GenBank_ID_Protein:
34085

# Drug_Target_26_GeneCard_ID:
KIT

# Drug_Target_26_Gene_Name:
KIT

# Drug_Target_26_Gene_Sequence:
>2931 bp
ATGAGAGGCGCTCGCGGCGCCTGGGATTTTCTCTGCGTTCTGCTCCTACTGCTTCGCGTC
CAGACAGGCTCTTCTCAACCATCTGTGAGTCCAGGGGAACCGTCTCCACCATCCATCCAT
CCAGGAAAATCAGACTTAATAGTCCGCGTGGGCGACGAGATTAGGCTGTTATGCACTGAT
CCGGGCTTTGTCAAATGGACTTTTGAGATCCTGGATGAAACGAATGAGAATAAGCAGAAT
GAATGGATCACGGAAAAGGCAGAAGCCACCAACACCGGCAAATACACGTGCACCAACAAA
CACGGCTTAAGCAATTCCATTTATGTGTTTGTTAGAGATCCTGCCAAGCTTTTCCTTGTT
GACCGCTCCTTGTATGGGAAAGAAGACAACGACACGCTGGTCCGCTGTCCTCTCACAGAC
CCAGAAGTGACCAATTATTCCCTCAAGGGGTGCCAGGGGAAGCCTCTTCCCAAGGACTTG
AGGTTTATTCCTGACCCCAAGGCGGGCATCATGATCAAAAGTGTGAAACGCGCCTACCAT
CGGCTCTGTCTGCATTGTTCTGTGGACCAGGAGGGCAAGTCAGTGCTGTCGGAAAAATTC
ATCCTGAAAGTGAGGCCAGCCTTCAAAGCTGTGCCTGTTGTGTCTGTGTCCAAAGCAAGC
TATCTTCTTAGGGAAGGGGAAGAATTCACAGTGACGTGCACAATAAAAGATGTGTCTAGT
TCTGTGTACTCAACGTGGAAAAGAGAAAACAGTCAGACTAAACTACAGGAGAAATATAAT
AGCTGGCATCACGGTGACTTCAATTATGAACGTCAGGCAACGTTGACTATCAGTTCAGCG
AGAGTTAATGATTCTGGAGTGTTCATGTGTTATGCCAATAATACTTTTGGATCAGCAAAT
GTCACAACAACCTTGGAAGTAGTAGATAAAGGATTCATTAATATCTTCCCCATGATAAAC
ACTACAGTATTTGTAAACGATGGAGAAAATGTAGATTTGATTGTTGAATATGAAGCATTC
CCCAAACCTGAACACCAGCAGTGGATCTATATGAACAGAACCTTCACTGATAAATGGGAA
GATTATCCCAAGTCTGAGAATGAAAGTAATATCAGATACGTAAGTGAACTTCATCTAACG
AGATTAAAAGGCACCGAAGGAGGCACTTACACATTCCTAGTGTCCAATTCTGACGTCAAT
GCTGCCATAGCATTTAATGTTTATGTGAATACAAAACCAGAAATCCTGACTTACGACAGG
CTCGTGAATGGCATGCTCCAATGTGTGGCAGCAGGATTCCCAGAGCCCACAATAGATTGG
TATTTTTGTCCAGGAACTGAGCAGAGATGCTCTGCTTCTGTACTGCCAGTGGATGTGCAG
ACACTAAACTCATCTGGGCCACCGTTTGGAAAGCTAGTGGTTCAGAGTTCTATAGATTCT
AGTGCATTCAAGCACAATGGCACGGTTGAATGTAAGGCTTACAACGATGTGGGCAAGACT
TCTGCCTATTTTAACTTTGCATTTAAAGGTAACAACAAAGAGCAAATCCATCCCCACACC
CTGTTCACTCCTTTGCTGATTGGTTTCGTAATCGTAGCTGGCATGATGTGCATTATTGTG
ATGATTCTGACCTACAAATATTTACAGAAACCCATGTATGAAGTACAGTGGAAGGTTGTT
GAGGAGATAAATGGAAACAATTATGTTTACATAGACCCAACACAACTTCCTTATGATCAC
AAATGGGAGTTTCCCAGAAACAGGCTGAGTTTTGGGAAAACCCTGGGTGCTGGAGCTTTC
GGGAAGGTTGTTGAGGCAACTGCTTATGGCTTAATTAAGTCAGATGCGGCCATGACTGTC
GCTGTAAAGATGCTCAAGCCGAGTGCCCATTTGACAGAACGGGAAGCCCTCATGTCTGAA
CTCAAAGTCCTGAGTTACCTTGGTAATCACATGAATATTGTGAATCTACTTGGAGCCTGC
ACCATTGGAGGGCCCACCCTGGTCATTACAGAATATTGTTGCTATGGTGATCTTTTGAAT
TTTTTGAGAAGAAAACGTGATTCATTTATTTGTTCAAAGCAGGAAGATCATGCAGAAGCT
GCACTTTATAAGAATCTTCTGCATTCAAAGGAGTCTTCCTGCAGCGATAGTACTAATGAG
TACATGGACATGAAACCTGGAGTTTCTTATGTTGTCCCAACCAAGGCCGACAAAAGGAGA
TCTGTGAGAATAGGCTCATACATAGAAAGAGATGTGACTCCCGCCATCATGGAGGATGAC
GAGTTGGCCCTAGACTTAGAAGACTTGCTGAGCTTTTCTTACCAGGTGGCAAAGGGCATG
GCTTTCCTCGCCTCCAAGAATTGTATTCACAGAGACTTGGCAGCCAGAAATATCCTCCTT
ACTCATGGTCGGATCACAAAGATTTGTGATTTTGGTCTAGCCAGAGACATCAAGAATGAT
TCTAATTATGTGGTTAAAGGAAACGCTCGACTACCTGTGAAGTGGATGGCACCTGAAAGC
ATTTTCAACTGTGTATACACGTTTGAAAGTGACGTCTGGTCCTATGGGATTTTTCTTTGG
GAGCTGTTCTCTTTAGGAAGCAGCCCCTATCCTGGAATGCCGGTCGATTCTAAGTTCTAC
AAGATGATCAAGGAAGGCTTCCGGATGCTCAGCCCTGAACACGCACCTGCTGAAATGTAT
GACATAATGAAGACTTGCTGGGATGCAGATCCCCTAAAAAGACCAACATTCAAGCAAATT
GTTCAGCTAATTGAGAAGCAGATTTCAGAGAGCACCAATCATATTTACTCCAACTTAGCA
AACTGCAGCCCCAACCGACAGAAGCCCGTGGTAGACCATTCTGTGCGGATCAATTCTGTC
GGCAGCACCGCTTCCTCCTCCCAGCCTCTGCTTGTGCACGACGATGTCTGA

# Drug_Target_26_General_Function:
Involved in protein kinase activity

# Drug_Target_26_General_References:
11018522	Mancini A, Koch A, Stefan M, Niemann H, Tamura T: The direct association of the multiple PDZ domain containing proteins (MUPP-1) with the human c-Kit C-terminus is regulated by tyrosine kinase activity. FEBS Lett. 2000 Sep 29;482(1-2):54-8.
12444928	Wollberg P, Lennartsson J, Gottfridsson E, Yoshimura A, Ronnstrand L: The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit. Biochem J. 2003 Mar 15;370(Pt 3):1033-8.
1279499	Giebel LB, Strunk KM, Holmes SA, Spritz RA: Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene. Oncogene. 1992 Nov;7(11):2207-17.
1370874	Spritz RA, Giebel LB, Holmes SA: Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Am J Hum Genet. 1992 Feb;50(2):261-9.
1376329	Fleischman RA: Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene. J Clin Invest. 1992 Jun;89(6):1713-7.
1717985	Giebel LB, Spritz RA: Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8696-9.
2448137	Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A: Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 1987 Nov;6(11):3341-51.
7687267	Spritz RA, Holmes SA, Itin P, Kuster W: Novel mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. J Invest Dermatol. 1993 Jul;101(1):22-5.
7691885	Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y, et al.: Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest. 1993 Oct;92(4):1736-44.
8680409	Riva P, Milani N, Gandolfi P, Larizza L: A 12-bp deletion (7818del12) in the c-kit protooncogene in a large Italian kindred with piebaldism. Hum Mutat. 1995;6(4):343-5.
9027509	Andre C, Hampe A, Lachaume P, Martin E, Wang XP, Manus V, Hu WX, Galibert F: Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes. Genomics. 1997 Jan 15;39(2):216-26.
9697690	Nishida T, Hirota S, Taniguchi M, Hashimoto K, Isozaki K, Nakamura H, Kanakura Y, Tanaka T, Takabayashi A, Matsuda H, Kitamura Y: Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet. 1998 Aug;19(4):323-4.

# Drug_Target_26_HGNC_ID:
HGNC:6342

# Drug_Target_26_HPRD_ID:
01287

# Drug_Target_26_ID:
504

# Drug_Target_26_Locus:
4q11-q12

# Drug_Target_26_Molecular_Weight:
109866

# Drug_Target_26_Name:
Mast/stem cell growth factor receptor

# Drug_Target_26_Number_of_Residues:
976

# Drug_Target_26_PDB_ID:
Not Available

# Drug_Target_26_Pathway:
Not Available

# Drug_Target_26_Pfam_Domain_Function:
PF00047	ig
PF07714	Pkinase_Tyr

# Drug_Target_26_Protein_Sequence:
>Mast/stem cell growth factor receptor precursor
MRGARGAWDFLCVLLLLLRVQTGSSQPSVSPGEPSPPSIHPGKSDLIVRVGDEIRLLCTD
PGFVKWTFEILDETNENKQNEWITEKAEATNTGKYTCTNKHGLSNSIYVFVRDPAKLFLV
DRSLYGKEDNDTLVRCPLTDPEVTNYSLKGCQGKPLPKDLRFIPDPKAGIMIKSVKRAYH
RLCLHCSVDQEGKSVLSEKFILKVRPAFKAVPVVSVSKASYLLREGEEFTVTCTIKDVSS
SVYSTWKRENSQTKLQEKYNSWHHGDFNYERQATLTISSARVNDSGVFMCYANNTFGSAN
VTTTLEVVDKGFINIFPMINTTVFVNDGENVDLIVEYEAFPKPEHQQWIYMNRTFTDKWE
DYPKSENESNIRYVSELHLTRLKGTEGGTYTFLVSNSDVNAAIAFNVYVNTKPEILTYDR
LVNGMLQCVAAGFPEPTIDWYFCPGTEQRCSASVLPVDVQTLNSSGPPFGKLVVQSSIDS
SAFKHNGTVECKAYNDVGKTSAYFNFAFKGNNKEQIHPHTLFTPLLIGFVIVAGMMCIIV
MILTYKYLQKPMYEVQWKVVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAF
GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC
TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKQEDHAEAALYKNLLHSKESSCSDSTNE
YMDMKPGVSYVVPTKADKRRSVRIGSYIERDVTPAIMEDDELALDLEDLLSFSYQVAKGM
AFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES
IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY
DIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHIYSNLANCSPNRQKPVVDHSVRINSV
GSTASSSQPLLVHDDV

# Drug_Target_26_Reaction:
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate

# Drug_Target_26_Signals:
1-25

# Drug_Target_26_Specific_Function:
This is the receptor for stem cell factor (mast cell growth factor). It has a tyrosine-protein kinase activity. Binding of the ligands leads to the autophosphorylation of KIT and its association with substrates such as phosphatidylinositol 3-kinase (Pi3K)

# Drug_Target_26_SwissProt_ID:
P10721

# Drug_Target_26_SwissProt_Name:
KIT_HUMAN

# Drug_Target_26_Synonyms:
CD117 antigen
EC 2.7.10.1
Mast/stem cell growth factor receptor precursor
Proto-oncogene tyrosine-protein kinase Kit
SCFR
c-kit

# Drug_Target_26_Theoretical_pI:
6.96

# Drug_Target_26_Transmembrane_Regions:
525-545

# Drug_Target_27_Cellular_Location:
Cytoplasmic

# Drug_Target_27_Chromosome_Location:
Not Available

# Drug_Target_27_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_27_Essentiality:
Non-Essential

# Drug_Target_27_GenAtlas_ID:
Not Available

# Drug_Target_27_GenBank_ID_Gene:
M31045

# Drug_Target_27_GenBank_ID_Protein:
Not Available

# Drug_Target_27_GeneCard_ID:
Not Available

# Drug_Target_27_Gene_Name:
clpA

# Drug_Target_27_Gene_Sequence:
Not Available

# Drug_Target_27_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_27_General_References:
12205096	Guo F, Maurizi MR, Esser L, Xia D: Crystal structure of ClpA, an Hsp100 chaperone and regulator of ClpAP protease. J Biol Chem. 2002 Nov 29;277(48):46743-52. Epub 2002 Aug 29.
12235156	Guo F, Esser L, Singh SK, Maurizi MR, Xia D: Crystal structure of the heterodimeric complex of the adaptor, ClpS, with the N-domain of the AAA+ chaperone, ClpA. J Biol Chem. 2002 Nov 29;277(48):46753-62. Epub 2002 Sep 15.
12426582	Zeth K, Ravelli RB, Paal K, Cusack S, Bukau B, Dougan DA: Structural analysis of the adaptor protein ClpS in complex with the N-terminal domain of ClpA. Nat Struct Biol. 2002 Dec;9(12):906-11.
1909328	Cummings HS, Sands JF, Foreman PC, Fraser J, Hershey JW: Structure and expression of the infA operon encoding translational initiation factor IF1. Transcriptional control by growth rate. J Biol Chem. 1991 Sep 5;266(25):16491-8.
2185473	Gottesman S, Squires C, Pichersky E, Carrington M, Hobbs M, Mattick JS, Dalrymple B, Kuramitsu H, Shiroza T, Foster T, et al.: Conservation of the regulatory subunit for the Clp ATP-dependent protease in prokaryotes and eukaryotes. Proc Natl Acad Sci U S A. 1990 May;87(9):3513-7.
2186030	Gottesman S, Clark WP, Maurizi MR: The ATP-dependent Clp protease of Escherichia coli. Sequence of clpA and identification of a Clp-specific substrate. J Biol Chem. 1990 May 15;265(14):7886-93.
3049606	Katayama Y, Gottesman S, Pumphrey J, Rudikoff S, Clark WP, Maurizi MR: The two-component, ATP-dependent Clp protease of Escherichia coli. Purification, cloning, and mutational analysis of the ATP-binding component. J Biol Chem. 1988 Oct 15;263(29):15226-36.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_27_HGNC_ID:
Not Available

# Drug_Target_27_HPRD_ID:
Not Available

# Drug_Target_27_ID:
3777

# Drug_Target_27_Locus:
Not Available

# Drug_Target_27_Molecular_Weight:
84208

# Drug_Target_27_Name:
ATP-dependent Clp protease ATP-binding subunit clpA

# Drug_Target_27_Number_of_Residues:
758

# Drug_Target_27_PDB_ID:
1KSF

# Drug_Target_27_Pathway:
Not Available

# Drug_Target_27_Pfam_Domain_Function:
PF00004	AAA
PF02861	Clp_N
PF07724	AAA_2

# Drug_Target_27_Protein_Sequence:
>ATP-dependent Clp protease ATP-binding subunit clpA
MLNQELELSLNMAFARAREHRHEFMTVEHLLLALLSNPSAREALEACSVDLVALRQELEA
FIEQTTPVLPASEEERDTQPTLSFQRVLQRAVFHVQSSGRNEVTGANVLVAIFSEQESQA
AYLLRKHEVSRLDVVNFISHGTRKDEPTQSSDPGSQPNSEEQAGGEERMENFTTNLNQLA
RVGGIDPLIGREKELERAIQVLCRRRKNNPLLVGESGVGKTAIAEGLAWRIVQGDVPEVM
ADCTIYSLDIGSLLAGTKYRGDFEKRFKALLKQLEQDTNSILFIDEIHTIIGAGAASGGQ
VDAANLIKPLLSSGKIRVIGSTTYQEFSNIFEKDRALARRFQKIDITEPSIEETVQIING
LKPKYEAHHDVRYTAKAVRAAVELAVKYINDRHLPDKAIDVIDEAGARARLMPVSKRKKT
VNVADIESVVARIARIPEKSVSQSDRDTLKNLGDRLKMLVFGQDKAIEALTEAIKMARAG
LGHEHKPVGSFLFAGPTGVGKTEVTVQLSKALGIELLRFDMSEYMERHTVSRLIGAPPGY
VGFDQGGLLTDAVIKHPHAVLLLDEIEKAHPDVFNILLQVMDNGTLTDNNGRKADFRNVV
LVMTTNAGVRETERKSIGLIHQDNSTDAMEEIKKIFTPEFRNRLDNIIWFDHLSTDVIHQ
VVDKFIVELQVQLDQKGVSLEVSQEARNWLAEKGYDRAMGARPMARVIQDNLKKPLANEL
LFGSLVDGGQVTVALDKEKNELTYGFQSAQKHKAEAAH

# Drug_Target_27_Reaction:
Not Available

# Drug_Target_27_Signals:
None

# Drug_Target_27_Specific_Function:
ATP-dependent specificity component of the clpP protease. It directs the protease to specific substrates. The primary function of the clpA-clpP complex appears to be the degradation of unfolded or abnormal proteins

# Drug_Target_27_SwissProt_ID:
P0ABH9

# Drug_Target_27_SwissProt_Name:
CLPA_ECOLI

# Drug_Target_27_Synonyms:
Not Available

# Drug_Target_27_Theoretical_pI:
6.26

# Drug_Target_27_Transmembrane_Regions:
None

# Drug_Target_28_Cellular_Location:
Endoplasmic reticulum
endoplasmic reticulum lumen. Melanosome. Note=Identified by mass spectrometry

# Drug_Target_28_Chromosome_Location:
Not Available

# Drug_Target_28_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_28_Essentiality:
Non-Essential

# Drug_Target_28_GenAtlas_ID:
HSP90B1

# Drug_Target_28_GenBank_ID_Gene:
M33716

# Drug_Target_28_GenBank_ID_Protein:
553797

# Drug_Target_28_GeneCard_ID:
HSP90B1

# Drug_Target_28_Gene_Name:
HSP90B1

# Drug_Target_28_Gene_Sequence:
>2412 bp
ATGAGGGCCCTGTGGGTGCTGGGCCTCTGCTGCGTCCTGCTGACCTTCGGGTCGGTCAGA
GCTGACGATGAAGTTGATGTGGATGGTACAGTAGAAGAGGATCTGGGTAAAAGTAGAGAA
GGATCAAGGACGGATGATGAAGTAGTACAGAGAGAGGAAGAAGCTATTCAGTTGGATGGA
TTAAATGCATCACAAATAAGAGAACTTAGAGAGAAGTCGGAAAAGTTTGCCTTCCAAGCC
GAAGTTAACAGAATGATGAAACTTATCATCAATTCATTGTATAAAAATAAAGAGATTTTC
CTGAGAGAACTGATTTCAAATGCTTCTGATGCTTTAGATAAGATAAGGCTAATATCACTG
ACTGATGAAAATGCTCTTTCTGGAAATGAGGAACTAACAGTCAAAATTAAGTGTGATAAG
GAGAAGAACCTGCTGCATGTCACAGACACCGGTGTAGGAATGACCAGAGAAGAGTTGGTT
AAAAACCTTGGTACCATAGCCAAATCTGGGACAAGCGAGTTTTTAAACAAAATGACTGAA
GCACAGGAAGATGGCCAGTCAACTTCTGAATTGATTGGCCAGTTTGGTGTCGGTTTCTAT
TCCGCCTTCCTTGTAGCAGATAAGGTTATTGTCACTTCAAAACACAACAACGATACCCAG
CACATCTGGGAGTCTGACTCCAATGAATTTTCTGTAATTGCTGACCCAAGAGGAAACACT
CTAGGACGGGGAACGACAATTACCCTTGTCTTAAAAGAAGAAGCATCTGATTACCTTGAA
TTGGATACAATTAAAAATCTCGTCAAAAAATATTCACAGTTCATAAACTTTCCTATTTAT
GTATGGAGCAGCAAGACTGAAACTGTTGAGGAGCCCATGGAGGAAGAAGAAGCAGCCAAA
GAAGAGAAAGAAGAATCTGATGATGAAGCTGCAGTAGAGGAAGAAGAAGAAGAAAAGAAA
CCAAAGACTAAAAAAGTTGAAAAAACTGTCTGGGACTGGGAACTTATGAATGATATCAAA
CCAATATGGCAGAGACCATCAAAAGAAGTAGAAGAAGATGAATACAAAGCTTTCTACAAA
TCATTTTCAAAGGAAAGTGATGACCCCATGGCTTATATTCACTTTACTGCTGAAGGGGAA
GTTACCTTCAAATCAATTTTATTTGTACCCACATCTGCTCCACGTGGTCTGTTTGACGAA
TATGGATCTAAAAAGAGCGATTACATTAAGCTCTATGTGCGCCGTGTATTCATCACAGAC
GACTTCCATGATATGATGCCTAAATACCTCAATTTTGTCAAGGGTGTGGTGGACTCAGAT
GATCTCCCCTTGAATGTTTCCCGCGAGACTCTTCAGCAACATAAACTGCTTAAGGTGATT
AGGAAGAAGCTTGTTCGTAAAACGCTGGACATGATCAAGAAGATTGCTGATGATAAATAC
AATGATACTTTTTGGAAAGAATTTGGTACCAACATCAAGCTTGGTGTGATTGAAGACCAC
TCGAATCGAACACGTCTTGCTAAACTTCTTAGGTTCCAGTCTTCTCATCATCCAACTGAC
ATTACTAGCCTAGACCAGTATGTGGAAAGAATGAAGGAAAAACAAGACAAAATCTACTTC
ATGGCTGGGTCCAGCAGAAAAGAGGCTGAATCTTCTCCATTTGTTGAGCGACTTCTGAAA
AAGGGCTATGAAGTTATTTACCTCACAGAACCTGTGGATGAATACTGTATTCAGGCCCTT
CCCGAATTTGATGGGAAGAGGTTCCAGAATGTTGCCAAGGAAGGAGTGAAGTTCGATGAA
AGTGAGAAAACTAAGGAGAGTCGTGAAGCAGTTGAGAAAGAATTTGAGCCTCTGCTGAAT
TGGATGAAAGATAAAGCCCTTAAGGACAAGATTGAAAAGGCTGTGGTGTCTCAGCGCCTG
ACAGAATCTCCGTGTGCTTTGGTGGCCAGCCAGTACGGATGGTCTGGCAACATGGAGAGA
ATCATGAAAGCACAAGCGTACCAAACGGGCAAGGACATCTCTACAAATTACTATGCGAGT
CAGAAGAAAACATTTGAAATTAATCCCAGACACCCGCTGATCAGAGACATGCTTCGACGA
ATTAAGGAAGATGAAGATGATAAAACAGTTTTGGATCTTGCTGTGGTTTTGTTTGAAACA
GCAACGCTTCGGTCAGGGTATCTTTTACCAGACACTAAAGCATATGGAGATAGAATAGAA
AGAATGCTTCGCCTCAGTTTGAACATTGACCCTGATGCAAAGGTGGAAGAAGAGCCCGAA
GAAGAACCTGAAGAGACAGCAGAAGACACAACAGAAGACACAGAGCAAGACGAAGATGAA
GAAATGGATGTGGGAACAGATGAAGAAGAAGAAACAGCAAAGGAATCTACAGCTGAAAAA
GATGAATTGTAA

# Drug_Target_28_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_28_General_References:
12665801	Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31.
12754519	Zhang H, Li XJ, Martin DB, Aebersold R: Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol. 2003 Jun;21(6):660-6. Epub 2003 May 18.
2377606	Maki RG, Old LJ, Srivastava PK: Human homologue of murine tumor rejection antigen gp96: 5'-regulatory and coding regions and relationship to stress-induced proteins. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5658-62.
2546060	Chang SC, Erwin AE, Lee AS: Glucose-regulated protein (GRP94 and GRP78) genes share common regulatory domains and are coordinately regulated by common trans-acting factors. Mol Cell Biol. 1989 May;9(5):2153-62.

# Drug_Target_28_HGNC_ID:
HGNC:12028

# Drug_Target_28_HPRD_ID:
01860

# Drug_Target_28_ID:
2091

# Drug_Target_28_Locus:
12q24.2-q24.3

# Drug_Target_28_Molecular_Weight:
92470

# Drug_Target_28_Name:
Endoplasmin

# Drug_Target_28_Number_of_Residues:
803

# Drug_Target_28_PDB_ID:
1QYE

# Drug_Target_28_Pathway:
Not Available

# Drug_Target_28_Pfam_Domain_Function:
PF00183	HSP90
PF02518	HATPase_c

# Drug_Target_28_Protein_Sequence:
>Endoplasmin precursor
MRALWVLGLCCVLLTFGSVRADDEVDVDGTVEEDLGKSREGSRTDDEVVQREEEAIQLDG
LNASQIRELREKSEKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASDALDKIRLISL
TDENALSGNEELTVKIKCDKEKNLLHVTDTGVGMTREELVKNLGTIAKSGTSEFLNKMTE
AQEDGQSTSELIGQFGVGFYSAFLVADKVIVTSKHNNDTQHIWESDSNEFSVIADPRGNT
LGRGTTITLVLKEEASDYLELDTIKNLVKKYSQFINFPIYVWSSKTETVEEPMEEEEAAK
EEKEESDDEAAVEEEEEEKKPKTKKVEKTVWDWELMNDIKPIWQRPSKEVEEDEYKAFYK
SFSKESDDPMAYIHFTAEGEVTFKSILFVPTSAPRGLFDEYGSKKSDYIKLYVRRVFITD
DFHDMMPKYLNFVKGVVDSDDLPLNVSRETLQQHKLLKVIRKKLVRKTLDMIKKIADDKY
NDTFWKEFGTNIKLGVIEDHSNRTRLAKLLRFQSSHHPTDITSLDQYVERMKEKQDKIYF
MAGSSRKEAESSPFVERLLKKGYEVIYLTEPVDEYCIQALPEFDGKRFQNVAKEGVKFDE
SEKTKESREAVEKEFEPLLNWMKDKALKDKIEKAVVSQRLTESPCALVASQYGWSGNMER
IMKAQAYQTGKDISTNYYASQKKTFEINPRHPLIRDMLRRIKEDEDDKTVLDLAVVLFET
ATLRSGYLLPDTKAYGDRIERMLRLSLNIDPDAKVEEEPEEEPEETAEDTTEDTEQDEDE
EMDVGTDEEEETAKESTAEKDEL

# Drug_Target_28_Reaction:
Not Available

# Drug_Target_28_Signals:
1-21

# Drug_Target_28_Specific_Function:
Molecular chaperone that functions in the processing and transport of secreted proteins

# Drug_Target_28_SwissProt_ID:
P14625

# Drug_Target_28_SwissProt_Name:
ENPL_HUMAN

# Drug_Target_28_Synonyms:
94 kDa glucose-regulated protein
Endoplasmin precursor
GRP94
Heat shock protein 90 kDa beta member 1
Tumor rejection antigen 1
gp96 homolog

# Drug_Target_28_Theoretical_pI:
4.48

# Drug_Target_28_Transmembrane_Regions:
None

# Drug_Target_29_Cellular_Location:
Cytoplasm (Potential)

# Drug_Target_29_Chromosome_Location:
Not Available

# Drug_Target_29_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_29_Essentiality:
Non-Essential

# Drug_Target_29_GenAtlas_ID:
Not Available

# Drug_Target_29_GenBank_ID_Gene:
U30501

# Drug_Target_29_GenBank_ID_Protein:
940146

# Drug_Target_29_GeneCard_ID:
Not Available

# Drug_Target_29_Gene_Name:
cheA

# Drug_Target_29_Gene_Sequence:
>2016 bp
ATGATGGAAGAATATCTCGGAGTGTTTGTCGATGAGACAAAAGAATACCTTCAAAATCTG
AACGATACCCTCCTCGAATTGGAGAAAAATCCCGAAGATATGGAACTCATAAACGAAGCG
TTCAGGGCTCTTCATACCCTGAAAGGAATGGCAGGTACAATGGGGTTTTCCAGTATGGCG
AAGCTCTGCCATACCTTAGAAAACATCCTCGATAAAGCCAGAAACAGCGAGATAAAGATA
ACTTCCGATCTCCTCGATAAGATCTTCGCGGGGGTCGATATGATAACCAGAATGGTTGAT
AAGATCGTCTCCGAGGGAAGTGACGACATCGGAGAAAACATAGACGTGTTCTCCGACACC
ATAAAAAGCTTTGCATCATCGGGAAAAGAGAAGCCTTCAGAAATCAAAAATGAAACGGAA
ACAAAGGGTGAGGAAGAACACAAAGGAGAATCAACAAGCAATGAAGAAGTCGTAGTTCTT
CCTGAAGAAGTTGCCCACGTTCTTCAGGAAGCGAGAAACAAGGGTTTCAAAACGTTTTAT
ATTAAAGTGATTCTCAAAGAAGGAACGCAGTTGAAATCCGCCAGGATTTACCTCGTTTTC
CACAAGCTTGAAGAACTGAAGTGTGAAGTTGTGAGAACGATTCCTTCGGTTGAAGAGATA
GAAGAAGAGAAATTCGAAAACGAAGTGGAACTCTTCGTAATCTCCCCTGTGGATCTGGAG
AAACTCTCTGAAGCTCTGTCAAGCATCGCCGATATAGAGAGGGTAATAATAAAAGAAGTA
ACCGCCGTCACCGAAGAATCAGGGGCTGAGAAAAGAACCGAGAAAGAAGAGAAAACTGAA
AAAACTGAGGAAAAGGCCGAAAGAAAAAAGGTTATTTCGCAAACAGTCAGGGTAGATATA
GAGAAACTGGGCAATTTGATGGATTTGATGGGAGAACTGGTCATCGCAAGGAGCAGAATA
CTGGAAACGCTCAAGAAATACAACATAAAAGAACTGGATGAGAGTTTGTCTCATCTCAGC
AGGATCACCTTAGACCTTCAGAATGTTGTGATGAAGATCAGAATGGTTCCCATCTCCTTT
GTTTTCAACAGATTCCCTCGAATGGTGAGAGACCTTGCCAAAAAGATGAACAAAGAAGTG
AATTTCATCATGAGAGGAGAAGACACAGAGCTCGACAGAACGTTCGTTGAAGAAATTGGC
GAACCCCTGCTCCATCTCCTGAGAAACGCCATCGACCACGGTATAGAACCCAAAGAAGAA
CGAATAGCCAAAGGAAAACCCCCCATTGGAACACTCATTCTCTCGGCACGTCACGAGGGA
AACAACGTGGTAATAGAAGTCGAAGATGACGGAAGGGGTATAGACAAGGAAAAGATCATC
AGAAAAGCCATAGAAAAGGGACTCATAGATGAATCAAAGGCCGCTACCCTTTCTGATCAG
GAGATTCTGAACTTCCTCTTCGTTCCGGGATTCTCCACAAAGGAAAAAGTCTCAGAAGTC
TCCGGAAGAGGCGTGGGAATGGATGTCGTGAAAAATGTGGTGGAATCTTTGAATGGTAGC
ATAAGCATAGAAAGCGAGAAAGATAAAGGAACAAAAGTTACGATAAGACTACCGCTCACT
CTGGCCATCATTCAGGCGCTCCTCGTCAAAGTCAACAATCTCGTCTACGCGATTCCGATA
GCGAACATAGACACAATACTCAGCATTTCAAAAGAGGATATTCAAAGAGTTCAGGACAGA
GATGTGATAGTCATAAGAGGAGAAGTGATACCCGTTTACCGTCTGTGGGAAGTGCTTCAA
ATAGAGCACAAAGAAGAACTGGAGGAGATGGAAGCGGTTATTGTGAGGGTAGGAAACAGG
AAGTACGGTATCGTCGTAGACGATCTTCTCGGTCAGGACGATATCGTGATAAAATCTCTT
GGAAAGGTGTTCTCTGAGGTGAAGGAATTCAGCGGAGCAGCTATTCTCGGTGATGGTAGT
ATAGCGCTGATAATCAACGTCTCCGGCATTGTATAA

# Drug_Target_29_General_Function:
Signal transduction mechanisms

# Drug_Target_29_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.
8550470	Swanson RV, Sanna MG, Simon MI: Thermostable chemotaxis proteins from the hyperthermophilic bacterium Thermotoga maritima. J Bacteriol. 1996 Jan;178(2):484-9.
9989504	Bilwes AM, Alex LA, Crane BR, Simon MI: Structure of CheA, a signal-transducing histidine kinase. Cell. 1999 Jan 8;96(1):131-41.

# Drug_Target_29_HGNC_ID:
Not Available

# Drug_Target_29_HPRD_ID:
Not Available

# Drug_Target_29_ID:
2615

# Drug_Target_29_Locus:
Not Available

# Drug_Target_29_Molecular_Weight:
75557

# Drug_Target_29_Name:
Chemotaxis protein cheA

# Drug_Target_29_Number_of_Residues:
671

# Drug_Target_29_PDB_ID:
1B3Q

# Drug_Target_29_Pathway:
Not Available

# Drug_Target_29_Pfam_Domain_Function:
PF01584	CheW
PF01627	Hpt
PF02518	HATPase_c
PF02895	H-kinase_dim
PF07194	P2

# Drug_Target_29_Protein_Sequence:
>Chemotaxis protein cheA
MMEEYLGVFVDETKEYLQNLNDTLLELEKNPEDMELINEAFRALHTLKGMAGTMGFSSMA
KLCHTLENILDKARNSEIKITSDLLDKIFAGVDMITRMVDKIVSEGSDDIGENIDVFSDT
IKSFASSGKEKPSEIKNETETKGEEEHKGESTSNEEVVVLPEEVAHVLQEARNKGFKTFY
IKVILKEGTQLKSARIYLVFHKLEELKCEVVRTIPSVEEIEEEKFENEVELFVISPVDLE
KLSEALSSIADIERVIIKEVTAVTEESGAEKRTEKEEKTEKTEEKAERKKVISQTVRVDI
EKLDNLMDLMGELVIARSRILETLKKYNIKELDESLSHLSRITLDLQNVVMKIRMVPISF
VFNRFPRMVRDLAKKMNKEVNFIMRGEDTELDRTFVEEIGEPLLHLLRNAIDHGIEPKEE
RIAKGKPPIGTLILSARHEGNNVVIEVEDDGRGIDKEKIIRKAIEKGLIDESKAATLSDQ
EILNFLFVPGFSTKEKVSEVSGRGVGMDVVKNVVESLNGSISIESEKDKGTKVTIRLPLT
LAIIQALLVKVNNLVYAIPIANIDTILSISKEDIQRVQDRDVIVIRGEVIPVYRLWEVLQ
IEHKEELEEMEAVIVRVGNRKYGIVVDDLLGQDDIVIKSLGKVFSEVKEFSGAAILGDGS
IALIINVSGIV

# Drug_Target_29_Reaction:
ATP + protein L-histidine = ADP + protein N-phospho-L-histidine

# Drug_Target_29_Signals:
None

# Drug_Target_29_Specific_Function:
Involved in the transmission of sensory signals from the chemoreceptors to the flagellar motors. CheA is autophosphorylated; it can transfer its phosphate group to either cheB or cheY

# Drug_Target_29_SwissProt_ID:
Q56310

# Drug_Target_29_SwissProt_Name:
CHEA_THEMA

# Drug_Target_29_Synonyms:
EC 2.7.13.3

# Drug_Target_29_Theoretical_pI:
4.64

# Drug_Target_29_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
M20568

# Drug_Target_2_GenBank_ID_Protein:
142344

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
nifH1

# Drug_Target_2_Gene_Sequence:
>873 bp
ATGGCTATGCGTCAATGCGCCATCTACGGCAAAGGTGGTATCGGTAAGTCCACCACTACT
CAGAACCTGGTGGCAGCCCTGGCTGAGATGGGCAAGAAGGTCATGATCGTTGGTTGTGAC
CCGAAAGCTGACTCCACCCGCCTGATCCTGCACTCCAAGGCCCAGAACACCATCATGGAA
ATGGCTGCCGAAGCCGGTACCGTGGAAGATCTGGAGCTGGAAGACGTGCTGAAGGCTGGC
TACGGCGGCGTCAAGTGCGTTGAGTCCGGTGGTCCGGAGCCGGGCGTTGGCTGCGCCGGC
CGTGGTGTTATCACCGCCATCAACTTCCTGGAAGAGGAAGGCGCCTACGAAGACGATCTG
GACTTCGTATTCTACGACGTGCTGGGCGACGTGGTGTGTGGCGGCTTCGCCATGCCGATC
CGCGAGAACAAGGCCCAGGAAATCTACATCGTCTGCTCCGGTGAGATGATGGCCATGTAC
GCCGCCAACAACATCTCCAAGGGCATCGTGAAGTATGCCAACTCCGGCAGCGTGCGTCTG
GGCGGCCTGATCTGCAACAGCCGTAACACCGACCGCGAAGACGAGCTGATCATCGCTCTG
GCCAACAAGCTGGGCACCCAGATGATCCACTTCGTGCCGCGTGACAACGTCGTGCAGCGC
GCCGAAATCCGCCGCATGACCGTGATCGAATACGATCCGAAAGCCAAGCAAGCCGACGAA
TACCGCGCTCTGGCCCGCAAGGTCGTCGACAACAAACTGCTGGTCATCCCGAACCCGATC
ACCATGGACGAGCTCGAAGAGCTGCTGATGGAATTCGGCATCATGGAAGTCGAAGACGAA
TCCATCGTCGGCAAAACCGCCGAAGAAGTCTGA

# Drug_Target_2_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_2_General_References:
11101289	Jang SB, Seefeldt LC, Peters JW: Insights into nucleotide signal transduction in nitrogenase: structure of an iron protein with MgADP bound. Biochemistry. 2000 Dec 5;39(48):14745-52.
11170380	Chiu H, Peters JW, Lanzilotta WN, Ryle MJ, Seefeldt LC, Howard JB, Rees DC: MgATP-Bound and nucleotide-free structures of a nitrogenase protein complex between the Leu 127 Delta-Fe-protein and the MoFe-protein. Biochemistry. 2001 Jan 23;40(3):641-50.
11170381	Strop P, Takahara PM, Chiu H, Angove HC, Burgess BK, Rees DC: Crystal structure of the all-ferrous [4Fe-4S]0 form of the nitrogenase iron protein from Azotobacter vinelandii. Biochemistry. 2001 Jan 23;40(3):651-6.
1313018	Seefeldt LC, Morgan TV, Dean DR, Mortenson LE: Mapping the site(s) of MgATP and MgADP interaction with the nitrogenase of Azotobacter vinelandii. Lysine 15 of the iron protein plays a major role in MgATP interaction. J Biol Chem. 1992 Apr 5;267(10):6680-8.
1529353	Georgiadis MM, Komiya H, Chakrabarti P, Woo D, Kornuc JJ, Rees DC: Crystallographic structure of the nitrogenase iron protein from Azotobacter vinelandii. Science. 1992 Sep 18;257(5077):1653-9.
2644218	Jacobson MR, Brigle KE, Bennett LT, Setterquist RA, Wilson MS, Cash VL, Beynon J, Newton WE, Dean DR: Physical and genetic map of the major nif gene cluster from Azotobacter vinelandii. J Bacteriol. 1989 Feb;171(2):1017-27.
3344210	Hiratsuka K, Roy KL: Sequence of a 1.4 kb Eco RI fragment of Azotobacter vinelandii nif DNA. Nucleic Acids Res. 1988 Feb 11;16(3):1207.
3863780	Brigle KE, Newton WE, Dean DR: Complete nucleotide sequence of the Azotobacter vinelandii nitrogenase structural gene cluster. Gene. 1985;37(1-3):37-44.
6801032	Hausinger RP, Howard JB: The amino acid sequence of the nitrogenase iron protein from Azotobacter vinelandii. J Biol Chem. 1982 Mar 10;257(5):2483-90.
9163420	Schindelin H, Kisker C, Schlessman JL, Howard JB, Rees DC: Structure of ADP x AIF4(-)-stabilized nitrogenase complex and its implications for signal transduction. Nature. 1997 May 22;387(6631):370-6.
9677296	Schlessman JL, Woo D, Joshua-Tor L, Howard JB, Rees DC: Conformational variability in structures of the nitrogenase iron proteins from Azotobacter vinelandii and Clostridium pasteurianum. J Mol Biol. 1998 Jul 24;280(4):669-85.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2874

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
31517

# Drug_Target_2_Name:
Nitrogenase iron protein 1

# Drug_Target_2_Number_of_Residues:
290

# Drug_Target_2_PDB_ID:
1FP6

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00142	Fer4_NifH

# Drug_Target_2_Protein_Sequence:
>Nitrogenase iron protein 1
MAMRQCAIYGKGGIGKSTTTQNLVAALAEMGKKVMIVGCDPKADSTRLILHSKAQNTIME
MAAEAGTVEDLELEDVLKAGYGGVKCVESGGPEPGVGCAGRGVITAINFLEEEGAYEDDL
DFVFYDVLGDVVCGGFAMPIRENKAQEIYIVCSGEMMAMYAANNISKGIVKYANSGSVRL
GGLICNSRNTDREDELIIALANKLGTQMIHFVPRDNVVQRAEIRRMTVIEYDPKAKQADE
YRALARKVVDNKLLVIPNPITMDELEELLMEFGIMEVEDESIVGKTAEEV

# Drug_Target_2_Reaction:
8 reduced ferredoxin + 8 H+ + N2 + 16 ATP + 16 H2O = 8 oxidized ferredoxin + H2 + 2 NH3 + 16 ADP + 16 phosphate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
The key enzymatic reactions in nitrogen fixation are catalyzed by the nitrogenase complex, which has 2 components:the iron protein (component 2) and a component 1 which is either a molybdenum-iron protein, a vanadium-iron, or an iron-iron protein

# Drug_Target_2_SwissProt_ID:
P00459

# Drug_Target_2_SwissProt_Name:
NIFH1_AZOVI

# Drug_Target_2_Synonyms:
EC 1.18.6.1
Nitrogenase Fe protein 1
Nitrogenase component II
Nitrogenase reductase

# Drug_Target_2_Theoretical_pI:
4.39

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_30_Cellular_Location:
Cytoplasm

# Drug_Target_30_Chromosome_Location:
Not Available

# Drug_Target_30_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_30_Essentiality:
Non-Essential

# Drug_Target_30_GenAtlas_ID:
Not Available

# Drug_Target_30_GenBank_ID_Gene:
X99208

# Drug_Target_30_GenBank_ID_Protein:
1430892

# Drug_Target_30_GeneCard_ID:
Not Available

# Drug_Target_30_Gene_Name:
recA

# Drug_Target_30_Gene_Sequence:
>1050 bp
ATGGCGCAGCAGGCCCCAGATCGCGAAAAGGCCCTCGAACTGGCGATGGCCCAGATCGAC
AAGAATTTCGGCAAAGGCTCGGTGATGCGCCTCGGCGAAGAGGTGCGCCAGCCGATCTCG
GTGATCCCCACCGGCTCCATCTCGCTGGATGTGGCGCTCGGCATCGGCGGCCTGCCGCGG
GGCCGCGTCATCGAGATCTACGGCCCGGAGTCCTCGGGTAAGACCACCGTGGCCCTGCAT
GCCGTCGCCAACGCGCAGGCCGCGGGCGGTATCGCGGCGTTCATCGACGCCGAGCACGCG
CTGGATCCCGAGTACGCCAAGAAGCTGGGTGTGGACACCGACTCGCTGCTGGTGTCGCAG
CCCGACACCGGTGAGCAGGCGCTGGAGATCGCCGACATGCTGGTGCGGTCCGGCGCGCTG
GACATCATCGTCATCGACTCGGTCGCCGCCCTGGTGCCGCGCGCCGAGATCGAGGGCGAG
ATGGGTGACAGCCACGTCGGCCTGCAGGCCCGCCTGATGAGCCAGGCGCTGCGCAAGATG
ACCGGCGCGTTGAACAACTCGGGCACCACCGCGATCTTCATCAACCAGCTCCGCGAGAAG
ATCGGTGTGATGTTCGGCTCGCCCGAGACCACCACGGGCGGTAAGGCACTGAAGTTCTAC
GCCTCGGTCCGCCTCGACGTGCGCCGTATCGAGACGCTCAAGGACGGCACCGACGCGGTC
GGTAACCGCACCCGCGTCAAGGTCGTCAAGAACAAGGTCTCCCCGCCGTTCAAGCAGGCC
GAGTTCGACATCCTCTACGGCCAGGGCATCAGCCGCGAGGGTTCGCTCATCGACATGGGC
GTCGAGCACGGCTTCATCCGCAAGTCCGGGTCCTGGTTCACCTACGAGGGTGAGCAGCTG
GGCCAGGGCAAGGAGAACGCCCGCAAGTTCCTGCTGGAGAACACCGACGTCGCCAACGAG
ATCGAGAAGAAGATCAAAGAGAAGCTCGGTATCGGCGCCGTCGTGACCGCTGAAGCCGAT
GACGTCCTCCCGGCCCCGGTTGACTTCTGA

# Drug_Target_30_General_Function:
Replication, recombination and repair

# Drug_Target_30_General_References:
9822818	Papavinasasundaram KG, Colston MJ, Davis EO: Construction and complementation of a recA deletion mutant of Mycobacterium smegmatis reveals that the intein in Mycobacterium tuberculosis recA does not affect RecA function. Mol Microbiol. 1998 Nov;30(3):525-34.

# Drug_Target_30_HGNC_ID:
Not Available

# Drug_Target_30_HPRD_ID:
Not Available

# Drug_Target_30_ID:
2282

# Drug_Target_30_Locus:
Not Available

# Drug_Target_30_Molecular_Weight:
37301

# Drug_Target_30_Name:
Protein recA

# Drug_Target_30_Number_of_Residues:
349

# Drug_Target_30_PDB_ID:
1UBG

# Drug_Target_30_Pathway:
Not Available

# Drug_Target_30_Pfam_Domain_Function:
PF00154	RecA

# Drug_Target_30_Protein_Sequence:
>Protein recA
MAQQAPDREKALELAMAQIDKNFGKGSVMRLGEEVRQPISVIPTGSISLDVALGIGGLPR
GRVIEIYGPESSGKTTVALHAVANAQAAGGIAAFIDAEHALDPEYAKKLGVDTDSLLVSQ
PDTGEQALEIADMLVRSGALDIIVIDSVAALVPRAEIEGEMGDSHVGLQARLMSQALRKM
TGALNNSGTTAIFINQLREKIGVMFGSPETTTGGKALKFYASVRLDVRRIETLKDGTDAV
GNRTRVKVVKNKVSPPFKQAEFDILYGQGISREGSLIDMGVEHGFIRKSGSWFTYEGEQL
GQGKENARKFLLENTDVANEIEKKIKEKLGIGAVVTAEADDVLPAPVDF

# Drug_Target_30_Reaction:
Not Available

# Drug_Target_30_Signals:
None

# Drug_Target_30_Specific_Function:
Can catalyze the hydrolysis of ATP in the presence of single-stranded DNA, the ATP-dependent uptake of single-stranded DNA by duplex DNA, and the ATP-dependent hybridization of homologous single-stranded DNAs. It interacts with lexA causing its activation and leading to its autocatalytic cleavage

# Drug_Target_30_SwissProt_ID:
Q59560

# Drug_Target_30_SwissProt_Name:
RECA_MYCS2

# Drug_Target_30_Synonyms:
Recombinase A

# Drug_Target_30_Theoretical_pI:
5.05

# Drug_Target_30_Transmembrane_Regions:
None

# Drug_Target_31_Cellular_Location:
Cytoplasmic

# Drug_Target_31_Chromosome_Location:
Not Available

# Drug_Target_31_Drug_References:
Not Available

# Drug_Target_31_Essentiality:
Non-Essential

# Drug_Target_31_GenAtlas_ID:
Not Available

# Drug_Target_31_GenBank_ID_Gene:
AE000657

# Drug_Target_31_GenBank_ID_Protein:
Not Available

# Drug_Target_31_GeneCard_ID:
Not Available

# Drug_Target_31_Gene_Name:
ntrC1

# Drug_Target_31_Gene_Sequence:
>1320 bp
GTGAACGTTTTGGTAATTGAAGATGACAAGGTTTTCAGAGGTTTACTCGAGGAATACCTT
TCCATGAAAGGTATAAAAGTTGAGAGTGCTGAGAGGGGAAAGGAAGCGTACAAACTCCTT
TCGGAAAAACACTTCAACGTGGTACTCCTTGATCTCCTGCTTCCAGACGTGAACGGACTG
GAAATACTCAAGTGGATTAAAGAAAGAAGCCCGGAAACGGAAGTAATCGTAATTACGGGA
CACGGAACTATAAAAACTGCGGTAGAAGCTATGAAAATGGGAGCGTACGACTTTTTAACA
AAACCCTGCATGCTCGAAGAAATAGAACTCACTATAAATAAGGCGATAGAACACAGGAAA
TTGAGGAAAGAAAACGAATTACTGAGAAGGGAAAAGGACTTAAAGGAAGAGGAGTACGTA
TTCGAAAGCCCCAAAATGAAGGAGATTCTGGAAAAAATTAAGAAGATTTCCTGTGCGGAA
TGTCCCGTCCTTATCACGGGAGAAAGCGGAGTTGGAAAGGAGGTTGTGGCACGGCTTATA
CACAAATTGAGCGACAGATCTAAAGAGCCCTTTGTTGCATTAAATGTTGCTTCAATTCCC
CGGGATATATTCGAAGCGGAACTCTTCGGGTACGAAAAGGGAGCCTTCACGGGAGCAGTA
TCTTCCAAGGAAGGTTTTTTTGAGCTTGCGGACGGAGGAACACTCTTTTTGGACGAGATA
GGTGAGCTGAGTTTAGAGGCTCAGGCAAAACTGCTCAGGGTAATTGAGAGCGGAAAGTTT
TACAGACTCGGCGGAAGGAAGGAAATTGAAGTAAACGTAAGGATTCTGGCCGCAACTAAT
AGAAACATTAAAGAACTTGTAAAGGAAGGAAAGTTCAGGGAAGACCTTTACTACAGACTC
GGAGTTATCGAGATAGAAATACCACCTTTGAGGGAAAGGAAGGAAGACATAATCCCTCTC
GCCAATCACTTTCTGAAAAAGTTTAGCAGGAAGTACGCAAAAGAAGTGGAGGGATTCACA
AAAAGTGCCCAAGAACTTCTACTAAGTTATCCCTGGTACGGAAACGTGAGGGAACTCAAA
AACGTAATTGAAAGGGCTGTACTCTTTTCCGAGGGAAAGTTTATAGACAGAGGGGAATTG
TCCTGCTTGGTAAATTCAAAAGGGATAAAAAACAAACACAAAAGTATAAAGGAAATTGAA
AAGGAAGAAATAATAAAAGTCTTGAAAGAGGTAAATTTCAATAAAAAACTTGCTTCCGAG
ATCCTTGGGATTCCCTTAAGAACTCTCTACAGGAGACTGAAGGAGTACGGAATAGAGTAA

# Drug_Target_31_General_Function:
Involved in nucleotide binding

# Drug_Target_31_General_References:
14561776	Lee SY, De La Torre A, Yan D, Kustu S, Nixon BT, Wemmer DE: Regulation of the transcriptional activator NtrC1: structural studies of the regulatory and AAA+ ATPase domains. Genes Dev. 2003 Oct 15;17(20):2552-63.
9537320	Deckert G, Warren PV, Gaasterland T, Young WG, Lenox AL, Graham DE, Overbeek R, Snead MA, Keller M, Aujay M, Huber R, Feldman RA, Short JM, Olsen GJ, Swanson RV: The complete genome of the hyperthermophilic bacterium Aquifex aeolicus. Nature. 1998 Mar 26;392(6674):353-8.

# Drug_Target_31_HGNC_ID:
Not Available

# Drug_Target_31_HPRD_ID:
Not Available

# Drug_Target_31_ID:
5259

# Drug_Target_31_Locus:
Not Available

# Drug_Target_31_Molecular_Weight:
50368

# Drug_Target_31_Name:
Transcriptional regulator

# Drug_Target_31_Number_of_Residues:
439

# Drug_Target_31_PDB_ID:
1NY5

# Drug_Target_31_Pathway:
Not Available

# Drug_Target_31_Pfam_Domain_Function:
PF00072	Response_reg
PF00158	Sigma54_activat
PF02954	HTH_8

# Drug_Target_31_Protein_Sequence:
>Transcriptional regulator
MNVLVIEDDKVFRGLLEEYLSMKGIKVESAERGKEAYKLLSEKHFNVVLLDLLLPDVNGL
EILKWIKERSPETEVIVITGHGTIKTAVEAMKMGAYDFLTKPCMLEEIELTINKAIEHRK
LRKENELLRREKDLKEEEYVFESPKMKEILEKIKKISCAECPVLITGESGVGKEVVARLI
HKLSDRSKEPFVALNVASIPRDIFEAELFGYEKGAFTGAVSSKEGFFELADGGTLFLDEI
GELSLEAQAKLLRVIESGKFYRLGGRKEIEVNVRILAATNRNIKELVKEGKFREDLYYRL
GVIEIEIPPLRERKEDIIPLANHFLKKFSRKYAKEVEGFTKSAQELLLSYPWYGNVRELK
NVIERAVLFSEGKFIDRGELSCLVNSKGIKNKHKSIKEIEKEEIIKVLKEVNFNKKLASE
ILGIPLRTLYRRLKEYGIE

# Drug_Target_31_Reaction:
Not Available

# Drug_Target_31_Signals:
None

# Drug_Target_31_Specific_Function:
Not Available

# Drug_Target_31_SwissProt_ID:
O67198

# Drug_Target_31_SwissProt_Name:
O67198_AQUAE

# Drug_Target_31_Synonyms:
NtrC family

# Drug_Target_31_Theoretical_pI:
8.26

# Drug_Target_31_Transmembrane_Regions:
None

# Drug_Target_32_Cellular_Location:
Cytoplasm. Melanosome

# Drug_Target_32_Chromosome_Location:
1

# Drug_Target_32_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_32_Essentiality:
Non-Essential

# Drug_Target_32_GenAtlas_ID:
Not Available

# Drug_Target_32_GenBank_ID_Gene:
AB034951

# Drug_Target_32_GenBank_ID_Protein:
11526573

# Drug_Target_32_GeneCard_ID:
HSPA8

# Drug_Target_32_Gene_Name:
HSPA8

# Drug_Target_32_Gene_Sequence:
>1482 bp
ATGTCCAAGGGACCTGCAGTTGGTATTGATCTTGGCACCACCTACTCTTGTGTGGGTGTT
TTCCAGCACGGAAAAGTCGAGATAATTGCCAATGATCAGGGAAACCGAACCACTCCAAGC
TATGTCGCCTTTACGGACACTGAACGGTTGATCGGTGATGCCGCAAAGAATCAAGTTGCA
ATGAACCCCACCAACACAGTTTTTGATGCCAAACGTCTGATTGGACGCAGATTTGATGAT
GCTGTTGTCCAGTCTGATATGAAACATTGGCCCTTTATGGTGGTGAATGATGCTGGCAGG
CCCAAGGTCCAAGTAGAATACAAGGGAGAGACCAAAAGCTTCTATCCAGAGGAGGTGTCT
TCTATGGTTCTGACAAAGATGAAGGAAATTGCAGAAGCCTACCTTGGGAAGACTGTTACC
AATGCTGTGGTCACAGTGCCAGCTTACTTTAATGACTCTCAGCGTCAGGCTACCAAAGAT
GCTGGAACTATTGCTGGTCTCAATGTACTTAGAATTATTAATGAGCCAACTGCTGCTGCT
ATTGCTTACGGCTTAGACAAAAAGGTTGGAGCAGAAAGAAACGTGCTCATCTTTGACCTG
GGAGGTGGCACTTTTGATGTGTCAATCCTCACTATTGAGGATGGAATCTTTGAGGTCAAG
TCTACAGCTGGAGACACCCACTTGGGTGGAGAAGATTTTGACAACCGAATGGTCAACCAT
TTTATTGCTGAGTTTAAGCGCAAGCATAAGAAGGACATCAGTGAGAACAAGAGAGCTGTA
AGACGCCTCCGTACTGCTTGTGAACGTGCTAAGCGTACCCTCTCTTCCAGCACCCAGGCC
AGTATTGAGATCGATTCTCTCTATGAAGGAATCGACTTCTATACCTCCATTACCCGTGCC
CGATTTGAAGAACTGAATGCTGACCTGTTCCGTGGCACCCTGGACCCAGTAGAGAAAGCC
CTTCGAGATGCCAAACTAGACAAGTCACAGATTCATGATATTGTCCTGGTTGGTGGTTCT
ACTCGTATCCCCAAGATTCAGAAGCTTCTCCAAGACTTCTTCAATGGAAAAGAACTGAAT
AAGAGCATCAACCCTGATGAAGCTGTTGCTTATGGTGCAGCTGTCCAGGCAGCCATCTTG
TCTGGAGACAAGTCTGAGAATGTTCAAGATTTGCTGCTCTTGGATGTCACTCCTCTTTCC
CTTGGTATTGAAACTGCTGGTGGAGTCATGACTGTCCTCATCAAGCGTAATACCACCATT
CCTACCAAGCAGACACAGACCTTCACTACCTATTCTGACAACCAGCCTGGTGTGCTTATT
CAGGTTTATGAAGGCGAGCGTGCCATGACAAAGGATAACAACCTGCTTGGCAAGTTTGAA
CTCACAGGCATGCCAGGAGGAATGCCTGGGGGATTTCCTGGTGGTGGAGCTCCTCCCTCT
GGTGGTGCTTCCTCAGGGCCCACCATTGAAGAGGTTGATTAA

# Drug_Target_32_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_32_General_References:
11093761	Tsukahara F, Yoshioka T, Muraki T: Molecular and functional characterization of HSC54, a novel variant of human heat-shock cognate protein 70. Mol Pharmacol. 2000 Dec;58(6):1257-63.
1286667	Rasmussen HH, van Damme J, Puype M, Gesser B, Celis JE, Vandekerckhove J: Microsequences of 145 proteins recorded in the two-dimensional gel protein database of normal human epidermal keratinocytes. Electrophoresis. 1992 Dec;13(12):960-9.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
1586970	Hattori H, Liu YC, Tohnai I, Ueda M, Kaneda T, Kobayashi T, Tanabe K, Ohtsuka K: Intracellular localization and partial amino acid sequence of a stress-inducible 40-kDa protein in HeLa cells. Cell Struct Funct. 1992 Feb;17(1):77-86.
3037489	Dworniczak B, Mirault ME: Structure and expression of a human gene coding for a 71 kd heat shock 'cognate' protein. Nucleic Acids Res. 1987 Jul 10;15(13):5181-97.
8713105	Egerton M, Moritz RL, Druker B, Kelso A, Simpson RJ: Identification of the 70kD heat shock cognate protein (Hsc70) and alpha-actinin-1 as novel phosphotyrosine-containing proteins in T lymphocytes. Biochem Biophys Res Commun. 1996 Jul 25;224(3):666-74.

# Drug_Target_32_HGNC_ID:
GNC:5241

# Drug_Target_32_HPRD_ID:
Not Available

# Drug_Target_32_ID:
6277

# Drug_Target_32_Locus:
11q24.1

# Drug_Target_32_Molecular_Weight:
70897.6

# Drug_Target_32_Name:
Heat shock cognate 71 kDa protein

# Drug_Target_32_Number_of_Residues:
646

# Drug_Target_32_PDB_ID:
3HSC

# Drug_Target_32_Pathway:
Not Available

# Drug_Target_32_Pfam_Domain_Function:
PF00012	HSP70

# Drug_Target_32_Protein_Sequence:
>Heat shock cognate 71 kDa protein
MSKGPAVGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVA
MNPTNTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEVS
SMVLTKMKEIAEAYLGKTVTNAVVTVPAYFNDSQRQATKDAGTIAGLNVLRIINEPTAAA
IAYGLDKKVGAERNVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNRMVNH
FIAEFKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGIDFYTSITRA
RFEELNADLFRGTLDPVEKALRDAKLDKSQIHDIVLVGGSTRIPKIQKLLQDFFNGKELN
KSINPDEAVAYGAAVQAAILSGDKSENVQDLLLLDVTPLSLGIETAGGVMTVLIKRNTTI
PTKQTQTFTTYSDNQPGVLIQVYEGERAMTKDNNLLGKFELTGIPPAPRGVPQIEVTFDI
DANGILNVSAVDKSTGKENKITITNDKGRLSKEDIERMVQEAEKYKAEDEKQRDKVSSKN
SLESYAFNMKATVEDEKLQGKINDEDKQKILDKCNEIINWLDKNQTAEKEEFEHQQKELE
KVCNPIITKLYQSAGGMPGGMPGGFPGGGAPPSGGASSGPTIEEVD

# Drug_Target_32_Reaction:
Not Available

# Drug_Target_32_Signals:
None

# Drug_Target_32_Specific_Function:
Chaperone. Isoform 2 may function as an endogenous inhibitory regulator of HSC70 by competing the co-chaperones

# Drug_Target_32_SwissProt_ID:
P11142

# Drug_Target_32_SwissProt_Name:
HSP7C_HUMAN

# Drug_Target_32_Synonyms:
Heat shock 70 kDa protein 8

# Drug_Target_32_Theoretical_pI:
5.16

# Drug_Target_32_Transmembrane_Regions:
None

# Drug_Target_33_Cellular_Location:
Cytoplasm

# Drug_Target_33_Chromosome_Location:
Not Available

# Drug_Target_33_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_33_Essentiality:
Non-Essential

# Drug_Target_33_GenAtlas_ID:
APAF1

# Drug_Target_33_GenBank_ID_Gene:
AF013263

# Drug_Target_33_GenBank_ID_Protein:
2330015

# Drug_Target_33_GeneCard_ID:
APAF1

# Drug_Target_33_Gene_Name:
APAF1

# Drug_Target_33_Gene_Sequence:
>3747 bp
ATGGATGCAAAAGCTCGAAATTGTTTGCTTCAACATAGAGAAGCTCTGGAAAAGGACATC
AAGACATCCTACATCATGGATCACATGATTAGTGATGGATTTTTAACAATATCAGAAGAG
GAAAAAGTAAGAAATGAGCCCACTCAACAGCAAAGAGCAGCTATGCTGATTAAAATGATA
CTTAAAAAAGATAATGATTCCTACGTATCATTCTACAATGCTCTACTACATGAAGGATAT
AAAGATCTTGCTGCCCTTCTCCATGATGGCATTCCTGTTGTCTCTTCTTCCAGTGGTAAA
GATTCAGTTAGTGGAATAACTTCGTATGTAAGGACAGTCCTGTGTGAAGGTGGAGTACCA
CAGAGGCCAGTTGTTTTTGTCACAAGGAAGAAGCTGGTGAATGCAATTCAGCAGAAGCTC
TCCAAATTGAAAGGTGAACCAGGATGGGTCACCATACATGGAATGGCAGGCTGTGGGAAG
TCTGTATTAGCTGCAGAAGCTGTTAGAGATCATTCCCTTTTAGAAGGTTGTTTCCCAGGG
GGAGTGCATTGGGTTTCAGTTGGGAAACAAGACAAATCTGGGCTTCTGATGAAACTGCAG
AATCTTTGCACACGGTTGGATCAGGATGAGAGTTTTTCCCAGAGGCTTCCACTTAATATT
GAAGAGGCTAAAGACCGTCTCCGCATTCTGATGCTTCGCAAACACCCAAGGTCTCTCTTG
ATCTTGGATGATGTTTGGGACTCTTGGGTGTTGAAAGCTTTTGACAGTCAGTGTCAGATT
CTTCTTACAACCAGAGACAAGAGTGTTACAGATTCAGTAATGGGTCCTAAATATGTAGTC
CCTGTGGAGAGTTCCTTAGGAAAGGAAAAAGGACTTGAAATTTTATCCCTTTTTGTTAAT
ATGAAGAAGGCAGATTTGCCAGAACAAGCTCATAGTATTATAAAAGAATGTAAAGGCTCT
CCCCTTGTAGTATCTTTAATTGGTGCACTTTTACGTGATTTTCCCAATCGCTGGGAGTAC
TACCTCAAACAGCTTCAGAATAAGCAGTTTAAGAGAATAAGGAAATCTTCGTCTTATGAT
TATGAGGCTCTAGATGAAGCCATGTCTATAAGTGTTGAAATGCTCAGAGAAGACATCAAA
GATTATTACACAGATCTTTCCATCCTTCAGAAGGACGTTAAGGTGCCTACAAAGGTGTTA
TGTATTCTCTGGGACATGGAAACTGAAGAAGTTGAAGACATACTGCAGGAGTTTGTAAAT
AAGTCTCTTTTATTCTGTGATCGGAATGGAAAGTCGTTTCGTTATTATTTACATGATCTT
CAAGTAGATTTTCTTACAGAGAAGAATTGCAGCCAGCTTCAGGATCTACATAAGAAGATA
ATCACTCAGTTTCAGAGATATCACCAGCCGCATACTCTTTCACCAGATCAGGAAGACTGT
ATGTATTGGTACAACTTTCTGGCCTATCACATGGCCAGTGCCAAGATGCACAAGGAACTT
TGTGCTTTAATGTTTTCCCTGGATTGGATTAAAGCAAAAACAGAACTTGTAGGCCCTGCT
CATCTGATTCATGAATTTGTGGAATACAGACATATACTAGATGAAAAGGATTGTGCAGTC
AGTGAGAATTTTCAGGAGTTTTTATCTTTAAATGGACACCTTCTTGGACGACAGCCATTT
CCTAATATTGTACAACTGGGTCTCTGTGAGCCGGAAACTTCAGAAGTTTATCAGCAAGCT
AAGCTGCAGGCCAAGCAGGAGGTCGATAATGGAATGCTTTACCTGGAATGGATAAACAAA
AAAAACATCACGAATCTTTCCTGCTTAGTTGTCCGCCCCCACACAGATGCTGTTTACCAT
GCCTGCTTTTCTGAGGATGGTCAGAGAATAGCTTCTTGTGGAGCTGATAAAACCTTACAG
GTGTTCAAAGCTGAAACAGGAGAGAAACTTCTAGAAATCAAGGCTCATGAGGATGAAGTG
CTTTGTTGTGCATTCTCTACAGATGACAGATTTATAGCAACCTGCTCAGTGGATAAAAAA
GTGAAGATTTGGAATTCTATGACTGGGGAACTAGTACACACCTATGATGAGCACTCAGAG
CAAGTCAATTGCTGCCATTTCACCAACAGTAGTCATCATCTTCTCTTAGCCACTGGGTCA
AGTGACTGCTTCCTCAAACTTTGGGATTTGAATCAAAAAGAATGTCGAAATACCATGTTT
GGTCATACAAATTCAGTCAATCACTGCAGATTTTCACCAGATGATAAGCTTTTGGCTAGT
TGTTCAGCTGATGGAACCTTAAAGCTTTGGGATGCGACATCAGCAAATGAGAGGAAAAGC
ATTAATGTGAAACAGTTCTTCCTAAATTTGGAGGACCCTCAAGAGGATATGGAAGTGATA
GTGAAGTGTTGTTCGTGGTCTGCTGATGGTGCAAGGATAATGGTGGCAGCAAAAAATAAA
ATCTTTCTTTTTGCCATTCATACTAGTGGCCTATTGGGAGAAATCCACACGGGCCATCAC
AGCACCATCCAGTACTGTGACTTCTCCCCACAAAACCATTTGGCAGTGGTTGCTTTGTCC
CAGTACTGTGTAGAGTTGTGGAATACAGACTCACGTTCAAAGGTGGCTGATTGCAGAGGA
CATTTAAGTTGGGTTCATGGTGTGATGTTTTCTCCTGATGGATCATCATTTTTGACATCT
TCTGATGACCAGACAATCAGGCTCTGGGAGACAAAGAAAGTATGTAAGAACTCTGCTGTA
ATGTTAAAGCAAGAAGTAGATGTTGTGTTTCAAGAAAATGAAGTGATGGTCCTTGCAGTT
GACCATATAAGACGTCTGCAACTCGTTAATGGAAGAACAGGTCAGATTGATTATCTGACT
GAAGCTCAAGTTAGCTGCTGTTGCTTAAGTCCACATCTTCAGTACATTGCATTTGGAGAT
GAAAATGGAGCCATTGAGATTTTAGAACTTGTAAACAATAGAATCTTCCAGTCCAGGTTT
CAGCACAAGAAAACTGTATGGCACATCCAGTTCACAGCCGATGAGAAGACTCTTATTTCA
AGTTCTGATGATGCTGAAATTCAGGTATGGAATTGGCAATTGGACAAATGTATCTTTCTA
CGAGGCCATCAGGAAACAGTGAAAGACTTTAGACTCTTGAAAAATTCAAGACTGCTTTCT
TGGTCATTTGATGGAACAGTGAAGGTATGGAATATTATTACTGGAAATAAAGAAAAAGAC
TTTGTCTGTCACCAGGGTACAGTACTTTCTTGTGACATTTCTCACGATGCTACCAAGTTT
TCATCTACCTCTGCTGACAAGACTGCAAAGATCTGGAGTTTTGATCTCCTTTTGCCACTT
CATGAATTGAGGGGCCACAACGGCTGTGTGCGCTGCTCTGCCTTCTCTGTGGACAGTACC
CTGCTGGCAACGGGAGATGACAATGGAGAAATCAGGATATGGAATGTCTCAAACGGTGAG
CTTCTTCATTTGTGTGCTCCGCTTTCAGAAGAAGGAGCTGCTACCCATGGAGGCTGGGTG
ACTGACCTTTGCTTTTCTCCAGATGGCAAAATGCTTATCTCTGCTGGAGGATATATTAAG
TGGTGGAACGTTGTCACTGGGGAATCCTCACAGACCTTCTACACAAATGGAACCAATCTT
AAGAAAATACACGTGTCCCCTGACTTCAAAACATATGTGACTGTGGATAATCTTGGTATT
TTATATATTTTACAGACTTTAGAATAA

# Drug_Target_33_General_Function:
Involved in protein binding

# Drug_Target_33_General_References:
10364241	Saleh A, Srinivasula SM, Acharya S, Fishel R, Alnemri ES: Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J Biol Chem. 1999 Jun 18;274(25):17941-5.
10393175	Hu Y, Benedict MA, Ding L, Nunez G: Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J. 1999 Jul 1;18(13):3586-95.
10441496	Hahn C, Hirsch B, Jahnke D, Durkop H, Stein H: Three new types of Apaf-1 in mammalian cells. Biochem Biophys Res Commun. 1999 Aug 11;261(3):746-9.
10543941	Vaughn DE, Rodriguez J, Lazebnik Y, Joshua-Tor L: Crystal structure of Apaf-1 caspase recruitment domain: an alpha-helical Greek key fold for apoptotic signaling. J Mol Biol. 1999 Oct 29;293(3):439-47.
10578182	Day CL, Dupont C, Lackmann M, Vaux DL, Hinds MG: Solution structure and mutagenesis of the caspase recruitment domain (CARD) from Apaf-1. Cell Death Differ. 1999 Nov;6(11):1125-32.
11389439	Moroni MC, Hickman ES, Lazzerini Denchi E, Caprara G, Colli E, Cecconi F, Muller H, Helin K: Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol. 2001 Jun;3(6):552-8.
12168954	Nakajima D, Okazaki N, Yamakawa H, Kikuno R, Ohara O, Nagase T: Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones. DNA Res. 2002 Jun 30;9(3):99-106.
12804598	Ogawa T, Shiga K, Hashimoto S, Kobayashi T, Horii A, Furukawa T: APAF-1-ALT, a novel alternative splicing form of APAF-1, potentially causes impeded ability of undergoing DNA damage-induced apoptosis in the LNCaP human prostate cancer cell line. Biochem Biophys Res Commun. 2003 Jun 27;306(2):537-43.
9267021	Zou H, Henzel WJ, Liu X, Lutschg A, Wang X: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 1997 Aug 8;90(3):405-13.
9455477	Ishikawa K, Nagase T, Nakajima D, Seki N, Ohira M, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O: Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 1997 Oct 31;4(5):307-13.
9651578	Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES: Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell. 1998 Jun;1(7):949-57.

# Drug_Target_33_HGNC_ID:
HGNC:576

# Drug_Target_33_HPRD_ID:
03755

# Drug_Target_33_ID:
340

# Drug_Target_33_Locus:
12q23

# Drug_Target_33_Molecular_Weight:
141841

# Drug_Target_33_Name:
Apoptotic protease-activating factor 1

# Drug_Target_33_Number_of_Residues:
1248

# Drug_Target_33_PDB_ID:
1Z6T

# Drug_Target_33_Pathway:
Not Available

# Drug_Target_33_Pfam_Domain_Function:
PF00400	WD40
PF00619	CARD
PF00931	NB-ARC

# Drug_Target_33_Protein_Sequence:
>Apoptotic protease-activating factor 1
MDAKARNCLLQHREALEKDIKTSYIMDHMISDGFLTISEEEKVRNEPTQQQRAAMLIKMI
LKKDNDSYVSFYNALLHEGYKDLAALLHDGIPVVSSSSGKDSVSGITSYVRTVLCEGGVP
QRPVVFVTRKKLVNAIQQKLSKLKGEPGWVTIHGMAGCGKSVLAAEAVRDHSLLEGCFPG
GVHWVSVGKQDKSGLLMKLQNLCTRLDQDESFSQRLPLNIEEAKDRLRILMLRKHPRSLL
ILDDVWDSWVLKAFDSQCQILLTTRDKSVTDSVMGPKYVVPVESSLGKEKGLEILSLFVN
MKKADLPEQAHSIIKECKGSPLVVSLIGALLRDFPNRWEYYLKQLQNKQFKRIRKSSSYD
YEALDEAMSISVEMLREDIKDYYTDLSILQKDVKVPTKVLCILWDMETEEVEDILQEFVN
KSLLFCDRNGKSFRYYLHDLQVDFLTEKNCSQLQDLHKKIITQFQRYHQPHTLSPDQEDC
MYWYNFLAYHMASAKMHKELCALMFSLDWIKAKTELVGPAHLIHEFVEYRHILDEKDCAV
SENFQEFLSLNGHLLGRQPFPNIVQLGLCEPETSEVYQQAKLQAKQEVDNGMLYLEWINK
KNITNLSRLVVRPHTDAVYHACFSEDGQRIASCGADKTLQVFKAETGEKLLEIKAHEDEV
LCCAFSTDDRFIATCSVDKKVKIWNSMTGELVHTYDEHSEQVNCCHFTNSSHHLLLATGS
SDCFLKLWDLNQKECRNTMFGHTNSVNHCRFSPDDKLLASCSADGTLKLWDATSANERKS
INVKQFFLNLEDPQEDMEVIVKCCSWSADGARIMVAAKNKIFLFDIHTSGLLGEIHTGHH
STIQYCDFSPQNHLAVVALSQYCVELWNTDSRSKVADCRGHLSWVHGVMFSPDGSSFLTS
SDDQTIRLWETKKVCKNSAVMLKQEVDVVFQENEVMVLAVDHIRRLQLINGRTGQIDYLT
EAQVSCCCLSPHLQYIAFGDENGAIEILELVNNRIFQSRFQHKKTVWHIQFTADEKTLIS
SSDDAEIQVWNWQLDKCIFLRGHQETVKDFRLLKNSRLLSWSFDGTVKVWNIITGNKEKD
FVCHQGTVLSCDISHDATKFSSTSADKTAKIWSFDLLLPLHELRGHNGCVRCSAFSVDST
LLATGDDNGEIRIWNVSNGELLHLCAPLSEEGAATHGGWVTDLCFSPDGKMLISAGGYIK
WWNVVTGESSQTFYTNGTNLKKIHVSPDFKTYVTVDNLGILYILQTLE

# Drug_Target_33_Reaction:
Not Available

# Drug_Target_33_Signals:
None

# Drug_Target_33_Specific_Function:
Oligomeric Apaf-1 mediates the cytochrome c-dependent autocatalytic activation of pro-caspase-9 (Apaf-3), leading to the activation of caspase-3 and apoptosis. This activation requires ATP. Isoform 6 is less effective in inducing apoptosis

# Drug_Target_33_SwissProt_ID:
O14727

# Drug_Target_33_SwissProt_Name:
APAF_HUMAN

# Drug_Target_33_Synonyms:
Apaf-1

# Drug_Target_33_Theoretical_pI:
6.37

# Drug_Target_33_Transmembrane_Regions:
None

# Drug_Target_34_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_34_Chromosome_Location:
Not Available

# Drug_Target_34_Drug_References:
Not Available

# Drug_Target_34_Essentiality:
Non-Essential

# Drug_Target_34_GenAtlas_ID:
Not Available

# Drug_Target_34_GenBank_ID_Gene:
Not Available

# Drug_Target_34_GenBank_ID_Protein:
Not Available

# Drug_Target_34_GeneCard_ID:
Not Available

# Drug_Target_34_Gene_Name:
purL

# Drug_Target_34_Gene_Sequence:
Not Available

# Drug_Target_34_General_Function:
Involved in catalytic activity

# Drug_Target_34_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.

# Drug_Target_34_HGNC_ID:
Not Available

# Drug_Target_34_HPRD_ID:
Not Available

# Drug_Target_34_ID:
5261

# Drug_Target_34_Locus:
Not Available

# Drug_Target_34_Molecular_Weight:
141342

# Drug_Target_34_Name:
Phosphoribosylformylglycinamidine synthase

# Drug_Target_34_Number_of_Residues:
1294

# Drug_Target_34_PDB_ID:
1T3T

# Drug_Target_34_Pathway:
Not Available

# Drug_Target_34_Pfam_Domain_Function:
PF00586	AIRS
PF02769	AIRS_C

# Drug_Target_34_Protein_Sequence:
>Phosphoribosylformylglycinamidine synthase
MEILRGSPALSAFRINKLLARFQAANLQVHNIYAEYVHFADLNAPLNDSEQAQLTRLLQY
GPALSSHTPAGKLLLVTPRPGTISPWSSKATDIAHNCGLQQVDRLERGVAYYIEASTLTA
EQWRQVAAELHDRMMETVFSSLTDAEKLFIHHQPAPVSSVDLLGEGRQALIDANLRLGLA
LAEDEIDYLQEAFTKLGRNPNDIELYMFAQANSEHCRHKIFNADWIIDGKPQPKSLFKMI
KNTFETTPDYVLSAYKDNAAVMEGSAVGRYFADHNTGRYDFHQEPAHILMKVETHNHPTA
ISPWPGAATGSGGEIRDEGATGRGAKPKAGLVGFSVSNLRIPGFEQPWEEDFGKPERIVT
ALDIMTEGPLGGAAFNNEFGRPALTGYFRTYEEKVNSHNGEELRGYHKPIMLAGGIGNIR
ADHVQKGEIVVGAKLIVLGGPAMNIGLGGGAASSMASGQSDADLDFASVQRDNPEMERRC
QEVIDRCWQLGDANPILFIHDVGAGGLSNAMPELVSDGGRGGKFELRDILSDEPGMSPLE
IWCNESQERYVLAVAADQLPLFDELCKRERAPYAVIGDATEEQHLSLHDNHFDNQPIDLP
LDVLLGKTPKMTRDVQTLKAKGDALNRADITIADAVKRVLHLPTVAEKTFLVTIGDRTVT
GMVARDQMVGPWQVPVADCAVTTASLDSYYGEAMSIGERAPVALLDFAASARLAVGEALT
NIAATQIGDIKRIKLSANWMAAAGHPGEDAGLYDAVKAVGEELCPQLGLTIPVGKDSMSM
KTRWQEGNEQREMTSPLSLVISAFARVEDVRHTLTPQLSTEDNALLLIDLGKGHNALGAT
ALAQVYRQLGDKPADVRDVAQLKGFYDAMQALVAARKLLAWHDRSDGGLLVTLAEMAFAG
HCGVQVDIAALGDDHLAALFNEELGGVIQVRAEDRDAVEALLAQYGLADCVHYLGQALAG
DRFVITANDQTVFSESRTTLRVWWAETTWQMQRLRDNPQCADQEHEAKANDTDPGLNVKL
SFDINEDIAAPYIATGARPKVAVLREQGVNSHVEMAAAFHRAGFDAIDVHMSDLLGGRIG
LGNFHALVACGGFSYGDVLGAGEGWAKSILFNHRVRDEFETFFHRPQTLALGVCNGCQMM
SNLRELIPGSELWPRFVRNHSDRFEARFSLVEVTQSPSLLLQGMVGSQMPIAVSHGEGRV
EVRDDAHLAALESKGLVALRYVDNFGKVTETYPANPNGSPNGITAVTTENGRVTIMMPHP
ERVFRTVANSWHPENWGEDSPWMRIFRNARKQLG

# Drug_Target_34_Reaction:
Not Available

# Drug_Target_34_Signals:
None

# Drug_Target_34_Specific_Function:
ATP + 2-N-formyl-1-N-(5-phospho-D- ribosyl)glycinamide + L-glutamine + H(2)O = ADP + phosphate + 2- (formamido)-1-N-(5-phospho-D-ribosyl)acetamidine + L-glutamate

# Drug_Target_34_SwissProt_ID:
P74881

# Drug_Target_34_SwissProt_Name:
PUR4_SALTY

# Drug_Target_34_Synonyms:
EC 6.3.5.3
FGAM synthase
FGAMS
FGARAT
Formylglycinamide ribotide amidotransferase
Formylglycinamide ribotide synthetase

# Drug_Target_34_Theoretical_pI:
5.21

# Drug_Target_34_Transmembrane_Regions:
None

# Drug_Target_35_Cellular_Location:
Cytoplasm. Melanosome. Note=Identified by mass spectrometry in melanosome fractions from stage I to

# Drug_Target_35_Chromosome_Location:
Not Available

# Drug_Target_35_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_35_Essentiality:
Non-Essential

# Drug_Target_35_GenAtlas_ID:
HSP90AA1

# Drug_Target_35_GenBank_ID_Gene:
X15183

# Drug_Target_35_GenBank_ID_Protein:
32488

# Drug_Target_35_GeneCard_ID:
HSP90AA1

# Drug_Target_35_Gene_Name:
HSP90AA1

# Drug_Target_35_Gene_Sequence:
>2199 bp
ATGCCTGAGGAAACCCAGACCCAAGACCAACCGATGGAGGAGGAGGAGGTTGAGACGTTC
GCCTTTCAGGCAGAAATTGCCCAGTTGATGTCATTGATCATCAATACTTTCTACTCGAAC
AAAGAGATCTTTCTGAGAGAGCTCATTTCAAATTCATCAGATGCATTGGACAAAATCCGG
TATGAAACTTTGACAGATCCCAGTAAATTAGACTCTGGGAAAGAGCTGCATATTAACCTT
ATACCGAACAAACAAGATCGAACTCTCACTATTGTGGATACTGGAATTGGAATGACCAAG
GCTGACTTGATCAATAACCTTGGTACTATCGCCAAGTCTGGGACCAAAGCGTTCATGGAA
GCTTTGCAGGCTGGTGCAGATATCTCTATGATTGGCCAGTTCGGTGTTGGTTTTTATTCT
GCTTATTTGGTTGCTGAGAAAGTAACTGTGATCACCAAACATAACGATGATGAGCAGTAC
GCTTGGGAGTCCTCAGCAGGGGGATCATTCACAGTGAGGACAGACACAGGTGAACCTATG
GGTCGTGGAACAAAAGTTATCCTACACCTGAAAGAAGACCAAACTGAGTACTTGGAGGAA
CGAAGAATAAAGGAGATTGTGAAGAAACATTCTCAGTTTATTGGATATCCCATTACTCTT
TTTGTGGAGAAGGAACGTGATAAAGAAGTAAGCGATGATGAGGCTGAAGAAAAGGAAGAC
AAAGAAGAAGAAAAAGAAAAAGAAGAGAAAGAGTCGGAAGACAAACCTGAAATTGAAGAT
GTTGGTTCTGATGAGGAAGAAGAAAAGAAGGATGGTGACAAGAAGAAGAAGAAGAAGATT
AAGGAAAAGTACATCGATCAAGAAGAGCTCAACAAAACAAAGCCCATCTGGACCAGAAAT
CCCGACGATATTACTAATGAGGAGTACGGAGAATTCTATAAGAGCTTGACCAATGACTGG
GAAGATCACTTGGCAGTGAAGCATTTTTCAGTTGAAGGACAGTTGGAATTCAGAGCCCTT
CTATTTGTCCCACGACGTGCTCCTTTTGATCTGTTTGAAAACAGAAAGAAAAAGAACAAT
ATCAAATTGTATGTACGCAGAGTTTTCATCATGGATAACTGTGAGGAGCTAATCCCTGAA
TATCTGAACTTCATTAGAGGGGTGGTAGACTCGGAGGATCTCCCTCTAAACATATCCCGT
GAGATGTTGCAACAAAGCAAAATTTTGAAAGTTATCAGGAAGAATTTGGTCAAAAAATGC
TTAGAACTCTTTACTGAACTGGCGGAAGATAAAGAGAACTACAAGAAATTCTATGAGCAG
TTCTCTAAAAACATAAAGCTTGGAATACACGAAGACTCTCAAAATCGGAAGAAGCTTTCA
GAGCTGTTAAGGTACTACACATCTGCCTCTGGTGATGAGATGGTTTCTCTCAAGGACTAC
TGCACCAGAATGAAGGAGAACCAGAAACATATCTATTATATCACAGGTGAGACCAAGGAC
CAGGTAGCTAACTCAGCCTTTGTGGAACGTCTTCGGAAACATGGCTTAGAAGTGATCTAT
ATGATTGAGCCCATTGATGAGTACTGTGTCCAACAGCTGAAGGAATTTGAGGGGAAGACT
TTAGTGTCAGTCACCAAAGAAGGCCTGGAACTTCCAGAGGATGAAGAAGAGAAAAAGAAG
CAGGAAGAGAAAAAAACAAAGTTTGAGAACCTCTGCAAAATCATGAAAGACATATTGGAG
AAAAAAGTTGAAAAGGTGGTTGTGTCAAACCGATTGGTGACATCTCCATGCTGTATTGTC
ACAAGCACATATGGCTGGACAGCAAACATGGAGAGAATCATGAAAGCTCAAGCCCTAAGA
GACAACTCAACAATGGGTTACATGGCAGCAAAGAAACACCTGGAGATAAACCCTGACCAT
TCCATTATTGAGACCTTAAGGCAAAAGGCAGAGGCTGATAAGAACGACAAGTCTGTGAAG
GATCTGGTCATCTTGCTTTATGAAACTGCGCTCCTGTCTTCTGGCTTCAGTCTGGAAGAT
CCCCAGACACATGCTAACAGGATCTACAGGATGATCAAACTTGGTCTGGGTATTGATGAA
GATGACCCTACTGCTGATGATACCAGTGCTGCTGTAACTGAAGAAATGCCACCCCTTGAA
GGAGATGACGACACATCACGCATGGAAGAAGTAGACTAA

# Drug_Target_35_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_35_General_References:
10508479	Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jager D, Jager E, Knuth A, Chen YT, Old LJ: Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer. 1999 Nov 12;83(4):456-64.
12604615	Lotz GP, Lin H, Harst A, Obermann WM: Aha1 binds to the middle domain of Hsp90, contributes to client protein activation, and stimulates the ATPase activity of the molecular chaperone. J Biol Chem. 2003 May 9;278(19):17228-35. Epub 2003 Feb 24.
1368637	Yamazaki M, Tashiro H, Yokoyama K, Soeda E: Molecular cloning of cDNA encoding a human heat-shock protein whose expression is induced by adenovirus type 12 E1A in HeLa cells. Agric Biol Chem. 1990 Dec;54(12):3163-70.
2469626	Hoffmann T, Hovemann B: Heat-shock proteins, Hsp84 and Hsp86, of mice and men: two related genes encode formerly identified tumour-specific transplantation antigens. Gene. 1988 Dec 30;74(2):491-501.
2492519	Lees-Miller SP, Anderson CW: Two human 90-kDa heat shock proteins are phosphorylated in vivo at conserved serines that are phosphorylated in vitro by casein kinase II. J Biol Chem. 1989 Feb 15;264(5):2431-7.
2507541	Lees-Miller SP, Anderson CW: The human double-stranded DNA-activated protein kinase phosphorylates the 90-kDa heat-shock protein, hsp90 alpha at two NH2-terminal threonine residues. J Biol Chem. 1989 Oct 15;264(29):17275-80.
2527334	Hickey E, Brandon SE, Smale G, Lloyd D, Weber LA: Sequence and regulation of a gene encoding a human 89-kilodalton heat shock protein. Mol Cell Biol. 1989 Jun;9(6):2615-26.
2591742	Walter T, Drabent B, Krebs H, Tomalak M, Heiss S, Benecke BJ: Cloning and analysis of a human 86-kDa heat-shock-protein-encoding gene. Gene. 1989 Nov 15;83(1):105-15.
2780322	Yamazaki M, Akaogi K, Miwa T, Imai T, Soeda E, Yokoyama K: Nucleotide sequence of a full-length cDNA for 90 kDa heat-shock protein from human peripheral blood lymphocytes. Nucleic Acids Res. 1989 Sep 12;17(17):7108.
7588731	Nemoto T, Ohara-Nemoto Y, Ota M, Takagi T, Yokoyama K: Mechanism of dimer formation of the 90-kDa heat-shock protein. Eur J Biochem. 1995 Oct 1;233(1):1-8.
9108479	Stebbins CE, Russo AA, Schneider C, Rosen N, Hartl FU, Pavletich NP: Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell. 1997 Apr 18;89(2):239-50.
9660753	Young JC, Obermann WM, Hartl FU: Specific binding of tetratricopeptide repeat proteins to the C-terminal 12-kDa domain of hsp90. J Biol Chem. 1998 Jul 17;273(29):18007-10.
9817749	Obermann WM, Sondermann H, Russo AA, Pavletich NP, Hartl FU: In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis. J Cell Biol. 1998 Nov 16;143(4):901-10.

# Drug_Target_35_HGNC_ID:
HGNC:5253

# Drug_Target_35_HPRD_ID:
00777

# Drug_Target_35_ID:
1939

# Drug_Target_35_Locus:
14q32.33

# Drug_Target_35_Molecular_Weight:
84661

# Drug_Target_35_Name:
Heat shock protein HSP 90-alpha

# Drug_Target_35_Number_of_Residues:
732

# Drug_Target_35_PDB_ID:
1UYL

# Drug_Target_35_Pathway:
Prednisolone Pathway	SMP00441
Prednisone Pathway	SMP00440

# Drug_Target_35_Pfam_Domain_Function:
PF00183	HSP90
PF02518	HATPase_c

# Drug_Target_35_Protein_Sequence:
>Heat shock protein HSP 90-alpha
MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIR
YESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFME
ALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPM
GRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAEEKED
KEEEKEKEEKESEDKPEIEDVGSDEEEEKKDGDKKKKKKIKEKYIDQEELNKTKPIWTRN
PDDITNEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFVPRRAPFDLFENRKKKNN
IKLYVRRVFIMDNCEELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNLVKKC
LELFTELAEDKENYKKFYEQFSKNIKLGIHEDSQNRKKLSELLRYYTSASGDEMVSLKDY
CTRMKENQKHIYYITGETKDQVANSAFVERLRKHGLEVIYMIEPIDEYCVQQLKEFEGKT
LVSVTKEGLELPEDEEEKKKQEEKKTKFENLCKIMKDILEKKVEKVVVSNRLVTSPCCIV
TSTYGWTANMERIMKAQALRDNSTMGYMAAKKHLEINPDHSIIETLRQKAEADKNDKSVK
DLVILLYETALLSSGFSLEDPQTHANRIYRMIKLGLGIDEDDPTADDTSAAVTEEMPPLE
GDDDTSRMEEVD

# Drug_Target_35_Reaction:
Not Available

# Drug_Target_35_Signals:
None

# Drug_Target_35_Specific_Function:
Molecular chaperone. Has ATPase activity

# Drug_Target_35_SwissProt_ID:
P07900

# Drug_Target_35_SwissProt_Name:
HS90A_HUMAN

# Drug_Target_35_Synonyms:
HSP 86
Renal carcinoma antigen NY- REN-38

# Drug_Target_35_Theoretical_pI:
4.66

# Drug_Target_35_Transmembrane_Regions:
None

# Drug_Target_36_Cellular_Location:
Cytoplasm

# Drug_Target_36_Chromosome_Location:
Not Available

# Drug_Target_36_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_36_Essentiality:
Non-Essential

# Drug_Target_36_GenAtlas_ID:
Not Available

# Drug_Target_36_GenBank_ID_Gene:
AE005674

# Drug_Target_36_GenBank_ID_Protein:
24053342

# Drug_Target_36_GeneCard_ID:
Not Available

# Drug_Target_36_Gene_Name:
metK

# Drug_Target_36_Gene_Sequence:
>1167 bp
GTGATATTAAATATGGCAAAACACCTTTTTACGTCCGAGTCCGTCTCTGAAGGGCATCCT
GACAAAATTGCTGACCAAATCTCTGATGCCGTTTTAGACGCGATCCTCGAACAGGATCCG
AAAGCACGCGTTGCTTGCGAAACCTACGTAAAAACCGGCATGGTTTTAGTTGGCGGCGAA
ATCACCACCAGCGCCTGGGTAGACATCGAAGAGATCACCCGTAACACCGTTCGCGAAATT
GGCTATGTGCATTCCGACATGGGCTTTGACGCTAACTCCTGTGCGGTTCTGAGCGCTATC
GGCAAACAGTCTCCTGACATCAACCAAGGCGTTGACCGTGCCGATCCGCTGGAACAGGGC
GCGGGTGACCAGGGTCTGATGTTTGGCTACGCAACTAATGAAACCGACGTGCTGATGCCA
GCACCTATCACCTATGCACACCGTCTGGTACAGCGTCAGGCTGAAGTGCGTAAAAACGGC
ACTCTGCCGTGGCTGCGCCCGGACGCGAAAAGCCAGGTGACTTTCCAGTATGACGACGGC
AAAATCGTTGGTATTGATGCTGTCGTGCTTTCCACTCAGCACTCTGAAGAGATCGACCAG
AAATCGCTGCAAGAAGCGGTAATGGAAGAGATCATCAAGCCAATTCTGCCCGCTGAATGG
CTGACTTCTGCCACCAAATTCTTCATCAACCCGACCGGTCGTTTCGTTATCGGTGGCCCA
ATGGGTGACTGCGGTCTGACTGGCCGTAAAATTATCGTTGATACCTACGGCGGCATGGCG
CGTCACGGTGGCGGTGCATTCTCTGGTAAAGATCCATCAAAAGTGGACCGTTCCGCAGCC
TACGCAGCACGTTATGTCGCGAAAAACATCGTTGCTGCTGGCCTGGCCGATCGTTGTGAA
ATTCAGGTTTCCTACGCAATCGGCGTGGCTGAACCGACCTCCATCATGGTAGAAACTTTC
GGTACTGAGAAAGTGCCTTCTGAACAACTGACTCTGCTGGTACGTGAGTTCTTCGACCTG
CGCCCATACGGACTGATTCAGATGCTGGATCTGCTGCACCCGATCTACAAAGAAACCGCA
GCATACGGTCACTTTGGTCGTGAACATTTCCCGTGGGAAAAAACCGACAAAGCGCAGCTG
CTGCGCGATGCTGCCGGTCTGAAGTAA

# Drug_Target_36_General_Function:
Coenzyme transport and metabolism

# Drug_Target_36_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_36_HGNC_ID:
Not Available

# Drug_Target_36_HPRD_ID:
Not Available

# Drug_Target_36_ID:
2727

# Drug_Target_36_Locus:
Not Available

# Drug_Target_36_Molecular_Weight:
41952

# Drug_Target_36_Name:
S-adenosylmethionine synthetase

# Drug_Target_36_Number_of_Residues:
384

# Drug_Target_36_PDB_ID:
1RG9

# Drug_Target_36_Pathway:
Not Available

# Drug_Target_36_Pfam_Domain_Function:
PF00438	S-AdoMet_synt_N
PF02772	S-AdoMet_synt_M
PF02773	S-AdoMet_synt_C

# Drug_Target_36_Protein_Sequence:
>S-adenosylmethionine synthetase
MAKHLFTSESVSEGHPDKIADQISDAVLDAILEQDPKARVACETYVKTGMVLVGGEITTS
AWVDIEEITRNTVREIGYVHSDMGFDANSCAVLSAIGKQSPDINQGVDRADPLEQGAGDQ
GLMFGYATNETDVLMPAPITYAHRLVQRQAEVRKNGTLPWLRPDAKSQVTFQYDDGKIVG
IDAVVLSTQHSEEIDQKSLQEAVMEEIIKPILPAEWLTSATKFFINPTGRFVIGGPMGDC
GLTGRKIIVDTYGGMARHGGGAFSGKDPSKVDRSAAYAARYVAKNIVAAGLADRCEIQVS
YAIGVAEPTSIMVETFGTEKVPSEQLTLLVREFFDLRPYGLIQMLDLLHPIYKETAAYGH
FGREHFPWEKTDKAQLLRDAAGLK

# Drug_Target_36_Reaction:
ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine

# Drug_Target_36_Signals:
None

# Drug_Target_36_Specific_Function:
Catalyzes the formation of S-adenosylmethionine from methionine and ATP. The overall synthetic reaction is composed of two sequential steps, AdoMet formation and the subsequent tripolyphosphate hydrolysis which occurs prior to release of AdoMet from the enzyme

# Drug_Target_36_SwissProt_ID:
P0A820

# Drug_Target_36_SwissProt_Name:
METK_SHIFL

# Drug_Target_36_Synonyms:
AdoMet synthetase
EC 2.5.1.6
MAT
Methionine adenosyltransferase

# Drug_Target_36_Theoretical_pI:
4.89

# Drug_Target_36_Transmembrane_Regions:
None

# Drug_Target_37_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_37_Chromosome_Location:
Not Available

# Drug_Target_37_Drug_References:
Not Available

# Drug_Target_37_Essentiality:
Non-Essential

# Drug_Target_37_GenAtlas_ID:
Not Available

# Drug_Target_37_GenBank_ID_Gene:
X55553

# Drug_Target_37_GenBank_ID_Protein:
Not Available

# Drug_Target_37_GeneCard_ID:
Not Available

# Drug_Target_37_Gene_Name:
recA

# Drug_Target_37_Gene_Sequence:
>1062 bp
ATGGCTATCGACGAAAACAAACAGAAAGCGTTGGCGGCAGCACTGGGCCAGATTGAGAAA
CAATTTGGTAAAGGCTCCATCATGCGCCTGGGTGAAGACCGTTCCATGGATGTGGAAACC
ATCTCTACCGGTTCGCTTTCACTGGATATCGCGCTTGGGGCAGGTGGTCTGCCGATGGGC
CGTATCGTCGAAATCTACGGACCGGAATCTTCCGGTAAAACCACGCTGACGCTGCAGGTG
ATCGCCGCAGCGCAGCGTGAAGGTAAAACCTGTGCGTTTATCGATGCTGAACACGCGCTG
GACCCAATCTACGCACGTAAACTGGGCGTCGATATCGATAACCTGCTGTGCTCCCAGCCG
GATACCGGCGAGCAGGCACTGGAAATCTGTGACGCCCTGGCGCGTTCTGGCGCAGTAGAC
GTTATCGTCGTTGACTCCGTGGCGGCACTGACGCCGAAAGCGGAAATCGAAGGCGAAATC
GGCGACTCTCACATGGGCCTTGCGGCACGTATGATGAGCCAGGCGATGCGTAAGCTGGCG
GGTAACCTGAAGCAGTCCAACACGCTGCTGATCTTCATCAACCAGATCCGTATGAAAATT
GGTGTGATGTTCGGTAACCCGGAAACCACTACCGGTGGTAACGCGCTGAAATTCTACGCC
TCTGTTCGTCTCGACATCCGTCGTATCGGCGCGGTGAAAGAGGGCGAAAACGTGGTGGGT
AGCGAAACCCGCGTGAAAGTGGTGAAGAACAAAATCGCTGCACCGTTTAAACAGGCTGAA
TTTCAGATCCTCTACGGCGAAGGTATCAACTTCTACGGCGAACTGGTTGACCTGGGCGTA
AAAGAGAAGCTGATCGAGAAAGCAGGCGCGTGGTACAGCTACAAAGGTGAGAAGATCGGT
CAGGGTAAAGCGAATGCAACTGCCTGGCTGAAAGATAACCCGGAAACCGCGAAAGAGATC
GAGAAGAAAGTACGTGAGTTGCTGCTGAGCAACCCGAACTCAACGCCGGATTTCTCTGTA
GATGACAGCGAAGGAGTAGCAGAAACTAACGAAGATTTTTAA

# Drug_Target_37_General_Function:
Involved in nucleotide binding

# Drug_Target_37_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.
2274037	Zhao XJ, McEntee K: DNA sequence analysis of the recA genes from Proteus vulgaris, Erwinia carotovora, Shigella flexneri and Escherichia coli B/r. Mol Gen Genet. 1990 Jul;222(2-3):369-76.

# Drug_Target_37_HGNC_ID:
Not Available

# Drug_Target_37_HPRD_ID:
Not Available

# Drug_Target_37_ID:
5263

# Drug_Target_37_Locus:
Not Available

# Drug_Target_37_Molecular_Weight:
37974

# Drug_Target_37_Name:
Protein recA

# Drug_Target_37_Number_of_Residues:
353

# Drug_Target_37_PDB_ID:
2REC

# Drug_Target_37_Pathway:
Not Available

# Drug_Target_37_Pfam_Domain_Function:
PF00154	RecA

# Drug_Target_37_Protein_Sequence:
>Protein recA
MAIDENKQKALAAALGQIEKQFGKGSIMRLGEDRSMDVETISTGSLSLDIALGAGGLPMG
RIVEIYGPESSGKTTLTLQVIAAAQREGKTCAFIDAEHALDPIYARKLGVDIDNLLCSQP
DTGEQALEICDALARSGAVDVIVVDSVAALTPKAEIEGEIGDSHMGLAARMMSQAMRKLA
GNLKQSNTLLIFINQIRMKIGVMFGNPETTTGGNALKFYASVRLDIRRIGAVKEGENVVG
SETRVKVVKNKIAAPFKQAEFQILYGEGINFYGELVDLGVKEKLIEKAGAWYSYKGEKIG
QGKANATAWLKDNPETAKEIEKKVRELLLSNPNSTPDFSVDDSEGVAETNEDF

# Drug_Target_37_Reaction:
Not Available

# Drug_Target_37_Signals:
None

# Drug_Target_37_Specific_Function:
Can catalyze the hydrolysis of ATP in the presence of single-stranded DNA, the ATP-dependent uptake of single-stranded DNA by duplex DNA, and the ATP-dependent hybridization of homologous single-stranded DNAs. It interacts with lexA causing its activation and leading to its autocatalytic cleavage (By similarity)

# Drug_Target_37_SwissProt_ID:
P0A7G9

# Drug_Target_37_SwissProt_Name:
RECA_SHIFL

# Drug_Target_37_Synonyms:
Recombinase A

# Drug_Target_37_Theoretical_pI:
4.82

# Drug_Target_37_Transmembrane_Regions:
None

# Drug_Target_38_Cellular_Location:
Not Available

# Drug_Target_38_Chromosome_Location:
Not Available

# Drug_Target_38_Drug_References:
Not Available

# Drug_Target_38_Essentiality:
Non-Essential

# Drug_Target_38_GenAtlas_ID:
Not Available

# Drug_Target_38_GenBank_ID_Gene:
J01901

# Drug_Target_38_GenBank_ID_Protein:
Not Available

# Drug_Target_38_GeneCard_ID:
Not Available

# Drug_Target_38_Gene_Name:
REP

# Drug_Target_38_Gene_Sequence:
>1611 bp
ATGCCGGGGTTTTACGAGATTGTGATTAAGGTCCCCAGCGACCTTGACGGGCATCTGCCC
GGCATTTCTGACAGCTTTGTGAACTGGGTGGCCGAGAAGGAATGGGAGTTGCCGCCAGAT
TCTGACATGGATCTGAATCTGATTGAGCAGGCACCCCTGACCGTGGCCGAGAAGCTGCAG
CGCGACTTTCTGACGGAATGGCGCCGTGTGAGTAAGGCCCCGGAGGCCCTTTTCTTTGTG
CAATTTGAGAAGGGAGAGAGCTACTTCCACATGCACGTGCTCGTGGAAACCACCGGGGTG
AAATCCATGGTTTTGGGACGTTTCCTGAGTCAGATTCGCGAAAAACTGATTCAGAGAATT
TACCGCGGGATCGAGCCGACTTTGCCAAACTGGTTCGCGGTCACAAAGACCAGAAATGGC
GCCGGAGGCGGGAACAAGGTGGTGGATGAGTGCTACATCCCCAATTACTTGCTCCCCAAA
ACCCAGCCTGAGCTCCAGTGGGCGTGGACTAATATGGAACAGTATTTAAGCGCCTGTTTG
AATCTCACGGAGCGTAAACGGTTGGTGGCGCAGCATCTGACGCACGTGTCGCAGACGCAG
GAGCAGAACAAAGAGAATCAGAATCCCAATTCTGATGCGCCGGTGATCAGATCAAAAACT
TCAGCCAGGTACATGGAGCTGGTCGGGTGGCTCGTGGACAAGGGGATTACCTCGGAGAAG
CAGTGGATCCAGGAGGACCAGGCCTCATACATCTCCTTCAATGCGGCCTCCAACTCGCGG
TCCCAAATCAAGGCTGCCTTGGACAATGCGGGAAAGATTATGAGCCTGACTAAAACCGCC
CCCGACTACCTGGTGGGCCAGCAGCCCGTGGAGGACATTTCCAGCAATCGGATTTATAAA
ATTTTGGAACTAAACGGGTACGATCCCCAATATGCGGCTTCCGTCTTTCTGGGATGGGCC
ACGAAAAAGTTCGGCAAGAGGAACACCATCTGGCTGTTTGGGCCTGCAACTACCGGGAAG
ACCAACATCGCGGAGGCCATAGCCCACACTGTGCCCTTCTACGGGTGCGTAAACTGGACC
AATGAGAACTTTCCCTTCAACGACTGTGTCGACAAGATGGTGATCTGGTGGGAGGAGGGG
AAGATGACCGCCAAGGTCGTGGAGTCGGCCAAAGCCATTCTCGGAGGAAGCAAGGTGCGC
GTGGACCAGAAATGCAAGTCCTCGGCCCAGATAGACCCGACTCCCGTGATCGTCACCTCC
AACACCAACATGTGCGCCGTGATTGACGGGAACTCAACGACCTTCGAACACCAGCAGCCG
TTGCAAGACCGGATGTTCAAATTTGAACTCACCCGCCGTCTGGATCATGACTTTGGGAAG
GTCACCAAGCAGGAAGTCAAAGACTTTTTCCGGTGGGCAAAGGATCACGTGGTTGAGGTG
GAGCATGAATTCTACGTCAAAAAGGGTGGAGCCAAGAAAAGACCCGCCCCCAGTGACGCA
GATATAAGTGAGCCCAAACGGGTGCGCGAGTCAGTTGCGCAGCCATCGACGTCAGACGCG
GAAGCTTCGATCAACTACGCAGACAGATTGGCTCGAGGACACTCTCTCTGA

# Drug_Target_38_General_Function:
Not Available

# Drug_Target_38_General_References:
6300419	Srivastava A, Lusby EW, Berns KI: Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol. 1983 Feb;45(2):555-64.

# Drug_Target_38_HGNC_ID:
Not Available

# Drug_Target_38_HPRD_ID:
Not Available

# Drug_Target_38_ID:
5264

# Drug_Target_38_Locus:
Not Available

# Drug_Target_38_Molecular_Weight:
60754

# Drug_Target_38_Name:
DNA replication protein

# Drug_Target_38_Number_of_Residues:
536

# Drug_Target_38_PDB_ID:
1S9H

# Drug_Target_38_Pathway:
Not Available

# Drug_Target_38_Pfam_Domain_Function:
PF01057	Parvo_NS1
PF08724	Rep_N

# Drug_Target_38_Protein_Sequence:
>DNA replication protein
MPGFYEIVIKVPSDLDGHLPGISDSFVNWVAEKEWELPPDSDMDLNLIEQAPLTVAEKLQ
RDFLTEWRRVSKAPEALFFVQFEKGESYFHMHVLVETTGVKSMVLGRFLSQIREKLIQRI
YRGIEPTLPNWFAVTKTRNGAGGGNKVVDECYIPNYLLPKTQPELQWAWTNMEQYLSACL
NLTERKRLVAQHLTHVSQTQEQNKENQNPNSDAPVIRSKTSARYMELVGWLVDKGITSEK
QWIQEDQASYISFNAASNSRSQIKAALDNAGKIMSLTKTAPDYLVGQQPVEDISSNRIYK
ILELNGYDPQYAASVFLGWATKKFGKRNTIWLFGPATTGKTNIAEAIAHTVPFYGCVNWT
NENFPFNDCVDKMVIWWEEGKMTAKVVESAKAILGGSKVRVDQKCKSSAQIDPTPVIVTS
NTNMCAVIDGNSTTFEHQQPLQDRMFKFELTRRLDHDFGKVTKQEVKDFFRWAKDHVVEV
EHEFYVKKGGAKKRPAPSDADISEPKRVRESVAQPSTSDAEASINYADRLARGHSL

# Drug_Target_38_Reaction:
Not Available

# Drug_Target_38_Signals:
None

# Drug_Target_38_Specific_Function:
Essential for DNA replication

# Drug_Target_38_SwissProt_ID:
P03132

# Drug_Target_38_SwissProt_Name:
VNCA_AAV2

# Drug_Target_38_Synonyms:
Non-capsid protein

# Drug_Target_38_Theoretical_pI:
7.10

# Drug_Target_38_Transmembrane_Regions:
None

# Drug_Target_39_Cellular_Location:
Cytoplasmic

# Drug_Target_39_Chromosome_Location:
Not Available

# Drug_Target_39_Drug_References:
Not Available

# Drug_Target_39_Essentiality:
Non-Essential

# Drug_Target_39_GenAtlas_ID:
Not Available

# Drug_Target_39_GenBank_ID_Gene:
AB032368

# Drug_Target_39_GenBank_ID_Protein:
Not Available

# Drug_Target_39_GeneCard_ID:
Not Available

# Drug_Target_39_Gene_Name:
ftsH

# Drug_Target_39_Gene_Sequence:
>1875 bp
ATGCCTCGAGCCCCCTTTAGCCTTCTCGCCCTGGTCCTGGGCCTCGCCTTCCTGGCCTGG
CCTTCAGCCTCGCGGGGCACCGTGGGCGCCCCAAGCGGGACGGTGAACTACACGACCTTC
CTGGAGGACCTCAAGGCGGGCCGGGTCAAGGAGGTGGTGGTGCGCGCCGGGGACACCCGG
ATCCAGGGGGTCCTGGAGGACGGCTCCGCCTTCACCACCTACGCGGCGAGCCCTCCGGAC
AACGCCACCCTCGAGGGCTGGATGGCCCGGGGGGTGAGCGTCCGGGTGGAGCCCCCCCAG
GGCCAAAACGCCCTCGGCTTCCTCTGGCCCCTCCTCCTCGTGGGCCTCCTCATCGGCGCC
CTCTACTACTTCTCCCGCAACGGCCGGGCCGGGCCTTCGGACTCCGCCTTCAGCTTCACC
AAAAGCCGGGCCCGGGTCCTCACCGAGGCCCCCAAGGTCACCTTCAAGGACGTGGCCGGG
GCGGAGGAGGCCAAGGAGGAACTCAAGGAGATCGTGGAGTTCCTCAAAAACCCCAGCCGC
TTCCACGAGATGGGCGCCCGCATCCCCAAGGGTGTCCTCCTGGTGGGGCCCCCGGGGGTG
GGCAAGACCCACCTGGCCCGGGCCGTGGCCGGGGAGGCCCGGGTGCCCTTCATCACCGCC
TCGGGCTCCGACTTCGTGGAGATGTTCGTGGGGGTAGGGGCGGCGAGGGTCCGGGACCTC
TTTGAGACCGCCAAGCGCCACGCCCCCTGCATCGTCTTCATTGACGAGATTGACGCCGTG
GGGAGGAAGCGGGGAAGCGGGGTGGGGGGCGGGAACGACGAGCGGGAGCAGACCCTGAAC
CAGCTCCTCGTGGAGATGGACGGCTTTGAGAAGGACACGGCCATCGTGGTCATGGCCGCC
ACCAACCGCCCCGACATCCTGGACCCCGCCCTGCTCCGCCCCGGGCGCTTTGACCGGCAG
ATCGCCATAGACGCCCCCGACGTCAAGGGCCGGGAGCAGATCCTCAGGATCCACGCCCGG
GGCAAGCCCCTGGCGGAGGACGTGGACCTGGCCCTCCTCGCCAAGCGCACCCCGGGCTTC
GTGGGGGCGGACCTGGAGAACCTCCTGAACGAAGCCGCCCTCCTCGCCGCCCGGGAGGGG
CGGAGGAAGATCACCATGAAGGACCTGGAGGAGGCCGCCGACCGGGTGATGATGGGCCCG
GCCAAGAAAAGCCTCGTCCTCTCCCCCCGCGACCGCAGGATCACCGCCTACCACGAGGCG
GGGCACGCCCTGGCGGCCCACTTCCTGGAGCACGCCGACGGGGTGCACAAGGTGACCATC
GTGCCCCGGGGAAGGGCCTTGGGCTTCATGATGCCCAGGCGGGAGGACATGCTCCACTGG
TCCAGAAAGCGCCTTTTGGACCAGATCGCCGTGGCCCTGGCGGGGCGGGCGGCGGAGGAG
ATCGTCTTTGACGACGTGACCACGGGGGCGGAGAACGACTTCCGCCAGGCCACGGAGCTC
GCCCGCCGCATGATCACCGAGTGGGGGATGCACCCCGAGTTCGGCCCCGTGGCCTACGCG
GTGCGGGAGGACACCTACCTGGGCGGCTACGACGTGCGCCAGTACTCGGAGGAGACCGCC
AAGCGCATTGACGAGGCGGTGCGCCGCCTCATTGAGGAGCAGTACCAGAGGGTGAAGGCC
CTTCTCCTGGAAAAGCGGGAGGTCCTGGAGCGGGTGGCGGAGACCCTCCTGGAGCGGGAG
ACCCTCACCGCCGAGGAGTTCCAACGGGTGGTGGAGGGGCTCCCCTTGGAGGCCCCCGAG
GAGGCCCGGGAGGAGCGGGAGCCCCCCCGGGTGGTGCCCAAGGTGAAGCCGGGGGGCGCC
CTGGGCGGGGCCTGA

# Drug_Target_39_General_Function:
Involved in nucleotide binding

# Drug_Target_39_General_References:
10377389	Motohashi K, Watanabe Y, Yohda M, Yoshida M: Heat-inactivated proteins are rescued by the DnaK.J-GrpE set and ClpB chaperones. Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7184-9.
10788805	Asahara Y, Atsuta K, Motohashi K, Taguchi H, Yohda M, Yoshida M: FtsH recognizes proteins with unfolded structure and hydrolyzes the carboxyl side of hydrophobic residues. J Biochem. 2000 May;127(5):931-7.
12377127	Niwa H, Tsuchiya D, Makyio H, Yoshida M, Morikawa K: Hexameric ring structure of the ATPase domain of the membrane-integrated metalloprotease FtsH from Thermus thermophilus HB8. Structure. 2002 Oct;10(10):1415-23.

# Drug_Target_39_HGNC_ID:
Not Available

# Drug_Target_39_HPRD_ID:
Not Available

# Drug_Target_39_ID:
5265

# Drug_Target_39_Locus:
Not Available

# Drug_Target_39_Molecular_Weight:
68462

# Drug_Target_39_Name:
FtsH

# Drug_Target_39_Number_of_Residues:
624

# Drug_Target_39_PDB_ID:
1IY2

# Drug_Target_39_Pathway:
Not Available

# Drug_Target_39_Pfam_Domain_Function:
PF00004	AAA
PF01434	Peptidase_M41
PF06480	FtsH_ext

# Drug_Target_39_Protein_Sequence:
>FtsH
MPRAPFSLLALVLGLAFLAWPSASRGTVGAPSGTVNYTTFLEDLKAGRVKEVVVRAGDTR
IQGVLEDGSAFTTYAASPPDNATLEGWMARGVSVRVEPPQGQNALGFLWPLLLVGLLIGA
LYYFSRNGRAGPSDSAFSFTKSRARVLTEAPKVTFKDVAGAEEAKEELKEIVEFLKNPSR
FHEMGARIPKGVLLVGPPGVGKTHLARAVAGEARVPFITASGSDFVEMFVGVGAARVRDL
FETAKRHAPCIVFIDEIDAVGRKRGSGVGGGNDEREQTLNQLLVEMDGFEKDTAIVVMAA
TNRPDILDPALLRPGRFDRQIAIDAPDVKGREQILRIHARGKPLAEDVDLALLAKRTPGF
VGADLENLLNEAALLAAREGRRKITMKDLEEAADRVMMGPAKKSLVLSPRDRRITAYHEA
GHALAAHFLEHADGVHKVTIVPRGRALGFMMPRREDMLHWSRKRLLDQIAVALAGRAAEE
IVFDDVTTGAENDFRQATELARRMITEWGMHPEFGPVAYAVREDTYLGGYDVRQYSEETA
KRIDEAVRRLIEEQYQRVKALLLEKREVLERVAETLLERETLTAEEFQRVVEGLPLEAPE
EAREEREPPRVVPKVKPGGALGGA

# Drug_Target_39_Reaction:
Not Available

# Drug_Target_39_Signals:
None

# Drug_Target_39_Specific_Function:
Seems to act as an ATP-dependent zinc metallopeptidase (By similarity)

# Drug_Target_39_SwissProt_ID:
Q9LCZ4

# Drug_Target_39_SwissProt_Name:
FTSH_THET8

# Drug_Target_39_Synonyms:
Not Available

# Drug_Target_39_Theoretical_pI:
6.61

# Drug_Target_39_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Endoplasmic reticulum membrane

# Drug_Target_3_Chromosome_Location:
1

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AK291314

# Drug_Target_3_GenBank_ID_Protein:
158256064

# Drug_Target_3_GeneCard_ID:
ATP2A1

# Drug_Target_3_Gene_Name:
ATP2A1

# Drug_Target_3_Gene_Sequence:
>2985 bp
ATGGAGGCCGCTCATGCTAAAACCACGGAGGAATGTTTGGCCTATTTTGGGGTGAGTGAG
ACCACGGGCCTCACCCCGGACCAAGTTAAGCGGAATCTGGAGAAATACGGCCTCAATGAG
CTCCCTGCTGAGGAAGGGAAGACCCTGTGGGAGCTGGTGATAGAGCAGTTTGAAGACCTC
CTGGTGCGGATTCTCCTCCTGGCCGCATGCATTTCCTTCGTGCTGGCCTGGTTTGAGGAA
GGTGAAGAGACCATCACTGCCTTTGTTGAACCCTTTGTCATCCTCTTGATCCTCATTGCC
AATGCCATCGTGGGGGTTTGGCAGGAGCGGAACGCAGAGAACGCCATCGAGGCCCTGAAG
GAGTATGAGCCAGAGATGGGGAAGGTCTACCGGGCTGACCGCAAGTCAGTGCAAAGGATC
AAGGCTCGGGACATCGTCCCTGGGGACATCGTGGAGGTGGCTGTGGGGGACAAAGTCCCT
GCAGACATCCGAATCCTCGCCATCAAATCCACCACGCTGCGGGTTGACCAGTCCATCCTG
ACAGGCGAGTCTGTATCTGTCATCAAACACACGGAGCCCGTTCCTGACCCCCGAGCTGTC
AACCAGGACAAGAAGAACATGCTTTTCTCGGGCACCAACATTGCAGCCGGCAAGGCCTTG
GGCATCGTGGCCACCACTGGTGTGGGCACCGAGATTGGGAAGATCCGAGACCAAATGGCT
GCCACAGAACAGGACAAGACCCCCTTGCAGCAGAAGCTGGATGAGTTTGGGGAGCAGCTC
TCCAAGGTCATCTCCCTCATCTGTGTGGCTGTCTGGCTTATCAACATTGGCCACTTCAAC
GACCCCGTCCATGGGGGCTCCTGGTTCCGCGGGGCCATCTACTACTTTAAGATTGCCGTG
GCCTTGGCTGTGGCTGCCATCCCCGAAGGTCTTCCTGCAGTCATCACCACCTGCCTGGCC
CTGGGTACCCGTCGGATGGCAAAGAAGAATGCCATTGTAAGAAGCTTGCCCTCCGTAGAG
ACCCTGGGCTGCACCTCTGTCATCTGTTCCGACAAGACAGGCACCCTCACCACCAACCAG
ATGTCTGTCTGCAAGATGTTTATCATTGACAAGGTGGATGGGGACATCTGCCTCCTGAAT
GAGTTCTCCATCACCGGCTCCACTTACGCTCCAGAGGGAGAGGTCTTGAAGAATGATAAG
CCAGTCCGGCCAGGGCAGTATGACGGGCTGGTGGAGCTGGCCACCATCTGTGCCCTCTGC
AATGACTCCTCCTTGGACTTCAACGAGGCCAAAGGTGTCTATGAGAAGGTCGGCGAGGCC
ACCGAGACAGCACTCACCACCCTGGTGGAGAAGATGAATGTGTTCAACACGGATGTGAGA
AGCCTCTCGAAGGTGGAGAGAGCCAACGCCTGCAACTCGGTGATCCGCCAGCTAATGAAG
AAGGAATTCACCCTGGAGTTCTCCCGAGACAGAAAGTCCATGTCTGTCTATTGCTCCCCA
GCCAAATCTTCCCGGGCTGCTGTGGGCAACAAGATGTTTGTCAAGGGTGCCCCTGAGGGC
GTCATCGACCGCTGTAACTATGTGCGAGTTGGCACCACCCGGGTGCCACTGACGGGGCCG
GTGAAGGAAAAGATCATGGCGGTGATCAAGGAGTGGGGCACTGGCCGGGACACCCTGCGC
TGCTTGGCCCTGGCCACCCGGGACACCCCCCCGAAGCGAGAGGAAATGGTCCTGGATGAC
TCTGCCAGGTTCCTGGAGTATGAGACGGACCTGACATTCGTGGGTGTAGTGGGCATGCTG
GACCCTCCGCGCAAGGAGGTCACGGGCTCCATCCAGCTGTGCCGTGACGCCGGGATCCGG
GTGATCATGATCACTGGGGACAACAAGGGCACAGCCATTGCCATCTGCCGGCGAATTGGC
ATCTTTGGGGAGAACGAGGAGGTGGCCGATCGCGCCTACACGGGCCGAGAGTTCGACGAC
CTGCCCCTGGCTGAACAGCGGGAAGCCTGCCGACGTGCCTGCTGCTTCGCCCGTGTGGAG
CCCTCGCACAAGTCCAAGATTGTGGAGTACCTGCAGTCCTACGATGAGATCACAGCCATG
ACAGGTGATGGCGTCAATGACGCCCCTGCCCTGAAGAAGGCTGAGATTGGCATTGCCATG
GGATCTGGCACTGCCGTGGCCAAGACTGCCTCTGAGATGGTGCTGGCTGACGACAACTTC
TCCACCATCGTAGCTGCTGTGGAGGAGGGCCGCGCCATCTACAACAACATGAAGCAGTTC
ATCCGCTACCTCATTTCCTCCAACGTGGGCGAGGTGGTCTGTATCTTCCTGACCGCTGCC
CTGGGGCTGCCTGAGGCCCTGATCCCGGTGCAGCTGCTATGGGTGAACTTGGTGACCGAC
GGGCTCCCAGCCACAGCCCTGGGCTTCAACCCACCAGACCTGGACATCATGGACCGCCCC
CCCCGGAGCCCCAAGGAGCCCCTCATCAGTGGCTGGCTCTTCTTCCGCTACATGGCAATC
GGGGGCTATGTGGGTGCAGCCACCGTGGGAGCAGCTGCCTGGTGGTTCCTGTACGCTGAG
GATGGGCCTCATGTCAACTACAGCCAGCTGACTCACTTCATGCAGTGCACCGAGGACAAC
ACCCACTTTGAGGGCATAGACTGTGAGGTCTTCGAGGCCCCCGAGCCCATGACCATGGCC
CTGTCCGTGCTGGTGACCATCGAGATGTGCAATGCACTGAACAGCCTGTCCGAGAACCAG
TCCCTGCTGCGGATGCCACCCTGGGTGAACATCTGGCTGCTGGGCTCCATCTGCCTCTCC
ATGTCCCTGCACTTCCTCATCCTCTATGTTGACCCCCTGCCGATGATCTTCAAGCTCCGG
GCCCTGGACCTCACCCAGTGGCTCATGGTCCTCAAGATCTCACTGCCAGTCATTGGGCTC
GACGAAATCCTCAAGTTCGTTGCTCGGAACTACCTAGAGGGATAA

# Drug_Target_3_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_3_General_References:
10914677	Odermatt A, Barton K, Khanna VK, Mathieu J, Escolar D, Kuntzer T, Karpati G, MacLennan DH: The mutation of Pro789 to Leu reduces the activity of the fast-twitch skeletal muscle sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA1) and is associated with Brody disease. Hum Genet. 2000 May;106(5):482-91.
11438520	Daiho T, Yamasaki K, Saino T, Kamidochi M, Satoh K, Iizuka H, Suzuki H: Mutations of either or both Cys876 and Cys888 residues of sarcoplasmic reticulum Ca2+-ATPase result in a complete loss of Ca2+ transport activity without a loss of Ca2+-dependent ATPase activity. Role of the CYS876-CYS888 disulfide bond. J Biol Chem. 2001 Aug 31;276(35):32771-8. Epub 2001 Jul 3.
14702039	Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21.
8825625	Zhang Y, Fujii J, Phillips MS, Chen HS, Karpati G, Yee WC, Schrank B, Cornblath DR, Boylan KB, MacLennan DH: Characterization of cDNA and genomic DNA encoding SERCA1, the Ca(2+)-ATPase of human fast-twitch skeletal muscle sarcoplasmic reticulum, and its elimination as a candidate gene for Brody disease. Genomics. 1995 Dec 10;30(3):415-24.

# Drug_Target_3_HGNC_ID:
GNC:811

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
6390

# Drug_Target_3_Locus:
16p12.1

# Drug_Target_3_Molecular_Weight:
110251.4

# Drug_Target_3_Name:
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1

# Drug_Target_3_Number_of_Residues:
1001

# Drug_Target_3_PDB_ID:
1XP5

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00122	E1-E2_ATPase
PF00689	Cation_ATPase_C
PF00690	Cation_ATPase_N
PF00702	Hydrolase

# Drug_Target_3_Protein_Sequence:
>Sarcoplasmic/endoplasmic reticulum calcium ATPase 1
MEAAHAKTTEECLAYFGVSETTGLTPDQVKRNLEKYGLNELPAEEGKTLWELVIEQFEDL
LVRILLLAACISFVLAWFEEGEETITAFVEPFVILLILIANAIVGVWQERNAENAIEALK
EYEPEMGKVYRADRKSVQRIKARDIVPGDIVEVAVGDKVPADIRILAIKSTTLRVDQSIL
TGESVSVIKHTEPVPDPRAVNQDKKNMLFSGTNIAAGKALGIVATTGVGTEIGKIRDQMA
ATEQDKTPLQQKLDEFGEQLSKVISLICVAVWLINIGHFNDPVHGGSWFRGAIYYFKIAV
ALAVAAIPEGLPAVITTCLALGTRRMAKKNAIVRSLPSVETLGCTSVICSDKTGTLTTNQ
MSVCKMFIIDKVDGDICLLNEFSITGSTYAPEGEVLKNDKPVRPGQYDGLVELATICALC
NDSSLDFNEAKGVYEKVGEATETALTTLVEKMNVFNTDVRSLSKVERANACNSVIRQLMK
KEFTLEFSRDRKSMSVYCSPAKSSRAAVGNKMFVKGAPEGVIDRCNYVRVGTTRVPLTGP
VKEKIMAVIKEWGTGRDTLRCLALATRDTPPKREEMVLDDSARFLEYETDLTFVGVVGML
DPPRKEVTGSIQLCRDAGIRVIMITGDNKGTAIAICRRIGIFGENEEVADRAYTGREFDD
LPLAEQREACRRACCFARVEPSHKSKIVEYLQSYDEITAMTGDGVNDAPALKKAEIGIAM
GSGTAVAKTASEMVLADDNFSTIVAAVEEGRAIYNNMKQFIRYLISSNVGEVVCIFLTAA
LGLPEALIPVQLLWVNLVTDGLPATALGFNPPDLDIMDRPPRSPKEPLISGWLFFRYMAI
GGYVGAATVGAAAWWFLYAEDGPHVNYSQLTHFMQCTEDNTHFEGIDCEVFEAPEPMTMA
LSVLVTIEMCNALNSLSENQSLLRMPPWVNIWLLGSICLSMSLHFLILYVDPLPMIFKLR
ALDLTQWLMVLKISLPVIGLDEILKFVARNYLEDPEDERRK

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen. Contributes to calcium sequestration involved in muscular excitation/contraction

# Drug_Target_3_SwissProt_ID:
O14983

# Drug_Target_3_SwissProt_Name:
AT2A1_HUMAN

# Drug_Target_3_Synonyms:
Calcium pump 1
Calcium-transporting ATPase sarcoplasmic reticulum type, fast twitch skeletal muscle isoform
Endoplasmic reticulum class 1/2 Ca(2+) ATPase
SERCA1
SR Ca(2+)-ATPase 1

# Drug_Target_3_Theoretical_pI:
4.80

# Drug_Target_3_Transmembrane_Regions:
49-69
90-110
254-273
296-313
758-777
788-808
829-851
898-917
931-949
965-985

# Drug_Target_40_Cellular_Location:
Not Available

# Drug_Target_40_Chromosome_Location:
1

# Drug_Target_40_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_40_Essentiality:
Non-Essential

# Drug_Target_40_GenAtlas_ID:
Not Available

# Drug_Target_40_GenBank_ID_Gene:
AY165122

# Drug_Target_40_GenBank_ID_Protein:
33438760

# Drug_Target_40_GeneCard_ID:
MYH14

# Drug_Target_40_Gene_Name:
MYH14

# Drug_Target_40_Gene_Sequence:
>5988 bp
ATGGCAGCCGTGACCATGTCGGTGCCCGGGCGGAAGGCGCCCCCCAGGCCGGGCCCAGTG
CCCGAGGCGGCCCAGCCGTTCCTGTTCACGCCCCGCGGGCCCAGCGCGGGTGGCGGGCCT
GGCTCGGGCACCTCCCCGCAGGTGGAGTGGACGGCCCGGCGTCTCGTGTGGGTGCCTTCG
GAGCTTCACGGGTTCGAGGCGGCGGCGCTGCGGGACGAAGGCGAGGAGGAGGCGGAGGTG
GAGCTGGCGGAGAGCGGGAGGCGGCTGCGACTGCCGCGGGACCAGATCCAGCGCATGAAC
CCGCCCAAGTTCAGCAAGGCCGAGGACATGGCCGAGCTGACCTGCCTCAACGAGGCCTCG
GTCCTGCACAACCTCCGGGAGCGGTACTACTCCGGCCTCATCTACACGTACTCCGGCCTT
TTCTGTGTGGTCATCAACCCGTACAAGCAGCTTCCCATCTACACAGAAGCCATTGTGGAG
ATGTACCGGGGCAAGAAGCGCCACGAGGTGCCACCCCACGTGTACGCAGTGACCGAGGGG
GCCTATCGGAGCATGCTGCAGGATCGTGAGGACCAGTCCATTCTCTGCACTGGAGAGTCT
GGAGCTGGGAAGACGGAAAACACCAAGAAGGTCATCCAGTACCTCGCCCACGTGGCATCG
TCTCCAAAGGGCAGGAAGGAGCCGGGTGTCCCCGGTGAGCTGGAGCGGCAGCTGCTTCAG
GCCAACCCCATCCTAGAGGCCTTTGGCAATGCCAAGACAGTGAAGAATGACAACTCCTCC
CGATTCGGCAAATTCATCCGCATCAACTTTGATGTTGCCGGGTACATCGTGGGCGCCAAC
ATTGAGACCTACCTGCTGGAGAAGTCGCGGGCCATCCGCCAGGCCAAGGACGAGTGCAGC
TTCCACATCTTCTACCAGCTGCTGGGGGGCGCTGGAGAGCAGCTCAAAGCCGACCTCCTC
CTCGAGCCCTGCTCCCACTACCGGTTCCTGACCAACGGGCCGTCATCCTCTCCCGGCCAG
GAGCGGGAACTCTTCCAGGAGACGCTGGAGTCGCTGCGGGTCCTGGGATTCAGCCACGAG
GAAATCATCTCCATGCTGCGGATGGTCTCAGCAGTTCTCCAGTTTGGCAACATTGCCTTG
AAGAGAGAACGGAACACCGATCAAGCCACCATGCCTGACAACACAGCTGCACAGAAGCTC
TGCCGCCTCTTGGGACTGGGGGTGACGGATTTCTCCCGAGCCTTGCTCACCCCTCGCATC
AAAGTTGGCCGAGACTATGTGCAGAAAGCCCAGACTAAGGAACAGGCTGACTTCGCGCTG
GAGGCCCTGGCCAAGGCCACCTACGAGCGCCTCTTCCGCTGGCTGGTTCTGCGCCTCAAC
CGGGCCTTGGACCGCAGCCCCCGCCAAGGCGCCTCCTTCCTGGGCATCCTGGACATCGCG
GGCTTTGAGATCTTCCAGCTGAACTCCTTCGAGCAGCTCTGCATCAACTACACCAACGAG
AAGCTGCAGCAGCTCTTCAACCACACCATGTTCGTGCTGGAGCAGGAGGAGTACCAGCGT
GAGGGCATCCCCTGGACCTTCCTCGACTTTGGCCTCGACCTGCAGCCCTGCATCGACCTC
ATCGAGCGGCCGGCCAACCCCCCTGGACTCCTGGCCCTGCTGGATGAGGAGTGCTGGTTC
CCGAAGGCCACAGACAAGTCGTTTGTGGAGAAGGTAGCCCAGGAGCAGGGCGGCCACCCC
AAGTTCCAGCGGCCGAGGCACCTGCGGGATCAGGCCGACTTCAGTGTTCTCCACTACGCG
GGCAAGGTCGACTACAAGGCCAACGAGTGGCTGATGAAAAACATGGACCCTCTGAATGAC
AACGTCGCAGCCTTGCTCCACCAGAGCACAGACCGGCTGACGGCAGAGATCTGGAAAGAC
GTGGAGGGCATCGTGGGGCTGGAACAGGTGAGCAGCCTGGGCGACGGCCCACCAGGTGGC
CGCCCCCGTCGGGGTATGTTCCGGACAGTGGGACAGCTCTACAAGGAGTCCCTGAGCCGC
CTCATGGCCACACTCAGCAACACCAACCCCAGTTTTGTCCGGTGCATTGTCCCCAACCAC
GAGAAGAGGGCCGGGAAGCTGGAGCCACGGCTGGTGCTGGACCAGCTTCGCTGCAACGGG
GTCCTGGAGGGCATCCGCATCTGTCGCCAGGGCTTCCCCAACCGCATCCTCTTCCAGGAG
TTCCGGCAGCGATACGAGATCCTGACACCCAATGCCATCCCCAAGGGCTTCATGGATGGG
AAGCAGGCCTGTGAAAAGATGATCCAGGCGCTGGAACTGGACCCCAACCTCTACCGCGTG
GGACAGAGCAAGATCTTCTTCCGGGCTGGGGTCCTGGCCCAGCTGGAAGAGGAGCGAGAC
CTGAAGGTCACCGACATCATCGTCTCCTTCCAGGCAGCTGCCCGGGGATACCTGGCTCGC
AGGGCCTTCCAGAAGCGCCAGCAGCAGCAGAGCGCCCTGAGGGTGATGCAGCGGAACTGC
GCGGCCTACCTCAAGCTGAGACACTGGCAGTGGTGGCGGCTGTTTACCAAGGTGAAGCCA
CTGCTGCAGGTGACGCGGCAGGATGAGGTGCTGCAGGCACGGGCCCAGGAGCTGCAGAAA
GTGCAGGAGCTACAGCAGCAGAGCGCCCGCGAAGTTGGGGAGCTCCAGGGCCGAGTGGCA
CAGCTGGAAGAGGAGCGCGCCCGCCTGGCAGAGCAATTGCGAGCAGAGGCAGAACTGTGT
GCAGAGGCCGAGGAGACGCGGGGGAGGCTGGCAGCCCGCAAGCAGGAGCTGGAGCTGGTG
GTGTCAGAGCTGGAGGCTCGCGTGGGCGAGGAGGAGGAGTGCAGCCGTCAAATGCAAACC
GAGAAGAAGAGGCTACAGCAGCACATACAGGAGCTAGAGGCCCACCTTGAGGCTGAGGAG
GGTGCGCGGCAGAAGCTGCAGCTGGAGAAGGTGACGACAGAGGCAAAAATGAAGAAATTT
GAAGAGGACCTGCTGCTCCTGGAAGACCAGAATTCCAAGCTGAGCAAGAGCGGAAGCTGC
TGGAAGATCGTCTGGCCGAGTTCTCATCCCAGGCAGCTGAGGAGGAGGAGAAGGTCAAGA
GCCTCAATAAGCTACGGCTCAAATATGAGGCCACAATCGCAGACATGGAGGGACCGCCTA
CGGAAGGAGGAGAAGGGTCGCCAGGAGCTGGAGAAGCTGAAGCGGAGGCTGGATGGGGAG
AGCTCAGAGCTGCAGGAGCAGATGGTGGAGCAGCAACAGCGGGCAGAGGAGCTGCGGGCC
CAGCTGGGCCGGAAGGAGGAGGAGCTGCAGGCTGCCCTGGCCAGGGCAGAAGACGAGGGT
GGGGCCCGGGCCCAGCTGCTGAAATCCCTGCGGGAGGCTCAAGCAGCCCTGGCCGAGGCC
CAGGAGGACCTGGAGTCTGAGCGTGTGGCCAGGACCAAGGCGGAGAAGCAGCGCCGGGAC
CTGGGCGAGGAGCTGGAGGCGCTGCGGGGCGAGCTGGAGGACACGCTGGACTCCACCAAC
GCACAGCAGGAGCTCCGGTCCAAGAGGGAACAGGAGGTGACGGAGCTGAAGAAGACTCTG
GAGGAGGAGACTCGCATCCACGAGGCGGCAGTGCAGGAGCTGAGGCAGCGCCACGGCCAG
GCCCTGGGGGAGCTGGCGGAGCAGCTGGAGCAGGCCCGGAGGGGCAAAGGTGCATGGGAG
AAGACCCGGCTGGCCCTGGAGGCCGAGGTGTCCGAGCTGCGGGCAGAACTGAGCAGCCTG
CAGACTGCACGTCAGGAGGGTGAGCAGCGGAGGCGCCGCCTGGAGTTACAGCTGCAGGAG
GTGCAGGGCCGGGCTGGTGATGGGGAGAGGGCACGAGCGGAGGCTGCTGAGAAGCTGCAG
CGAGCCCAGGCTGAACTGGAGAATGTGTCTGGGGCGCTGAACGAGGCTGAGTCCAAAACC
ATCCGTCTTAGCAAGGAGCTGAGCAGCACAGAAGCCCAGCTGCACGATGCCCAGGAGCTG
CTGCAGGAGGAGACCAGGGCGAAATTGGCCTTGGGGTCCCGGGTGCGAGCCATGGAGGCT
GAGGCAGCCGGGCTGCGTGAGCAGCTGGAGGAGGAGGCAGCTGCCAGGGAACGGGCGGGC
CGTGAACTGCAGACTGCCCAGGCCCAGCTTTCCGAGTGGCGGCGGCGCCAGGAGGAGGAG
GCAGGGGCACTGGAGGCAGGGGAGGAGGCACGGCGCCGGGCAGCCCGGGAGGCCGAGGCC
CTGACCCAGCGCCTGGCAGAAAAGACAGAGACCGTGGATCGGCTGGAGCGGGGCCGCCGC
CGGCTGCAGCAGGAGCTGGACGACGCCACCATGGACCTGGAGCAGCAGCGGCAGCTTGTG
AGCACCCTGGAGAAGAAGCAGCGCAAGTTTGACCAGCTTCTGGCAGAGGAGAAGGCAGCT
GTACTTCGGGCAGTGGAGGAACGTGAGCGGGCCGAGGCAGAGGGCCGGGAGCGTGAGGCT
CGGGCCCTGTCACTGACACGGGCACTGGAGGAGGAGCAGGAGGCACGTGAGGAGCTGGAG
CGGCAGAACCGGGCCCTGCGGGCTGAGCTGGAGGCACTGCTGAGCAGCAAGGATGACGTC
GGCAAGAGCGTGCATGAGCTGGAACGAGCCTGCCGGGTAGCAGAACAGGCAGCCAATGAT
CTGCGAGCACAGGTGACAGAACTGGAGGATGAGCTGACAGCGGCCGAGGATGCCAAGCTG
CGTCTGGAGGTGACTGTGCAGGCTCTCAAGACTCAGCATGAGCGTGACCTGCAGGGCCGT
GATGAGGCTGGTGAAGAGAGGCGGAGGCAGCTGGCCAAGCAGCTGAGAGATGCAGAGGTG
GAGCGGGATGAGGAGCGGAAGCAGCGCACTCTGGCCGTGGCTGCCCGCAAGAAGCTGGAG
GGAGAGCTGGAGGAGCTGAAGGCTCAGATGGCCTCTGCCGGCCAGGGCAAGGAGGAGGCG
GTGAAGCAGCTTCGCAAGATGCAGGCCCAGATGAAGGAGCTATGGCGGGAGGTGGAGGAG
ACACGCACCTCCCGGGAGGAGATCTTCTCCCAGAATCGGGAAAGTGAAAAGCGCCTCAAG
GGCCTGGAGGCTGAGGTGCTGCGGCTGCAGGAGGAACTGGCCGCCTCGGACCGTGCTCGG
CGGCAGGCCCAGCAGGACCGGGATGAGATGGCAGATGAGGTGGCCAATGGTAACCTTAGC
AAGGCAGCCATTCTGGAGGAGAAGCGTCAGCTGGAGGGGCGCCTGGGGCAGTTGGAGGAA
GAGCTGGAGGAGGAGCAGAGCAACTCAGAGCTGCTCAATGACCGCTACCGCAAGCTGCTC
CTGCAGGTAGAGTCACTGACCACAGAGCTGTCAGCTGAGCGCAGTTTCTCAGCCAAGGCA
GAGAGCGGGCGGCAGCAGCTGGAACGGCAGATCCAGGAGCTACGGGGACGCCTGGGTGAG
GAGGATGCTGGGGCCCGTGCCCGCCACAAGATGACCATTGCTGCCCTTGAGTCTAAGTTG
GCCCAGGCTGAGGAGCAGCTAGAGCAAGAGACCAGAGAGCGCATCCTCTCTGGAAAGCTG
GTGCGCAGAGCTGAGAAGCGGCTTAAAGAGGTGGTGCTCCAGGTGGAGGAGGAGCGGAGG
GTGGCTGACCAGCTCCGGGACCAGCTGGAGAAGGGAAACCTTCGAGTCAAGCAGCTGAAG
CGGCAGCTGGAGGAGGCCGAGGAGGAGGCATCCCGGGCTCAGGCTGGCCGCCGGAGGCTG
CAGCGTGAGCTGGAAGATGTCACAGAGTCGGCCGAGTCCATGAACCGTGAAGTGACCACA
CTGAGGAACCGGCTTCGACGCGGCCCCCTCACCTTCACCACCCGCACGGTGCGCCAGGTC
TTCCGACTAGAGGAGGGCGTGGCATCCGACGAGGAGGCAGAGGAAGCACAGCCTGGGTCT
GGGCCATCCCCGGAGCCTGAGGGGTCCCCACCAGCCCACCCCCAGTGA

# Drug_Target_40_General_Function:
Cell cycle control, cell division, chromosome partitioning

# Drug_Target_40_General_References:
11919279	Desjardins PR, Burkman JM, Shrager JB, Allmond LA, Stedman HH: Evolutionary implications of three novel members of the human sarcomeric myosin heavy chain gene family. Mol Biol Evol. 2002 Apr;19(4):375-93.
12909352	Leal A, Endele S, Stengel C, Huehne K, Loetterle J, Barrantes R, Winterpacht A, Rautenstrauss B: A novel myosin heavy chain gene in human chromosome 19q13.3. Gene. 2003 Jul 17;312:165-71.
14594953	Golomb E, Ma X, Jana SS, Preston YA, Kawamoto S, Shoham NG, Goldin E, Conti MA, Sellers JR, Adelstein RS: Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family. J Biol Chem. 2004 Jan 23;279(4):2800-8. Epub 2003 Nov 1.
14702039	Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
15498874	Wan D, Gong Y, Qin W, Zhang P, Li J, Wei L, Zhou X, Li H, Qiu X, Zhong F, He L, Yu J, Yao G, Jiang H, Qian L, Yu Y, Shu H, Chen X, Xu H, Guo M, Pan Z, Chen Y, Ge C, Yang S, Gu J: Large-scale cDNA transfection screening for genes related to cancer development and progression. Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15724-9. Epub 2004 Oct 21.
17974005	Bechtel S, Rosenfelder H, Duda A, Schmidt CP, Ernst U, Wellenreuther R, Mehrle A, Schuster C, Bahr A, Blocker H, Heubner D, Hoerlein A, Michel G, Wedler H, Kohrer K, Ottenwalder B, Poustka A, Wiemann S, Schupp I: The full-ORF clone resource of the German cDNA Consortium. BMC Genomics. 2007 Oct 31;8:399.
18083107	Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, Li Y, Hu Y, Tan Z, Stokes M, Sullivan L, Mitchell J, Wetzel R, Macneill J, Ren JM, Yuan J, Bakalarski CE, Villen J, Kornhauser JM, Smith B, Li D, Zhou X, Gygi SP, Gu TL, Polakiewicz RD, Rush J, Comb MJ: Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.

# Drug_Target_40_HGNC_ID:
GNC:23212

# Drug_Target_40_HPRD_ID:
Not Available

# Drug_Target_40_ID:
6395

# Drug_Target_40_Locus:
19q13.33

# Drug_Target_40_Molecular_Weight:
227999.8

# Drug_Target_40_Name:
Myosin-14

# Drug_Target_40_Number_of_Residues:
1995

# Drug_Target_40_PDB_ID:
Not Available

# Drug_Target_40_Pathway:
Not Available

# Drug_Target_40_Pfam_Domain_Function:
PF00063	Myosin_head
PF00612	IQ
PF01576	Myosin_tail_1
PF02736	Myosin_N

# Drug_Target_40_Protein_Sequence:
>Myosin-14
MAAVTMSVPGRKAPPRPGPVPEAAQPFLFTPRGPSAGGGPGSGTSPQVEWTARRLVWVPS
ELHGFEAAALRDEGEEEAEVELAESGRRLRLPRDQIQRMNPPKFSKAEDMAELTCLNEAS
VLHNLRERYYSGLIYTYSGLFCVVINPYKQLPIYTEAIVEMYRGKKRHEVPPHVYAVTEG
AYRSMLQDREDQSILCTGESGAGKTENTKKVIQYLAHVASSPKGRKEPGVPGELERQLLQ
ANPILEAFGNAKTVKNDNSSRFGKFIRINFDVAGYIVGANIETYLLEKSRAIRQAKDECS
FHIFYQLLGGAGEQLKADLLLEPCSHYRFLTNGPSSSPGQERELFQETLESLRVLGFSHE
EIISMLRMVSAVLQFGNIALKRERNTDQATMPDNTAAQKLCRLLGLGVTDFSRALLTPRI
KVGRDYVQKAQTKEQADFALEALAKATYERLFRWLVLRLNRALDRSPRQGASFLGILDIA
GFEIFQLNSFEQLCINYTNEKLQQLFNHTMFVLEQEEYQREGIPWTFLDFGLDLQPCIDL
IERPANPPGLLALLDEECWFPKATDKSFVEKVAQEQGGHPKFQRPRHLRDQADFSVLHYA
GKVDYKANEWLMKNMDPLNDNVAALLHQSTDRLTAEIWKDVEGIVGLEQVSSLGDGPPGG
RPRRGMFRTVGQLYKESLSRLMATLSNTNPSFVRCIVPNHEKRAGKLEPRLVLDQLRCNG
VLEGIRICRQGFPNRILFQEFRQRYEILTPNAIPKGFMDGKQACEKMIQALELDPNLYRV
GQSKIFFRAGVLAQLEEERDLKVTDIIVSFQAAARGYLARRAFQKRQQQQSALRVMQRNC
AAYLKLRHWQWWRLFTKVKPLLQVTRQDEVLQARAQELQKVQELQQQSAREVGELQGRVA
QLEEERARLAEQLRAEAELCAEAEETRGRLAARKQELELVVSELEARVGEEEECSRQMQT
EKKRLQQHIQELEAHLEAEEGARQKLQLEKVTTEAKMKKFEEDLLLLEDQNSKLSKSGSC
WKIVWPSSHPRQLRRRRRSRASISYGSNMRPQSQTWRDRLRKEEKGRQELEKLKRRLDGE
SSELQEQMVEQQQRAEELRAQLGRKEEELQAALARAEDEGGARAQLLKSLREAQAALAEA
QEDLESERVARTKAEKQRRDLGEELEALRGELEDTLDSTNAQQELRSKREQEVTELKKTL
EEETRIHEAAVQELRQRHGQALGELAEQLEQARRGKGAWEKTRLALEAEVSELRAELSSL
QTARQEGEQRRRRLELQLQEVQGRAGDGERARAEAAEKLQRAQAELENVSGALNEAESKT
IRLSKELSSTEAQLHDAQELLQEETRAKLALGSRVRAMEAEAAGLREQLEEEAAARERAG
RELQTAQAQLSEWRRRQEEEAGALEAGEEARRRAAREAEALTQRLAEKTETVDRLERGRR
RLQQELDDATMDLEQQRQLVSTLEKKQRKFDQLLAEEKAAVLRAVEERERAEAEGREREA
RALSLTRALEEEQEAREELERQNRALRAELEALLSSKDDVGKSVHELERACRVAEQAAND
LRAQVTELEDELTAAEDAKLRLEVTVQALKTQHERDLQGRDEAGEERRRQLAKQLRDAEV
ERDEERKQRTLAVAARKKLEGELEELKAQMASAGQGKEEAVKQLRKMQAQMKELWREVEE
TRTSREEIFSQNRESEKRLKGLEAEVLRLQEELAASDRARRQAQQDRDEMADEVANGNLS
KAAILEEKRQLEGRLGQLEEELEEEQSNSELLNDRYRKLLLQVESLTTELSAERSFSAKA
ESGRQQLERQIQELRGRLGEEDAGARARHKMTIAALESKLAQAEEQLEQETRERILSGKL
VRRAEKRLKEVVLQVEEERRVADQLRDQLEKGNLRVKQLKRQLEEAEEEASRAQAGRRRL
QRELEDVTESAESMNREVTTLRNRLRRGPLTFTTRTVRQVFRLEEGVASDEEAEEAQPGS
GPSPEPEGSPPAHPQ

# Drug_Target_40_Reaction:
Not Available

# Drug_Target_40_Signals:
None

# Drug_Target_40_Specific_Function:
Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping (By similarity)

# Drug_Target_40_SwissProt_ID:
Q7Z406

# Drug_Target_40_SwissProt_Name:
MYH14_HUMAN

# Drug_Target_40_Synonyms:
Myosin heavy chain 14
Myosin heavy chain, non-muscle IIc
NMHC II-C
Non-muscle myosin heavy chain IIc

# Drug_Target_40_Theoretical_pI:
5.69

# Drug_Target_40_Transmembrane_Regions:
None

# Drug_Target_41_Cellular_Location:
Not Available

# Drug_Target_41_Chromosome_Location:
Not Available

# Drug_Target_41_Drug_References:
Not Available

# Drug_Target_41_Essentiality:
Non-Essential

# Drug_Target_41_GenAtlas_ID:
Not Available

# Drug_Target_41_GenBank_ID_Gene:
X59645

# Drug_Target_41_GenBank_ID_Protein:
Not Available

# Drug_Target_41_GeneCard_ID:
Not Available

# Drug_Target_41_Gene_Name:
hgdC

# Drug_Target_41_Gene_Sequence:
>783 bp
ATGAGTATCTATACCTTGGGAATCGATGTTGGATCTACTGCATCCAAGTGCATTATCCTG
AAAGATGGAAAAGAAATCGTGGCGAAATCCCTGGTAGCCGTGGGGACCGGAACTTCCGGT
CCCGCACGGTCTATTTCGGAAGTCCTGGAAAATGCCCACATGAAAAAAGAAGACATGGCC
TTTACCCTGGCTACCGGCTACGGACGCAATTCGCTGGAAGGCATTGCCGACAAGCAGATG
AGCGAACTGAGCTGCCATGCCATGGGCGCCAGCTTTATCTGGCCCAACGTCCATACCGTC
ATCGATATCGGCGGGCAGGATGTGAAGGTCATCCATGTGGAAAACGGGACCATGACCAAT
TTCCAGATGAATGATAAATGCGCTGCCGGGACTGGCCGTTTCCTGGATGTTATGGCCAAT
ATCCTGGAAGTGAAGGTTTCCGACCTGGCTGAGCTGGGAGCCAAATCCACCAAACGGGTG
GCTATCAGCTCCACCTGTACTGTGTTTGCAGAAAGTGAAGTCATCAGCCAGCTGTCCAAA
GGAACCGACAAGATCGACATCATTGCCGGGATCCATCGTTCTGTAGCCAGCCGGGTCATT
GGTCTTGCCAATCGGGTGGGGATTGTGAAAGACGTGGTCATGACCGGCGGTGTAGCCCAG
AACTATGGCGTGAGAGGAGCCCTGGAAGAAGGCCTTGGCGTGGAAATCAAGACGTCTCCC
CTGGCTCAGTACAACGGTGCCCTGGGTGCCGCTCTGTATGCGTATAAAAAAGCAGCCAAA
TAA

# Drug_Target_41_General_Function:
Lipid transport and metabolism

# Drug_Target_41_General_References:
11106419	Hans M, Buckel W, Bill E: The iron-sulfur clusters in 2-hydroxyglutaryl-CoA dehydratase from Acidaminococcus fermentans. Biochemical and spectroscopic investigations. Eur J Biochem. 2000 Dec;267(24):7082-93.
11243821	Locher KP, Hans M, Yeh AP, Schmid B, Buckel W, Rees DC: Crystal structure of the Acidaminococcus fermentans 2-hydroxyglutaryl-CoA dehydratase component A. J Mol Biol. 2001 Mar 16;307(1):297-308.
2659350	Dutscho R, Wohlfarth G, Buckel P, Buckel W: Cloning and sequencing of the genes of 2-hydoxyglutaryl-CoA dehydratase from Acidaminococcus fermentans. Eur J Biochem. 1989 May 15;181(3):741-6.
7607244	Muller U, Buckel W: Activation of (R)-2-hydroxyglutaryl-CoA dehydratase from Acidaminococcus fermentans. Eur J Biochem. 1995 Jun 1;230(2):698-704.
8365476	Bendrat K, Muller U, Klees AG, Buckel W: Identification of the gene encoding the activator of (R)-2-hydroxyglutaryl-CoA dehydratase from Acidaminococcus fermentans by gene expression in Escherichia coli. FEBS Lett. 1993 Aug 30;329(3):329-31.

# Drug_Target_41_HGNC_ID:
Not Available

# Drug_Target_41_HPRD_ID:
Not Available

# Drug_Target_41_ID:
5266

# Drug_Target_41_Locus:
Not Available

# Drug_Target_41_Molecular_Weight:
27270

# Drug_Target_41_Name:
Activator of

# Drug_Target_41_Number_of_Residues:
260

# Drug_Target_41_PDB_ID:
1HUX

# Drug_Target_41_Pathway:
Not Available

# Drug_Target_41_Pfam_Domain_Function:
PF01869	BcrAD_BadFG

# Drug_Target_41_Protein_Sequence:
>Activator of
MSIYTLGIDVGSTASKCIILKDGKEIVAKSLVAVGTGTSGPARSISEVLENAHMKKEDMA
FTLATGYGRNSLEGIADKQMSELSCHAMGASFIWPNVHTVIDIGGQDVKVIHVENGTMTN
FQMNDKCAAGTGRFLDVMANILEVKVSDLAELGAKSTKRVAISSTCTVFAESEVISQLSK
GTDKIDIIAGIHRSVASRVIGLANRVGIVKDVVMTGGVAQNYGVRGALEEGLGVEIKTSP
LAQYNGALGAALYAYKKAAK

# Drug_Target_41_Reaction:
Not Available

# Drug_Target_41_Signals:
None

# Drug_Target_41_Specific_Function:
Required for the activation of (R)-2-hydroxyglutaryl-CoA dehydratase. This protein is extremely sensitive towards oxygen

# Drug_Target_41_SwissProt_ID:
P11568

# Drug_Target_41_SwissProt_Name:
HGDC_ACIFV

# Drug_Target_41_Synonyms:
2-hydroxyglutaryl- CoA dehydratase component A
R)-2-hydroxyglutaryl-CoA dehydratase

# Drug_Target_41_Theoretical_pI:
7.97

# Drug_Target_41_Transmembrane_Regions:
None

# Drug_Target_42_Cellular_Location:
Not Available

# Drug_Target_42_Chromosome_Location:
Not Available

# Drug_Target_42_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_42_Essentiality:
Non-Essential

# Drug_Target_42_GenAtlas_ID:
HSPA1A

# Drug_Target_42_GenBank_ID_Gene:
M59828

# Drug_Target_42_GenBank_ID_Protein:
188488

# Drug_Target_42_GeneCard_ID:
HSPA1A

# Drug_Target_42_Gene_Name:
HSPA1A

# Drug_Target_42_Gene_Sequence:
>1926 bp
ATGGCCAAAGCCGCGGCGATCGGCATCGACCTGGGCACCACCTACTCCTGCGTGGGGGTG
TTCCAACACGGCAAGGTGGAGATCATCGCCAACGACCAGGGCAACCGCACCACCCCCAGC
TACGTGGCCTTCACGGACACCGAGCGGCTCATCGGGGATGCGGCCAAGAACCAGGTGGCG
CTGAACCCGCAGAACACCGTGTTTGACGCGAAGCGCCTGATTGGCCGCAAGTTCGGCGAC
CCGGTGGTGCAGTCGGACATGAAGCACTGGCCTTTCCAGGTGATCAACGACGGAGACAAG
CCCAAGGTGCAGGTGAGCTACAAGGGGGAGACCAAGGCATTCTACCCCGAGGAGATCTCG
TCCATGGTGCTGACCAAGATGAAGGAGATCGCCGAGGCGTACCTGGGCTACCCGGTGACC
AACGCGGTGATCACCGTGCCGGCCTACTTCAACGACTCGCAGCGCCAGGCCACCAAGGAT
GCGGGTGTGATCGCGGGGCTCAACGTGCTGCGGATCATCAACGAGCCCACGGCCGCCGCC
ATCGCCTACGGCCTGGACAGAACGGGCAAGGGGGAGCGCAACGTGCTCATCTTTGACCTG
GGCGGGGGCACCTTCGACGTGTCCATCCTGACGATCGACGACGGCATCTTCGAGGTGAAG
GCCACGGCCGGGGACACCCACCTGGGTGGGGAGGACTTTGACAACAGGCTGGTGAACCAC
TTCGTGGAGGAGTTCAAGAGAAAACACAAGAAGGACATCAGCCAGAACAAGCGAGCCGTG
AGGCGGCTGCGCACCGCCTGCGAGAGGGCCAAGAGGACCCTGTCGTCCAGCACCCAGGCC
AGCCTGGAGATCGACTCCCTGTTTGAGGGCATCGACTTCTACACGTCCATCACCAGGGCG
AGGTTCGAGGAGCTGTGCTCCGACCTGTTCCGAAGCACCCTGGAGCCCGTGGAGAAGGCT
CTGCGCGACGCCAAGCTGGACAAGGCCCAGATTCACGACCTGGTCCTGGTCGGGGGCTCC
ACCCGCATCCCCAAGGTGCAGAAGCTGCTGCAGGACTTCTTCAACGGGCGCGACCTGAAC
AAGAGCATCAACCCCGACGAGGCTGTGGCCTACGGGGCGGCGGTGCAGGCGGCCATCCTG
ATGGGGGACAAGTCCGAGAACGTGCAGGACCTGCTGCTGCTGGACGTGGCTCCCCTGTCG
CTGGGGCTGGAGACGGCCGGAGGCGTGATGACTGCCCTGATCAAGCGCAACTCCACCATC
CCCACCAAGCAGACGCAGATCTTCACCACCTACTCCGACAACCAACCCGGGGTGCTGATC
CAGGTGTACGAGGGCGAGAGGGCCATGACGAAAGACAACAATCTGTTGGGGCGCTTCGAG
CTGAGCGGCATCCCTCCGGCCCCCAGGGGCGTGCCCCAGATCGAGGTGACCTTCGACATC
GATGCCAACGGCATCCTGAACGTCACGGCCACGGACAAGAGCACCGGCAAGGCCAACAAG
ATCACCATCACCAACGACAAGGGCCGCCTGAGCAAGGAGGAGATCGAGCGCATGGTGCAG
GAGGCGGAGAAGTACAAAGCGGAGGACGAGGTGCAGCGCGAGAGGGTGTCAGCCAAGAAC
GCCCTGGAGTCCTACGCCTTCAACATGAAGAGCGCCGTGGAGGATGAGGGGCTCAAGGGC
AAGATCAGCGAGGCCGACAAGAAGAAGGTGCTGGACAAGTGTCAAGAGGTCATCTCGTGG
CTGGACGCCAACACCTTGGCCGAGAAGGACGAGTTTGAGCACAAGAGGAAGGAGCTGGAG
CAGGTGTGTAACCCCATCATCAGCGGACTGTACCAGGGTGCCGGTGGTCCCGGGCCTGGG
GGCTTCGGGGCTCAGGGTCCCAAGGGAGGGTCTGGGTCAGGCCCCACCATTGAGGAGGTA
GATTAG

# Drug_Target_42_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_42_General_References:
10216320	Osipiuk J, Walsh MA, Freeman BC, Morimoto RI, Joachimiak A: Structure of a new crystal form of human Hsp70 ATPase domain. Acta Crystallogr D Biol Crystallogr. 1999 May;55(Pt 5):1105-7.
14574404	Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, Wilming L, Jones MC, Horton R, Hunt SE, Scott CE, Gilbert JG, Clamp ME, Bethel G, Milne S, Ainscough R, Almeida JP, Ambrose KD, Andrews TD, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beare DM, Beasley H, Beasley O, Bird CP, Blakey S, Bray-Allen S, Brook J, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Clark SY, Clark G, Clee CM, Clegg S, Cobley V, Collier RE, Collins JE, Colman LK, Corby NR, Coville GJ, Culley KM, Dhami P, Davies J, Dunn M, Earthrowl ME, Ellington AE, Evans KA, Faulkner L, Francis MD, Frankish A, Frankland J, French L, Garner P, Garnett J, Ghori MJ, Gilby LM, Gillson CJ, Glithero RJ, Grafham DV, Grant M, Gribble S, Griffiths C, Griffiths M, Hall R, Halls KS, Hammond S, Harley JL, Hart EA, Heath PD, Heathcott R, Holmes SJ, Howden PJ, Howe KL, Howell GR, Huckle E, Humphray SJ, Humphries MD, Hunt AR, Johnson CM, Joy AA, Kay M, Keenan SJ, Kimberley AM, King A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd CR, Lloyd DM, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, Maslen GL, Matthews L, McCann OT, McLaren SJ, McLay K, McMurray A, Moore MJ, Mullikin JC, Niblett D, Nickerson T, Novik KL, Oliver K, Overton-Larty EK, Parker A, Patel R, Pearce AV, Peck AI, Phillimore B, Phillips S, Plumb RW, Porter KM, Ramsey Y, Ranby SA, Rice CM, Ross MT, Searle SM, Sehra HK, Sheridan E, Skuce CD, Smith S, Smith M, Spraggon L, Squares SL, Steward CA, Sycamore N, Tamlyn-Hall G, Tester J, Theaker AJ, Thomas DW, Thorpe A, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, White SS, Whitehead SL, Whittaker H, Wild A, Willey DJ, Wilmer TE, Wood JM, Wray PW, Wyatt JC, Young L, Younger RM, Bentley DR, Coulson A, Durbin R, Hubbard T, Sulston JE, Dunham I, Rogers J, Beck S: The DNA sequence and analysis of human chromosome 6. Nature. 2003 Oct 23;425(6960):805-11.
1700760	Milner CM, Campbell RD: Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics. 1990;32(4):242-51.
2538825	Sargent CA, Dunham I, Trowsdale J, Campbell RD: Human major histocompatibility complex contains genes for the major heat shock protein HSP70. Proc Natl Acad Sci U S A. 1989 Mar;86(6):1968-72.
3786141	Drabent B, Genthe A, Benecke BJ: In vitro transcription of a human hsp 70 heat shock gene by extracts prepared from heat-shocked and non-heat-shocked human cells. Nucleic Acids Res. 1986 Nov 25;14(22):8933-48.
3931075	Hunt C, Morimoto RI: Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6455-9.

# Drug_Target_42_HGNC_ID:
HGNC:5232

# Drug_Target_42_HPRD_ID:
06784

# Drug_Target_42_ID:
1549

# Drug_Target_42_Locus:
6p21.3

# Drug_Target_42_Molecular_Weight:
70053

# Drug_Target_42_Name:
Heat shock 70 kDa protein 1

# Drug_Target_42_Number_of_Residues:
641

# Drug_Target_42_PDB_ID:
1S3X

# Drug_Target_42_Pathway:
Not Available

# Drug_Target_42_Pfam_Domain_Function:
PF00012	HSP70

# Drug_Target_42_Protein_Sequence:
>Heat shock 70 kDa protein 1
MAKAAAIGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVA
LNPQNTVFDAKRLIGRKFGDPVVQSDMKHWPFQVINDGDKPKVQVSYKGETKAFYPEEIS
SMVLTKMKEIAEAYLGYPVTNAVITVPAYFNDSQRQATKDAGVIAGLNVLRIINEPTAAA
IAYGLDRTGKGERNVLIFDLGGGTFDVSILTIDDGIFEVKATAGDTHLGGEDFDNRLVNH
FVEEFKRKHKKDISQNKRAVRRLRTACERAKRTLSSSTQASLEIDSLFEGIDFYTSITRA
RFEELCSDLFRSTLEPVEKALRDAKLDKAQIHDLVLVGGSTRIPKVQKLLQDFFNGRDLN
KSINPDEAVAYGAAVQAAILMGDKSENVQDLLLLDVAPLSLGLETAGGVMTALIKRNSTI
PTKQTQIFTTYSDNQPGVLIQVYEGERAMTKDNNLLGRFELSGIPPAPRGVPQIEVTFDI
DANGILNVTATDKSTGKANKITITNDKGRLSKEEIERMVQEAEKYKAEDEVQRERVSAKN
ALESYAFNMKSAVEDEGLKGKISEADKKKVLDKCQEVISWLDANTLAEKDEFEHKRKELE
QVCNPIISGLYQGAGGPGPGGFGAQGPKGGSGSGPTIEEVD

# Drug_Target_42_Reaction:
Not Available

# Drug_Target_42_Signals:
None

# Drug_Target_42_Specific_Function:
In cooperation with other chaperones, Hsp70s stabilize preexistent proteins against aggregation and mediate the folding of newly translated polypeptides in the cytosol as well as within organelles. These chaperones participate in all these processes through their ability to recognize nonnative conformations of other proteins. They bind extended peptide segments with a net hydrophobic character exposed by polypeptides during translation and membrane translocation, or following stress-induced damage

# Drug_Target_42_SwissProt_ID:
P08107

# Drug_Target_42_SwissProt_Name:
HSP71_HUMAN

# Drug_Target_42_Synonyms:
HSP70-1/HSP70-2
HSP70.1

# Drug_Target_42_Theoretical_pI:
5.31

# Drug_Target_42_Transmembrane_Regions:
None

# Drug_Target_43_Cellular_Location:
Not Available

# Drug_Target_43_Chromosome_Location:
Not Available

# Drug_Target_43_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_43_Essentiality:
Non-Essential

# Drug_Target_43_GenAtlas_ID:
GALK1

# Drug_Target_43_GenBank_ID_Gene:
U26401

# Drug_Target_43_GenBank_ID_Protein:
Not Available

# Drug_Target_43_GeneCard_ID:
Not Available

# Drug_Target_43_Gene_Name:
GALK1

# Drug_Target_43_Gene_Sequence:
>1179 bp
ATGGCTGCTTTGAGACAGCCCCAGGTCGCGGAGCTGCTGGCCGAGGCCCGGCGAGCCTTC
CGGGAGGAGTTCGGGGCCGAGCCCGAGCTGGCCGTGTCAGCGCCGGGCCGCGTCAACCTC
ATCGGGGAACACACGGACTACAACCAGGGCCTGGTGCTGCCTATGGCTCTGGAGCTCATG
ACGGTGCTGGTGGGCAGCCCCCGCAAGGATGGGCTGGTGTCTCTCCTCACCACCTCTGAG
GGTGCCGATGAGCCCCAGCGGCTGCAGTTTCCACTGCCCACAGCCCAGCGCTCGCTGGAG
CCTGGGACTCCTCGGTGGGCCAACTATGTCAAGGGAGTGATTCAGTACTACCCAGCTGCC
CCCCTCCCTGGCTTCAGTGCAGTGGTGGTCAGCTCAGTGCCCCTGGGGGGTGGCCTGTCC
AGCTCAGCATCCTTGGAAGTGGCCACGTACACCTTCCTCCAGCAGCTCTGTCCAGACTCG
GGCACAATAGCTGCCCGCGCCCAGGTGTGTCAGCAGGCCGAGCACAGCTTCGCAGGGATG
CCCTGTGGCATCATGGACCAGTTCATCTCACTTATGGGACAGAAAGGCCACGCGCTGCTC
ATTGACTGCAGGTCCTTGGAGACCAGCCTGGTGCCACTCTCGGACCCCAAGCTGGCCGTG
CTCATCACCAACTCTAATGTCCGCCACTCCCTGGCCTCCAGCGAGTACCCTGTGCGGCGG
CGCCAATGTGAAGAAGTGGCCCGGGCGCTGGGCAAGGAAAGCCTCCGGGAGGTACAACTG
GAAGAGCTAGAGGCTGCCAGGGACCTGGTGAGCAAAGAGGGCTTCCGGCGGGCCCGGCAC
GTGGTGGGGGAGATTCGGCGCACGGCCCAGGCAGCGGCCGCCCTGAGACGTGGCGACTAC
AGAGCCTTTGGCCGCCTCATGGTGGAGAGCCACCGCTCACTCAGAGACGACTATGAGGTG
AGCTGCCCAGAGCTGGACCAGCTGGTGGAGGCTGCGCTTGCTGTGCCTGGGGTTTATGGC
AGCCGCATGACGGGCGGTGGCTTCGGTGGCTGCACGGTGACACTGCTGGAGGCCTCCGCT
GCTCCCCACGCCATGCGGCACATCCAGGAGCACTACGGCGGGACTGCCACCTTCTACCTC
TCTCAAGCAGCCGATGGAGCCAAGGTGCTGTGCTTGTGA

# Drug_Target_43_General_Function:
Involved in galactokinase activity

# Drug_Target_43_General_References:
10521295	Kalaydjieva L, Perez-Lezaun A, Angelicheva D, Onengut S, Dye D, Bosshard NU, Jordanova A, Savov A, Yanakiev P, Kremensky I, Radeva B, Hallmayer J, Markov A, Nedkova V, Tournev I, Aneva L, Gitzelmann R: A founder mutation in the GK1 gene is responsible for galactokinase deficiency in Roma (Gypsies). Am J Hum Genet. 1999 Nov;65(5):1299-307.
11231902	Okano Y, Asada M, Fujimoto A, Ohtake A, Murayama K, Hsiao KJ, Choeh K, Yang Y, Cao Q, Reichardt JK, Niihira S, Imamura T, Yamano T: A genetic factor for age-related cataract: identification and characterization of a novel galactokinase variant, "Osaka," in Asians. Am J Hum Genet. 2001 Apr;68(4):1036-42. Epub 2001 Feb 23.
7542884	Ai Y, Basu M, Bergsma DJ, Stambolian D: Comparison of the enzymatic activities of human galactokinase GALK1 and a related human galactokinase protein GK2. Biochem Biophys Res Commun. 1995 Jul 17;212(2):687-91.
7670469	Stambolian D, Ai Y, Sidjanin D, Nesburn K, Sathe G, Rosenberg M, Bergsma DJ: Cloning of the galactokinase cDNA and identification of mutations in two families with cataracts. Nat Genet. 1995 Jul;10(3):307-12.
8908517	Bergsma DJ, Ai Y, Skach WR, Nesburn K, Anoia E, Van Horn S, Stambolian D: Fine structure of the human galactokinase GALK1 gene. Genome Res. 1996 Oct;6(10):980-5.

# Drug_Target_43_HGNC_ID:
HGNC:4118

# Drug_Target_43_HPRD_ID:
Not Available

# Drug_Target_43_ID:
5646

# Drug_Target_43_Locus:
17q24

# Drug_Target_43_Molecular_Weight:
42273

# Drug_Target_43_Name:
Galactokinase

# Drug_Target_43_Number_of_Residues:
392

# Drug_Target_43_PDB_ID:
1WUU

# Drug_Target_43_Pathway:
Not Available

# Drug_Target_43_Pfam_Domain_Function:
PF00288	GHMP_kinases_N
PF08544	GHMP_kinases_C

# Drug_Target_43_Protein_Sequence:
>Galactokinase
MAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELM
TVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAA
PLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGM
PCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRR
RQCEEVARALGKESLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDY
RAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASA
APHAMRHIQEHYGGTATFYLSQAADGAKVLCL

# Drug_Target_43_Reaction:
Not Available

# Drug_Target_43_Signals:
None

# Drug_Target_43_Specific_Function:
Major enzyme for galactose metabolism

# Drug_Target_43_SwissProt_ID:
P51570

# Drug_Target_43_SwissProt_Name:
GALK1_HUMAN

# Drug_Target_43_Synonyms:
EC 2.7.1.6
Galactose kinase

# Drug_Target_43_Theoretical_pI:
6.42

# Drug_Target_43_Transmembrane_Regions:
None

# Drug_Target_44_Cellular_Location:
Not Available

# Drug_Target_44_Chromosome_Location:
Not Available

# Drug_Target_44_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_44_Essentiality:
Non-Essential

# Drug_Target_44_GenAtlas_ID:
DTYMK

# Drug_Target_44_GenBank_ID_Gene:
X54729

# Drug_Target_44_GenBank_ID_Protein:
37206

# Drug_Target_44_GeneCard_ID:
DTYMK

# Drug_Target_44_Gene_Name:
DTYMK

# Drug_Target_44_Gene_Sequence:
>636 bp
ATGGCGGCCCGGCGCGGGGCTCTCATAGTGCTGGAGGGCGTGGACCGCGCCGGGAAGAGC
ACGCAGAGCCGCAAGCTGGTGGAAGCGCTGTCGCGCGGGCCACCGCCCGAACTGCTCCGG
TTCCCGGAAAGATCAACTGAAATCGGCAAACTTCTGAGTTCCTACTTGCAAAAGAAAAGT
GACGTGGAGGATCACTCGGTGCACCTGCTTTTTTCTGCAAATCGCTGGGAACAAGTGCCG
TTAATTAAGGAAAAGTTGAGCCAGGGCGTGACCCTCGTCGTGGACAGATACGCATTTTCT
GGTGTGGCCTTCACCGGTGCCAAGGAGAATTTTTCCCTAGACTGGTGTAAACAGCCAGAC
GTGGGCCTTCCCAAACCCGACCTGGTCCTGTTCCTCCAGTTACAGCTGGCGGATGCTGCC
AAGCGGGGAGCGTTTGGCCATGAGCGCTATGAGAACGGGGCTTTCCAGGAGCGGGCGCTC
CGGTGTTTCCACCAGCTCATGAAAGACACGACTTTGAACTGGAAGATGGTGGATGCTTCC
AAAAGACTCGAAGCTGTCCATGAGGAACTCCGCGTGCTCTCTGAGGACGCCATCCGCACT
GCCACAGAGAAGCCGCTGGGGGAGCTATGGAAGTGA

# Drug_Target_44_General_Function:
Nucleotide transport and metabolism

# Drug_Target_44_General_References:
2017365	Su JY, Sclafani RA: Molecular cloning and expression of the human deoxythymidylate kinase gene in yeast. Nucleic Acids Res. 1991 Feb 25;19(4):823-7.
8024690	Huang SH, Tang A, Drisco B, Zhang SQ, Seeger R, Li C, Jong A: Human dTMP kinase: gene expression and enzymatic activity coinciding with cell cycle progression and cell growth. DNA Cell Biol. 1994 May;13(5):461-71.

# Drug_Target_44_HGNC_ID:
HGNC:3061

# Drug_Target_44_HPRD_ID:
01773

# Drug_Target_44_ID:
2254

# Drug_Target_44_Locus:
2q37.3

# Drug_Target_44_Molecular_Weight:
23820

# Drug_Target_44_Name:
Thymidylate kinase

# Drug_Target_44_Number_of_Residues:
212

# Drug_Target_44_PDB_ID:
1E9A

# Drug_Target_44_Pathway:
Methotrexate Pathway	SMP00432

# Drug_Target_44_Pfam_Domain_Function:
PF02223	Thymidylate_kin

# Drug_Target_44_Protein_Sequence:
>Thymidylate kinase
MAARRGALIVLEGVDRAGKSTQSRKLVEALCAAGHRAELLRFPERSTEIGKLLSSYLQKK
SDVEDHSVHLLFSANRWEQVPLIKEKLSQGVTLVVDRYAFSGVAFTGAKENFSLDWCKQP
DVGLPKPDLVLFLQLQLADAAKRGAFGHERYENGAFQERALRCFHQLMKDTTLNWKMVDA
SKSIEAVHEDIRVLSEDAIRTATEKPLGELWK

# Drug_Target_44_Reaction:
ATP + dTMP = ADP + dTDP

# Drug_Target_44_Signals:
None

# Drug_Target_44_Specific_Function:
Catalyzes the conversion of dTMP to dTDP

# Drug_Target_44_SwissProt_ID:
P23919

# Drug_Target_44_SwissProt_Name:
KTHY_HUMAN

# Drug_Target_44_Synonyms:
EC 2.7.4.9
dTMP kinase

# Drug_Target_44_Theoretical_pI:
8.49

# Drug_Target_44_Transmembrane_Regions:
None

# Drug_Target_45_Cellular_Location:
Not Available

# Drug_Target_45_Chromosome_Location:
Not Available

# Drug_Target_45_Drug_References:
Not Available

# Drug_Target_45_Essentiality:
Non-Essential

# Drug_Target_45_GenAtlas_ID:
Not Available

# Drug_Target_45_GenBank_ID_Gene:
X01666

# Drug_Target_45_GenBank_ID_Protein:
Not Available

# Drug_Target_45_GeneCard_ID:
Not Available

# Drug_Target_45_Gene_Name:
gshB

# Drug_Target_45_Gene_Sequence:
>951 bp
ATGATCAAGCTCGGCATCGTGATGGACCCCATCGCAAACATCAACATCAAGAAAGATTCC
AGTTTTGCTATGTTGCTGGAAGCACAGCGTCGTGGTTACGAACTTCACTATATGGAGATG
GGCGATCTGTATCTGATCAATGGTGAAGCCCGCGCCCATACCCGCACGCTGAACGTGAAG
CAGAACTACGAAGAGTGGTTTTCGTTCGTCGGTGAACAGGATCTGCCGCTGGCCGATCTC
GATGTGATCCTGATGCGTAAAGACCCGCCGTTTGATACCGAGTTTATCTACGCGACCTAT
ATTCTGGAACGTGCCGAAGAGAAAGGGACGCTGATCGTTAACAAGCCGCAGAGCCTGCGC
GACTGTAACGAGAAACTGTTTACCGCCTGGTTCTCTGACTTAACGCCAGAAACGCTGGTT
ACGCGCAATAAAGCGCAGCTAAAAGCGTTCTGGGAGAAACACAGCGACATCATTCTTAAG
CCGCTGGACGGTATGGGCGGCGCGTCGATTTTCCGCGTGAAAGAAGGCGATCCAAACCTC
GGCGTGATTGCCGAAACCCTGACTGAGCATGGCACTCGCTACTGCATGGCGCAAAATTAC
CTGCCAGCCATTAAAGATGGCGACAAACGCGTGCTGGTGGTGGATGGCGAGCCGGTACCG
TACTGCCTGGCGCGTATTCCGCAGGGGGGCGAAACCCGTGGCAATCTGGCTGCCGGTGGT
CGCGGTGAACCTCGTCCGCTGACGGAAAGTGACTGGAAAATCGCCCGTCAGATCGGGCCG
ACGCTGAAAGAAAAAGGGCTGATTTTTGTTGGTCTGGATATCATCGGCGACCGTCTGACT
GAAATTAACGTCACCAGCCCAACCTGTATTCGTGAGATTGAAGCAGAGTTTCCGGTGTCG
ATCACCGGAATGTTAATGGATGCCATCGAAGCACGTTTACAGCAGCAGTAA

# Drug_Target_45_General_Function:
Involved in catalytic activity

# Drug_Target_45_General_References:
1540581	Tanaka T, Kato H, Nishioka T, Oda J: Mutational and proteolytic studies on a flexible loop in glutathione synthetase from Escherichia coli B: the loop and arginine 233 are critical for the catalytic reaction. Biochemistry. 1992 Mar 3;31(8):2259-65.
3042775	Kato H, Tanaka T, Nishioka T, Kimura A, Oda J: Role of cysteine residues in glutathione synthetase from Escherichia coli B. Chemical modification and oligonucleotide site-directed mutagenesis. J Biol Chem. 1988 Aug 25;263(24):11646-51.
6393055	Gushima H, Yasuda S, Soeda E, Yokota M, Kondo M, Kimura A: Complete nucleotide sequence of the E. coli glutathione synthetase gsh-II. Nucleic Acids Res. 1984 Dec 21;12(24):9299-307.
8241129	Tanaka T, Yamaguchi H, Kato H, Nishioka T, Katsube Y, Oda J: Flexibility impaired by mutations revealed the multifunctional roles of the loop in glutathione synthetase. Biochemistry. 1993 Nov 23;32(46):12398-404.
8445637	Yamaguchi H, Kato H, Hata Y, Nishioka T, Kimura A, Oda J, Katsube Y: Three-dimensional structure of the glutathione synthetase from Escherichia coli B at 2.0 A resolution. J Mol Biol. 1993 Feb 20;229(4):1083-100.
9010922	Matsuda K, Mizuguchi K, Nishioka T, Kato H, Go N, Oda J: Crystal structure of glutathione synthetase at optimal pH: domain architecture and structural similarity with other proteins. Protein Eng. 1996 Dec;9(12):1083-92.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_45_HGNC_ID:
Not Available

# Drug_Target_45_HPRD_ID:
Not Available

# Drug_Target_45_ID:
5269

# Drug_Target_45_Locus:
Not Available

# Drug_Target_45_Molecular_Weight:
35561

# Drug_Target_45_Name:
Glutathione synthetase

# Drug_Target_45_Number_of_Residues:
316

# Drug_Target_45_PDB_ID:
2GLT

# Drug_Target_45_Pathway:
Not Available

# Drug_Target_45_Pfam_Domain_Function:
PF02951	GSH-S_N
PF02955	GSH-S_ATP

# Drug_Target_45_Protein_Sequence:
>Glutathione synthetase
MIKLGIVMDPIANINIKKDSSFAMLLEAQRRGYELHYMEMGDLYLINGEARAHTRTLNVK
QNYEEWFSFVGEQDLPLADLDVILMRKDPPFDTEFIYATYILERAEEKGTLIVNKPQSLR
DCNEKLFTAWFSDLTPETLVTRNKAQLKAFWEKHSDIILKPLDGMGGASIFRVKEGDPNL
GVIAETLTEHGTRYCMAQNYLPAIKDGDKRVLVVDGEPVPYCLARIPQGGETRGNLAAGG
RGEPRPLTESDWKIARQIGPTLKEKGLIFVGLDIIGDRLTEINVTSPTCIREIEAEFPVS
ITGMLMDAIEARLQQQ

# Drug_Target_45_Reaction:
Not Available

# Drug_Target_45_Signals:
None

# Drug_Target_45_Specific_Function:
ATP + gamma-L-glutamyl-L-cysteine + glycine = ADP + phosphate + glutathione

# Drug_Target_45_SwissProt_ID:
P04425

# Drug_Target_45_SwissProt_Name:
GSHB_ECOLI

# Drug_Target_45_Synonyms:
EC 6.3.2.3
GSH synthetase
GSH-S
GSHase
Glutathione synthase

# Drug_Target_45_Theoretical_pI:
4.85

# Drug_Target_45_Transmembrane_Regions:
None

# Drug_Target_46_Cellular_Location:
Cytoplasm

# Drug_Target_46_Chromosome_Location:
Not Available

# Drug_Target_46_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_46_Essentiality:
Non-Essential

# Drug_Target_46_GenAtlas_ID:
RFK

# Drug_Target_46_GenBank_ID_Gene:
AK002011

# Drug_Target_46_GenBank_ID_Protein:
7023634

# Drug_Target_46_GeneCard_ID:
RFK

# Drug_Target_46_Gene_Name:
RFK

# Drug_Target_46_Gene_Sequence:
>489 bp
ATGCCCCGAGCGGACTGCATTATGAGGCACCTGCCTTACTTCTGCCGGGGTCAAGTGGTG
CGGGGCTTCGGCCGCGGCTCCAAGCAGCTGGGCATCCCCACAGCTAATTTTCCTGAGCAA
GTGGTAGATAATCTTCCAGCTGATATATCCACTGGTATTTACTATGGTTGGGCCAGTGTT
GGAAGTGGAGATGTCCATAAGATGGTGGTGAGCATAGGATGGAACCCATATTACAAGAAT
ACGAAGAAGTCTATGGAAACACATATCATGCATACCTTCAAAGAGGACTTCTATGGGGAA
ATCCTCAGTGTGGCCATTGTTGGCTACCTGAGACCAGAAAAGAACTTTGATTCTTTAGAG
TCACTTATTTCAGCAATTCAAGGTGATATTGAAGAAGCTAAGAAACGACTAGAGTTACCA
GAACATTTGAAAATCAAAGAAGACAATTTCTTCCAGGTTTCTAAAAGCAAAATAATGAAT
GGCCACTGA

# Drug_Target_46_General_Function:
Coenzyme transport and metabolism

# Drug_Target_46_General_References:
12623014	Karthikeyan S, Zhou Q, Mseeh F, Grishin NV, Osterman AL, Zhang H: Crystal structure of human riboflavin kinase reveals a beta barrel fold and a novel active site arch. Structure. 2003 Mar;11(3):265-73.

# Drug_Target_46_HGNC_ID:
HGNC:30324

# Drug_Target_46_HPRD_ID:
17969

# Drug_Target_46_ID:
408

# Drug_Target_46_Locus:
9q21.13

# Drug_Target_46_Molecular_Weight:
18410

# Drug_Target_46_Name:
Riboflavin kinase

# Drug_Target_46_Number_of_Residues:
162

# Drug_Target_46_PDB_ID:
1Q9S

# Drug_Target_46_Pathway:
Not Available

# Drug_Target_46_Pfam_Domain_Function:
PF01687	Flavokinase

# Drug_Target_46_Protein_Sequence:
>Riboflavin kinase
MPRADCIMRHLPYFCRGQVVRGFGRGSKQLGIPTANFPEQVVDNLPADISTGIYYGWASV
GSGDVHKMVVSIGWNPYYKNTKKSMETHIMHTFKEDFYGEILNVAIVGYLRPEKNFDSLE
SLISAIQGDIEEAKKRLELPEHLKIKEDNFFQVSKSKIMNGH

# Drug_Target_46_Reaction:
ATP + riboflavin = ADP + FMN

# Drug_Target_46_Signals:
None

# Drug_Target_46_Specific_Function:
Catalyzes the phosphorylation of riboflavin (vitamin B2) to form flavin-mononucleotide (FMN)

# Drug_Target_46_SwissProt_ID:
Q969G6

# Drug_Target_46_SwissProt_Name:
RIFK_HUMAN

# Drug_Target_46_Synonyms:
ATP:riboflavin 5'-phosphotransferase
EC 2.7.1.26
Flavokinase

# Drug_Target_46_Theoretical_pI:
8.22

# Drug_Target_46_Transmembrane_Regions:
None

# Drug_Target_47_Cellular_Location:
Nucleus

# Drug_Target_47_Chromosome_Location:
Not Available

# Drug_Target_47_Drug_References:
Not Available

# Drug_Target_47_Essentiality:
Non-Essential

# Drug_Target_47_GenAtlas_ID:
PMS2

# Drug_Target_47_GenBank_ID_Gene:
U13696

# Drug_Target_47_GenBank_ID_Protein:
Not Available

# Drug_Target_47_GeneCard_ID:
Not Available

# Drug_Target_47_Gene_Name:
PMS2

# Drug_Target_47_Gene_Sequence:
>2589 bp
ATGGAGCGAGCTGAGAGCTCGAGTACAGAACCTGCTAAGGCCATCAAACCTATTGATCGG
AAGTCAGTCCATCAGATTTGCTCTGGGCAGGTGGTACTGAGTCTAAGCACTGCGGTAAAG
GAGTTAGTAGAAAACAGTCTGGATGCTGGTGCCACTAATATTGATCTAAAGCTTAAGGAC
TATGGAGTGGATCTTATTGAAGTTTCAGACAATGGATGTGGGGTAGAAGAAGAAAACTTC
GAAGGCTTAACTCTGAAACATCACACATCTAAGATTCAAGAGTTTGCCGACCTAACTCAG
GTTGAAACTTTTGGCTTTCGGGGGGAAGCTCTGAGCTCACTTTGTGCACTGAGCGATGTC
ACCATTTCTACCTGCCACGCATCGGCGAAGGTTGGAACTCGACTGATGTTTGATCACAAT
GGGAAAATTATCCAGAAAACCCCCTACCCCCGCCCCAGAGGGACCACAGTCAGCGTGCAG
CAGTTATTTTCCACACTACCTGTGCGCCATAAGGAATTTCAAAGGAATATTAAGAAGGAG
TATGCCAAAATGGTCCAGGTCTTACATGCATACTGTATCATTTCAGCAGGCATCCGTGTA
AGTTGCACCAATCAGCTTGGACAAGGAAAACGACAGCCTGTGGTATGCACAGGTGGAAGC
CCCAGCATAAAGGAAAATATCGGCTCTGTGTTTGGGCAGAAGCAGTTGCAAAGCCTCATT
CCTTTTGTTCAGCTGCCCCCTAGTGACTCCGTGTGTGAAGAGTACGGTTTGAGCTGTTCG
GATGCTCTGCATAATCTTTTTTACATCTCAGGTTTCATTTCACAATGCACGCATGGAGTT
GGAAGGAGTTCAACAGACAGACAGTTTTTCTTTATCAACCGGCGGCCTTGTGACCCAGCA
AAGGTCTGCAGACTCGTGAATGAGGTCTACCACATGTATAATCGACACCAGTATCCATTT
GTTGTTCTTAACATTTCTGTTGATTCAGAATGCGTTGATATCAATGTTACTCCAGATAAA
AGGCAAATTTTGCTACAAGAGGAAAAGCTTTTGTTGGCAGTTTTAAAGACCTCTTTGATA
GGAATGTTTGATAGTGATGTCAACAAGCTAAATGTCAGTCAGCAGCCACTGCTGGATGTT
GAAGGTAACTTAATAAAAATGCATGCAGCGGATTTGGAAAAGCCCATGGTAGAAAAGCAG
GATCAATCCCCTTCATTAAGGACTGGAGAAGAAAAAAAAGACGTGTCCATTTCCAGACTG
CGAGAGGCCTTTTCTCTTCGTCACACAACAGAGAACAAGCCTCACAGCCCAAAGACTCCA
GAACCAAGAAGGAGCCCTCTAGGACAGAAAAGGGGTATGCTGTCTTCTAGCACTTCAGGT
GCCATCTCTGACAAAGGCGTCCTGAGACCTCAGAAAGAGGCAGTGAGTTCCAGTCACGGA
CCCAGTGACCCTACGGACAGAGCGGAGGTGGAGAAGGACTCGGGGCACGGCAGCACTTCC
GTGGATTCTGAGGGGTTCAGCATCCCAGACACGGGCAGTCACTGCAGCAGCGAGTATGCG
GCCAGCTCCCCAGGGGACAGGGGCTCGCAGGAACATGTGGACTCTCAGGAGAAAGCGCCT
GAAACTGACGACTCTTTTTCAGATGTGGACTGCCATTCAAACCAGGAAGATACCGGATGT
AAATTTCGAGTTTTGCCTCAGCCAACTAATCTCGCAACCCCAAACACAAAGCGTTTTAAA
AAAGAAGAAATTCTTTCCAGTTCTGACATTTGTCAAAAGTTAGTAAATACTCAGGACATG
TCAGCCTCTCAGGTTGATGTAGCTGTGAAAATTAATAAGAAAGTTGTGCCCCTGGACTTT
TCTATGAGTTCTTTAGCTAAACGAATAAAGCAGTTACATCATGAAGCACAGCAAAGTGAA
GGGGAACAGAATTACAGGAAGTTTAGGGCAAAGATTTGTCCTGGAGAAAATCAAGCAGCC
GAAGATGAACTAAGAAAAGAGATAAGTAAAACGATGTTTGCAGAAATGGAAATCATTGGT
CAGTTTAACCTGGGATTTATAATAACCAAACTGAATGAGGATATCTTCATAGTGGACCAG
CATGCCACGGACGAGAAGTATAACTTCGAGATGCTGCAGCAGCACACCGTGCTCCAGGGG
CAGAGGCTCATAGCACCTCAGACTCTCAACTTAACTGCTGTTAATGAAGCTGTTCTGATA
GAAAATCTGGAAATATTTAGAAAGAATGGCTTTGATTTTGTTATCGATGAAAATGCTCCA
GTCACTGAAAGGGCTAAACTGATTTCCTTGCCAACTAGTAAAAACTGGACCTTCGGACCC
CAGGACGTCGATGAACTGATCTTCATGCTGAGCGACAGCCCTGGGGTCATGTGCCGGCCT
TCCCGAGTCAAGCAGATGTTTGCCTCCAGAGCCTGCCGGAAGTCGGTGATGATTGGGACT
GCTCTTAACACAAGCGAGATGAAGAAACTGATCACCCACATGGGGGAGATGGACCACCCC
TGGAACTGTCCCCATGGAAGGCCAACCATGAGACACATCGCCAACCTGGGTGTCATTTCT
CAGAACTGA

# Drug_Target_47_General_Function:
Involved in ATP binding

# Drug_Target_47_General_References:
10480359	Wang Q, Lasset C, Desseigne F, Saurin JC, Maugard C, Navarro C, Ruano E, Descos L, Trillet-Lenoir V, Bosset JF, Puisieux A: Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer. Hum Genet. 1999 Jul-Aug;105(1-2):79-85.
10783165	Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J: BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 2000 Apr 15;14(8):927-39.
11793469	Yuan ZQ, Gottlieb B, Beitel LK, Wong N, Gordon PH, Wang Q, Puisieux A, Foulkes WD, Trifiro M: Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms. Hum Mutat. 2002 Feb;19(2):108-13.
7661930	Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, Krush AJ, Berk T, Cohen Z, Tetu B, et al.: The molecular basis of Turcot's syndrome. N Engl J Med. 1995 Mar 30;332(13):839-47.
8072530	Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, et al.: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 1994 Sep 1;371(6492):75-80.
9419979	Miyaki M, Nishio J, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Nagato M, Chong JM, Koike M, Terada T, Kawahara Y, Fukutome A, Tomiyama J, Chuganji Y, Momoi M, Utsunomiya J: Drastic genetic instability of tumors and normal tissues in Turcot syndrome. Oncogene. 1997 Dec 4;15(23):2877-81.

# Drug_Target_47_HGNC_ID:
HGNC:9122

# Drug_Target_47_HPRD_ID:
Not Available

# Drug_Target_47_ID:
4838

# Drug_Target_47_Locus:
7p22.2

# Drug_Target_47_Molecular_Weight:
95799

# Drug_Target_47_Name:
PMS1 protein homolog 2

# Drug_Target_47_Number_of_Residues:
862

# Drug_Target_47_PDB_ID:
1H7U

# Drug_Target_47_Pathway:
Not Available

# Drug_Target_47_Pfam_Domain_Function:
PF01119	DNA_mis_repair
PF02518	HATPase_c
PF08676	MutL_C

# Drug_Target_47_Protein_Sequence:
>PMS1 protein homolog 2
MERAESSSTEPAKAIKPIDRKSVHQICSGQVVLSLSTAVKELVENSLDAGATNIDLKLKD
YGVDLIEVSDNGCGVEEENFEGLTLKHHTSKIQEFADLTQVETFGFRGEALSSLCALSDV
TISTCHASAKVGTRLMFDHNGKIIQKTPYPRPRGTTVSVQQLFSTLPVRHKEFQRNIKKE
YAKMVQVLHAYCIISAGIRVSCTNQLGQGKRQPVVCTGGSPSIKENIGSVFGQKQLQSLI
PFVQLPPSDSVCEEYGLSCSDALHNLFYISGFISQCTHGVGRSSTDRQFFFINRRPCDPA
KVCRLVNEVYHMYNRHQYPFVVLNISVDSECVDINVTPDKRQILLQEEKLLLAVLKTSLI
GMFDSDVNKLNVSQQPLLDVEGNLIKMHAADLEKPMVEKQDQSPSLRTGEEKKDVSISRL
REAFSLRHTTENKPHSPKTPEPRRSPLGQKRGMLSSSTSGAISDKGVLRPQKEAVSSSHG
PSDPTDRAEVEKDSGHGSTSVDSEGFSIPDTGSHCSSEYAASSPGDRGSQEHVDSQEKAP
ETDDSFSDVDCHSNQEDTGCKFRVLPQPTNLATPNTKRFKKEEILSSSDICQKLVNTQDM
SASQVDVAVKINKKVVPLDFSMSSLAKRIKQLHHEAQQSEGEQNYRKFRAKICPGENQAA
EDELRKEISKTMFAEMEIIGQFNLGFIITKLNEDIFIVDQHATDEKYNFEMLQQHTVLQG
QRLIAPQTLNLTAVNEAVLIENLEIFRKNGFDFVIDENAPVTERAKLISLPTSKNWTFGP
QDVDELIFMLSDSPGVMCRPSRVKQMFASRACRKSVMIGTALNTSEMKKLITHMGEMDHP
WNCPHGRPTMRHIANLGVISQN

# Drug_Target_47_Reaction:
Not Available

# Drug_Target_47_Signals:
None

# Drug_Target_47_Specific_Function:
Involved in the repair of mismatches in DNA

# Drug_Target_47_SwissProt_ID:
P54278

# Drug_Target_47_SwissProt_Name:
PMS2_HUMAN

# Drug_Target_47_Synonyms:
DNA mismatch repair protein PMS2

# Drug_Target_47_Theoretical_pI:
6.72

# Drug_Target_47_Transmembrane_Regions:
None

# Drug_Target_48_Cellular_Location:
Secreted protein

# Drug_Target_48_Chromosome_Location:
Not Available

# Drug_Target_48_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_48_Essentiality:
Non-Essential

# Drug_Target_48_GenAtlas_ID:
Not Available

# Drug_Target_48_GenBank_ID_Gene:
X59040

# Drug_Target_48_GenBank_ID_Protein:
505281

# Drug_Target_48_GeneCard_ID:
Not Available

# Drug_Target_48_Gene_Name:
C3

# Drug_Target_48_Gene_Sequence:
>756 bp
ATGAAAGGTTTAAGAAAATCAATTTTATGTTTAGTTTTGTCAGCAGGAGTAATAGCTCCA
GTAACATCTGGGATGATTCAAAGTCCTCAAAAATGTTATGCTTATTCCATTAATCAAAAG
GCTTATTCAAATACTTACCAGGAGTTTACTAATATTGATCAAGCAAAAGCTTGGGGTAAT
GCTCAGTATAAAAAGTATGGACTAAGCAAATCAGAAAAAGAAGCTATAGTATCATATACT
AAAAGCGCTAGTGAAATAAATGGAAAGCTAAGACAAAATAAGGGAGTTATCAATGGATTT
CCTTCAAATTTAATAAAACAAGTTGAACTTTTAGATAAATCTTTTAATAAAATGAAGACC
CCTGAAAATATTATGTTATTTAGAGGCGACGACCCTGCTTATTTAGGAACAGAATTTCAA
AACACTCTTCTTAATTCAAATGGTACAATTAATAAAACGGCTTTTGAAAAGGCTAAAGCT
AAGTTTTTAAATAAAGATAGACTTGAATATGGATATATTAGTACTTCATTAATGAATGTT
TCTCAATTTGCAGGAAGACCAATTATTACAAAATTTAAAGTAGCAAAAGGCTCAAAGGCA
GGATATATTGACCCTATTAGTGCTTTTGCAGGACAACTTGAAATGTTGCTTCCTAGACAT
AGTACTTATCATATAGACGATATGAGATTGTCTTCTGATGGTAAACAAATAATAATTACA
GCAACAATGATGGGCACAGCTATCAATCCTAAATAA

# Drug_Target_48_General_Function:
Involved in protein binding

# Drug_Target_48_General_References:
1910014	Popoff MR, Hauser D, Boquet P, Eklund MW, Gill DM: Characterization of the C3 gene of Clostridium botulinum types C and D and its expression in Escherichia coli. Infect Immun. 1991 Oct;59(10):3673-9.
1917836	Moriishi K, Syuto B, Yokosawa N, Oguma K, Saito M: Purification and characterization of ADP-ribosyltransferases (exoenzyme C3) of Clostridium botulinum type C and D strains. J Bacteriol. 1991 Oct;173(19):6025-9.
2108433	Popoff M, Boquet P, Gill DM, Eklund MW: DNA sequence of exoenzyme C3, an ADP-ribosyltransferase encoded by Clostridium botulinum C and D phages. Nucleic Acids Res. 1990 Mar 11;18(5):1291.

# Drug_Target_48_HGNC_ID:
Not Available

# Drug_Target_48_HPRD_ID:
Not Available

# Drug_Target_48_ID:
2683

# Drug_Target_48_Locus:
Not Available

# Drug_Target_48_Molecular_Weight:
27841

# Drug_Target_48_Name:
Mono-ADP-ribosyltransferase C3

# Drug_Target_48_Number_of_Residues:
251

# Drug_Target_48_PDB_ID:
2BOV

# Drug_Target_48_Pathway:
Not Available

# Drug_Target_48_Pfam_Domain_Function:
PF03496	Binary_toxA

# Drug_Target_48_Protein_Sequence:
>Mono-ADP-ribosyltransferase C3 precursor
MKGLRKSILCLVLSAGVIAPVTSGMIQSPQKCYAYSINQKAYSNTYQEFTNIDQAKAWGN
AQYKKYGLSKSEKEAIVSYTKSASEINGKLRQNKGVINGFPSNLIKQVELLDKSFNKMKT
PENIMLFRGDDPAYLGTEFQNTLLNSNGTINKTAFEKAKAKFLNKDRLEYGYISTSLMNV
SQFAGRPIITKFKVAKGSKAGYIDPISAFAGQLEMLLPRHSTYHIDDMRLSSDGKQIIIT
ATMMGTAINPK

# Drug_Target_48_Reaction:
Not Available

# Drug_Target_48_Signals:
1-40

# Drug_Target_48_Specific_Function:
ADP-ribosylates eukaryotic Rho and Rac proteins on an asparagine residue

# Drug_Target_48_SwissProt_ID:
P15879

# Drug_Target_48_SwissProt_Name:
ARC3_CBDP

# Drug_Target_48_Synonyms:
EC 2.4.2.-
Exoenzyme C3
Mono-ADP-ribosyltransferase C3 precursor

# Drug_Target_48_Theoretical_pI:
10.20

# Drug_Target_48_Transmembrane_Regions:
None

# Drug_Target_49_Cellular_Location:
Cytoplasmic

# Drug_Target_49_Chromosome_Location:
Not Available

# Drug_Target_49_Drug_References:
Not Available

# Drug_Target_49_Essentiality:
Non-Essential

# Drug_Target_49_GenAtlas_ID:
Not Available

# Drug_Target_49_GenBank_ID_Gene:
AE000511

# Drug_Target_49_GenBank_ID_Protein:
Not Available

# Drug_Target_49_GeneCard_ID:
Not Available

# Drug_Target_49_Gene_Name:
clpX

# Drug_Target_49_Gene_Sequence:
>1341 bp
TTAAGGAAGAATTTTAGAATGCGTTTTAGCAATGATCAAAGGTTCAGCCTGTTTTAAAAC
ACAATCTTTAGTGATACGCACTTCCGATCCTTTAAGCTTGGGTAAATCAAACATAATATC
CAAACAAAAATCTTCAATGATCGCCCTTAAGCCCCTAGCCCCGGTTTTTCTTTCTAATGC
GAGTTGAGCGATTTCTTTAATGGCTTCTTCTTCAAAGATCAAATCCACCTCATCCATTTT
GAAAAGCTGCTGGTATTGCTTGATAAGAGCGTTTTTAGGTTTTTGTAAAATATCCACCAT
CGCTTCTAAACTGATGCTATCTAGCGTGCTTAAAACCGGCAAACGGCCAATAAGCTCAGG
GATAAGCCCATAAGTAACCAGGTCATGGGTTTGGACTAAATGCAAGATCGCTTCTTGCTC
TTTTTTGCTCATCTTTTCTTGAGTGAAACCCAACACATTCTGCGTGGTGCGTTTTTTAAT
GATTTCAGCTAACCCATCAAACGCTCCAGCACAAATGAATAAAATATCGCTCGTGTCAAT
TTGAATGAAATTGCCCTCAGGGTGCTTTCTGCCGCCTTTGGGGGGGATATTCACTAAAGA
ACCTTCAACGATTTTCAACAACGCTTGCTGAACGCCCTCGCCAGAAACATCTCTAGTGAT
AGAGCGGTTTTCTGACAAACGGCTGATTTTATCAATCTCATCAATAAACACAATGCCTTT
TTGGGCTTTTTGGACATTCCAGTCGCTCGCTTGCAACAATCTTGTGAGAATATTTTCCAC
GTCTTCGCCCACATAGCCCGCTTCAGTCAAGCTAGTCGCATCGCTAATGGCGATAGGAAT
ATCCAAATGCTTGGCCAGAGTTTGCGCCATTAAAGTTTTGCCTGATCCTGTAGGGCCGAT
TAGTAAAATATTAGACTTGCTCAACTCCACTTCTTCTAAATGCTCTAACTCCACATTGCT
GTCTTGGTTGTCTTGTTTTTTGAGTTTTTCTTTAAAAGATAAGCGTTTGTAATGGTTATA
CACGGCTACGGAAAAAACCTTTTTAGCCTGCTCTTGCCCTATCACATAATTGTCTAAAAC
CGCCTTAAGCTCTTTAGGGGCTGGAATGTAAGAGAGTAAAAACTCTTCTTCATAAGCGCT
AGATTCCATTCTTCTCAATCGGTCTCTTTTGAGCGCCAATAAAGAATTGTCGTATTTGTG
CAATTCCCCATGCATCACATCTATACAATATTCGCACACGCACACATCTTTATTGAGATT
GCTCGCAAAAATAATGCGGCGTTTTTTGGGATCTCTTGATTCTGGTTTTTTGCAAAAACT
GCAATAAAGCGTTTCGTTCAT

# Drug_Target_49_General_Function:
Involved in nucleotide binding

# Drug_Target_49_General_References:
9252185	Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzegerald LM, Lee N, Adams MD, Hickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM, Cotton MD, Weidman JM, Fujii C, Bowman C, Watthey L, Wallin E, Hayes WS, Borodovsky M, Karp PD, Smith HO, Fraser CM, Venter JC: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997 Aug 7;388(6642):539-47.

# Drug_Target_49_HGNC_ID:
Not Available

# Drug_Target_49_HPRD_ID:
Not Available

# Drug_Target_49_ID:
5270

# Drug_Target_49_Locus:
Not Available

# Drug_Target_49_Molecular_Weight:
50354

# Drug_Target_49_Name:
ATP-dependent Clp protease ATP-binding subunit clpX

# Drug_Target_49_Number_of_Residues:
446

# Drug_Target_49_PDB_ID:
1UM8

# Drug_Target_49_Pathway:
Not Available

# Drug_Target_49_Pfam_Domain_Function:
PF07724	AAA_2

# Drug_Target_49_Protein_Sequence:
>ATP-dependent Clp protease ATP-binding subunit clpX
MNETLYCSFCKKPESRDPKKRRIIFASNLNKDVCVCEYCIDVMHGELHKYDNSLLALKRD
RLRRMESSAYEEEFLLSYIPAPKELKAVLDNYVIGQEQAKKVFSVAVYNHYKRLSFKEKL
KKQDNQDSNVELEHLEEVELSKSNILLIGPTGSGKTLMAQTLAKHLDIPIAISDATSLTE
AGYVGEDVENILTRLLQASDWNVQKAQKGIVFIDEIDKISRLSENRSITRDVSGEGVQQA
LLKIVEGSLVNIPPKGGRKHPEGNFIQIDTSDILFICAGAFDGLAEIIKKRTTQNVLGFT
QEKMSKKEQEAILHLVQTHDLVTYGLIPELIGRLPVLSTLDSISLEAMVDILQKPKNALI
KQYQQLFKMDEVDLIFEEEAIKEIAQLALERKTGARGLRAIIEDFCLDIMFDLPKLKGSE
VRITKDCVLKQAEPLIIAKTHSKILP

# Drug_Target_49_Reaction:
Not Available

# Drug_Target_49_Signals:
None

# Drug_Target_49_Specific_Function:
ATP-dependent specificity component of the Clp protease. It directs the protease to specific substrates. Can perform chaperone functions in the absence of clpP (By similarity)

# Drug_Target_49_SwissProt_ID:
O25926

# Drug_Target_49_SwissProt_Name:
CLPX_HELPY

# Drug_Target_49_Synonyms:
Not Available

# Drug_Target_49_Theoretical_pI:
6.44

# Drug_Target_49_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
Not Available

# Drug_Target_4_GenBank_ID_Protein:
Not Available

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
MYH11

# Drug_Target_4_Gene_Sequence:
Not Available

# Drug_Target_4_General_Function:
Not Available

# Drug_Target_4_General_References:
Not Available

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
6999

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
Not Available

# Drug_Target_4_Name:
Myosin-11

# Drug_Target_4_Number_of_Residues:
0

# Drug_Target_4_PDB_ID:
Not Available

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
Not Available

# Drug_Target_4_Protein_Sequence:
Not Available

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
Not Available

# Drug_Target_4_Specific_Function:
Not Available

# Drug_Target_4_SwissProt_ID:
P35749

# Drug_Target_4_SwissProt_Name:
MYH11_HUMAN

# Drug_Target_4_Synonyms:
Not Available

# Drug_Target_4_Theoretical_pI:
Not Available

# Drug_Target_4_Transmembrane_Regions:
Not Available

# Drug_Target_50_Cellular_Location:
Centrosome. Spindle. Note=Localizes on centrosomes in interphase cells and at each spindle pole in m

# Drug_Target_50_Chromosome_Location:
Not Available

# Drug_Target_50_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_50_Essentiality:
Non-Essential

# Drug_Target_50_GenAtlas_ID:
AURKA

# Drug_Target_50_GenBank_ID_Gene:
D84212

# Drug_Target_50_GenBank_ID_Protein:
2641948

# Drug_Target_50_GeneCard_ID:
AURKA

# Drug_Target_50_Gene_Name:
AURKA

# Drug_Target_50_Gene_Sequence:
>1209 bp
ATGGACCGATCTAAAGAAAACTGCATTTCAGGACCTGTTAAGGCTACAGCTCCAGTTGGA
GGTCCAAAACGTGTTCTCGTGACTCAGCAATTTCCTTGTCAGAATCCATTACCTGTAAAT
AGTGGCCAGGCTCAGCGGGTCTTGTGTCCTTCAAATTCTTCCCAGCGCGTTCCTTTGCAA
GCACAAAAGCTTGTCTCCAGTCACAAGCCGGTTCAGAATCAGAAGCAGAAGCAATTGCAG
GCAACCAGTGTACCTCATCCTGTCTCCAGGCCACTGAATAACACCCAAAAGAGCAAGCAG
CCCCTGCCATCGCACCTGAAAATAATCCTGAGGAGGAACTGGCATCAAAACAGAAAAATG
AAGAATCAAAAAGAGGCAGTGGCTTTGGAAGACTTTGAAATTGGTCGCCCTCTGGGTAAA
GGAAAGTTTGGTAATGTTTATTTGGCAAGAGAAAAGCAAAGCAAGTTTATTCTGGCTCTT
AAAGTGTTATTTAAAGCTCAGCTGGAGAAAGCCGGAGTGGAGCATCAGCTCAGAAGAGAA
GTAGAAATACAGTCCCACCTTCGGCATCCTAATATTCTTAGACTGTATGGTTATTTCCAT
GATGCTACCAGAGTCTACCTAATTCTGGAATATGCACCACTTGGAACAGTTTATAGAGAA
CTTCAGAAACTTTCAAAGTTTGATGAGCAGAGAACTGCTAACTTATATAACAGAATTGCA
AATGCCCTGTCTTACTGTCATTCGAAGAGAGTTATTCATAGAGACATTAAGCCAGAGAAC
TTACTTCTTGGATCAGCTGGAGAGCTTAAAATTGCAGATTTTGGGTGGTCAGTACATGCT
CCATCTTCCAGGAGGACCACTCTCTGTGGCACCCTGGACTACCTGCCCCCTGAAATGATT
GAAGGTCGGATGCATGATGAGAAGGTGGATCTCTGGAGCCTTGGAGTTCTTTGCTATGAA
TTTTTAGTTGGGAAGCCTCCTTTTGAGGCAAACACATACCAAGAGACCTACAAAAGAATA
TCACGGGTTGAATTCACATTCCCTGACTTTGTAACAGAGGGAGCCAGGGACCTCATTTCA
AGACTGTTGAAGCATAATCCCAGCCAGAGGCCAATGCTCAGAGAAGTACTTGAACACCCC
TGGATCACAGCAAATTCATCAAAACCATCAAATTGCCAAAACAAAGAATCAGCTAGCAAA
CAGTCTTAG

# Drug_Target_50_General_Function:
Involved in protein kinase activity

# Drug_Target_50_General_References:
11413462	Nigg EA: Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol. 2001 Jan;2(1):21-32.
11780052	Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, Bailey J, Barlow KF, Bates KN, Beard LM, Beare DM, Beasley OP, Bird CP, Blakey SE, Bridgeman AM, Brown AJ, Buck D, Burrill W, Butler AP, Carder C, Carter NP, Chapman JC, Clamp M, Clark G, Clark LN, Clark SY, Clee CM, Clegg S, Cobley VE, Collier RE, Connor R, Corby NR, Coulson A, Coville GJ, Deadman R, Dhami P, Dunn M, Ellington AG, Frankland JA, Fraser A, French L, Garner P, Grafham DV, Griffiths C, Griffiths MN, Gwilliam R, Hall RE, Hammond S, Harley JL, Heath PD, Ho S, Holden JL, Howden PJ, Huckle E, Hunt AR, Hunt SE, Jekosch K, Johnson CM, Johnson D, Kay MP, Kimberley AM, King A, Knights A, Laird GK, Lawlor S, Lehvaslaiho MH, Leversha M, Lloyd C, Lloyd DM, Lovell JD, Marsh VL, Martin SL, McConnachie LJ, McLay K, McMurray AA, Milne S, Mistry D, Moore MJ, Mullikin JC, Nickerson T, Oliver K, Parker A, Patel R, Pearce TA, Peck AI, Phillimore BJ, Prathalingam SR, Plumb RW, Ramsay H, Rice CM, Ross MT, Scott CE, Sehra HK, Shownkeen R, Sims S, Skuce CD, Smith ML, Soderlund C, Steward CA, Sulston JE, Swann M, Sycamore N, Taylor R, Tee L, Thomas DW, Thorpe A, Tracey A, Tromans AC, Vaudin M, Wall M, Wallis JM, Whitehead SL, Whittaker P, Willey DL, Williams L, Williams SA, Wilming L, Wray PW, Hubbard T, Durbin RM, Bentley DR, Beck S, Rogers J: The DNA sequence and comparative analysis of human chromosome 20. Nature. 2001 Dec 20-27;414(6866):865-71.
11790771	Tanaka M, Ueda A, Kanamori H, Ideguchi H, Yang J, Kitajima S, Ishigatsubo Y: Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1. J Biol Chem. 2002 Mar 22;277(12):10719-26. Epub 2002 Jan 14.
12467573	Nowakowski J, Cronin CN, McRee DE, Knuth MW, Nelson CG, Pavletich NP, Rogers J, Sang BC, Scheibe DN, Swanson RV, Thompson DA: Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography. Structure. 2002 Dec;10(12):1659-67.
9153231	Kimura M, Kotani S, Hattori T, Sumi N, Yoshioka T, Todokoro K, Okano Y: Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosophila and yeast Ipl1. J Biol Chem. 1997 May 23;272(21):13766-71.
9514916	Shindo M, Nakano H, Kuroyanagi H, Shirasawa T, Mihara M, Gilbert DJ, Jenkins NA, Copeland NG, Yagita H, Okumura K: cDNA cloning, expression, subcellular localization, and chromosomal assignment of mammalian aurora homologues, aurora-related kinase (ARK) 1 and 2. Biochem Biophys Res Commun. 1998 Mar 6;244(1):285-92.
9771714	Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S: Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet. 1998 Oct;20(2):189-93.

# Drug_Target_50_HGNC_ID:
HGNC:11393

# Drug_Target_50_HPRD_ID:
04066

# Drug_Target_50_ID:
1422

# Drug_Target_50_Locus:
20q13.2-q13.3

# Drug_Target_50_Molecular_Weight:
45810

# Drug_Target_50_Name:
Serine/threonine-protein kinase 6

# Drug_Target_50_Number_of_Residues:
403

# Drug_Target_50_PDB_ID:
2BMC

# Drug_Target_50_Pathway:
Not Available

# Drug_Target_50_Pfam_Domain_Function:
PF00069	Pkinase

# Drug_Target_50_Protein_Sequence:
>Serine/threonine-protein kinase 6
MDRSKENCISGPVKATAPVGGPKRVLVTQQFPCQNPLPVNSGQAQRVLCPSNSSQRVPLQ
AQKLVSSHKPVQNQKQKQLQATSVPHPVSRPLNNTQKSKQPLPSAPENNPEEELASKQKN
EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR
EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL
ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM
IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI
SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS

# Drug_Target_50_Reaction:
ATP + a protein = ADP + a phosphoprotein

# Drug_Target_50_Signals:
None

# Drug_Target_50_Specific_Function:
May play a role in cell cycle regulation during anaphase and/or telophase, in relation to the function of the centrosome/spindle pole region during chromosome segregation. Maybe involved in microtubule formation and/or stabilization. May play a key role during tumor development and progression

# Drug_Target_50_SwissProt_ID:
O14965

# Drug_Target_50_SwissProt_Name:
STK6_HUMAN

# Drug_Target_50_Synonyms:
Aurora kinase A
Aurora-A
Aurora-related kinase 1
Aurora/IPL1-related kinase 1
Breast-tumor-amplified kinase
EC 2.7.11.1
Serine/threonine kinase 15
hARK1

# Drug_Target_50_Theoretical_pI:
9.90

# Drug_Target_50_Transmembrane_Regions:
None

# Drug_Target_51_Cellular_Location:
Cytoplasm

# Drug_Target_51_Chromosome_Location:
Not Available

# Drug_Target_51_Drug_References:
Not Available

# Drug_Target_51_Essentiality:
Non-Essential

# Drug_Target_51_GenAtlas_ID:
Not Available

# Drug_Target_51_GenBank_ID_Gene:
U18997

# Drug_Target_51_GenBank_ID_Protein:
Not Available

# Drug_Target_51_GeneCard_ID:
Not Available

# Drug_Target_51_Gene_Name:
pckA

# Drug_Target_51_Gene_Sequence:
>1623 bp
ATGCGCGTTAACAATGGTTTGACCCCGCAAGAACTCGAGGCTTATGGTATCAGTGACGTA
CATGATATCGTTTACAACCCAAGCTACGACCTGCTGTATCAGGAAGAGCTCGATCCGAGC
CTGACAGGTTATGAGCGCGGGGTGTTAACTAATCTGGGTGCCGTTGCCGTCGATACCGGG
ATCTTCACCGGTCGTTCACCAAAAGATAAGTATATCGTCCGTGACGATACCACTCGCGAT
ACTTTCTGGTGGGCAGACAAAGGCAAAGGTAAGAACGACAACAAACCTCTCTCTCCGGAA
ACCTGGCAGCATCTGAAAGGCCTGGTGACCAGGCAGCTTTCCGGCAAACGTCTGTTCGTT
GTCGACGCTTTCTGTGGTGCGAACCCGGATACTCGTCTTTCCGTCCGTTTCATCACCGAA
GTGGCCTGGCAGGCGCATTTTGTCAAAAACATGTTTATTCGCCCGAGCGATGAAGAACTG
GCAGGTTTCAAACCAGACTTTATCGTTATGAACGGCGCGAAGTGCACTAACCCGCAGTGG
AAAGAACAGGGTCTCAACTCCGAAAACTTCGTGGCGTTTAACCTGACCGAGCGCATGCAG
CTGATTGGCGGCACCTGGTACGGCGGCGAAATGAAGAAAGGGATGTTCTCGATGATGAAC
TACCTGCTGCCGCTGAAAGGTATCGCTTCTATGCACTGCTCCGCCAACGTTGGTGAGAAA
GGCGATGTTGCGGTGTTCTTCGGCCTTTCCGGCACCGGTAAAACCACCCTTTCCACCGAC
CCGAAACGTCGCCTGATTGGCGATGACGAACACGGCTGGGACGATGACGGCGTGTTTAAC
TTCGAAGGCGGCTGCTACGCAAAAACTATCAAGCTGTCGAAAGAAGCGGAACCTGAAATC
TACAACGCTATCCGTCGTGATGCGTTGCTGGAAAACGTCACCGTGCGTGAAGATGGCACT
ATCGACTTTGATGATGGTTCAAAAACCGAGAACACCCGCGTTTCTTATCCGATCTATCAC
ATCGATAACATTGTTAAGCCGGTTTCCAAAGCGGGCCACGCGACTAAGGTTATCTTCCTG
ACTGCTGATGCTTTCGGCGTGTTGCCGCCGGTTTCTCGCCTGACTGCCGATCAAACCCAG
TATCACTTCCTCTCTGGCTTCACCGCCAAACTGGCCGGTACTGAGCGTGGCATCACCGAA
CCGACGCCAACCTTCTCCGCTTGCTTCGGCGCGGCATTCCTGTCGCTGCACCCGACTCAG
TACGCAGAAGTGCTGGTGAAACGTATGCAGGCGGCGGGCGCGCAGGCTTATCTGGTTAAC
ACTGGCTGGAACGGCACTGGCAAACGTATCTCGATTAAAGATACCCGCGCCATTATCGAC
GCCATCCTCAACGGTTCGCTGGATAATGCAGAAACCTTCACTCTGCCGATGTTTAACCTG
GCGATCCCAACCGAACTGCCGGGCGTAGACACGAAGATTCTCGATCCGCGTAACACCTAC
GCTTCTCCGGAACAGTGGCAGGAAAAAGCCGAAACCCTGGCGAAACTGTTTATCGACAAC
TTCGATAAATACACCGACACCCCTGCGGGTGCCGCGCTGGTAGCGGCTGGTCCGAAACTG
TAA

# Drug_Target_51_General_Function:
Involved in phosphoenolpyruvate carboxykinase (ATP) activity

# Drug_Target_51_General_References:
1701430	Medina V, Pontarollo R, Glaeske D, Tabel H, Goldie H: Sequence of the pckA gene of Escherichia coli K-12: relevance to genetic and allosteric regulation and homology of E. coli phosphoenolpyruvate carboxykinase with the enzymes from Trypanosoma brucei and Saccharomyces cerevisiae. J Bacteriol. 1990 Dec;172(12):7151-6.
6292200	Mizuno T, Wurtzel ET, Inouye M: Osmoregulation of gene expression. II. DNA sequence of the envZ gene of the ompB operon of Escherichia coli and characterization of its gene product. J Biol Chem. 1982 Nov 25;257(22):13692-8.
7883719	Hou SY, Chao YP, Liao JC: A mutant phosphoenolpyruvate carboxykinase in Escherichia coli conferring oxaloacetate decarboxylase activity. J Bacteriol. 1995 Mar;177(6):1620-3.
8577250	Ramseier TM, Bledig S, Michotey V, Feghali R, Saier MH Jr: The global regulatory protein FruR modulates the direction of carbon flow in Escherichia coli. Mol Microbiol. 1995 Jun;16(6):1157-69.
8599762	Tari LW, Matte A, Pugazhenthi U, Goldie H, Delbaere LT: Snapshot of an enzyme reaction intermediate in the structure of the ATP-Mg2+-oxalate ternary complex of Escherichia coli PEP carboxykinase. Nat Struct Biol. 1996 Apr;3(4):355-63.
8609605	Matte A, Goldie H, Sweet RM, Delbaere LT: Crystal structure of Escherichia coli phosphoenolpyruvate carboxykinase: a new structural family with the P-loop nucleoside triphosphate hydrolase fold. J Mol Biol. 1996 Feb 16;256(1):126-43.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.
9406547	Tari LW, Matte A, Goldie H, Delbaere LT: Mg(2+)-Mn2+ clusters in enzyme-catalyzed phosphoryl-transfer reactions. Nat Struct Biol. 1997 Dec;4(12):990-4.

# Drug_Target_51_HGNC_ID:
Not Available

# Drug_Target_51_HPRD_ID:
Not Available

# Drug_Target_51_ID:
4794

# Drug_Target_51_Locus:
Not Available

# Drug_Target_51_Molecular_Weight:
59644

# Drug_Target_51_Name:
Phosphoenolpyruvate carboxykinase [ATP]

# Drug_Target_51_Number_of_Residues:
540

# Drug_Target_51_PDB_ID:
1OS1

# Drug_Target_51_Pathway:
Not Available

# Drug_Target_51_Pfam_Domain_Function:
PF01293	PEPCK_ATP

# Drug_Target_51_Protein_Sequence:
>Phosphoenolpyruvate carboxykinase [ATP]
MRVNNGLTPQELEAYGISDVHDIVYNPSYDLLYQEELDPSLTGYERGVLTNLGAVAVDTG
IFTGRSPKDKYIVRDDTTRDTFWWADKGKGKNDNKPLSPETWQHLKGLVTRQLSGKRLFV
VDAFCGANPDTRLSVRFITEVAWQAHFVKNMFIRPSDEELAGFKPDFIVMNGAKCTNPQW
KEQGLNSENFVAFNLTERMQLIGGTWYGGEMKKGMFSMMNYLLPLKGIASMHCSANVGEK
GDVAVFFGLSGTGKTTLSTDPKRRLIGDDEHGWDDDGVFNFEGGCYAKTIKLSKEAEPEI
YNAIRRDALLENVTVREDGTIDFDDGSKTENTRVSYPIYHIDNIVKPVSKAGHATKVIFL
TADAFGVLPPVSRLTADQTQYHFLSGFTAKLAGTERGITEPTPTFSACFGAAFLSLHPTQ
YAEVLVKRMQAAGAQAYLVNTGWNGTGKRISIKDTRAIIDAILNGSLDNAETFTLPMFNL
AIPTELPGVDTKILDPRNTYASPEQWQEKAETLAKLFIDNFDKYTDTPAGAALVAAGPKL

# Drug_Target_51_Reaction:
Not Available

# Drug_Target_51_Signals:
None

# Drug_Target_51_Specific_Function:
ATP + oxaloacetate = ADP + phosphoenolpyruvate + CO(2)

# Drug_Target_51_SwissProt_ID:
P22259

# Drug_Target_51_SwissProt_Name:
PCKA_ECOLI

# Drug_Target_51_Synonyms:
EC 4.1.1.49
PEP carboxykinase
PEPCK
Phosphoenolpyruvate carboxylase

# Drug_Target_51_Theoretical_pI:
5.39

# Drug_Target_51_Transmembrane_Regions:
None

# Drug_Target_52_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_52_Chromosome_Location:
Not Available

# Drug_Target_52_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_52_Essentiality:
Non-Essential

# Drug_Target_52_GenAtlas_ID:
Not Available

# Drug_Target_52_GenBank_ID_Gene:
U00096

# Drug_Target_52_GenBank_ID_Protein:
1786291

# Drug_Target_52_GeneCard_ID:
Not Available

# Drug_Target_52_Gene_Name:
coaE

# Drug_Target_52_Gene_Sequence:
>621 bp
TTACGGTTTTTCCTGTGAGACAAACTGCGACGCAAGCTGCAAATAGTGTGCGTGCAGGCG
GGCAACATCCGATGCGATAGCATCCGGTGCGCCGTTATTATCAATGACGTCATCTGCCAC
GGCAAGGCGGGCTTCGCGCGTTGCCTGAGCAGCAAGGATTTGTTCGACATGCTCGCGAGT
TACATCATCGCGCTGCATGGTGCGCTTAAGTTGCGTTTCTGGGCTGACATCCACCACAAG
CACTCGATTCGCTTTTTTATACAGTGAGTTTTCTACCAGCAATGGCACAACCCACAGTAC
ATAGGGGGAAGTAGCTTGCTGGATCTGGTGTTGCGTCTCTTGCTGAATCAGCGGATGCAG
CAGGGCGTTAAGCCAGTTTTTCTCTTCCGGGTTGGCGAAGATCCGCTCGCGCAAGGCCCG
GCGCTGCAATGTTCCATCAGCAGCAATCATGTTAGCGCCAAAGTGATCAGCAATGGCATG
TAGCGCAGGTGCACCTGGTTCAACCACCTGACGCGCAATAATATCGGCATCAATGACGTT
AATTCCGAGATCAGCAAACGCATTGGCAACGGTACTCTTGCCACTGCCAATGCCTCCCGT
TAAGGCAACTATATACCTCAT

# Drug_Target_52_General_Function:
Coenzyme transport and metabolism

# Drug_Target_52_General_References:
10493123	Fountoulakis M, Takacs MF, Berndt P, Langen H, Takacs B: Enrichment of low abundance proteins of Escherichia coli by hydroxyapatite chromatography. Electrophoresis. 1999 Aug;20(11):2181-95.
11292795	Mishra P, Park PK, Drueckhammer DG: Identification of yacE (coaE) as the structural gene for dephosphocoenzyme A kinase in Escherichia coli K-12. J Bacteriol. 2001 May;183(9):2774-8.
8202364	Fujita N, Mori H, Yura T, Ishihama A: Systematic sequencing of the Escherichia coli genome: analysis of the 2.4-4.1 min (110,917-193,643 bp) region. Nucleic Acids Res. 1994 May 11;22(9):1637-9.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_52_HGNC_ID:
Not Available

# Drug_Target_52_HPRD_ID:
Not Available

# Drug_Target_52_ID:
2270

# Drug_Target_52_Locus:
Not Available

# Drug_Target_52_Molecular_Weight:
22622

# Drug_Target_52_Name:
Dephospho-CoA kinase

# Drug_Target_52_Number_of_Residues:
206

# Drug_Target_52_PDB_ID:
1VIY

# Drug_Target_52_Pathway:
Not Available

# Drug_Target_52_Pfam_Domain_Function:
PF01121	CoaE

# Drug_Target_52_Protein_Sequence:
>Dephospho-CoA kinase
MRYIVALTGGIGSGKSTVANAFADLGINVIDADIIARQVVEPGAPALHAIADHFGANMIA
ADGTLQRRALRERIFANPEEKNWLNALLHPLIQQETQHQIQQATSPYVLWVVPLLVENSL
YKKANRVLVVDVSPETQLKRTMQRDDVTREHVEQILAAQATREARLAVADDVIDNNGAPD
AIASDVARLHAHYLQLASQFVSQEKP

# Drug_Target_52_Reaction:
ATP + dephospho-CoA = ADP + CoA

# Drug_Target_52_Signals:
None

# Drug_Target_52_Specific_Function:
Catalyzes the phosphorylation of the 3'-hydroxyl group of dephosphocoenzyme A to form coenzyme A

# Drug_Target_52_SwissProt_ID:
P0A6I9

# Drug_Target_52_SwissProt_Name:
COAE_ECOLI

# Drug_Target_52_Synonyms:
Dephosphocoenzyme A kinase
EC 2.7.1.24

# Drug_Target_52_Theoretical_pI:
6.15

# Drug_Target_52_Transmembrane_Regions:
None

# Drug_Target_53_Cellular_Location:
Cell junction

# Drug_Target_53_Chromosome_Location:
Not Available

# Drug_Target_53_Drug_References:
Not Available

# Drug_Target_53_Essentiality:
Non-Essential

# Drug_Target_53_GenAtlas_ID:
PTK2

# Drug_Target_53_GenBank_ID_Gene:
L13616

# Drug_Target_53_GenBank_ID_Protein:
Not Available

# Drug_Target_53_GeneCard_ID:
Not Available

# Drug_Target_53_Gene_Name:
PTK2

# Drug_Target_53_Gene_Sequence:
>3159 bp
ATGGCAGCTGCTTACCTTGACCCCAACTTGAATCACACACCAAATTCGAGTACTAAGACT
CACCTGGGTACTGGTATGGAACGTTCTCCTGGTGCAATGGAGCGAGTATTAAAGGTCTTT
CATTATTTTGAAAGCAATAGTGAGCCAACCACCTGGGCCAGTATTATCAGGCATGGAGAT
GCTACTGATGTCAGGGGCATCATTCAGAAGATAGTGGACAGTCACAAAGTAAAGCATGTG
GCCTGCTATGGATTCCGCCTCAGTCACCTGCGGTCAGAGGAGGTTCACTGGCTTCACGTG
GATATGGGCGTCTCCAGTGTGAGGGAGAAGTATGAGCTTGCTCACCCACCAGAGGAGTGG
AAATATGAATTGAGAATTCGTTATTTGCCAAAAGGATTTCTAAACCAGTTTACTGAAGAT
AAGCCAACTTTGAATTTCTTCTATCAACAGGTGAAGAGCGATTATATGTTAGAGATAGCT
GATCAAGTGGACCAGGAAATTGCTTTGAAGTTGGGTTGTCTAGAAATACGGCGATCATAC
TGGGAGATGCGGGGCAATGCACTAGAAAAGAAGTCTAACTATGAAGTATTAGAAAAAGAT
GTTGGTTTAAAGCGATTTTTTCCTAAGAGTTTACTGGATTCTGTCAAGGCCAAAACACTA
AGAAAACTGATCCAACAAACATTTAGACAATTTGCCAACCTTAATAGAGAAGAAAGTATT
CTGAAATTCTTTGAGATCCTGTCTCCAGTCTACAGATTTGATAAGGAATGCTTCAAGTGT
GCTCTTGGTTCAAGCTGGATTATTTCAGTGGAACTGGCAATCGGCCCAGAAGAAGGAATC
AGTTACCTAACGGACAAGGGCTGCAATCCCACACATCTTGCTGACTTCACTCAAGTGCAA
ACCATTCAGTATTCAAACAGTGAAGACAAGGACAGAAAAGGAATGCTACAACTAAAAATA
GCAGGTGCACCCGAGCCTCTGACAGTGACGGCACCATCCCTAACCATTGCGGAGAATATG
GCTGACCTAATAGATGGGTACTGCCGGCTGGTGAATGGAACCTCGCAGTCATTTATCATC
AGACCTCAGAAAGAAGGTGAACGGGCTTTGCCATCAATACCAAAGTTGGCCAACAGCGAA
AAGCAAGGCATGCGGACACACGCCGTCTCTGTGTCAGAAACAGATGATTATGCTGAGATT
ATAGATGAAGAAGATACTTACACCATGCCCTCAACCAGGGATTATGAGATTCAAAGAGAA
AGAATAGAACTTGGACGATGTATTGGAGAAGGCCAATTTGGAGATGTACATCAAGGCATT
TATATGAGTCCAGAGAATCCAGCTTTGGCGGTTGCAATTAAAACATGTAAAAACTGTACT
TCGGACAGCGTGAGAGAGAAATTTCTTCAAGAAGCCTTAACAATGCGTCAGTTTGACCAT
CCTCATATTGTGAAGCTGATTGGAGTCATCACAGAGAATCCTGTCTGGATAATCATGGAG
CTGTGCACACTTGGAGAGCTGAGGTCATTTTTGCAAGTAAGGAAATACAGTTTGGATCTA
GCATCTTTGATCCTGTATGCCTATCAGCTTAGTACAGCTCTTGCATATCTAGAGAGCAAA
AGATTTGTACACAGGGACATTGCTGCTCGGAATGTTCTGGTGTCCTCAAATGATTGTGTA
AAATTAGGAGACTTTGGATTATCCCGATATATGGAAGATAGTACTTACTACAAAGCTTCC
AAAGGAAAATTGCCTATTAAATGGATGGCTCCAGAGTCAATCAATTTTCGACGTTTTACC
TCAGCTAGTGACGTATGGATGTTTGGTGTGTGTATGTGGGAGATACTGATGCATGGTGTG
AAGCCTTTTCAAGGAGTGAAGAACAATGATGTAATCGGTCGAATTGAAAATGGGGAAAGA
TTACCAATGCCTCCAAATTGTCCTCCTACCCTCTACAGCCTTATGACGAAATGCTGGGCC
TATGACCCCAGCAGGCGGCCCAGGTTTACTGAACTTAAAGCTCAGCTCAGCACAATCCTG
GAGGAAGAGAAGGCTCAGCAAGAAGAGCGCATGAGGATGGAGTCCAGAAGACAGGCCACA
GTGTCCTGGGACTCCGGAGGGTCTGATGAAGCACCGCCCAAGCCCAGCAGACCGGGTTAT
CCCAGTCCGAGGTCCAGCGAAGGATTTTATCCCAGCCCACAGCACATGGTACAAACCAAT
CATTACCAGGTTTCTGGCTACCCTGGTTCACATGGAATCACAGCCATGGCTGGCAGCATC
TATCCAGGTCAGGCATCTCTTTTGGACCAAACAGATTCATGGAATCATAGACCTCAGGAG
ATAGCAATGTGGCAGCCCAATGTGGAGGACTCTACAGTATTGGACCTGCGAGGGATTGGG
CAAGTGTTGCCAACCCATCTGATGGAAGAGCGTCTAATCCGACAGCAACAGGAAATGGAA
GAAGATCAGCGCTGGCTGGAAAAAGAGGAAAGATTTCTGAAACCTGATGTGAGACTCTCT
CGAGGCAGTATTGACAGGGAGGATGGAAGTCTTCAGGGTCCGATTGGAAACCAACATATA
TATCAGCCTGTGGGTAAACCAGATCCTGCAGCTCCACCAAAGAAACCGCCTCGCCCTGGA
GCTCCCGGTCATCTGGGAAGCCTTGCCAGCCTCAGCAGCCCTGCTGACAGCTACAACGAG
GGTGTCAAGCTTCAGCCCCAGGAAATCAGCCCCCCTCCTACTGCCAACCTGGACCGGTCG
AATGATAAGGTGTACGAGAATGTGACGGGCCTGGTGAAAGCTGTCATCGAGATGTCCAGT
AAAATCCAGCCAGCCCCACCAGAGGAGTATGTCCCTATGGTGAAGGAAGTCGGCTTGGCC
CTGAGGACATTATTGGCCACTGTGGATGAGACCATTCCCCTCCTACCAGCCAGCACCCAC
CGAGAGATTGAGATGGCACAGAAGCTATTGAACTCTGACCTGGGTGAGCTCATCAACAAG
ATGAAACTGGCCCAGCAGTATGTCATGACCAGCCTCCAGCAAGAGTACAAAAAGCAAATG
CTGACTGCTGCTCACGCCCTGGCTGTGGATGCCAAAAACTTACTCGATGTCATTGACCAA
GCAAGACTGAAAATGCTTGGGCAGACGAGACCACACTGA

# Drug_Target_53_General_Function:
Involved in protein-tyrosine kinase activity

# Drug_Target_53_General_References:
12387730	Relou IA, Bax LA, van Rijn HJ, Akkerman JW: Site-specific phosphorylation of platelet focal adhesion kinase by low-density lipoprotein. Biochem J. 2003 Jan 15;369(Pt 2):407-16.
7692878	Whitney GS, Chan PY, Blake J, Cosand WL, Neubauer MG, Aruffo A, Kanner SB: Human T and B lymphocytes express a structurally conserved focal adhesion kinase, pp125FAK. DNA Cell Biol. 1993 Nov;12(9):823-30.
8247543	Lee ST, Strunk KM, Spritz RA: A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes. Oncogene. 1993 Dec;8(12):3403-10.
8422239	Andre E, Becker-Andre M: Expression of an N-terminally truncated form of human focal adhesion kinase in brain. Biochem Biophys Res Commun. 1993 Jan 15;190(1):140-7.

# Drug_Target_53_HGNC_ID:
HGNC:9611

# Drug_Target_53_HPRD_ID:
Not Available

# Drug_Target_53_ID:
5271

# Drug_Target_53_Locus:
8q24-qter

# Drug_Target_53_Molecular_Weight:
119234

# Drug_Target_53_Name:
Focal adhesion kinase 1

# Drug_Target_53_Number_of_Residues:
1052

# Drug_Target_53_PDB_ID:
1MP8

# Drug_Target_53_Pathway:
Not Available

# Drug_Target_53_Pfam_Domain_Function:
PF03623	Focal_AT
PF07714	Pkinase_Tyr

# Drug_Target_53_Protein_Sequence:
>Focal adhesion kinase 1
MAAAYLDPNLNHTPNSSTKTHLGTGMERSPGAMERVLKVFHYFESNSEPTTWASIIRHGD
ATDVRGIIQKIVDSHKVKHVACYGFRLSHLRSEEVHWLHVDMGVSSVREKYELAHPPEEW
KYELRIRYLPKGFLNQFTEDKPTLNFFYQQVKSDYMLEIADQVDQEIALKLGCLEIRRSY
WEMRGNALEKKSNYEVLEKDVGLKRFFPKSLLDSVKAKTLRKLIQQTFRQFANLNREESI
LKFFEILSPVYRFDKECFKCALGSSWIISVELAIGPEEGISYLTDKGCNPTHLADFTQVQ
TIQYSNSEDKDRKGMLQLKIAGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGTSQSFII
RPQKEGERALPSIPKLANSEKQGMRTHAVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRE
RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH
PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK
RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT
SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA
YDPSRRPRFTELKAQLSTILEEEKAQQEERMRMESRRQATVSWDSGGSDEAPPKPSRPGY
PSPRSSEGFYPSPQHMVQTNHYQVSGYPGSHGITAMAGSIYPGQASLLDQTDSWNHRPQE
IAMWQPNVEDSTVLDLRGIGQVLPTHLMEERLIRQQQEMEEDQRWLEKEERFLKPDVRLS
RGSIDREDGSLQGPIGNQHIYQPVGKPDPAAPPKKPPRPGAPGHLGSLASLSSPADSYNE
GVKLQPQEISPPPTANLDRSNDKVYENVTGLVKAVIEMSSKIQPAPPEEYVPMVKEVGLA
LRTLLATVDETIPLLPASTHREIEMAQKLLNSDLGELINKMKLAQQYVMTSLQQEYKKQM
LTAAHALAVDAKNLLDVIDQARLKMLGQTRPH

# Drug_Target_53_Reaction:
Not Available

# Drug_Target_53_Signals:
None

# Drug_Target_53_Specific_Function:
Non-receptor protein-tyrosine kinase implicated in signaling pathways involved in cell motility, proliferation and apoptosis. Activated by tyrosine-phosphorylation in response to either integrin clustering induced by cell adhesion or antibody cross-linking, or via G-protein coupled receptor (GPCR) occupancy by ligands such as bombesin or lysophosphatidic acid, or via LDL receptor occupancy. Plays a potential role in oncogenic transformations resulting in increased kinase activity

# Drug_Target_53_SwissProt_ID:
Q05397

# Drug_Target_53_SwissProt_Name:
FAK1_HUMAN

# Drug_Target_53_Synonyms:
EC 2.7.10.2
FADK 1
Protein- tyrosine kinase 2
pp125FAK

# Drug_Target_53_Theoretical_pI:
6.61

# Drug_Target_53_Transmembrane_Regions:
None

# Drug_Target_54_Cellular_Location:
Not Available

# Drug_Target_54_Chromosome_Location:
Not Available

# Drug_Target_54_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_54_Essentiality:
Non-Essential

# Drug_Target_54_GenAtlas_ID:
Not Available

# Drug_Target_54_GenBank_ID_Gene:
X14112

# Drug_Target_54_GenBank_ID_Protein:
59524

# Drug_Target_54_GeneCard_ID:
Not Available

# Drug_Target_54_Gene_Name:
TK

# Drug_Target_54_Gene_Sequence:
>1131 bp
TCAGTTAGCCTCCCCCATCTCCCGGGCAAACGTGCGCGCCAGGTCGCAGATCGTCGGTAT
GGAGCCTGGGGTGGTGACGTGGGTCTGGACCATCCCGGAGGTAAGTTGCAGCAGGGCGTC
CCGGCAGCCGGCGGGCGATTGGTCGTAATCCAGGATAAAGACATGCATGGGACGGAGGCG
TTTGGCCAAGACGTCCAAAGCCCAGGCAAACACGTTATACAGGTCGCCGTTGGGGGCCAG
CAACTCGGGGGCCCGAAACAGGGTAAATAACGTGTCCCCGATATGGGGTCGTGGGCCCGC
GTTGCTCTGGGGCTCGGCACCCTGGGGCGGCACGGCCGCCCCCGAAAGCTGTCCCCAATC
CTCCCGCCACGACCCGCCGCCCTGCAGATACCGCACCGTATTGGCAAGCAGCCCATAAAC
GCGGCGAATCGCGGCCAGCATAGCCAGGTCAAGCCGCTCGCCGGGGCGCTGGCGTTTGGC
CAGGCGGTCGATGTGTCTGTCCTCCGGAAGGGCCCCCAACACGATGTTTGTGCCGGGCAA
GGTCGGCGGGATGAGGGCCACGAACGCCAGCACGGCCTGGGGGGTCATGCTGCCCATAAG
GTATCGCGCGGCCGGGTAGCACAGGAGGGCGGCGATGGGATGGCGGTCGAAGATGAGGGT
GAGGGCCGGGGGCGGGGCATGTGAGCTCCCAGCCTCCCCCCCGATATGAGGAGCCAGAAC
GGCGTCGGTCACGGCATAAGGCATGCCCATTGTTATCTGGGCGCTTGTCATTACCACCGC
CGCGTCCCCGGCCGATATCTCACCCTGGTCGAGGCGGTGTTGTGTGGTGTAGATGTTCGC
GATTGTCTCGGAAGCCCCCAACACCCGCCAGTAAGTCATCGGCTCGGGTACGTAGACGAT
ATCGTCGCGCGAACCCAGGGCCACCAGCAGTTGCGTGGTGGTGGTTTTCCCCATCCCGTG
GGGACCGTCTATATAAACCCGCAGTAGCGTGGGCATTTTCTGCTCCAGGCGGACTTCCGT
GGCTTTTTGTTGCCGGCGAGGGCGCAACGCCGTACGTCGGTTGTTATGGCCGCGAGAACG
CGCAGCCTGGTCGAACGCAGACGCGTGTTGATGGCAGGGGTACGAAGCCAT

# Drug_Target_54_General_Function:
Involved in thymidine kinase activity

# Drug_Target_54_General_References:
2839594	McGeoch DJ, Dalrymple MA, Davison AJ, Dolan A, Frame MC, McNab D, Perry LJ, Scott JE, Taylor P: The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol. 1988 Jul;69 ( Pt 7):1531-74.
6258156	McKnight SL: The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene. Nucleic Acids Res. 1980 Dec 20;8(24):5949-64.
7552712	Brown DG, Visse R, Sandhu G, Davies A, Rizkallah PJ, Melitz C, Summers WC, Sanderson MR: Crystal structures of the thymidine kinase from herpes simplex virus type-1 in complex with deoxythymidine and ganciclovir. Nat Struct Biol. 1995 Oct;2(10):876-81.
7628623	Wild K, Bohner T, Aubry A, Folkers G, Schulz GE: The three-dimensional structure of thymidine kinase from herpes simplex virus type 1. FEBS Lett. 1995 Jul 17;368(2):289-92.
9336833	Wild K, Bohner T, Folkers G, Schulz GE: The structures of thymidine kinase from herpes simplex virus type 1 in complex with substrates and a substrate analogue. Protein Sci. 1997 Oct;6(10):2097-106.
9715911	Champness JN, Bennett MS, Wien F, Visse R, Summers WC, Herdewijn P, de Clerq E, Ostrowski T, Jarvest RL, Sanderson MR: Exploring the active site of herpes simplex virus type-1 thymidine kinase by X-ray crystallography of complexes with aciclovir and other ligands. Proteins. 1998 Aug 15;32(3):350-61.
9989588	Bennett MS, Wien F, Champness JN, Batuwangala T, Rutherford T, Summers WC, Sun H, Wright G, Sanderson MR: Structure to 1.9 A resolution of a complex with herpes simplex virus type-1 thymidine kinase of a novel, non-substrate inhibitor: X-ray crystallographic comparison with binding of aciclovir. FEBS Lett. 1999 Jan 25;443(2):121-5.

# Drug_Target_54_HGNC_ID:
Not Available

# Drug_Target_54_HPRD_ID:
Not Available

# Drug_Target_54_ID:
2559

# Drug_Target_54_Locus:
-

# Drug_Target_54_Molecular_Weight:
40973

# Drug_Target_54_Name:
Thymidine kinase

# Drug_Target_54_Number_of_Residues:
376

# Drug_Target_54_PDB_ID:
1OF1

# Drug_Target_54_Pathway:
Not Available

# Drug_Target_54_Pfam_Domain_Function:
PF00693	Herpes_TK

# Drug_Target_54_Protein_Sequence:
>Thymidine kinase
MASYPCHQHASAFDQAARSRGHNNRRTALRPRRQQEATEVRPEQKMPTLLRVYIDGPHGM
GKTTTTQLLVALGSRDDIVYVPEPMTYWRVLGASETIANIYTTQHRLDQGEISAGDAAVV
MTSAQITMGMPYAVTDAVLAPHIGGEAGSSHAPPPALTLIFDRHPIAALLCYPAARYLMG
SMTPQAVLAFVALIPPTLPGTNIVLGALPEDRHIDRLAKRQRPGERLDLAMLAAIRRVYG
LLANTVRYLQCGGSWREDWGQLSGTAVPPQGAEPQSNAGPRPHIGDTLFTLFRAPELLAP
NGDLYNVFAWALDVLAKRLRSMHVFILDYDQSPAGCRDALLQLTSGMVQTHVTTPGSIPT
ICDLARTFAREMGEAN

# Drug_Target_54_Reaction:
ATP + thymidine = ADP + thymidine 5'-phosphate

# Drug_Target_54_Signals:
None

# Drug_Target_54_Specific_Function:
In latent infection, may allow the virus to be reactivated and to grow in cells lacking a high concentration of phosphorylated nucleic acid precursors, such as nerve cells that do not replicate their genome

# Drug_Target_54_SwissProt_ID:
P03176

# Drug_Target_54_SwissProt_Name:
KITH_HHV11

# Drug_Target_54_Synonyms:
EC 2.7.1.21

# Drug_Target_54_Theoretical_pI:
7.96

# Drug_Target_54_Transmembrane_Regions:
None

# Drug_Target_55_Cellular_Location:
Not Available

# Drug_Target_55_Chromosome_Location:
Not Available

# Drug_Target_55_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_55_Essentiality:
Non-Essential

# Drug_Target_55_GenAtlas_ID:
Not Available

# Drug_Target_55_GenBank_ID_Gene:
Not Available

# Drug_Target_55_GenBank_ID_Protein:
Not Available

# Drug_Target_55_GeneCard_ID:
Not Available

# Drug_Target_55_Gene_Name:
ABCE1

# Drug_Target_55_Gene_Sequence:
Not Available

# Drug_Target_55_General_Function:
Not Available

# Drug_Target_55_General_References:
Not Available

# Drug_Target_55_HGNC_ID:
Not Available

# Drug_Target_55_HPRD_ID:
Not Available

# Drug_Target_55_ID:
7126

# Drug_Target_55_Locus:
Not Available

# Drug_Target_55_Molecular_Weight:
Not Available

# Drug_Target_55_Name:
ATP-binding cassette sub-family E member 1

# Drug_Target_55_Number_of_Residues:
0

# Drug_Target_55_PDB_ID:
Not Available

# Drug_Target_55_Pathway:
Not Available

# Drug_Target_55_Pfam_Domain_Function:
Not Available

# Drug_Target_55_Protein_Sequence:
Not Available

# Drug_Target_55_Reaction:
Not Available

# Drug_Target_55_Signals:
Not Available

# Drug_Target_55_Specific_Function:
Not Available

# Drug_Target_55_SwissProt_ID:
P61221

# Drug_Target_55_SwissProt_Name:
ABCE1_HUMAN

# Drug_Target_55_Synonyms:
Not Available

# Drug_Target_55_Theoretical_pI:
Not Available

# Drug_Target_55_Transmembrane_Regions:
Not Available

# Drug_Target_56_Cellular_Location:
Lysosome (Probable). Cytoplasmic granule. Note=Matrix of eosinophil's large specific granule

# Drug_Target_56_Chromosome_Location:
Not Available

# Drug_Target_56_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_56_Essentiality:
Non-Essential

# Drug_Target_56_GenAtlas_ID:
RNASE2

# Drug_Target_56_GenBank_ID_Gene:
M30510

# Drug_Target_56_GenBank_ID_Protein:
181955

# Drug_Target_56_GeneCard_ID:
RNASE2

# Drug_Target_56_Gene_Name:
RNASE2

# Drug_Target_56_Gene_Sequence:
>486 bp
ATGGTTCCAAAACTGTTCACTTCCCAAATTTGTCTGCTTCTTCTGTTGGGGCTTCTGGCT
GTGGAGGGCTCACTCCATGTCAAACCTCCACAGTTTACCTGGGCTCAATGGTTTGAAACC
CAGCACATCAATATGACCTCCCAGCAATGCACCAATGCAATGCAGGTCATTAACAATTAT
CAACGGCGATGCAAAAACCAAAATACTTTCCTTCTTACAACTTTTGCTAACGTAGTTAAT
GTTTGTGGTAACCCAAATATGACCTGTCCTAGTAACAAAACTCGCAAAAATTGTCACCAC
AGTGGAAGCCAGGTGCCTTTAATCCACTGTAACCTCACAACTCCAAGTCCACAGAATATT
TCAAACTGCAGGTATGCGCAGACACCAGCAAACATGTTCTATATAGTTGCATGTGACAAC
AGAGATCAACGACGAGACCCTCCACAGTATCCGGTGGTTCCAGTTCACCTGGATAGAATC
ATCTAA

# Drug_Target_56_General_Function:
Involved in nucleic acid binding

# Drug_Target_56_General_References:
11102386	Zhang J, Rosenberg HF: Sequence variation at two eosinophil-associated ribonuclease loci in humans. Genetics. 2000 Dec;156(4):1949-58.
11154698	Leonidas DD, Boix E, Prill R, Suzuki M, Turton R, Minson K, Swaminathan GJ, Youle RJ, Acharya KR: Mapping the ribonucleolytic active site of eosinophil-derived neurotoxin (EDN). High resolution crystal structures of EDN complexes with adenylic nucleotide inhibitors. J Biol Chem. 2001 May 4;276(18):15009-17. Epub 2001 Jan 11.
12855582	Yang D, Rosenberg HF, Chen Q, Dyer KD, Kurosaka K, Oppenheim JJ: Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood. 2003 Nov 1;102(9):3396-403. Epub 2003 Jul 10.
1587793	Sakakibara R, Hashida K, Kitahara T, Ishiguro M: Characterization of a unique nonsecretory ribonuclease from urine of pregnant women. J Biochem (Tokyo). 1992 Mar;111(3):325-30.
2387583	Hamann KJ, Ten RM, Loegering DA, Jenkins RB, Heise MT, Schad CR, Pease LR, Gleich GJ, Barker RL: Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily. Genomics. 1990 Aug;7(4):535-46.
2591744	Hamann KJ, Barker RL, Loegering DA, Pease LR, Gleich GJ: Sequence of human eosinophil-derived neurotoxin cDNA: identity of deduced amino acid sequence with human nonsecretory ribonucleases. Gene. 1989 Nov 15;83(1):161-7.
2734298	Rosenberg HF, Tenen DG, Ackerman SJ: Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4460-4.
2745977	Barker RL, Loegering DA, Ten RM, Hamann KJ, Pease LR, Gleich GJ: Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases. J Immunol. 1989 Aug 1;143(3):952-5.
3166997	Beintema JJ, Hofsteenge J, Iwama M, Morita T, Ohgi K, Irie M, Sugiyama RH, Schieven GL, Dekker CA, Glitz DG: Amino acid sequence of the nonsecretory ribonuclease of human urine. Biochemistry. 1988 Jun 14;27(12):4530-8.
3182786	Sorrentino S, Tucker GK, Glitz DG: Purification and characterization of a ribonuclease from human liver. J Biol Chem. 1988 Nov 5;263(31):16125-31.
3458170	Gleich GJ, Loegering DA, Bell MP, Checkel JL, Ackerman SJ, McKean DJ: Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci U S A. 1986 May;83(10):3146-50.
3926759	Niwata Y, Ohgi K, Sanda A, Takizawa Y, Irie M: Purification and properties of bovine kidney ribonucleases. J Biochem (Tokyo). 1985 Mar;97(3):923-34.
7547911	de Beer T, Vliegenthart JF, Loffler A, Hofsteenge J: The hexopyranosyl residue that is C-glycosidically linked to the side chain of tryptophan-7 in human RNase Us is alpha-mannopyranose. Biochemistry. 1995 Sep 19;34(37):11785-9.
7947762	Hofsteenge J, Muller DR, de Beer T, Loffler A, Richter WJ, Vliegenthart JF: New type of linkage between a carbohydrate and a protein: C-glycosylation of a specific tryptophan residue in human RNase Us. Biochemistry. 1994 Nov 22;33(46):13524-30.
8759319	Mosimann SC, Newton DL, Youle RJ, James MN: X-ray crystallographic structure of recombinant eosinophil-derived neurotoxin at 1.83 A resolution. J Mol Biol. 1996 Jul 26;260(4):540-52.
9450956	Krieg J, Hartmann S, Vicentini A, Glasner W, Hess D, Hofsteenge J: Recognition signal for C-mannosylation of Trp-7 in RNase 2 consists of sequence Trp-x-x-Trp. Mol Biol Cell. 1998 Feb;9(2):301-9.

# Drug_Target_56_HGNC_ID:
HGNC:10045

# Drug_Target_56_HPRD_ID:
00577

# Drug_Target_56_ID:
2390

# Drug_Target_56_Locus:
14q24-q31

# Drug_Target_56_Molecular_Weight:
18354

# Drug_Target_56_Name:
Nonsecretory ribonuclease

# Drug_Target_56_Number_of_Residues:
161

# Drug_Target_56_PDB_ID:
1K2A

# Drug_Target_56_Pathway:
Not Available

# Drug_Target_56_Pfam_Domain_Function:
PF00074	RnaseA

# Drug_Target_56_Protein_Sequence:
>Nonsecretory ribonuclease precursor
MVPKLFTSQICLLLLLGLLAVEGSLHVKPPQFTWAQWFETQHINMTSQQCTNAMQVINNY
QRRCKNQNTFLLTTFANVVNVCGNPNMTCPSNKTRKNCHHSGSQVPLIHCNLTTPSPQNI
SNCRYAQTPANMFYIVACDNRDQRRDPPQYPVVPVHLDRII

# Drug_Target_56_Reaction:
Endonucleolytic cleavage to nucleoside 3'-phosphates and 3'-phosphooligonucleotides ending in Cp or Up with 2',3'-cyclic phosphate intermediates REFERENCE 1 AUTHORS Anfinsen, C.B. and White, F.H., Jr. TITLE The ribonucleases: occurrence, structure, and properties. JOURNAL In: Boyer, P.D., Lardy, H. and Myrback, K. (Eds.), The Enzymes, 2nd ed., vol. 5, Academic Press, New York, 1961, p. 95-122. REFERENCE 2 [PMID:14247667] AUTHORS BEARD JR, RAZZELL WE. TITLE PURIFICATION OF ALKALINE RIBONUCLEASE II FROM MITOCHONDRIAL AND SOLUBLE FRACTIONS OF LIVER. JOURNAL J. Biol. Chem. 239 (1964) 4186-93. ORGANISM pig [GN:ssc], rat [GN:rno], cow [GN:bta]

# Drug_Target_56_Signals:
1-27

# Drug_Target_56_Specific_Function:
This is a non-secretory ribonuclease. It is a pyrimidine specific nuclease with a slight preference for U. Cytotoxin and helminthotoxin. Selectively chemotactic for dendritic cells. Possesses a wide variety of biological activities

# Drug_Target_56_SwissProt_ID:
P10153

# Drug_Target_56_SwissProt_Name:
RNAS2_HUMAN

# Drug_Target_56_Synonyms:
EC 3.1.27.5
Eosinophil-derived neurotoxin
Nonsecretory ribonuclease precursor
RNase 2
RNase UpI-2
Ribonuclease 2
Ribonuclease US

# Drug_Target_56_Theoretical_pI:
8.83

# Drug_Target_56_Transmembrane_Regions:
None

# Drug_Target_57_Cellular_Location:
Not Available

# Drug_Target_57_Chromosome_Location:
Not Available

# Drug_Target_57_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_57_Essentiality:
Non-Essential

# Drug_Target_57_GenAtlas_ID:
MAPKAPK2

# Drug_Target_57_GenBank_ID_Gene:
U12779

# Drug_Target_57_GenBank_ID_Protein:
530090

# Drug_Target_57_GeneCard_ID:
MAPKAPK2

# Drug_Target_57_Gene_Name:
MAPKAPK2

# Drug_Target_57_Gene_Sequence:
>1113 bp
ATGCTGTCCAACTCCCAGGGCCAGAGCCCGCCGGTGCCGTTCCCCGCCCCGGCCCCGCCG
CCGCAGCCCCCCACCCCTGCCCTGCCGCACCCCCCGGCGCAGCCGCCGCCGCCGCCCCCG
CAGCAGTTCCCGCAGTTCCACGTCAAGTCCGGCCTGCAGATCAAGAAGAACGCCATCATC
GATGACTACAAGGTCACCAGCCAGGTCCTGGGGCTGGGCATCAACGGCAAAGTTTTGCAG
ATCTTCAACAAGAGGACCCAGGAGAAATTCGCCCTCAAAATGCTTCAGGACTGCCCCAAG
GCCCGCAGGGAGGTGGAGCTGCACTGGCGGGCCTCCCAGTGCCCGCACATCGTACGGATC
GTGGATGTGTACGAGAATCTGTACGCAGGGAGGAAGTGCCTGCTGATTGTCATGGAATGT
TTGGACGGTGGAGAACTCTTTAGCCGAATCCAGGATCGAGGAGACCAGGCATTCACAGAA
AGAGAAGCATCCGAAATCATGAAGAGCATCGGTGAGGCCATCCAGTATCTGCATTCAATC
AACATTGCCCATCGGGATGTCAAGCCTGAGAATCTCTTATACACCTCCAAAAGGCCCAAC
GCCATCCTGAAACTCACTGACTTTGGCTTTGCCAAGGAAACCACCAGCCACAACTCTTTG
ACCACTCCTTGTTATACACCGTACTATGTGGCTCCAGAAGTGCTGGGTCCAGAGAAGTAT
GACAAGTCCTGTGACATGTGGTCCCTGGGTGTCATCATGTACATCCTGCTGTGTGGGTAT
CCCCCCTTCTACTCCAACCACGGCCTTGCCATCTCTCCGGGCATGAAGACTCGCATCCGA
ATGGGCCAGTATGAATTTCCCAACCCAGAATGGTCAGAAGTATCAGAGGAAGTGAAGATG
CTCATTCGGAATCTGCTGAAAACAGAGCCCACCCAGAGAATGACCATCACCGAGTTTATG
AACCACCCTTGGATCATGCAATCAACAAAGGTCCCTCAAACCCCACTGCACACCAGCCGG
GTCCTGAAGGAGGACAAGGAGCGGTGGGAGGATGTCAAGGGGTGTCTTCATGACAAGAAC
AGCGACCAGGCCACTTGGCTGACCAGGTTGTGA

# Drug_Target_57_General_Function:
Involved in protein kinase activity

# Drug_Target_57_General_References:
8179591	Zu YL, Wu F, Gilchrist A, Ai Y, Labadia ME, Huang CK: The primary structure of a human MAP kinase activated protein kinase 2. Biochem Biophys Res Commun. 1994 Apr 29;200(2):1118-24.
8280084	Stokoe D, Caudwell B, Cohen PT, Cohen P: The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2. Biochem J. 1993 Dec 15;296 ( Pt 3):843-9.

# Drug_Target_57_HGNC_ID:
HGNC:6887

# Drug_Target_57_HPRD_ID:
11882

# Drug_Target_57_ID:
2511

# Drug_Target_57_Locus:
1q32

# Drug_Target_57_Molecular_Weight:
45568

# Drug_Target_57_Name:
MAP kinase-activated protein kinase 2

# Drug_Target_57_Number_of_Residues:
400

# Drug_Target_57_PDB_ID:
1NY3

# Drug_Target_57_Pathway:
Not Available

# Drug_Target_57_Pfam_Domain_Function:
PF00069	Pkinase

# Drug_Target_57_Protein_Sequence:
>MAP kinase-activated protein kinase 2
MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAII
DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRI
VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI
NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY
DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM
LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSAL
ATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH

# Drug_Target_57_Reaction:
ATP + a protein = ADP + a phosphoprotein

# Drug_Target_57_Signals:
None

# Drug_Target_57_Specific_Function:
Its physiological substrate seems to be the small heat shock protein (HSP27/HSP25). In vitro can phosphorylate glycogen synthase at 'Ser-7' and tyrosine hydroxylase (on 'Ser-19' and 'Ser-40'). This kinase phosphorylates Ser in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Mediates both ERK and p38 MAPK/MAPK14 dependent neutrophil responses. Participates in TNF alpha-stimulated exocytosis of secretory vesicles in neutrophils. Plays a role in phagocytosis-induced respiratory burst activity

# Drug_Target_57_SwissProt_ID:
P49137

# Drug_Target_57_SwissProt_Name:
MAPK2_HUMAN

# Drug_Target_57_Synonyms:
EC 2.7.11.1
MAPK-activated protein kinase 2
MAPKAP kinase 2
MAPKAPK-2
MK2

# Drug_Target_57_Theoretical_pI:
8.92

# Drug_Target_57_Transmembrane_Regions:
None

# Drug_Target_58_Cellular_Location:
Not Available

# Drug_Target_58_Chromosome_Location:
Not Available

# Drug_Target_58_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_58_Essentiality:
Non-Essential

# Drug_Target_58_GenAtlas_ID:
Not Available

# Drug_Target_58_GenBank_ID_Gene:
Not Available

# Drug_Target_58_GenBank_ID_Protein:
Not Available

# Drug_Target_58_GeneCard_ID:
Not Available

# Drug_Target_58_Gene_Name:
VCP

# Drug_Target_58_Gene_Sequence:
Not Available

# Drug_Target_58_General_Function:
Not Available

# Drug_Target_58_General_References:
Not Available

# Drug_Target_58_HGNC_ID:
Not Available

# Drug_Target_58_HPRD_ID:
Not Available

# Drug_Target_58_ID:
7082

# Drug_Target_58_Locus:
Not Available

# Drug_Target_58_Molecular_Weight:
Not Available

# Drug_Target_58_Name:
Transitional endoplasmic reticulum ATPase

# Drug_Target_58_Number_of_Residues:
0

# Drug_Target_58_PDB_ID:
Not Available

# Drug_Target_58_Pathway:
Not Available

# Drug_Target_58_Pfam_Domain_Function:
Not Available

# Drug_Target_58_Protein_Sequence:
Not Available

# Drug_Target_58_Reaction:
Not Available

# Drug_Target_58_Signals:
Not Available

# Drug_Target_58_Specific_Function:
Not Available

# Drug_Target_58_SwissProt_ID:
P55072

# Drug_Target_58_SwissProt_Name:
TERA_HUMAN

# Drug_Target_58_Synonyms:
Not Available

# Drug_Target_58_Theoretical_pI:
Not Available

# Drug_Target_58_Transmembrane_Regions:
Not Available

# Drug_Target_59_Cellular_Location:
Not Available

# Drug_Target_59_Chromosome_Location:
Not Available

# Drug_Target_59_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_59_Essentiality:
Non-Essential

# Drug_Target_59_GenAtlas_ID:
Not Available

# Drug_Target_59_GenBank_ID_Gene:
J02732

# Drug_Target_59_GenBank_ID_Protein:
143369

# Drug_Target_59_GeneCard_ID:
Not Available

# Drug_Target_59_Gene_Name:
purF

# Drug_Target_59_Gene_Sequence:
>1431 bp
ATGCTTGCTGAAATCAAAGGCTTAAATGAAGAATGCGGCGTTTTTGGGATTTGGGGACAT
GAAGAAGCCCCGCAAATCACGTATTACGGTCTCCACAGCCTTCAGCACCGAGGACAGGAG
GGTGCTGGCATCGTAGCGACTGACGGTGAAAAGCTGACGGCTCACAAAGGCCAAGGTCTG
ATCACTGAAGTATTTCAAAACGGCGAACTCAGCAAAGTAAAGGGAAAAGGCGCTATCGGG
CACGTTCGGTACGCAACGGCTGGAGGCGGCGGATACGAAAATGTTCAGCCGCTCCTCTTC
CGTTCCCAAAACAACGGCAGCCTGGCGCTTGCTCATAACGGAAATCTTGTCAACGCCACT
CAGCTGAAGCAGCAGCTCGAAAATCAAGGGAGCATCTTTCAAACCTCTTCGGATACAGAG
GTTTTGGCTCACCTGATCAAAAGAAGCGGACACTTCACGCTGAAGGATCAAATTAAAAAC
TCGCTTTCTATGCTGAAAGGCGCCTACGCGTTCCTGATCATGACCGAAACAGAAATGATT
GTCGCACTTGATCCAAACGGGCTGAGACCGCTATCCATCGGCATGATGGGCGACGCTTAT
GTGGTCGCATCAGAAACATGCGCATTTGACGTCGTCGGCGCAACGTACCTTCGCGAGGTA
GAGCCGGGAGAAATGCTGATCATTAATGATGAAGGCATGAAATCAGAGCGTTTTTCCATG
AATATCAATCGTTCCATTTGCAGCATGGAGTACATTTATTTCTCCAGACCAGACAGCAAT
ATTGACGGTATTAATGTGCACAGTGCCCGTAAAAACCTTGGGAAAATGCTGGCTCAGGAA
TCCGCAGTTGAAGCTGACGTCGTAACCGGGGTTCCGGATTCCAGTATTTCAGCGGCGATC
GGCTATGCAGAGGCAACAGGCATTCCGTATGAGCTTGGCTTAATCAAAAACCGTTATGTT
GGCAGAACGTTTATTCAGCCGTCCCAGGCTCTGCGTGAGCAAGGCGTCAGAATGAAGCTG
TCTGCGGTGCGCGGGGTTGTAGAAGGCAAACGCGTCGTGATGGTGGATGACTCTATCGTG
CGAGGAACAACTAGCCGCCGGATTGTCACGATGCTAAGAGAGGCGGGTGCGACAGAGGTG
CATGTGAAAATCAGTTCACCGCCGATCGCTCATCCGTGCTTTTACGGCATTGACACTTCC
ACACATGAAGAACTGATCGCGTCTTCGCATTCTGTCGGAGAAATCCGTCAGGAAATCGGA
GCCGATACCCTCTCATTTTTGAGTGTGGAAGGGCTGCTGAAAGGCATCGGCAGAAAATAC
GATGACTCGAATTGCGGACAGTGTCTCGCTTGCTTTACAGGAAAATATCCGACTGAAATT
TACCAGGATACAGTGCTTCCTCACGTAAAAGAAGCAGTATTAACCAAATAA

# Drug_Target_59_General_Function:
Nucleotide transport and metabolism

# Drug_Target_59_General_References:
3036807	Ebbole DJ, Zalkin H: Cloning and characterization of a 12-gene cluster from Bacillus subtilis encoding nine enzymes for de novo purine nucleotide synthesis. J Biol Chem. 1987 Jun 15;262(17):8274-87.
3090047	Makaroff CA, Paluh JL, Zalkin H: Mutagenesis of ligands to the [4 Fe-4S] center of Bacillus subtilis glutamine phosphoribosylpyrophosphate amidotransferase. J Biol Chem. 1986 Aug 25;261(24):11416-23.
6094545	Mantsala P, Zalkin H: Glutamine amidotransferase function. Replacement of the active-site cysteine in glutamine phosphoribosylpyrophosphate amidotransferase by site-directed mutagenesis. J Biol Chem. 1984 Nov 25;259(22):14230-6.
6411716	Vollmer SJ, Switzer RL, Hermodson MA, Bower SG, Zalkin H: The glutamine-utilizing site of Bacillus subtilis glutamine phosphoribosylpyrophosphate amidotransferase. J Biol Chem. 1983 Sep 10;258(17):10582-5.
6411717	Makaroff CA, Zalkin H, Switzer RL, Vollmer SJ: Cloning of the Bacillus subtilis glutamine phosphoribosylpyrophosphate amidotransferase gene in Escherichia coli. Nucleotide sequence determination and properties of the plasmid-encoded enzyme. J Biol Chem. 1983 Sep 10;258(17):10586-93.
8197456	Smith JL, Zaluzec EJ, Wery JP, Niu L, Switzer RL, Zalkin H, Satow Y: Structure of the allosteric regulatory enzyme of purine biosynthesis. Science. 1994 Jun 3;264(5164):1427-33.
9271502	Chen S, Tomchick DR, Wolle D, Hu P, Smith JL, Switzer RL, Zalkin H: Mechanism of the synergistic end-product regulation of Bacillus subtilis glutamine phosphoribosylpyrophosphate amidotransferase by nucleotides. Biochemistry. 1997 Sep 2;36(35):10718-26.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_59_HGNC_ID:
Not Available

# Drug_Target_59_HPRD_ID:
Not Available

# Drug_Target_59_ID:
2515

# Drug_Target_59_Locus:
Not Available

# Drug_Target_59_Molecular_Weight:
51620

# Drug_Target_59_Name:
Amidophosphoribosyltransferase

# Drug_Target_59_Number_of_Residues:
476

# Drug_Target_59_PDB_ID:
1GPH

# Drug_Target_59_Pathway:
Not Available

# Drug_Target_59_Pfam_Domain_Function:
PF00156	Pribosyltran
PF00310	GATase_2

# Drug_Target_59_Protein_Sequence:
>Amidophosphoribosyltransferase precursor
MLAEIKGLNEECGVFGIWGHEEAPQITYYGLHSLQHRGQEGAGIVATDGEKLTAHKGQGL
ITEVFQNGELSKVKGKGAIGHVRYATAGGGGYENVQPLLFRSQNNGSLALAHNGNLVNAT
QLKQQLENQGSIFQTSSDTEVLAHLIKRSGHFTLKDQIKNSLSMLKGAYAFLIMTETEMI
VALDPNGLRPLSIGMMGDAYVVASETCAFDVVGATYLREVEPGEMLIINDEGMKSERFSM
NINRSICSMEYIYFSRPDSNIDGINVHSARKNLGKMLAQESAVEADVVTGVPDSSISAAI
GYAEATGIPYELGLIKNRYVGRTFIQPSQALREQGVRMKLSAVRGVVEGKRVVMVDDSIV
RGTTSRRIVTMLREAGATEVHVKISSPPIAHPCFYGIDTSTHEELIASSHSVGEIRQEIG
ADTLSFLSVEGLLKGIGRKYDDSNCGQCLACFTGKYPTEIYQDTVLPHVKEAVLTK

# Drug_Target_59_Reaction:
5-phospho-beta-D-ribosylamine + diphosphate + L-glutamate = L-glutamine + 5-phospho-alpha-D-ribose 1-diphosphate + H2O

# Drug_Target_59_Signals:
None

# Drug_Target_59_Specific_Function:
5-phospho-beta-D-ribosylamine + diphosphate + L-glutamate = L-glutamine + 5-phospho-alpha-D-ribose 1-diphosphate + H(2)O

# Drug_Target_59_SwissProt_ID:
P00497

# Drug_Target_59_SwissProt_Name:
PUR1_BACSU

# Drug_Target_59_Synonyms:
ATASE
Amidophosphoribosyltransferase precursor
EC 2.4.2.14
GPATase
Glutamine phosphoribosylpyrophosphate amidotransferase

# Drug_Target_59_Theoretical_pI:
6.28

# Drug_Target_59_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
ITPKA

# Drug_Target_5_GenBank_ID_Gene:
X54938

# Drug_Target_5_GenBank_ID_Protein:
32105

# Drug_Target_5_GeneCard_ID:
ITPKA

# Drug_Target_5_Gene_Name:
ITPKA

# Drug_Target_5_Gene_Sequence:
>1386 bp
ATGACCCTGCCCGGGGGCCCAACGGGCATGGCGCGGCCGGGGGGCGCGAGGCCCTGCAGC
CCGGGGCTGGAGCGGGCCCCGCGCCGGAGTGTCGGGGAGCTGCGCCTGCTCTTCGAGGCG
CGCTGTGCGGCGGTCGCTGCGGCCGCCGCCGCGGGGGAGCCCCGGGCCCGCGGGGCCAAG
CGGCGTGGGGGACAGGTCCCCAACGGGCTTCCGCGGGCTCCCCCGGCCCCGGTGATCCCT
CAGCTGACCGTGACAGCCGAGGAGCCCGACGTGCCCCCGACCAGCCCTGGGCCGCCGGAG
CGGGAGAGGGACTGCCTCCCGGCAGCGGGCTCTTCGCACCTGCAGCAGCCGCGCCGCCTT
TCCACCTCGTCGGTCTCCTCCACTGGCTCCTCGTCGCTGCTCGAGGACTCGGAGGACGAC
CTGCTGAGCGACAGTGAGAGCCGGAGCCGCGGCAACGTGCAGCTGGAAGCGGGCGAGGAC
GTGGGTCAGAAAAACCACTGGCAGAAGATCCGGACCATGGTCAATCTGCCGGTCATAAGC
CCTTTCAAGAAGCGCTACGCCTGGGTGCAGCTGGCAGGGCACACTGGGAGTTTTAAGGCG
GCGGGCACCAGCGGGCTGATCCTGAAGCGCTGCTCGGAGCCGGAGCGCTACTGCCTGGCG
CGGCTGATGGCTGACGCGCTGCGCGGCTGCGTGCCTGCCTTCCACGGCGTGGTGGAGCGC
GACGGCGAAAGCTACCTGCAGCTGCAGGACCTGCTCGATGGCTTCGACGGACCTTGTGTG
CTCGACTGCAAAATGGGCGTCAGGACTTACCTAGAGGAGGAGCTGACCAAGGCCCGTGAG
CGGCCCAAGCTGCGGAAGGACATGTACAAGAAAATGCTGGCGGTGGATCCTGAAGCTCCC
ACGGAGGAGGAGCACGCGCAGCGCGCCGTCACCAAGCCGCGCTACATGCAGTGGCGGGAA
GGCATCAGCTCCAGCACCACCCTCGGCTTCCGCATCGAGGGCATCAAGAAAGCGGACGGC
TCCTGCAGCACCGACTTCAAGACTACGCGAAGCCGAGAGCAGGTGCTTCGCGTCTTTGAA
GAGTTTGTGCAAGGAGATGAGGAAGTGCTGAGGCGGTATCTGAACCGCCTGCAGCAGATC
CGGGACACCCTGGAGGTATCCGAGTTCTTCAGGAGGCACGAGGTGATCGGCAGCTCGCTC
CTCTTTGTGCACGATCACTGCCATCGCGCCGGCGTGTGGCTCATCGACTTCGGCAAGACC
ACGCCCCTCCCCGATGGCCAGATCCTGGACCACCGGCGGCCCTGGGAGGAGGGCAACCGC
GAGGACGGCTATTTGCTGGGGCTGGACAATCTCATTGGCATCCTGGCCAGCCTGGCTGAG
AGATGA

# Drug_Target_5_General_Function:
Involved in inositol trisphosphate 3-kinase activity

# Drug_Target_5_General_References:
1847047	Takazawa K, Perret J, Dumont JE, Erneux C: Molecular cloning and expression of a human brain inositol 1,4,5-trisphosphate 3-kinase. Biochem Biophys Res Commun. 1991 Jan 31;174(2):529-35.
2175886	Takazawa K, Perret J, Dumont JE, Erneux C: Human brain inositol 1,4,5-trisphosphate 3-kinase cDNA sequence. Nucleic Acids Res. 1990 Dec 11;18(23):7141.

# Drug_Target_5_HGNC_ID:
HGNC:6178

# Drug_Target_5_HPRD_ID:
00941

# Drug_Target_5_ID:
2950

# Drug_Target_5_Locus:
15q14-q21

# Drug_Target_5_Molecular_Weight:
51009

# Drug_Target_5_Name:
Inositol-trisphosphate 3-kinase A

# Drug_Target_5_Number_of_Residues:
461

# Drug_Target_5_PDB_ID:
1W2F

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF03770	IPK

# Drug_Target_5_Protein_Sequence:
>Inositol-trisphosphate 3-kinase A
MTLPGGPTGMARPGGARPCSPGLERAPRRSVGELRLLFEARCAAVAAAAAAGEPRARGAK
RRGGQVPNGLPRAPPAPVIPQLTVTAEEPDVPPTSPGPPERERDCLPAAGSSHLQQPRRL
STSSVSSTGSSSLLEDSEDDLLSDSESRSRGNVQLEAGEDVGQKNHWQKIRTMVNLPVIS
PFKKRYAWVQLAGHTGSFKAAGTSGLILKRCSEPERYCLARLMADALRGCVPAFHGVVER
DGESYLQLQDLLDGFDGPCVLDCKMGVRTYLEEELTKARERPKLRKDMYKKMLAVDPEAP
TEEEHAQRAVTKPRYMQWREGISSSTTLGFRIEGIKKADGSCSTDFKTTRSREQVLRVFE
EFVQGDEEVLRRYLNRLQQIRDTLEVSEFFRRHEVIGSSLLFVHDHCHRAGVWLIDFGKT
TPLPDGQILDHRRPWEEGNREDGYLLGLDNLIGILASLAER

# Drug_Target_5_Reaction:
ATP + 1D-myo-inositol 1,4,5-trisphosphate = ADP + 1D-myo-inositol 1,3,4,5-tetrakisphosphate

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
ATP + 1D-myo-inositol 1,4,5-trisphosphate = ADP + 1D-myo-inositol 1,3,4,5-tetrakisphosphate

# Drug_Target_5_SwissProt_ID:
P23677

# Drug_Target_5_SwissProt_Name:
IP3KA_HUMAN

# Drug_Target_5_Synonyms:
EC 2.7.1.127
IP3 3-kinase A
IP3K A
Inositol 1,4,5- trisphosphate 3-kinase A

# Drug_Target_5_Theoretical_pI:
7.72

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_60_Cellular_Location:
Cell membrane

# Drug_Target_60_Chromosome_Location:
Not Available

# Drug_Target_60_Drug_References:
Not Available

# Drug_Target_60_Essentiality:
Non-Essential

# Drug_Target_60_GenAtlas_ID:
Not Available

# Drug_Target_60_GenBank_ID_Gene:
Not Available

# Drug_Target_60_GenBank_ID_Protein:
Not Available

# Drug_Target_60_GeneCard_ID:
Not Available

# Drug_Target_60_Gene_Name:
lmrA

# Drug_Target_60_Gene_Sequence:
Not Available

# Drug_Target_60_General_Function:
Involved in nucleotide binding

# Drug_Target_60_General_References:
11337471	Bolotin A, Wincker P, Mauger S, Jaillon O, Malarme K, Weissenbach J, Ehrlich SD, Sorokin A: The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res. 2001 May;11(5):731-53.

# Drug_Target_60_HGNC_ID:
Not Available

# Drug_Target_60_HPRD_ID:
Not Available

# Drug_Target_60_ID:
5275

# Drug_Target_60_Locus:
Not Available

# Drug_Target_60_Molecular_Weight:
64699

# Drug_Target_60_Name:
Multidrug resistance ABC transporter ATP-binding and permease protein

# Drug_Target_60_Number_of_Residues:
590

# Drug_Target_60_PDB_ID:
1MV5

# Drug_Target_60_Pathway:
Not Available

# Drug_Target_60_Pfam_Domain_Function:
PF00005	ABC_tran
PF00664	ABC_membrane

# Drug_Target_60_Protein_Sequence:
>Multidrug resistance ABC transporter ATP-binding and permease protein
MERGPQMANRIEGKAVDKTSIKHFIKLIRAAKPRYLFFIIGILAGIVGTLIQLQVPKMVQ
PLVNSFGHGVNGGKVALVIALYIGSAAVSAIAAIVLGIFGESVVKNLRTRVWDKMIHLPV
KYFDEVKTGEMSSRLANDTTQVKNLIANSIPQAFTSILLLVGSIVFMLQMQWRLTLAMII
AVPVVMLIMFPIMTFGQKIGRTRQDSLANFQGIASESLSEIRLVKSSNAEKQASKKAEND
VNALYKIGVKEAIFDGLMSPVMMLSMMLMIFGLLAYGIYLISTGVMSLGTLLGMMMYLMN
LIGAVPTVATFFTELAKASGSTGRLTELLDEEQEVLHQGESLDLEGKTLSARHVDFAYDD
SEQILRDISFEAQPNSIIAFAGPSGGGKSTIFSLLERFYQPTAGEITIDGQPIDNISLEN
WRSQIGFVSQDSAIMAGTIRENLTYGLEGDYTDEDLWQVLDLAFARSFVENMPDQLNTEV
GERGVKISGGQRQRLAIARAFLRNPKILMLDEATASLDSESESMVQKALDSLMKGRTTLV
IAHRLSTIVDADKIYFIEKGQITGSGKHNELVATHPLYAKYVSEQLTVGQ

# Drug_Target_60_Reaction:
Not Available

# Drug_Target_60_Signals:
None

# Drug_Target_60_Specific_Function:
Efflux transporter for a variety of amphiphilic cationic compounds, including antibiotics (By similarity)

# Drug_Target_60_SwissProt_ID:
Q9CHL8

# Drug_Target_60_SwissProt_Name:
LMRA_LACLA

# Drug_Target_60_Synonyms:
EC 3.6.3.44

# Drug_Target_60_Theoretical_pI:
6.34

# Drug_Target_60_Transmembrane_Regions:
35-55
79-99
150-170
176-196
261-281
292-312

# Drug_Target_61_Cellular_Location:
Mitochondrion
mitochondrial outer membrane. Note=Its hydrophobic N-terminal sequence may be involve

# Drug_Target_61_Chromosome_Location:
Not Available

# Drug_Target_61_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_61_Essentiality:
Non-Essential

# Drug_Target_61_GenAtlas_ID:
HK1

# Drug_Target_61_GenBank_ID_Gene:
M75126

# Drug_Target_61_GenBank_ID_Protein:
184021

# Drug_Target_61_GeneCard_ID:
HK1

# Drug_Target_61_Gene_Name:
HK1

# Drug_Target_61_Gene_Sequence:
>2754 bp
ATGATCGCCGCGCAGCTCCTGGCCTATTACTTCACGGAGCTGAAGGATGACCAGGTCAAA
AAGATTGACAAGTATCTGTATGCCATGCGGCTCTCCGATGAAACTCTCATAGATATCATG
ACTCGCTTCAGGAAGGAGATGAAGAATGGCCTCTCCCGGGATTTTAATCCAACAGCCACA
GTCAAGATGTTGCCAACATTCGTAAGGTCCATTCCTGATGGCTCTGAAAAGGGAGATTTC
ATTGCCCTGGATCTTGGTGGGTCTTCCTTTCGAATTCTGCGGGTGCAAGTGAATCATGAG
AAAAACCAGAATGTTCACATGGAGTCCGAGGTTTATGACACCCCAGAGAACATCGTGCAC
GGCAGTGGAAGCCAGCTTTTTGATCATGTTGCTGAGTGCCTGGGAGATTTCATGGAGAAA
AGGAAGATCAAGGACAAGAAGTTACCTGTGGGATTCACGTTTTCTTTTCCTTGCCAACAA
TCCAAAATAGATGAGGCCATCCTGATCACCTGGACAAAGCGATTTAAAGCGAGCGGAGTG
GAAGGAGCAGATGTGGTCAAACTGCTTAACAAAGCCATCAAAAAGCGAGGGGACTATGAT
GCCAACATCGTAGCTGTGGTGAATGACACAGTGGGCACCATGATGACCTGTGGCTATGAC
GACCAGCACTGTGAAGTCGGCCTGATCATCGGCACTGGCACCAATGCTTGCTACATGGAG
GAACTGAGGCACATTGATCTGGTGGAAGGAGACGAGGGGAGGATGTGTATCAATACAGAA
TGGGGAGCCTTTGGAGACGATGGATCATTAGAAGACATCCGGACAGAGTTTGACAGGGAG
ATAGACCGGGGATCCCTCAACCCTGGAAAACAGCTGTTTGAGAAGATGGTCAGTGGCATG
TACTTGGGAGAGCTGGTTCGACTGATCCTAGTCAAGATGGCCAAGGAGGGCCTCTTATTT
GAAGGGCGGATCACCCCGGAGCTGCTCACCCGAGGGAAGTTTAACACCAGTGATGTGTCA
GCCATCGAAAAGAATAAGGAAGGCCTCCACAATGCCAAAGAAATCCTGACCCGCCTGGGA
GTGGAGCCGTCCGATGATGACTGTGTCTCAGTCCAGCACGTTTGCACCATTGTCTCATTT
CGCTCAGCCAACTTGGTGGCTGCCACACTGGGCGCCATCTTGAACCGCCTGCGTGATAAC
AAGGGCACACCCAGGCTGCGGACCACGGTTGGTGTCGACGGATCTCTTTACAAGACGCAC
CCACAGTATTCCCGGCGTTTCCACAAGACTCTAAGGCGCTTGGTGCCAGACTCCGATGTG
CGCTTCCTCCTCTCGGAGAGTGGCAGCGGCAAGGGGGCTGCCATGGTGACGGCGGTGGCC
TACCGCTTGGCCGAGCAGCACCGGCAGATAGAGGAGACCCTGGCTCATTTCCACCTCACC
AAAGACATGCTGCTGGAGGTGAAGAAGAGGATGCGGGCCGAGATGGAGCTGGGGCTGAGG
AAGCAGACGCACAACAATGCCGTGGTTAAGATGCTGCCCTCCTTCGTCCGGAGAACTCCC
GACGGGACCGAGAATGGTGACTTCTTGGCCCTGGATCTTGGAGGAACCAATTTCCGTGTG
CTGCTGGTGAAAATCCGTAGTGGGAAAAAGAGAACGGTGGAAATGCACAACAAGATCTAC
GCCATTCCTATTGAAATCATGCAGGGCACTGGGGAAGAGCTGTTTGATCACATTGTCTCC
TGCATCTCTGACTTCTTGGACTACATGGGGATCAAAGGCCCCAGGATGCCTCTGGGCTTC
ACGTTCTCATTTCCCTGCCAGCAGACGAGTCTGGACGCGGGAATCTTGATCACGTGGACA
AAGGGTTTTAAGGCAACAGACTGCGTGGGCCACGATGTAGTCACCTTACTAAGGGATGCG
ATAAAAAGGAGAGAGGAATTTGACCTGGACGTGGTGGCTGTGGTCAACGACACAGTGGGC
ACCATGATGACCTGTGCTTATGAGGAGCCCACCTGTGAGGTTGGACTCATTGTTGGGACC
GGCAGCAATGCCTGCTACATGGAGGAGATGAAGAACGTGGAGATGGTGGAGGGGGACCAG
GGGCAGATGTGCATCAACATGGAGTGGGGGGCCTTTGGGGACAACGGGTGTCTGGATGAT
ATCAGGACACACTACGACAGACTGGTGAACGAATATTCCCTAAATGCTGGGAAACAAAGG
TATGAGAAGATGATCAGTGGTATGTACCTGGGTGAAATCGTCCGCAACATCTTAATCGAC
TTCACCAAGAAGGGATTCCTCTTCCGAGGGCAGATCTCTGAGACGATGAAGACCCGGGGC
ATCTTTGAGACCAAGTTTCTCTCTCAGATCGAGAGTGACCGATTAGCACTGCTCCAGGTC
CGGGCTATCCTCCAGCAGCTAGGTCTGAATAGCACCTGCGATGACAGTATCCTCGTCAAG
ACAGTGTGCGGGGTGGTGTCCAGGAGGGCCGCACAGCTGTGTGGCGCAGGCATGGCTGCG
GTTGTGGATAAGATCCGCGAGAACAGAGGACTGGACCGTCTGAATGTGACTGTGGGAGTG
GACGGGACACTCTACAAGCTTCATCCACACTTCTCCAGAATCATGCACCAGACGGTGAAG
GAACTGTCACCAAAATGTAACGTGTCCTTCCTCCTGTCTGAGGATGGCAGCGGCAAGGGG
GCCGCCCTCATCACGGCCGTGGGCGTGCGGTTACGCACAGAGGCAAGCAGCTAA

# Drug_Target_61_General_Function:
Involved in hexokinase activity

# Drug_Target_61_General_References:
10574795	Rosano C, Sabini E, Rizzi M, Deriu D, Murshudov G, Bianchi M, Serafini G, Magnani M, Bolognesi M: Binding of non-catalytic ATP to human hexokinase I highlights the structural components for enzyme-membrane association control. Structure. 1999 Nov 15;7(11):1427-37.
10686099	Aleshin AE, Kirby C, Liu X, Bourenkov GP, Bartunik HD, Fromm HJ, Honzatko RB: Crystal structures of mutant monomeric hexokinase I reveal multiple ADP binding sites and conformational changes relevant to allosteric regulation. J Mol Biol. 2000 Mar 3;296(4):1001-15.
10978502	Andreoni F, Ruzzo A, Magnani M: Structure of the 5' region of the human hexokinase type I (HKI) gene and identification of an additional testis-specific HKI mRNA. Biochim Biophys Acta. 2000 Sep 7;1493(1-2):19-26.
1637300	Magnani M, Bianchi M, Casabianca A, Stocchi V, Daniele A, Altruda F, Ferrone M, Silengo L: A recombinant human 'mini'-hexokinase is catalytically active and regulated by hexose 6-phosphates. Biochem J. 1992 Jul 1;285 ( Pt 1):193-9.
1985912	Magnani M, Serafini G, Bianchi M, Casabianca A, Stocchi V: Human hexokinase type I microheterogeneity is due to different amino-terminal sequences. J Biol Chem. 1991 Jan 5;266(1):502-5.
3207429	Nishi S, Seino S, Bell GI: Human hexokinase: sequences of amino- and carboxyl-terminal halves are homologous. Biochem Biophys Res Commun. 1988 Dec 30;157(3):937-43.
7655856	Bianchi M, Magnani M: Hexokinase mutations that produce nonspherocytic hemolytic anemia. Blood Cells Mol Dis. 1995;21(1):2-8.
8706938	Aleshin AE, Zeng C, Fromm HJ, Honzatko RB: Crystallization and preliminary X-ray analysis of human brain hexokinase. FEBS Lett. 1996 Aug 5;391(1-2):9-10.
9028305	Murakami K, Piomelli S: Identification of the cDNA for human red blood cell-specific hexokinase isozyme. Blood. 1997 Feb 1;89(3):762-6.
9493266	Aleshin AE, Zeng C, Bourenkov GP, Bartunik HD, Fromm HJ, Honzatko RB: The mechanism of regulation of hexokinase: new insights from the crystal structure of recombinant human brain hexokinase complexed with glucose and glucose-6-phosphate. Structure. 1998 Jan 15;6(1):39-50.
9531504	Ruzzo A, Andreoni F, Magnani M: Structure of the human hexokinase type I gene and nucleotide sequence of the 5' flanking region. Biochem J. 1998 Apr 15;331 ( Pt 2):607-13.
9735292	Aleshin AE, Zeng C, Bartunik HD, Fromm HJ, Honzatko RB: Regulation of hexokinase I: crystal structure of recombinant human brain hexokinase complexed with glucose and phosphate. J Mol Biol. 1998 Sep 18;282(2):345-57.

# Drug_Target_61_HGNC_ID:
HGNC:4922

# Drug_Target_61_HPRD_ID:
00809

# Drug_Target_61_ID:
1881

# Drug_Target_61_Locus:
10q22

# Drug_Target_61_Molecular_Weight:
102487

# Drug_Target_61_Name:
Hexokinase-1

# Drug_Target_61_Number_of_Residues:
917

# Drug_Target_61_PDB_ID:
1HKB

# Drug_Target_61_Pathway:
Not Available

# Drug_Target_61_Pfam_Domain_Function:
PF00349	Hexokinase_1
PF03727	Hexokinase_2

# Drug_Target_61_Protein_Sequence:
>Hexokinase-1
MIAAQLLAYYFTELKDDQVKKIDKYLYAMRLSDETLIDIMTRFRKEMKNGLSRDFNPTAT
VKMLPTFVRSIPDGSEKGDFIALDLGGSSFRILRVQVNHEKNQNVHMESEVYDTPENIVH
GSGSQLFDHVAECLGDFMEKRKIKDKKLPVGFTFSFPCQQSKIDEAILITWTKRFKASGV
EGADVVKLLNKAIKKRGDYDANIVAVVNDTVGTMMTCGYDDQHCEVGLIIGTGTNACYME
ELRHIDLVEGDEGRMCINTEWGAFGDDGSLEDIRTEFDREIDRGSLNPGKQLFEKMVSGM
YLGELVRLILVKMAKEGLLFEGRITPELLTRGKFNTSDVSAIEKNKEGLHNAKEILTRLG
VEPSDDDCVSVQHVCTIVSFRSANLVAATLGAILNRLRDNKGTPRLRTTVGVDGSLYKTH
PQYSRRFHKTLRRLVPDSDVRFLLSESGSGKGAAMVTAVAYRLAEQHRQIEETLAHFHLT
KDMLLEVKKRMRAEMELGLRKQTHNNAVVKMLPSFVRRTPDGTENGDFLALDLGGTNFRV
LLVKIRSGKKRTVEMHNKIYAIPIEIMQGTGEELFDHIVSCISDFLDYMGIKGPRMPLGF
TFSFPCQQTSLDAGILITWTKGFKATDCVGHDVVTLLRDAIKRREEFDLDVVAVVNDTVG
TMMTCAYEEPTCEVGLIVGTGSNACYMEEMKNVEMVEGDQGQMCINMEWGAFGDNGCLDD
IRTHYDRLVDEYSLNAGKQRYEKMISGMYLGEIVRNILIDFTKKGFLFRGQISETLKTRG
IFETKFLSQIESDRLALLQVRAILQQLGLNSTCDDSILVKTVCGVVSRRAAQLCGAGMAA
VVDKIRENRGLDRLNVTVGVDGTLYKLHPHFSRIMHQTVKELSPKCNVSFLLSEDGSGKG
AALITAVGVRLRTEASS

# Drug_Target_61_Reaction:
ATP + D-hexose = ADP + D-hexose 6-phosphate

# Drug_Target_61_Signals:
None

# Drug_Target_61_Specific_Function:
ATP + D-hexose = ADP + D-hexose 6-phosphate

# Drug_Target_61_SwissProt_ID:
P19367

# Drug_Target_61_SwissProt_Name:
HXK1_HUMAN

# Drug_Target_61_Synonyms:
Brain form hexokinase
EC 2.7.1.1
HK I
Hexokinase type I

# Drug_Target_61_Theoretical_pI:
6.78

# Drug_Target_61_Transmembrane_Regions:
None

# Drug_Target_62_Cellular_Location:
Cytoplasm

# Drug_Target_62_Chromosome_Location:
Not Available

# Drug_Target_62_Drug_References:
Not Available

# Drug_Target_62_Essentiality:
Non-Essential

# Drug_Target_62_GenAtlas_ID:
Not Available

# Drug_Target_62_GenBank_ID_Gene:
AE000657

# Drug_Target_62_GenBank_ID_Protein:
Not Available

# Drug_Target_62_GeneCard_ID:
Not Available

# Drug_Target_62_Gene_Name:
dnaA

# Drug_Target_62_Gene_Sequence:
>1200 bp
TTAACAAATCTTATCAAAAGCCTGTTTTTCTAAAAATCCTACAAGGTGTTTAAACTTCCT
ATCCTTTTTCTTCTCCTCCTCCACGGACCTTATGGCGTGTATGACCGTAGTGTGATCCTT
CCTCTTAAAAGCCCTTGCGATTTCTATCAGACTTGCGGAACACACCTTCCTGCACAGGTA
CATCGCTATCTTTCTCGCCTCGCTCGTCCTTTTATTCCTCTTGTCAGAGAGTATGTCTTC
CACCTTCACCGCGTAGTAATTTGCCACAAACTCTACTATTTGCATTAGCTTGTCCCTTTC
CTTCCTTTCTTTTCTTTCTAAGCCTTCAAATCCCTTTAACTTTATGAGTTTAATCTTCCC
CTCTATCTCCCTTACGTTTTTCGTGTTCTCTAAAAGGTAATCAATAACTTCCTTTCTGAG
TTCAAGGTTAAACTCCTTTAACTTTTCCTTTATTATCTTGAACCTCGTTTTATTGTCCAG
CTCTATCTCTACCAGAATACCGCCTTCGAACCTGCTCACCAGTCTGTCAGAAACTCCGTC
GAGCTTTTGAGGGTGTCTGTCTGAGGCTAGGATTATCTGCTTTTCTAGGAGGTAGAGAGT
ATTAAAAATGTGGAAAAACTCTATCTGAGTTCTTTCCTTCCCCGAAAGGAATTGAACGTC
GTCGAGGAGAAGAAGGTCAACACTCTTGTACATATTCCTGAACTCGTTTATCGTTCCCTT
TTTCAGATGTTCAACCATAGCCTGTGCAAAGTCGTCCGCCGAGGAGTATATAACTCTGTA
GCCTCTCTTTTTCGCTTCGTTTCCCGCGGCCTGAAGGAGGTGTGTCTTTCCAGTTCCCAC
GCTACCGTATATAAAGATCGGGTTGTACAAACTTCCGAGGTTTTCTAAAGCTTCCTTTAC
TACCTCGTAAGCGAGTCTGTTCCCCTCACCTACTATAAAGTTCTCCAGAGTGTACTTGGG
ATTGAGGAAGTCCTTTATCTCTACCTTTTTCTTTTCTTCCTTTTCTTTTACCTCTATAAG
TTTTCTTACTTCTTCTTCTAAGAAGGTGTTCACTATTGTCTCGAGCCACTCTCTGTAGTC
TTCTCCTGGAGCTATGAACAAAAACTTTCCCTTTTCCTGTTTTATCTCGAATTTTTTCAA
AAACTCCCTCGCGTAGGAGTCCACGCTCTCTATCTTCTTTATTAGTGCGTTTAGTTCCAT

# Drug_Target_62_General_Function:
Involved in nucleotide binding

# Drug_Target_62_General_References:
12234917	Erzberger JP, Pirruccello MM, Berger JM: The structure of bacterial DnaA: implications for general mechanisms underlying DNA replication initiation. EMBO J. 2002 Sep 16;21(18):4763-73.
9537320	Deckert G, Warren PV, Gaasterland T, Young WG, Lenox AL, Graham DE, Overbeek R, Snead MA, Keller M, Aujay M, Huber R, Feldman RA, Short JM, Olsen GJ, Swanson RV: The complete genome of the hyperthermophilic bacterium Aquifex aeolicus. Nature. 1998 Mar 26;392(6674):353-8.

# Drug_Target_62_HGNC_ID:
Not Available

# Drug_Target_62_HPRD_ID:
Not Available

# Drug_Target_62_ID:
5276

# Drug_Target_62_Locus:
Not Available

# Drug_Target_62_Molecular_Weight:
46841

# Drug_Target_62_Name:
Chromosomal replication initiator protein dnaA

# Drug_Target_62_Number_of_Residues:
399

# Drug_Target_62_PDB_ID:
1L8Q

# Drug_Target_62_Pathway:
Not Available

# Drug_Target_62_Pfam_Domain_Function:
PF00308	Bac_DnaA
PF08299	Bac_DnaA_C

# Drug_Target_62_Protein_Sequence:
>Chromosomal replication initiator protein dnaA
MELNALIKKIESVDSYAREFLKKFEIKQEKGKFLFIAPGEDYREWLETIVNTFLEEEVRK
LIEVKEKEEKKKVEIKDFLNPKYTLENFIVGEGNRLAYEVVKEALENLGSLYNPIFIYGS
VGTGKTHLLQAAGNEAKKRGYRVIYSSADDFAQAMVEHLKKGTINEFRNMYKSVDLLLLD
DVQFLSGKERTQIEFFHIFNTLYLLEKQIILASDRHPQKLDGVSDRLVSRFEGGILVEIE
LDNKTRFKIIKEKLKEFNLELRKEVIDYLLENTKNVREIEGKIKLIKLKGFEGLERKERK
ERDKLMQIVEFVANYYAVKVEDILSDKRNKRTSEARKIAMYLCRKVCSASLIEIARAFKR
KDHTTVIHAIRSVEEEKKKDRKFKHLVGFLEKQAFDKIC

# Drug_Target_62_Reaction:
Not Available

# Drug_Target_62_Signals:
None

# Drug_Target_62_Specific_Function:
Plays an important role in the initiation and regulation of chromosomal replication. Binds to the origin of replication; it binds specifically double-stranded DNA at a 9 bp consensus (dnaA box):5'-TTATC[CA]A[CA]A-3'. DnaA binds to ATP and to acidic phospholipids (By similarity)

# Drug_Target_62_SwissProt_ID:
O66659

# Drug_Target_62_SwissProt_Name:
DNAA_AQUAE

# Drug_Target_62_Synonyms:
Not Available

# Drug_Target_62_Theoretical_pI:
9.58

# Drug_Target_62_Transmembrane_Regions:
None

# Drug_Target_63_Cellular_Location:
Not Available

# Drug_Target_63_Chromosome_Location:
Not Available

# Drug_Target_63_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_63_Essentiality:
Non-Essential

# Drug_Target_63_GenAtlas_ID:
Not Available

# Drug_Target_63_GenBank_ID_Gene:
Not Available

# Drug_Target_63_GenBank_ID_Protein:
Not Available

# Drug_Target_63_GeneCard_ID:
Not Available

# Drug_Target_63_Gene_Name:
BCKDK

# Drug_Target_63_Gene_Sequence:
Not Available

# Drug_Target_63_General_Function:
Not Available

# Drug_Target_63_General_References:
Not Available

# Drug_Target_63_HGNC_ID:
Not Available

# Drug_Target_63_HPRD_ID:
Not Available

# Drug_Target_63_ID:
7081

# Drug_Target_63_Locus:
Not Available

# Drug_Target_63_Molecular_Weight:
Not Available

# Drug_Target_63_Name:
[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial

# Drug_Target_63_Number_of_Residues:
0

# Drug_Target_63_PDB_ID:
Not Available

# Drug_Target_63_Pathway:
Not Available

# Drug_Target_63_Pfam_Domain_Function:
Not Available

# Drug_Target_63_Protein_Sequence:
Not Available

# Drug_Target_63_Reaction:
Not Available

# Drug_Target_63_Signals:
Not Available

# Drug_Target_63_Specific_Function:
Not Available

# Drug_Target_63_SwissProt_ID:
O14874

# Drug_Target_63_SwissProt_Name:
BCKD_HUMAN

# Drug_Target_63_Synonyms:
Not Available

# Drug_Target_63_Theoretical_pI:
Not Available

# Drug_Target_63_Transmembrane_Regions:
Not Available

# Drug_Target_64_Cellular_Location:
Cytoplasm. Cell membrane

# Drug_Target_64_Chromosome_Location:
Not Available

# Drug_Target_64_Drug_References:
Not Available

# Drug_Target_64_Essentiality:
Non-Essential

# Drug_Target_64_GenAtlas_ID:
Not Available

# Drug_Target_64_GenBank_ID_Gene:
D10279

# Drug_Target_64_GenBank_ID_Protein:
Not Available

# Drug_Target_64_GeneCard_ID:
Not Available

# Drug_Target_64_Gene_Name:
secA

# Drug_Target_64_Gene_Sequence:
>2526 bp
ATGCTTGGAATTTTAAATAAAATGTTTGATCCAACAAAACGTACGCTGAATAGATACGAA
AAAATTGCTAACGATATTGATGCGATTCGCGGAGACTATGAAAATCTCTCTGACGACGCA
TTGAAACATAAAACAATTGAATTTAAAGAGCGTCTTGAAAAAGGGGCGACAACGGATGAT
CTTCTTGTTGAAGCTTTCGCTGTTGTTCGAGAAGCTTCACGCCGCGTAACAGGCATGTTT
CCGTTTAAAGTCCAGCTCATGGGGGGCGTGGCGCTTCATGACGGAAATATAGCGGAAATG
AAAACAGGGGAAGGGAAAACATTAACGTCTACCCTGCCTGTTTATTTAAATGCGTTAACC
GGTAAAGGCGTACACGTCGTGACTGTCAACGAATACTTGGCAAGCCGTGACGCTGAGCAA
ATGGGGAAAATTTTCGAGTTTCTCGGTTTGACTGTCGGTTTGAATTTAAACTCAATGTCA
AAAGACGAAAAACGGGAAGCTTATGCCGCTGATATTACTTACTCCACAAACAACGAGCTT
GGCTTCGACTATTTGCGTGACAATATGGTTCTTTATAAAGAGCAGATGGTTCAGCGCCCG
CTTCATTTTGCGGTAATAGATGAAGTTGACTCTATTTTAATTGATGAAGCAAGAACACCG
CTTATCATTTCTGGACAAGCTGCAAAATCCACTAAGCTGTACGTACAGGCAAATGCTTTT
GTCCGCACGTTAAAAGCGGAGAAGGATTACACGTACGATATCAAAACAAAAGCTGTACAG
CTTACTGAAGAAGGAATGACGAAGGCGGAAAAAGCATTCGGCATCGATAACCTCTTTGAT
GTGAAGCATGTCGCGCTCAACCACCATATCAACCAGGCCTTAAAAGCTCACGTTGCGATG
CAAAAGGACGTTGACTATGTAGTGGAAGACGGACAGGTTGTTATTGTTGATTCCTTCACG
GGACGTCTGATGAAAGGCCGCCGCTACAGTGAGGGGCTTCACCAAGCGATTGAAGCAAAG
GAAGGGCTTGAGATTCAAAACGAAAGCATGACCTTGGCGACGATTACGTTCCAAAACTAC
TTCCGAATGTACGAAAAACTTGCCGGTATGACGGGTACAGCTAAGACAGAGGAAGAAGAA
TTCCGCAACATCTACAACATGCAGGTTGTCACGATCCCTACCAACAGGCCTGTTGTCCGT
GATGACCGCCCGGATTTAATTTACCGCACGATGGAAGGAAAGTTTAAGGCAGTTGCGGAG
GATGTCGCACAGCGTTACATGACGGGACAGCCTGTTCTAGTCGGTACGGTTGCCGTTGAA
ACATCTGAATTGATTTCTAAGCTGCTTAAAAACAAAGGAATTCCGCATCAAGTGTTAAAT
GCCAAAAACCATGAACGTGAAGCGCAGATCATTGAAGAGGCCGGCCAAAAAGGCGCAGTT
ACGATTGCGACTAACATGGCGGGGCGCGGAACGGACATTAAGCTTGGCGAAGGTGTAAAA
GAGCTTGGCGGGCTCGCTGTAGTCGGAACAGAACGACATGAATCACGCCGGATTGACAAT
CAGCTTCGAGGTCGTTCCGGACGTCAGGGAGACCCGGGGATTACTCAATTTTATCTTTCT
ATGGAAGATGAATTGATGCGCAGATTCGGAGCTGAGCGGACAATGGCGATGCTTGACCGC
TTCGGCATGGACGACTCTACTCCAATCCAAAGCAAAATGGTATCTCGCGCGGTTGAATCG
TCTCAAAAACGCGTCGAAGGCAATAACTTCGATTCGCGTAAACAGCTTCTGCAATATGAT
GATGTTCTCCGCCAGCAGCGTGAGGTCATTTATAAGCAGCGCTTTGAAGTCATTGACTCT
GAAAACCTGCGTGAAATCGTTGAAAATATGATCAAGTCTTCTCTCGAACGCGCAATTGCA
GCCTATACGCCAAGAGAAGAGCTTCCTGAGGAGTGGAAGCTTGACGGTCTAGTTGATCTT
ATCAACACAACTTATCTTGATGAAGGTGCACTTGAGAAGAGCGATATCTTCGGCAAAGAA
CCGGATGAAATGCTTGAGCTCATTATGGATCGCATCATCACAAAATATAATGAGAAGGAA
GAGCAATTCGGCAAAGAGCAAATGCGCGAATTCGAAAAAGTTATCGTTCTTCGTGCCGTT
GATTCTAAATGGATGGATCATATTGATGCGATGGATCAGCTCCGCCAAGGGATTCACCTT
CGTGCTTACGCGCAGACGAACCCGCTTCGTGAGTATCAAATGGAAGGTTTTGCGATGTTT
GAGCATATGATTGAATCAATTGAGGACGAAGTCGCAAAATTTGTGATGAAAGCTGAGATT
GAAAACAATCTGGAGCGTGAAGAGGTTGTACAAGGTCAAACAACAGCTCATCAGCCGCAA
GAAGGCGACGATAACAAAAAAGCAAAGAAAGCACCGGTTCGCAAAGTGGTTGATATCGGA
CGAAATGCCCCATGCCACTGCGGAAGCGGGAAAAAATATAAAAATTGCTGCGGCCGTACT
GAATAG

# Drug_Target_64_General_Function:
Involved in nucleic acid binding

# Drug_Target_64_General_References:
1832735	Overhoff B, Klein M, Spies M, Freudl R: Identification of a gene fragment which codes for the 364 amino-terminal amino acid residues of a SecA homologue from Bacillus subtilis: further evidence for the conservation of the protein export apparatus in gram-positive and gram-negative bacteria. Mol Gen Genet. 1991 Sep;228(3):417-23.
1901557	Sadaie Y, Takamatsu H, Nakamura K, Yamane K: Sequencing reveals similarity of the wild-type div+ gene of Bacillus subtilis to the Escherichia coli secA gene. Gene. 1991 Feb 1;98(1):101-5.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_64_HGNC_ID:
Not Available

# Drug_Target_64_HPRD_ID:
Not Available

# Drug_Target_64_ID:
5277

# Drug_Target_64_Locus:
Not Available

# Drug_Target_64_Molecular_Weight:
95532

# Drug_Target_64_Name:
Preprotein translocase subunit secA

# Drug_Target_64_Number_of_Residues:
841

# Drug_Target_64_PDB_ID:
1TF5

# Drug_Target_64_Pathway:
Not Available

# Drug_Target_64_Pfam_Domain_Function:
PF00271	Helicase_C
PF01043	SecA_PP_bind
PF02810	SEC-C
PF07516	SecA_SW
PF07517	SecA_DEAD

# Drug_Target_64_Protein_Sequence:
>Preprotein translocase subunit secA
MLGILNKMFDPTKRTLNRYEKIANDIDAIRGDYENLSDDALKHKTIEFKERLEKGATTDD
LLVEAFAVVREASRRVTGMFPFKVQLMGGVALHDGNIAEMKTGEGKTLTSTLPVYLNALT
GKGVHVVTVNEYLASRDAEQMGKIFEFLGLTVGLNLNSMSKDEKREAYAADITYSTNNEL
GFDYLRDNMVLYKEQMVQRPLHFAVIDEVDSILIDEARTPLIISGQAAKSTKLYVQANAF
VRTLKAEKDYTYDIKTKAVQLTEEGMTKAEKAFGIDNLFDVKHVALNHHINQALKAHVAM
QKDVDYVVEDGQVVIVDSFTGRLMKGRRYSEGLHQAIEAKEGLEIQNESMTLATITFQNY
FRMYEKLAGMTGTAKTEEEEFRNIYNMQVVTIPTNRPVVRDDRPDLIYRTMEGKFKAVAE
DVAQRYMTGQPVLVGTVAVETSELISKLLKNKGIPHQVLNAKNHEREAQIIEEAGQKGAV
TIATNMAGRGTDIKLGEGVKELGGLAVVGTERHESRRIDNQLRGRSGRQGDPGITQFYLS
MEDELMRRFGAERTMAMLDRFGMDDSTPIQSKMVSRAVESSQKRVEGNNFDSRKQLLQYD
DVLRQQREVIYKQRFEVIDSENLREIVENMIKSSLERAIAAYTPREELPEEWKLDGLVDL
INTTYLDEGALEKSDIFGKEPDEMLELIMDRIITKYNEKEEQFGKEQMREFEKVIVLRAV
DSKWMDHIDAMDQLRQGIHLRAYAQTNPLREYQMEGFAMFEHMIESIEDEVAKFVMKAEI
ENNLEREEVVQGQTTAHQPQEGDDNKKAKKAPVRKVVDIGRNAPCHCGSGKKYKNCCGRT
E

# Drug_Target_64_Reaction:
Not Available

# Drug_Target_64_Signals:
None

# Drug_Target_64_Specific_Function:
Involved in protein export. Interacts with the secY/secE subunits. SecA has a central role in coupling the hydrolysis of ATP to the transfer of pre-secretory proteins across the membrane

# Drug_Target_64_SwissProt_ID:
P28366

# Drug_Target_64_SwissProt_Name:
SECA_BACSU

# Drug_Target_64_Synonyms:
Not Available

# Drug_Target_64_Theoretical_pI:
5.36

# Drug_Target_64_Transmembrane_Regions:
None

# Drug_Target_65_Cellular_Location:
Not Available

# Drug_Target_65_Chromosome_Location:
Not Available

# Drug_Target_65_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_65_Essentiality:
Non-Essential

# Drug_Target_65_GenAtlas_ID:
Not Available

# Drug_Target_65_GenBank_ID_Gene:
M32445

# Drug_Target_65_GenBank_ID_Protein:
146020

# Drug_Target_65_GeneCard_ID:
Not Available

# Drug_Target_65_Gene_Name:
folC

# Drug_Target_65_Gene_Sequence:
>1269 bp
ATGATTATCAAACGCACTCCTCAAGCCGCGTCGCCTCTGGCTTCGTGGCTTTCTTATCTG
GAAAACCTGCACAGTAAAACTATCGATCTCGGCCTTGAGCGCGTGAGCCTGGTCGCGGCG
CGTCTTGGCGTCCTGAAACCAGCGCCATTTGTGTTTACCGTTGCGGGTACGAATGGCAAA
GGCACCACCTGCCGTACGCTGGAGTCGATTCTGATGGCGGCAGGGTACAAAGTGGGCGTC
TACAGTTCGCCTCATCTGGTGCGTTATACCGAGCGCGTACGTGTGCAGGGCCAGGAATTG
CCGGAATCGGCCCACACCGCCTCTTTTGCGGAGATTGAATCGGCACGCGGTGATATTTCC
CTGACCTATTTCGAGTACGGTACGCTGTCGGCGTTGTGGCTGTTCAAGCAGGCACAACTT
GACGTGGTGATTCTGGAAGTAGGGCTGGGCGGTCGTCTGGACGCAACCAATATTGTCGAC
GCCGATGTCGCGGTAGTAACCAGTATTGCGCTGGATCATACCGACTGGCTGGGTCCAGAT
CGCGAAAGTATTGGTCGCGAGAAAGCAGGCATCTTCCGCAGCGAAAAACCGGCAATTGTC
GGTGAGCCGGAAATGCCTTCTACCATTGCTGATGTGGCGCAGGAAAAAGGTGCACTGTTA
CAACGTCGGGGCGTTGAGTGGAACTATTCCGTCACCGATCATGACTGGGCGTTTAGCGAT
GCTCACGGCACGCTGGAAAATCTGCCGTTGCCGCTTGTCCCGCAACCGAATGCCGCAACA
GCGCTGGCGGCACTGCGTGCCAGCGGGCTGGAAGTCAGTGAAAATGCCATTCGCGACGGG
ATTGCCAGCGCAATTTTGCCGGGACGTTTCCAGATTGTGAGCGAGTCGCCACGCGTTATT
TTTGATGTCGCGCATAATCCACATGCGGCGGAATATCTCACCGGGCGTATGAAAGCGCTA
CCGAAAAACGGGCGCATGCTGGCGGTTATCGGTATGCTACATGATAAAGATATTGCCGGA
ACTCTGGCCTGGTTGAAAAGCGTGGTTGATGACTGGTATTGTGCGCCACTGGAAGGGCCG
CGCGGTGCCACGGCAGAACAACTGCTTGAGCATTTGGGTAACGGCAAATCATTTGATAGC
GTTGCGCAGGCATGGGATGCCGCAATGGCGGACGCTAAAGCGGAAGACACCGTGCTGGTG
TGTGGTTCTTTCCACACGGTCGCACATGTCATGGAAGTGATTGACGCGAGGAGAAGCGGT
GGCAAGTAA

# Drug_Target_65_General_Function:
Coenzyme transport and metabolism

# Drug_Target_65_General_References:
1989505	Kimlova LJ, Pyne C, Keshavjee K, Huy J, Beebakhee G, Bognar AL: Mutagenesis of the folC gene encoding folylpolyglutamate synthetase-dihydrofolate synthetase in Escherichia coli. Arch Biochem Biophys. 1991 Jan;284(1):9-16.
3040734	Nonet ML, Marvel CC, Tolan DR: The hisT-purF region of the Escherichia coli K-12 chromosome. Identification of additional genes of the hisT and purF operons. J Biol Chem. 1987 Sep 5;262(25):12209-17.
3040739	Bognar AL, Osborne C, Shane B: Primary structure of the Escherichia coli folC gene and its folylpolyglutamate synthetase-dihydrofolate synthetase product and regulation of expression by an upstream gene. J Biol Chem. 1987 Sep 5;262(25):12337-43.
9205837	Yamamoto Y, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kimura S, Kitagawa M, Makino K, Miki T, Mitsuhashi N, Mizobuchi K, Mori H, Nakade S, Nakamura Y, Nashimoto H, Oshima T, Oyama S, Saito N, Sampei G, Satoh Y, Sivasundaram S, Tagami H, Horiuchi T, et al.: Construction of a contiguous 874-kb sequence of the Escherichia coli -K12 genome corresponding to 50.0-68.8 min on the linkage map and analysis of its sequence features. DNA Res. 1997 Apr 28;4(2):91-113.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_65_HGNC_ID:
Not Available

# Drug_Target_65_HPRD_ID:
Not Available

# Drug_Target_65_ID:
137

# Drug_Target_65_Locus:
Not Available

# Drug_Target_65_Molecular_Weight:
45406

# Drug_Target_65_Name:
FolC bifunctional protein [Includes: Folylpolyglutamate synthase

# Drug_Target_65_Number_of_Residues:
422

# Drug_Target_65_PDB_ID:
1W7K

# Drug_Target_65_Pathway:
Not Available

# Drug_Target_65_Pfam_Domain_Function:
PF02875	Mur_ligase_C
PF08245	Mur_ligase_M

# Drug_Target_65_Protein_Sequence:
>FolC bifunctional protein [Includes: Folylpolyglutamate synthase
MIIKRTPQAASPLASWLSYLENLHSKTIDLGLERVSLVAARLGVLKPAPFVFTVAGTNGK
GTTCRTLESILMAAGYKVGVYSSPHLVRYTERVRVQGQELPESAHTASFAEIESARGDIS
LTYFEYGTLSALWLFKQAQLDVVILEVGLGGRLDATNIVDADVAVVTSIALDHTDWLGPD
RESIGREKAGIFRSEKPAIVGEPEMPSTIADVAQEKGALLQRRGVEWNYSVTDHDWAFSD
AHGTLENLPLPLVPQPNAATALAALRASGLEVSENAIRDGIASAILPGRFQIVSESPRVI
FDVAHNPHAAEYLTGRMKALPKNGRVLAVIGMLHDKDIAGTLAWLKSVVDDWYCAPLEGP
RGATAEQLLEHLGNGKSFDSVAQAWDAAMADAKAEDTVLVCGSFHTVAHVMEVIDARRSG
GK

# Drug_Target_65_Reaction:
ATP + 7,8-dihydropteroate + L-glutamate = ADP + phosphate + 7,8-dihydropteroylglutamate

# Drug_Target_65_Signals:
None

# Drug_Target_65_Specific_Function:
Conversion of folates to polyglutamate derivatives

# Drug_Target_65_SwissProt_ID:
P08192

# Drug_Target_65_SwissProt_Name:
FOLC_ECOLI

# Drug_Target_65_Synonyms:
EC 6.3.2.17
FPGS
Folylpoly-gamma-glutamate synthetase
Tetrahydrofolate synthase

# Drug_Target_65_Theoretical_pI:
5.59

# Drug_Target_65_Transmembrane_Regions:
None

# Drug_Target_66_Cellular_Location:
Not Available

# Drug_Target_66_Chromosome_Location:
Not Available

# Drug_Target_66_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_66_Essentiality:
Non-Essential

# Drug_Target_66_GenAtlas_ID:
PAPSS1

# Drug_Target_66_GenBank_ID_Gene:
Y10387

# Drug_Target_66_GenBank_ID_Protein:
Not Available

# Drug_Target_66_GeneCard_ID:
Not Available

# Drug_Target_66_Gene_Name:
PAPSS1

# Drug_Target_66_Gene_Sequence:
>1875 bp
ATGGAGATCCCCGGGAGCTTGTGCAAGAAAGTCAAGCTGAGCAATAACGCGCAGAACTGG
GGAATGCAGAGAGCAACCAATGTCACCTACCAAGCCCATCATGTCAGCAGGAACAAGAGA
GGTCAGGTGGTGGGGACCAGAGGTGGCTTTCGTGGTTGCACAGTTTGGCTAACAGGCTTG
TCTGGAGCGGGAAAGACTACTGTGAGCATGGCCTTGGAGGAGTACCTGGTTTGTCATGGT
ATTCCATGCTACACTCTGGATGGTGACAATATTCGTCAAGGTCTCAATAAAAATCTTGGC
TTTAGTCCTGAAGACAGAGAAGAGAATGTTCGACGCATCGCAGAAGTTGCTAAACTGTTT
GCAGATGCTGGCTTAGTGTGCATCACAAGTTTCATATCACCTTACACTCAGGATCGCAAC
AATGCAAGGCAAATTCATGAAGGTGCAAGTTTACCGTTTTTTGAAGTATTTGTTGATGCT
CCTCTGCATGTTTGTGAACAGAGGGATGTCAAAGGACTCTACAAAAAAGCCCGGGCAGGA
GAAATTAAAGGTTTCACTGGGATCGATTCTGAATATGAAAAGCCAGAGGCCCCTGAGTTG
GTGCTGAAAACAGACTCCTGTGATGTAAATGACTGTGTCCAGCAAGTTGTGGAACTTCTA
CAGGAACGGGATATTGTACCTGTGGATGCATCTTATGAAGTAAAAGAACTATATGTGCCA
GAAAATAAACTTCATTTGGCAAAAACAGATGCGGAAACATTACCAGCACTGAAAATTAAT
AAAGTGGATATGCAGTGGGTGCAGGTTTTGGCAGAAGGTTGGGCAACCCCATTGAATGGC
TTTATGAGAGAGAGGGAGTACTTGCAGTGCCTTCATTTTGATTGTCTTCTGGATGGAGGT
GTCATTAACTTGTCAGTACCTATAGTTCTGACTGCGACTCATGAAGATAAAGAGAGGCTG
GACGGCTGTACAGCATTTGCTCTGATGTATGAGGGCCGCCGTGTGGCCATTCTTCGCAAT
CCAGAGTTTTTTGAGCACAGGAAAGAGGAGCGCTGTGCCAGACAGTGGGGAACGACATGC
AAGAACCACCCCTATATTAAGATGGTGATGGAACAAGGAGATTGGCTGATTGGAGGAGAT
CTTCAAGTCTTGGATCGAGTTTATTGGAATGATGGTCTTGATCAGTATCGTCTTACTCCT
ACTGAGCTAAAGCAGAAATTTAAAGATATGAATGCTGATGCTGTCTTTGCATTTCAACTA
CGCAACCCAGTGCACAATGGACATGCCCTGTTAATGCAGGATACCCATAAGCAACTTCTA
GAGAGGGGCTACCGGCGCCCTGTCCTCCTCCTCCACCCTCTGGGTGCTTGGACAAAGGAT
GACGATGTTCCTTTGATGTGGCGTATGAAGCAGCATGCTGCAGTGTTGGAGGAAGGAGTT
CTGAATCCTGAGACGACAGTGGTGGCCATCTTCCCATCTCCCATGATGTATGCTGGACCA
ACTGAGGTCCAGTGGCATTGCAGAGCACGGATGGTTGCAGGAGCCAACTTTTACATTGTT
GGACGAGACCCTGCTGGCATGCCTCATCCAGAAACAGGGAAGGATCTTTATGAGCCAAGT
CATGGTGCCAAAGTGCTGACGATGGCCCCTGGTTTAATCACTTTGGAAATAGTTCCCTTT
CGAGTTGCAGCTTACAACAAGAAAAAGAAGCGTATGGACTACTATGACTCTGAACACCAT
GAAGACTTTGAATTTATTTCAGGAACACGAATGCGCAAACTTGCTCGAGAAGGCCAGAAA
CCACCTGAAGGTTTCATGGCTCCCAAGGCTTGGACCGTGCTGACAGAATACTACAAATCC
TTGGAGAAAGCTTAG

# Drug_Target_66_General_Function:
Involved in ATP binding

# Drug_Target_66_General_References:
10679223	Xu ZH, Otterness DM, Freimuth RR, Carlini EJ, Wood TC, Mitchell S, Moon E, Kim UJ, Xu JP, Siciliano MJ, Weinshilboum RM: Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPSS1) and PAPSS2: gene cloning, characterization and chromosomal localization. Biochem Biophys Res Commun. 2000 Feb 16;268(2):437-44.
9576487	Girard JP, Baekkevold ES, Amalric F: Sulfation in high endothelial venules: cloning and expression of the human PAPS synthetase. FASEB J. 1998 May;12(7):603-12.
9648242	Yanagisawa K, Sakakibara Y, Suiko M, Takami Y, Nakayama T, Nakajima H, Takayanagi K, Natori Y, Liu MC: cDNA cloning, expression, and characterization of the human bifunctional ATP sulfurylase/adenosine 5'-phosphosulfate kinase enzyme. Biosci Biotechnol Biochem. 1998 May;62(5):1037-40.
9668121	Venkatachalam KV, Akita H, Strott CA: Molecular cloning, expression, and characterization of human bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase and its functional domains. J Biol Chem. 1998 Jul 24;273(30):19311-20.
9915785	Venkatachalam KV, Fuda H, Koonin EV, Strott CA: Site-selected mutagenesis of a conserved nucleotide binding HXGH motif located in the ATP sulfurylase domain of human bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase. J Biol Chem. 1999 Jan 29;274(5):2601-4.

# Drug_Target_66_HGNC_ID:
HGNC:8603

# Drug_Target_66_HPRD_ID:
Not Available

# Drug_Target_66_ID:
5278

# Drug_Target_66_Locus:
4q24

# Drug_Target_66_Molecular_Weight:
70834

# Drug_Target_66_Name:
Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthetase 1

# Drug_Target_66_Number_of_Residues:
624

# Drug_Target_66_PDB_ID:
1X6V

# Drug_Target_66_Pathway:
Not Available

# Drug_Target_66_Pfam_Domain_Function:
PF01583	APS_kinase
PF01747	ATP-sulfurylase

# Drug_Target_66_Protein_Sequence:
>Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthetase 1
MEIPGSLCKKVKLSNNAQNWGMQRATNVTYQAHHVSRNKRGQVVGTRGGFRGCTVWLTGL
SGAGKTTVSMALEEYLVCHGIPCYTLDGDNIRQGLNKNLGFSPEDREENVRRIAEVAKLF
ADAGLVCITSFISPYTQDRNNARQIHEGASLPFFEVFVDAPLHVCEQRDVKGLYKKARAG
EIKGFTGIDSEYEKPEAPELVLKTDSCDVNDCVQQVVELLQERDIVPVDASYEVKELYVP
ENKLHLAKTDAETLPALKINKVDMQWVQVLAEGWATPLNGFMREREYLQCLHFDCLLDGG
VINLSVPIVLTATHEDKERLDGCTAFALMYEGRRVAILRNPEFFEHRKEERCARQWGTTC
KNHPYIKMVMEQGDWLIGGDLQVLDRVYWNDGLDQYRLTPTELKQKFKDMNADAVFAFQL
RNPVHNGHALLMQDTHKQLLERGYRRPVLLLHPLGGWTKDDDVPLMWRMKQHAAVLEEGV
LNPETTVVAIFPSPMMYAGPTEVQWHCRARMVAGANFYIVGRDPAGMPHPETGKDLYEPS
HGAKVLTMAPGLITLEIVPFRVAAYNKKKKRMDYYDSEHHEDFEFISGTRMRKLAREGQK
PPEGFMAPKAWTVLTEYYKSLEKA

# Drug_Target_66_Reaction:
Not Available

# Drug_Target_66_Signals:
None

# Drug_Target_66_Specific_Function:
Bifunctional enzyme with both ATP sulfurylase and APS kinase activity, which mediates two steps in the sulfate activation pathway. The first step is the transfer of a sulfate group to ATP to yield adenosine 5'-phosphosulfate (APS), and the second step is the transfer of a phosphate group from ATP to APS yielding 3'-phosphoadenylylsulfate (PAPS:activated sulfate donor used by sulfotransferase). In mammals, PAPS is the sole source of sulfate; APS appears to be only an intermediate in the sulfate- activation pathway. Also involved in the biosynthesis of sulfated L-selectin ligands in endothelial cells

# Drug_Target_66_SwissProt_ID:
O43252

# Drug_Target_66_SwissProt_Name:
PAPS1_HUMAN

# Drug_Target_66_Synonyms:
PAPS synthetase 1
PAPSS 1
SK 1
SK1
Sulfurylase kinase 1

# Drug_Target_66_Theoretical_pI:
6.85

# Drug_Target_66_Transmembrane_Regions:
None

# Drug_Target_67_Cellular_Location:
Cytoplasmic

# Drug_Target_67_Chromosome_Location:
Not Available

# Drug_Target_67_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_67_Essentiality:
Non-Essential

# Drug_Target_67_GenAtlas_ID:
Not Available

# Drug_Target_67_GenBank_ID_Gene:
U38840

# Drug_Target_67_GenBank_ID_Protein:
1063668

# Drug_Target_67_GeneCard_ID:
Not Available

# Drug_Target_67_Gene_Name:
ruvB

# Drug_Target_67_Gene_Sequence:
>1005 bp
GTGAGTGAATTTCTCACACCTGAAAGGACCGTTTACGACTCTGGTGTACAGTTTCTAAGG
CCCAAAAGCCTCGATGAATTCATTGGTCAGGAAAACGTGAAAAAGAAACTCTCCCTCGCT
CTCGAAGCCGCGAAGATGAGGGGAGAAGTGCTCGATCATGTCCTCCTCGCAGGACCACCG
GGACTCGGAAAGACGACCCTTGCACACATAATCGCCAGCGAACTCCAGACGAACATCCAC
GTTACGAGCGGACCGGTTCTTGTGAAACAGGGAGATATGGCCGCTATCCTCACAAGTCTG
GAACGGGGAGACGTTCTTTTCATAGACGAAATACACCGATTGAACAAGGCAGTGGAAGAG
CTTCTTTACTCTGCCATCGAAGACTTCCAGATAGACATCATGATCGGAAAGGGCCCGAGT
GCAAAGTCCATTAGGATAGACATCCAGCCTTTTACGCTCGTTGGAGCCACGACGAGAAGT
GGTCTTTTGAGTTCTCCTCTCAGAAGCAGGTTTGGTATCATCCTCGAACTGGACTTCTAC
ACTGTGAAAGAACTGAAGGAAATCATAAAAAGAGCGGCCAGCTTGATGGACGTTGAGATA
GAAGACGCAGCAGCAGAGATGATCGCGAAAAGATCGAGAGGCACACCGAGGATCGCTATA
AGACTCACGAAGAGAGTGAGGGACATGCTCACGGTGGTAAAGGCAGACAGAATCAATACC
GATATCGTTTTGAAGACCATGGAAGTTCTGAACATAGACGACGAGGGACTTGATGAGTTC
GACAGGAAGATCCTGAAGACGATCATAGAGATTTACAGGGGAGGCCCCGTCGGATTGAAC
GCCCTCGCCGCTTCACTCGGTGTAGAAGCGGACACCCTGAGCGAAGTTTATGAACCTTAC
CTCCTCCAGGCAGGATTCCTCGCCAGAACTCCCAGAGGAAGGATCGTCACTGAAAAGGCT
TACAAACACCTGAAGTACGAAGTCCCGGAAAACCGTCTTTTCTGA

# Drug_Target_67_General_Function:
Involved in nucleotide binding

# Drug_Target_67_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.
8626340	Tong J, Wetmur JG: Cloning, sequencing, and expression of ruvB and characterization of RuvB proteins from two distantly related thermophilic eubacteria. J Bacteriol. 1996 May;178(9):2695-700.

# Drug_Target_67_HGNC_ID:
Not Available

# Drug_Target_67_HPRD_ID:
Not Available

# Drug_Target_67_ID:
2751

# Drug_Target_67_Locus:
Not Available

# Drug_Target_67_Molecular_Weight:
37157

# Drug_Target_67_Name:
Holliday junction ATP-dependent DNA helicase ruvB

# Drug_Target_67_Number_of_Residues:
334

# Drug_Target_67_PDB_ID:
1IN4

# Drug_Target_67_Pathway:
Not Available

# Drug_Target_67_Pfam_Domain_Function:
PF00004	AAA
PF05491	RuvB_C
PF05496	RuvB_N

# Drug_Target_67_Protein_Sequence:
>Holliday junction ATP-dependent DNA helicase ruvB
MSEFLTPERTVYDSGVQFLRPKSLDEFIGQENVKKKLSLALEAAKMRGEVLDHVLLAGPP
GLGKTTLAHIIASELQTNIHVTSGPVLVKQGDMAAILTSLERGDVLFIDEIHRLNKAVEE
LLYSAIEDFQIDIMIGKGPSAKSIRIDIQPFTLVGATTRSGLLSSPLRSRFGIILELDFY
TVKELKEIIKRAASLMDVEIEDAAAEMIAKRSRGTPRIAIRLTKRVRDMLTVVKADRINT
DIVLKTMEVLNIDDEGLDEFDRKILKTIIEIYRGGPVGLNALAASLGVEADTLSEVYEPY
LLQAGFLARTPRGRIVTEKAYKHLKYEVPENRLF

# Drug_Target_67_Reaction:
Not Available

# Drug_Target_67_Signals:
None

# Drug_Target_67_Specific_Function:
The ruvA-ruvB complex in the presence of ATP renatures cruciform structure in supercoiled DNA with palindromic sequence, indicating that it may promote strand exchange reactions in homologous recombination. RuvAB is an helicase that mediates the Holliday junction migration by localized denaturation and reannealing

# Drug_Target_67_SwissProt_ID:
Q56313

# Drug_Target_67_SwissProt_Name:
RUVB_THEMA

# Drug_Target_67_Synonyms:
EC 3.6.1.-

# Drug_Target_67_Theoretical_pI:
6.39

# Drug_Target_67_Transmembrane_Regions:
None

# Drug_Target_68_Cellular_Location:
Not Available

# Drug_Target_68_Chromosome_Location:
Not Available

# Drug_Target_68_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_68_Essentiality:
Non-Essential

# Drug_Target_68_GenAtlas_ID:
Not Available

# Drug_Target_68_GenBank_ID_Gene:
Not Available

# Drug_Target_68_GenBank_ID_Protein:
Not Available

# Drug_Target_68_GeneCard_ID:
Not Available

# Drug_Target_68_Gene_Name:
lysX

# Drug_Target_68_Gene_Sequence:
Not Available

# Drug_Target_68_General_Function:
Not Available

# Drug_Target_68_General_References:
Not Available

# Drug_Target_68_HGNC_ID:
Not Available

# Drug_Target_68_HPRD_ID:
Not Available

# Drug_Target_68_ID:
7121

# Drug_Target_68_Locus:
Not Available

# Drug_Target_68_Molecular_Weight:
Not Available

# Drug_Target_68_Name:
Alpha-aminoadipate--lysW ligase lysX

# Drug_Target_68_Number_of_Residues:
0

# Drug_Target_68_PDB_ID:
Not Available

# Drug_Target_68_Pathway:
Not Available

# Drug_Target_68_Pfam_Domain_Function:
Not Available

# Drug_Target_68_Protein_Sequence:
Not Available

# Drug_Target_68_Reaction:
Not Available

# Drug_Target_68_Signals:
Not Available

# Drug_Target_68_Specific_Function:
Not Available

# Drug_Target_68_SwissProt_ID:
Q5SH23

# Drug_Target_68_SwissProt_Name:
LYSX_THET8

# Drug_Target_68_Synonyms:
Not Available

# Drug_Target_68_Theoretical_pI:
Not Available

# Drug_Target_68_Transmembrane_Regions:
Not Available

# Drug_Target_69_Cellular_Location:
Cytoplasm

# Drug_Target_69_Chromosome_Location:
Not Available

# Drug_Target_69_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_69_Essentiality:
Non-Essential

# Drug_Target_69_GenAtlas_ID:
Not Available

# Drug_Target_69_GenBank_ID_Gene:
X51584

# Drug_Target_69_GenBank_ID_Protein:
42060

# Drug_Target_69_GeneCard_ID:
Not Available

# Drug_Target_69_Gene_Name:
murD

# Drug_Target_69_Gene_Sequence:
>1317 bp
ATGGCTGATTATCAGGGTAAAAATGTCGTCATTATCGGCCTGGGCCTCACCGGGCTTTCC
TGCGTGGACTTTTTCCTCGCTCGCGGTGTGACGCCGCGCGTTATGGATACGCGTATGACA
CCGCCTGGCCTGGATAAATTACCCGAAGCCGTAGAACGCCACACGGGCAGTCTGAATGAT
GAATGGCTGATGGCGGCAGATCTGATTGTCGCCAGTCCCGGTATTGCACTGGCGCATCCA
TCCTTAAGCGCTGCCGCTGATGCCGGAATCGAAATCGTTGGCGATATCGAGCTGTTCTGT
CGCGAAGCACAAGCACCGATTGTGGCGATTACCGGTTCTAACGGCAAAAGCACGGTCACC
ACGCTAGTGGGTGAAATGGCGAAAGCGGCGGGGGTTAACGTTGGTGTGGGTGGCAATATT
GGCCTGCCTGCGTTGATGCTACTGGATGATGAGTGTGAACTGTACGTGCTGGAACTGTCG
AGCTTCCAGCTGGAAACCACCTCCAGCTTACAGGCGGTAGCAGCGACCATTCTGAACGTG
ACTGAAGATCATATGGATCGCTATCCGTTTGGTTTACAACAGTATCGTGCAGCAAAACTG
CGCATTTACGAAAACGCGAAAGTTTGCGTGGTTAATGCTGATGATGCCTTAACAATGCCG
ATTCGCGGTGCGGATGAACGCTGCGTCAGCTTTGGCGTCAACATGGGTGACTATCACCTG
AATCATCAGCAGGGCGAAACCTGGCTGCGGGTTAAAGGCGAGAAAGTGCTGAATGTGAAA
GAGATGAAACTTTCCGGGCAGCATAACTACACCAATGCGCTGGCGGCGCTGGCGCTGGCA
GATGCTGCAGGGTTACCGCGTGCCAGCAGCCTGAAAGCGTTAACCACATTCACTGGTCTG
CCGCATCGCTTTGAAGTTGTGCTGGAGCATAACGGCGTACGTTGGATTAACGATTCGAAA
GCGACCAACGTCGGCAGTACGGAAGCGGCGCTGAATGGCCTGCACGTAGACGGCACACTG
CATTTGTTGCTGGGTGGCGATGGTAAATCGGCGGACTTTAGCCCACTGGCGCGTTACCTG
AATGGCGATAACGTACGTCTGTATTGTTTCGGTCGTGACGGCGCGCAGCTGGCGGCGCTA
CGCCCGGAAGTGGCAGAACAAACCGAAACTATGGAACAGGCGATGCGCTTGCTGGCTCCG
CGTGTTCAGCCGGGCGATATGGTTCTGCTCTCCCCAGCCTGTGCCAGCCTTGATCAGTTC
AAGAACTTTGAACAACGAGGCAATGAGTTTGCCCGTCTGGCGAAGGAGTTAGGTTGA

# Drug_Target_69_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_69_General_References:
10966819	Bertrand JA, Fanchon E, Martin L, Chantalat L, Auger G, Blanot D, van Heijenoort J, Dideberg O: "Open" structures of MurD: domain movements and structural similarities with folylpolyglutamate synthetase. J Mol Biol. 2000 Sep 1;301(5):1257-66.
1630901	Yura T, Mori H, Nagai H, Nagata T, Ishihama A, Fujita N, Isono K, Mizobuchi K, Nakata A: Systematic sequencing of the Escherichia coli genome: analysis of the 0-2.4 min region. Nucleic Acids Res. 1992 Jul 11;20(13):3305-8.
1765076	Pratviel-Sosa F, Mengin-Lecreulx D, van Heijenoort J: Over-production, purification and properties of the uridine diphosphate N-acetylmuramoyl-L-alanine:D-glutamate ligase from Escherichia coli. Eur J Biochem. 1991 Dec 18;202(3):1169-76.
2129548	Mengin-Lecreulx D, van Heijenoort J: Nucleotide sequence of the murD gene encoding the UDP-MurNAc-L-Ala-D-Glu synthetase of Escherichia coli. Nucleic Acids Res. 1990 Jan 11;18(1):183.
2179861	Ikeda M, Wachi M, Ishino F, Matsuhashi M: Nucleotide sequence involving murD and an open reading frame ORF-Y spacing murF and ftsW in Escherichia coli. Nucleic Acids Res. 1990 Feb 25;18(4):1058.
2509435	Ikeda M, Sato T, Wachi M, Jung HK, Ishino F, Kobayashi Y, Matsuhashi M: Structural similarity among Escherichia coli FtsW and RodA proteins and Bacillus subtilis SpoVE protein, which function in cell division, cell elongation, and spore formation, respectively. J Bacteriol. 1989 Nov;171(11):6375-8.
9218784	Bertrand JA, Auger G, Fanchon E, Martin L, Blanot D, van Heijenoort J, Dideberg O: Crystal structure of UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase from Escherichia coli. EMBO J. 1997 Jun 16;16(12):3416-25.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_69_HGNC_ID:
Not Available

# Drug_Target_69_HPRD_ID:
Not Available

# Drug_Target_69_ID:
2317

# Drug_Target_69_Locus:
Not Available

# Drug_Target_69_Molecular_Weight:
46974

# Drug_Target_69_Name:
UDP-N-acetylmuramoylalanine--D-glutamate ligase

# Drug_Target_69_Number_of_Residues:
438

# Drug_Target_69_PDB_ID:
1EEH

# Drug_Target_69_Pathway:
Not Available

# Drug_Target_69_Pfam_Domain_Function:
PF02875	Mur_ligase_C
PF08245	Mur_ligase_M

# Drug_Target_69_Protein_Sequence:
>UDP-N-acetylmuramoylalanine--D-glutamate ligase
MADYQGKNVVIIGLGLTGLSCVDFFLARGVTPRVMDTRMTPPGLDKLPEAVERHTGSLND
EWLMAADLIVASPGIALAHPSLSAAADAGIEIVGDIELFCREAQAPIVAITGSNGKSTVT
TLVGEMAKAAGVNVGVGGNIGLPALMLLDDECELYVLELSSFQLETTSSLQAVAATILNV
TEDHMDRYPFGLQQYRAAKLRIYENAKVCVVNADDALTMPIRGADERCVSFGVNMGDYHL
NHQQGETWLRVKGEKVLNVKEMKLSGQHNYTNALAALALADAAGLPRASSLKALTTFTGL
PHRFEVVLEHNGVRWINDSKATNVGSTEAALNGLHVDGTLHLLLGGDGKSADFSPLARYL
NGDNVRLYCFGRDGAQLAALRPEVAEQTETMEQAMRLLAPRVQPGDMVLLSPACASLDQF
KNFEQRGNEFARLAKELG

# Drug_Target_69_Reaction:
ATP + UDP-N-acetylmuramoyl-L-alanine + D-glutamate = ADP + phosphate + UDP-N-acetylmuramoyl-L-alanyl-D-glutamate

# Drug_Target_69_Signals:
None

# Drug_Target_69_Specific_Function:
Cell wall formation. Catalyzes the addition of glutamate to the nucleotide precursor UDP-N-acetylmuramoyl-L-alanine (UMA)

# Drug_Target_69_SwissProt_ID:
P14900

# Drug_Target_69_SwissProt_Name:
MURD_ECOLI

# Drug_Target_69_Synonyms:
D-glutamic acid- adding enzyme
EC 6.3.2.9
UDP-N- acetylmuramoyl-L-alanyl-D-glutamate synthetase

# Drug_Target_69_Theoretical_pI:
4.96

# Drug_Target_69_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
Not Available

# Drug_Target_6_GenBank_ID_Protein:
Not Available

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
KIF2C

# Drug_Target_6_Gene_Sequence:
Not Available

# Drug_Target_6_General_Function:
Not Available

# Drug_Target_6_General_References:
Not Available

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
7132

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
Not Available

# Drug_Target_6_Name:
Kinesin-like protein KIF2C

# Drug_Target_6_Number_of_Residues:
0

# Drug_Target_6_PDB_ID:
Not Available

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
Not Available

# Drug_Target_6_Protein_Sequence:
Not Available

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
Not Available

# Drug_Target_6_Specific_Function:
Not Available

# Drug_Target_6_SwissProt_ID:
Q99661

# Drug_Target_6_SwissProt_Name:
KIF2C_HUMAN

# Drug_Target_6_Synonyms:
Not Available

# Drug_Target_6_Theoretical_pI:
Not Available

# Drug_Target_6_Transmembrane_Regions:
Not Available

# Drug_Target_70_Cellular_Location:
Not Available

# Drug_Target_70_Chromosome_Location:
Not Available

# Drug_Target_70_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_70_Essentiality:
Non-Essential

# Drug_Target_70_GenAtlas_ID:
Not Available

# Drug_Target_70_GenBank_ID_Gene:
L20897

# Drug_Target_70_GenBank_ID_Protein:
304887

# Drug_Target_70_GeneCard_ID:
Not Available

# Drug_Target_70_Gene_Name:
purT

# Drug_Target_70_Gene_Sequence:
>1179 bp
ATGACGTTATTAGGCACTGCGCTGCGTCCGGCAGCAACTCGCGTGATGTTATTAGGCTCC
GGTGAACTGGGTAAAGAAGTGGCAATCGAGTGTCAGCGTCTCGGCGTAGAGGTGATTGCC
GTCGATCGCTATGCCGACGCACCAGCCATGCATGTCGCGCATCGCTCCCATGTCATTAAT
ATGCTTGATGGTGATGCATTACGCCGTGTGGTTGAACTGGAAAAACCACATTATATCGTG
CCGGAGATCGAAGCTATTGCCACCGATATGCTGATCCAACTTGAAGAGGAAGGACTGAAT
GTTGTCCCCTGCGCTCGCGCAACGAAATTAACGATGAATCGCGAGGGTATCCGTCGCCTG
GCGGCAGAAGAGCTGCAGCTGCCCACTTCCACTTATCGTTTTGCCGATAGCGAAAGCCTT
TTCCGCGAGGCGGTTGCTGACATTGGCTATCCCTGCATTGTAAAACCGGTGATGAGCTCT
TCCGGCAAGGGGCAGACGTTTATTCGTTCTGCAGAGCAACTTGCTCAGGCATGGAAGTAC
GCTCAGCAAGGCGGTCGCGCCGGAGCGGGCCGCGTAATTGTTGAAGGCGTCGTTAAGTTT
GACTTCGAAATTACCCTGCTAACCGTCAGCGCGGTGGATGGCGTCCATTTCTGTGCACCA
GTAGGTCATCGCCAGGAAGATGGCGACTACCGTGAATCCTGGCAACCACAGCAAATGAGC
CCGCTTGCCCTTGAACGTGCGCAGGAGATTGCCCGTAAAGTGGTGCTGGCACTGGGCGGT
TATGGGTTGTTTGGTGTCGAGCTATTTGTCTGTGGTGATGAGGTGATTTTCAGTGAGGTC
TCCCCTCGTCCACATGATACCGGGATGGTGACGTTAATTTCTCAAGATCTCTCAGAGTTT
GCCCTGCATGTACGTGCCTTCCTCGGACTTCCGGTTGGCGGGATCCGTCAGTATGGTCCT
GCAGCTTCTGCCGTTATTCTGCCACAACTGACCAGTCAGAATGTCACGTTTGATAATGTG
CAGAATGCCGTAGGCGCAGATTTGCAGATTCGTTTATTTGGTAAGCCGGAAATTGATGGC
AGCCGTCGTCTGGGGGTGGCACTGGCTACTGCAGAGAGTGTTGTTGACGCCATTGAACGC
GCGAAGCACGCCGCCGGACAGGTAAAAGTACAGGGTTAA

# Drug_Target_70_General_Function:
Nucleotide transport and metabolism

# Drug_Target_70_General_References:
10913290	Thoden JB, Firestine S, Nixon A, Benkovic SJ, Holden HM: Molecular structure of Escherichia coli PurT-encoded glycinamide ribonucleotide transformylase. Biochemistry. 2000 Aug 1;39(30):8791-802.
8117714	Marolewski A, Smith JM, Benkovic SJ: Cloning and characterization of a new purine biosynthetic enzyme: a non-folate glycinamide ribonucleotide transformylase from E. coli. Biochemistry. 1994 Mar 8;33(9):2531-7.
9097040	Itoh T, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Kasai H, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Seki Y, Horiuchi T, et al.: A 460-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 40.1-50.0 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):379-92.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_70_HGNC_ID:
Not Available

# Drug_Target_70_HPRD_ID:
Not Available

# Drug_Target_70_ID:
2817

# Drug_Target_70_Locus:
Not Available

# Drug_Target_70_Molecular_Weight:
42434

# Drug_Target_70_Name:
Phosphoribosylglycinamide formyltransferase 2

# Drug_Target_70_Number_of_Residues:
392

# Drug_Target_70_PDB_ID:
1EZ1

# Drug_Target_70_Pathway:
Not Available

# Drug_Target_70_Pfam_Domain_Function:
PF02222	ATP-grasp

# Drug_Target_70_Protein_Sequence:
>Phosphoribosylglycinamide formyltransferase 2
MTLLGTALRPAATRVMLLGSGELGKEVAIECQRLGVEVIAVDRYADAPAMHVAHRSHVIN
MLDGDALRRVVELEKPHYIVPEIEAIATDMLIQLEEEGLNVVPCARATKLTMNREGIRRL
AAEELQLPTSTYRFADSESLFREAVADIGYPCIVKPVMSSSGKGQTFIRSAEQLAQAWKY
AQQGGRAGAGRVIVEGVVKFDFEITLLTVSAVDGVHFCAPVGHRQEDGDYRESWQPQQMS
PLALERAQEIARKVVLALGGYGLFGVELFVCGDEVIFSEVSPRPHDTGMVTLISQDLSEF
ALHVRAFLGLPVGGIRQYGPAASAVILPQLTSQNVTFDNVQNAVGADLQIRLFGKPEIDG
SRRLGVALATAESVVDAIERAKHAAGQVKVQG

# Drug_Target_70_Reaction:
Not Available

# Drug_Target_70_Signals:
None

# Drug_Target_70_Specific_Function:
Catalyzes two reactions:the first one is the production of beta-formyl glycinamide ribonucleotide (GAR) from formate, ATP and beta GAR; the second, a side reaction, is the production of acetyl phosphate and ADP from acetate and ATP

# Drug_Target_70_SwissProt_ID:
P33221

# Drug_Target_70_SwissProt_Name:
PURT_ECOLI

# Drug_Target_70_Synonyms:
5'-phosphoribosylglycinamide transformylase 2
EC 2.1.2.-
Formate-dependent GAR transformylase
GAR transformylase 2
GART 2

# Drug_Target_70_Theoretical_pI:
5.46

# Drug_Target_70_Transmembrane_Regions:
None

# Drug_Target_71_Cellular_Location:
Not Available

# Drug_Target_71_Chromosome_Location:
Not Available

# Drug_Target_71_Drug_References:
Not Available

# Drug_Target_71_Essentiality:
Non-Essential

# Drug_Target_71_GenAtlas_ID:
Not Available

# Drug_Target_71_GenBank_ID_Gene:
X12777

# Drug_Target_71_GenBank_ID_Protein:
Not Available

# Drug_Target_71_GeneCard_ID:
Not Available

# Drug_Target_71_Gene_Name:
parM

# Drug_Target_71_Gene_Sequence:
>963 bp
ATGTTGGTATTCATTGATGACGGTTCAACAAACATCAAACTACAGTGGCAGGAAAGCGAC
GGAACAATTAAACAGCACATTAGCCCGAACAGCTTCAAACGCGAGTGGGCAGTCTCTTTT
GGTGATAAAAAGGTCTTTAACTACACACTGAACGGCGAACAGTATTCATTTGATCCAATC
AGCCCGGATGCTGTAGTCACAACCAATATCGCATGGCAATACAGCGACGTTAATGTCGTT
GCAGTGCATCACGCCTTACTGACCAGTGGTCTGCCGGTAAGCGAAGTGGATATTGTTTGC
ACACTTCCTCTGACAGAGTATTACGACAGAAATAACCAACCCAATACGGAAAATATTGAG
CGTAAGAAAGCAAACTTCCGGAAAAAAATTACATTAAATGGCGGGGATACATTCACAATA
AAAGATGTAAAAGTCATGCCTGAATCTATACCGGCAGGTTATGAAGTTCTACAAGAACTG
GATGAGTTAGATTCTTTATTAATTATAGATCTCGGGGGCACCACATTAGATATTTCTCAG
GTAATGGGGAAATTATCGGGGATCAGTAAAATATACGGAGACTCATCTCTTGGTGTCTCT
CTGGTTACATCTGCAGTAAAAGATGCCCTTTCTCTTGCGAGAACAAAAGGAAGTAGCTAT
CTTGCTGACGATATAATCATTCACAGAAAAGATAATAACTATCTGAAGCAACGAATTAAT
GATGAGAACAAAATATCAATAGTCACCGAAGCAATGAATGAAGCACTTCGTAAACTTGAG
CAACGTGTATTAAATACGCTCAATGAATTTTCTGGTTATACTCATGTTATGGTTATAGGC
GGTGGCGCAGAATTAATATGCGATGCAGTAAAAAAACACACACAGATTCGTGATGAACGT
TTTTTCAAAACCAATAACTCTCAATATGATTTAGTTAACGGTATGTATCTCATAGGTAAT
TAA

# Drug_Target_71_General_Function:
Not Available

# Drug_Target_71_General_References:
12486014	van den Ent F, Moller-Jensen J, Amos LA, Gerdes K, Lowe J: F-actin-like filaments formed by plasmid segregation protein ParM. EMBO J. 2002 Dec 16;21(24):6935-43.
3023637	Gerdes K, Molin S: Partitioning of plasmid R1. Structural and functional analysis of the parA locus. J Mol Biol. 1986 Aug 5;190(3):269-79.
3172224	Tabuchi A, Min YN, Kim CK, Fan YL, Womble DD, Rownd RH: Genetic organization and nucleotide sequence of the stability locus of IncFII plasmid NR1. J Mol Biol. 1988 Aug 5;202(3):511-25.

# Drug_Target_71_HGNC_ID:
Not Available

# Drug_Target_71_HPRD_ID:
Not Available

# Drug_Target_71_ID:
5281

# Drug_Target_71_Locus:
Not Available

# Drug_Target_71_Molecular_Weight:
35766

# Drug_Target_71_Name:
Plasmid segregation protein parM

# Drug_Target_71_Number_of_Residues:
320

# Drug_Target_71_PDB_ID:
1MWM

# Drug_Target_71_Pathway:
Not Available

# Drug_Target_71_Pfam_Domain_Function:
PF06406	StbA

# Drug_Target_71_Protein_Sequence:
>Plasmid segregation protein parM
MLVFIDDGSTNIKLQWQESDGTIKQHISPNSFKREWAVSFGDKKVFNYTLNGEQYSFDPI
SPDAVVTTNIAWQYSDVNVVAVHHALLTSGLPVSEVDIVCTLPLTEYYDRNNQPNTENIE
RKKANFRKKITLNGGDTFTIKDVKVMPESIPAGYEVLQELDELDSLLIIDLGGTTLDISQ
VMGKLSGISKIYGDSSLGVSLVTSAVKDALSLARTKGSSYLADDIIIHRKDNNYLKQRIN
DENKISIVTEAMNEALRKLEQRVLNTLNEFSGYTHVMVIGGGAELICDAVKKHTQIRDER
FFKTNNSQYDLVNGMYLIGN

# Drug_Target_71_Reaction:
Not Available

# Drug_Target_71_Signals:
None

# Drug_Target_71_Specific_Function:
Involved in the control of plasmid partition. Required for the accurate segregation of the plasmid

# Drug_Target_71_SwissProt_ID:
P11904

# Drug_Target_71_SwissProt_Name:
PARM_ECOLX

# Drug_Target_71_Synonyms:
ParA locus 36 kDa protein
Protein stbA

# Drug_Target_71_Theoretical_pI:
5.08

# Drug_Target_71_Transmembrane_Regions:
None

# Drug_Target_72_Cellular_Location:
Not Available

# Drug_Target_72_Chromosome_Location:
Not Available

# Drug_Target_72_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_72_Essentiality:
Non-Essential

# Drug_Target_72_GenAtlas_ID:
GSK3B

# Drug_Target_72_GenBank_ID_Gene:
L33801

# Drug_Target_72_GenBank_ID_Protein:
529237

# Drug_Target_72_GeneCard_ID:
GSK3B

# Drug_Target_72_Gene_Name:
GSK3B

# Drug_Target_72_Gene_Sequence:
>1263 bp
ATGTCAGGGCGGCCCAGAACCACCTCCTTTGCGGAGAGCTGCAAGCCGGTGCAGCAGCCT
TCAGCTTTTGGCAGCATGAAAGTTAGCAGAGACAAGGACGGCAGCAAGGTGACAACAGTG
GTGGCAACTCCTGGGCAGGGTCCAGACAGGCCACAAGAAGTCAGCTATACAGACACTAAA
GTGATTGGAAATGGATCATTTGGTGTGGTATATCAAGCCAAACTTTGTGATTCAGGAGAA
CTGGTCGCCATCAAGAAAGTATTGCAGGACAAGAGATTTAAGAATCGAGAGCTCCAGATC
ATGAGAAAGCTAGATCACTGTAACATAGTCCGATTGCGTTATTTCTTCTACTCCAGTGGT
GAGAAGAAAGATGAGGTCTATCTTAATCTGGTGCTGGACTATGTTCCGGAAACAGTATAC
AGAGTTGCCAGACACTATAGTCGAGCCAAACAGACGCTCCCTGTGATTTATGTCAAGTTG
TATATGTATCAGCTGTTCCGAAGTTTAGCCTATATCCATTCCTTTGGAATCTGCCATCGG
GATATTAAACCGCAGAACCTCTTGTTGGATCCTGATACTGCTGTATTAAAACTCTGTGAC
TTTGGAAGTGCAAAGCAGCTGGTCCGAGGAGAACCCAATGTTTCGTATATCTGTTCTCGG
TACTATAGGGCACCAGAGTTGATCTTTGGAGCCACTGATTATACCTCTAGTATAGATGTA
TGGTCTGCTGGCTGTGTGTTGGCTGAGCTGTTACTAGGACAACCAATATTTCCAGGGGAT
AGTGGTGTGGATCAGTTGGTAGAAATAATCAAGGTCCTGGGAACTCCAACAAGGGAGCAA
ATCAGAGAAATGAACCCAAACTACACAGAATTTAAATTCCCTCAAATTAAGGCACATCCT
TGGACTAAGGTCTTCCGACCCCGAACTCCACCGGAGGCAATTGCACTGTGTAGCCGTCTG
CTGGAGTATACACCAACTGCCCGACTAACACCACTGGAAGCTTGTGCACATTCATTTTTT
GATGAATTACGGGACCCAAATGTCAAACATCCAAATGGGCGAGACACACCTGCACTCTTC
AACTTCACCACTCAAGAACTGTCAAGTAATCCACCTCTGGCTACCATCCTTATTCCTCCT
CATGCTCGGATTCAAGCAGCTGCTTCAACCCCCACAAATGCCACAGCAGCGTCAGATGCT
AATACTGGAGACCGTGGACAGACCAATAATGCTGCTTCTGCATCAGCTTCCAACTCCACC
TGA

# Drug_Target_72_General_Function:
Involved in protein kinase activity

# Drug_Target_72_General_References:
10486203	Lau KF, Miller CC, Anderton BH, Shaw PC: Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter. Genomics. 1999 Sep 1;60(2):121-8.
10523816	Rhoads AR, Karkera JD, Detera-Wadleigh SD: Radiation hybrid mapping of genes in the lithium-sensitive wnt signaling pathway. Mol Psychiatry. 1999 Sep;4(5):437-42.
11004522	Hong YR, Chen CH, Chang JH, Wang S, Sy WD, Chou CK, Howng SL: Cloning and characterization of a novel human ninein protein that interacts with the glycogen synthase kinase 3beta. Biochim Biophys Acta. 2000 Jul 24;1492(2-3):513-6.
11440715	Dajani R, Fraser E, Roe SM, Young N, Good V, Dale TC, Pearl LH: Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell. 2001 Jun 15;105(6):721-32.
11738041	Bax B, Carter PS, Lewis C, Guy AR, Bridges A, Tanner R, Pettman G, Mannix C, Culbert AA, Brown MJ, Smith DG, Reith AD: The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure. 2001 Dec;9(12):1143-52.
7980435	Stambolic V, Woodgett JR: Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J. 1994 Nov 1;303 ( Pt 3):701-4.
9736715	Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S: Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11211-6.

# Drug_Target_72_HGNC_ID:
HGNC:4617

# Drug_Target_72_HPRD_ID:
05418

# Drug_Target_72_ID:
1721

# Drug_Target_72_Locus:
3q13.3

# Drug_Target_72_Molecular_Weight:
46745

# Drug_Target_72_Name:
Glycogen synthase kinase-3 beta

# Drug_Target_72_Number_of_Residues:
420

# Drug_Target_72_PDB_ID:
1J1C

# Drug_Target_72_Pathway:
Not Available

# Drug_Target_72_Pfam_Domain_Function:
PF00069	Pkinase

# Drug_Target_72_Protein_Sequence:
>Glycogen synthase kinase-3 beta
MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK
VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG
EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR
DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV
WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP
WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALF
NFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST

# Drug_Target_72_Reaction:
ATP + [tau-protein] = ADP + O-phospho-[tau-protein] ALL_REAC (other) R03744

# Drug_Target_72_Signals:
None

# Drug_Target_72_Specific_Function:
Participates in the Wnt signaling pathway. Implicated in the hormonal control of several regulatory proteins including glycogen synthase, MYB and the transcription factor JUN. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA

# Drug_Target_72_SwissProt_ID:
P49841

# Drug_Target_72_SwissProt_Name:
GSK3B_HUMAN

# Drug_Target_72_Synonyms:
EC 2.7.11.26
GSK-3 beta

# Drug_Target_72_Theoretical_pI:
8.97

# Drug_Target_72_Transmembrane_Regions:
None

# Drug_Target_73_Cellular_Location:
Not Available

# Drug_Target_73_Chromosome_Location:
Not Available

# Drug_Target_73_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_73_Essentiality:
Non-Essential

# Drug_Target_73_GenAtlas_ID:
UCK2

# Drug_Target_73_GenBank_ID_Gene:
D78335

# Drug_Target_73_GenBank_ID_Protein:
1655420

# Drug_Target_73_GeneCard_ID:
UCK2

# Drug_Target_73_Gene_Name:
UCK2

# Drug_Target_73_Gene_Sequence:
>786 bp
ATGGCCGGGGACAGCGAGCAGACCCTGCAGAACCACCAGCAGCCCAACGGCGGCGAGCCC
TTCCTTATAGGCGTCAGCGGGGGAACAGCTAGCGGCAAGTCTTCCGTGTGTGCTAAGATC
GTGCAGCTCCTGGGGCAGAATGAGGTGGACTATCGCCAGAAGCAGGTGGTCATCCTGAGC
CAGGATAGCTTCTACCGTGTCCTTACCTCGGAGCAGAAGGCCAAAGCCCTGAAGGGCCAG
TTCAACTTTGACCACCCGGATGCCTTTGACAATGAACTCATTCTCAAAACACTCAAAGAA
ATCACTGAAGGGAAAACAGTCCAGATCCCCGTGTATGACTTTGTCTCCCATTCCCGGAAG
GAGGAGACAGTTACTGTCTATCCCGCAGACGTGGTGCTCTTTGAAGGGATCCTGGCCTTC
TACTCCCAGGAGGTACGAGACCTGTTCCAGATGAAGCTTTTTGTGGATACAGATGCGGAC
ACCCGGCTCTCACGCAGAGTATTAAGGGACATCAGCGAGAGAGGCAGGGATCTTGAGCAG
ATTTTATCTCAGTACATTACGTTCGTCAAGCCTGCCTTTGAGGAATTCTGCTTGCCAACA
AAGAAGTATGCTGATGTGATCATCCCTAGAGGTGCAGATAATCTGGTGGCCATCAACCTC
ATCGTGCAGCACATCCAGGACATCCTGAATGGAGGGCCCTCCAAACGGCAGACCAATGGC
TGTCTCAACGGCTACACCCCTTCACGCAAGAGGCAGGCATCGGAGTCCAGCAGCAGGCCG
CATTGA

# Drug_Target_73_General_Function:
Nucleotide transport and metabolism

# Drug_Target_73_General_References:
11306702	Van Rompay AR, Norda A, Linden K, Johansson M, Karlsson A: Phosphorylation of uridine and cytidine nucleoside analogs by two human uridine-cytidine kinases. Mol Pharmacol. 2001 May;59(5):1181-6.
11494055	Koizumi K, Shimamoto Y, Azuma A, Wataya Y, Matsuda A, Sasaki T, Fukushima M: Cloning and expression of uridine/cytidine kinase cDNA from human fibrosarcoma cells. Int J Mol Med. 2001 Sep;8(3):273-8.
8812458	Ozaki K, Kuroki T, Hayashi S, Nakamura Y: Isolation of three testis-specific genes (TSA303, TSA806, TSA903) by a differential mRNA display method. Genomics. 1996 Sep 1;36(2):316-9.

# Drug_Target_73_HGNC_ID:
HGNC:12562

# Drug_Target_73_HPRD_ID:
01882

# Drug_Target_73_ID:
2697

# Drug_Target_73_Locus:
1q23

# Drug_Target_73_Molecular_Weight:
29299

# Drug_Target_73_Name:
Uridine-cytidine kinase 2

# Drug_Target_73_Number_of_Residues:
261

# Drug_Target_73_PDB_ID:
1XRJ

# Drug_Target_73_Pathway:
Not Available

# Drug_Target_73_Pfam_Domain_Function:
PF00485	PRK

# Drug_Target_73_Protein_Sequence:
>Uridine-cytidine kinase 2
MAGDSEQTLQNHQQPNGGEPFLIGVSGGTASGKSSVCAKIVQLLGQNEVDYRQKQVVILS
QDSFYRVLTSEQKAKALKGQFNFDHPDAFDNELILKTLKEITEGKTVQIPVYDFVSHSRK
EETVTVYPADVVLFEGILAFYSQEVRDLFQMKLFVDTDADTRLSRRVLRDISERGRDLEQ
ILSQYITFVKPAFEEFCLPTKKYADVIIPRGADNLVAINLIVQHIQDILNGGPSKRQTNG
CLNGYTPSRKRQASESSSRPH

# Drug_Target_73_Reaction:
ATP + uridine = ADP + UMP

# Drug_Target_73_Signals:
None

# Drug_Target_73_Specific_Function:
Phosphorylates uridine and cytidine to uridine monophosphate and cytidine monophosphate. Does not phosphorylate deoxyribonucleosides or purine ribonucleosides. Can use ATP or GTP as a phosphate donor. Can also phosphorylate cytidine and uridine nucleoside analogs such as 6-azauridine, 5-fluorouridine, 4- thiouridine, 5-bromouridine, 4-N-acetylcytidine, 4-N- benzoylcytidine, 5-fluorocytidine, 2-thiocytidine, 5- methylcytidine, and 4-N-anisoylcytidine

# Drug_Target_73_SwissProt_ID:
Q9BZX2

# Drug_Target_73_SwissProt_Name:
UCK2_HUMAN

# Drug_Target_73_Synonyms:
Cytidine monophosphokinase 2
EC 2.7.1.48
UCK 2
Uridine monophosphokinase 2

# Drug_Target_73_Theoretical_pI:
6.68

# Drug_Target_73_Transmembrane_Regions:
None

# Drug_Target_74_Cellular_Location:
Not Available

# Drug_Target_74_Chromosome_Location:
Not Available

# Drug_Target_74_Drug_References:
Not Available

# Drug_Target_74_Essentiality:
Non-Essential

# Drug_Target_74_GenAtlas_ID:
Not Available

# Drug_Target_74_GenBank_ID_Gene:
AF408636

# Drug_Target_74_GenBank_ID_Protein:
Not Available

# Drug_Target_74_GeneCard_ID:
Not Available

# Drug_Target_74_Gene_Name:
Not Available

# Drug_Target_74_Gene_Sequence:
>996 bp
ATGATCCATCTGTACGACGCAAAGTCGTTCGCTAAATTGCGCGCGGCCCAGTATGCAGCG
TTTCACACTGACGCTCCTGGTTCCTGGTTCGACCACACATCCGGGGTGCTCGAGTCGGTT
GAGGACGGCACGCCTGTTCTCGCCATCGGTGTCGAAAGCGGCGACGCCATCGTATTCGAC
AAGAATGCGCAGCGCATCGTCGCGTACAAGGAGAAATCCGTCAAAGCTGAGGATGGTTCC
GTCTCGGTCGTTCAAGTTGAGAACGGTTTCATGAAACAGGGCCATCGTGGATGGCTCGTC
GACCTCACTGGCGAGCTCGTCGGTTGCAGTCCGGTAGTCGCCGAGTTCGGTGGTCATCGT
TATGCGTCTGGCATGGTGATCGTCACTGGCAAGGGCAACTCCGGGAAGACTCCTCTCGTG
CACGCGTTGGGTGAGGCTCTCGGTGGTAAGGACAAATACGCTACCGTGCGGTTTGGCGAA
CCACTGTCGGGCTACAACACCGATTTCAACGTGTTCGTGGATGATATCGCTCGTGCAATG
CTCCAGCATCGTGTGATCGTGATTGACTCGCTGAAGAACGTCATCGGTGCAGCTGGTGGT
AATACCACTTCCGGTGGTATTTCTCGTGGCGCCTTCGACCTTCTTTCCGATATCGGCGCC
ATGGCTGCATCCCGTGGATGCGTAGTCATAGCGTCGCTCAACCCAACTTCGAATGACGAC
AAGATCGTCGAATTGGTCAAGGAAGCGAGCCGCTCCAACAGCACGTCTCTCGTTATCTCG
ACAGATGTCGACGGCGAATGGCAAGTACTGACACGTACCGGTGAAGGTCTGCAACGCCTG
ACACACACTCTGCAGACGAGTTATGGCGAGCATTCGGTCCTCACCATCCACACGAGTAAG
CAATCTGGTGGCAAACAAGCCTCCGGCAAAGCTATTCAGACCGTAATCAAAAACGACGAA
CTGGAATCGGTCCTTCGTCGTCTCACCTCCAACTGA

# Drug_Target_74_General_Function:
Not Available

# Drug_Target_74_General_References:
12033785	Gottlieb P, Potgieter C, Wei H, Toporovsky I: Characterization of phi12, a bacteriophage related to phi6: nucleotide sequence of the large double-stranded RNA. Virology. 2002 Apr 10;295(2):266-71.

# Drug_Target_74_HGNC_ID:
Not Available

# Drug_Target_74_HPRD_ID:
Not Available

# Drug_Target_74_ID:
4774

# Drug_Target_74_Locus:
Not Available

# Drug_Target_74_Molecular_Weight:
35109

# Drug_Target_74_Name:
NTPase P4

# Drug_Target_74_Number_of_Residues:
331

# Drug_Target_74_PDB_ID:
1W4C

# Drug_Target_74_Pathway:
Not Available

# Drug_Target_74_Pfam_Domain_Function:
Not Available

# Drug_Target_74_Protein_Sequence:
>NTPase P4
MIHLYDAKSFAKLRAAQYAAFHTDAPGSWFDHTSGVLESVEDGTPVLAIGVESGDAIVFD
KNAQRIVAYKEKSVKAEDGSVSVVQVENGFMKQGHRGWLVDLTGELVGCSPVVAEFGGHR
YASGMVIVTGKGNSGKTPLVHALGEALGGKDKYATVRFGEPLSGYNTDFNVFVDDIARAM
LQHRVIVIDSLKNVIGAAGGNTTSGGISRGAFDLLSDIGAMAASRGCVVIASLNPTSNDD
KIVELVKEASRSNSTSLVISTDVDGEWQVLTRTGEGLQRLTHTLQTSYGEHSVLTIHTSK
QSGGKQASGKAIQTVIKNDELESVLRRLTSN

# Drug_Target_74_Reaction:
Not Available

# Drug_Target_74_Signals:
None

# Drug_Target_74_Specific_Function:
Not Available

# Drug_Target_74_SwissProt_ID:
Q94M05

# Drug_Target_74_SwissProt_Name:
Q94M05_9VIRU

# Drug_Target_74_Synonyms:
Not Available

# Drug_Target_74_Theoretical_pI:
6.51

# Drug_Target_74_Transmembrane_Regions:
None

# Drug_Target_75_Cellular_Location:
Cytoplasm. Nucleus

# Drug_Target_75_Chromosome_Location:
7

# Drug_Target_75_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_75_Essentiality:
Non-Essential

# Drug_Target_75_GenAtlas_ID:
Not Available

# Drug_Target_75_GenBank_ID_Gene:
U88666

# Drug_Target_75_GenBank_ID_Protein:
1857944

# Drug_Target_75_GeneCard_ID:
SRPK2

# Drug_Target_75_Gene_Name:
SRPK2

# Drug_Target_75_Gene_Sequence:
>2061 bp
ATGTCAGTTAACTCTGAGAAGTCGTCCTCTTCAGAAAGGCCGGAGCCTCAACAGAAAGCT
CCTTTAGTTCCTCCTCCTCCACCGCCACCACCACCACCACCGCCACCTTTGCCAGACCCC
ACACCCCCGGAGCCAGAGGAGGAGATCCTGGGATCAGATGATGAGGAGCAAGAGGACCCT
GCGGACTACTGCAAAGGTGGATATCATCCAGTGAAAATTGGAGACCTCTTCAATGGCCGG
TATCATGTTATTAGAAAGCTTGGATGGGGGCACTTCTCTACTGTCTGGCTGTGCTGGGAT
ATGCAGGGGAAAAGATTTGTTGCAATGAAAGTTGTAAAAAGTGCCCAGCATTATACGGAG
ACAGCCTTGGATGAAATAAAATTGCTCAAATGTGTTCGAGAAAGTGATCCCAGTGACCCA
AACAAAGACATGGTGGTCCAGCTCATTGACGACTTCAAGATTTCAGGCATGAATGGGATA
CATGTCTGCATGGTCTTCGAAGTACTTGGCCACCATCTCCTCAAGTGGATCATCAAATCC
AACTATCAAGGCCTCCCAGTACGTTGTGTGAAGAGTATCATTCGACAGGTCCTTCAAGGG
TTAGATTACTTACACAGTAAGTGCAAGATCATTCATACTGACATAAAGCCGGAAAATATC
TTGATGTGTGTGGATGATGCATATGTGAGAAGAATGGCAGCTGAGCCTGAGTGGCAGAAA
GCAGGTGCTCCTCCTCCTTCAGGGTCTGCAGTGAGTACGGCTCCACAGCAGAAACCTATA
GGAAAAATATCTAAAAACAAAAAGAAAAAACTGAAAAAGAAACAGAAGAGGCAGGCTGAG
TTATTGGAGAAGCGCCTGCAGGAGATAGAAGAATTGGAGCGAGAAGCTGAAAGGAAAATA
ATAGAAGAAAACATCACCTCAGCTGCACCTTCCAATGACCAGGATGGCGAATACTGCCCA
GAGGTGAAACTAAAAACAACAGGATTAGAGGAGGCGGCTGAGGCAGAGACTGCAAAGGAC
AATGGTGAAGCTGAGGACCAGGAAGAGAAAGAAGATGCTGAGAAAGAAAACATTGAAAAA
GATGAAGATGATGTAGATCAGGAACTTGCGAACATAGACCCTACGTGGATAGAATCACCT
AAAACCAATGGCCATATTGAGAATGGCCCATTCTCACTGGAGCAGCAACTGGACGATGAA
GATGATGATGAAGAAGACTGCCCAAATCCTGAGGAATATAATCTTGATGAGCCAAATGCA
GAAAGTGATTACACATATAGCAGCTCCTATGAACAATTCAATGGTGAATTGCCAAATGGA
CGACATAAAATTCCCGAGTCACAGTTCCCAGAGTTTTCCACCTCGTTGTTCTCTGGATCC
TTAGAACCTGTGGCCTGCGGCTCTGTGCTTTCTGAGGGATCACCACTTACTGAGCAAGAG
GAGAGCAGTCCATCCCATGACAGAAGCAGAACGGTTTCAGCCTCCAGTACTGGGGATTTG
CCAAAAGCAAAAACCCGGGCAGCTGACTTGTTGGTGAATCCCCTGGATCCGCGGAATCGA
GATAAAATTAGAGTAAAAATTGCTGACCTGGGAAATGCTTGTTGGGTGCATAAACACTTC
ACGGAAGACATCCAGACGCGTCAGTACCGCTCCATAGAGGTTTTAATAGGAGCGGGGTAC
AGCACCCCTGCGGACATCTGGAGCACGGCGTGTATGGCATTTGAGCTGGCAACGGGAGAT
TATTTGTTTGAACCACATTCTGGGGAAGACTATTCCAGAGACGAAGACCACATAGCCCAC
ATCATAGAGCTGCTAGGCAGTATTCCAAGGCACTTTGCTCTATCTGGAAAATATTCTCGG
GAATTCTTCAATCGCAGAGGAGAACTGCGACACATCACCAAGCTGAAGCCCTGGAGCCTC
TTTGATGTACTTGTGGAAAAGTATGGCTGGCCCCATGAAGATGCTGCACAGTTTACAGAT
TTCCTGATCCCGATGTTAGAAATGGTTCCAGAAAAACGAGCCTCAGCTGGCGAATGTCGG
CATCCTTGGTTGAATTCTTAG

# Drug_Target_75_General_Function:
Involved in ATP binding

# Drug_Target_75_General_References:
12134018	Daub H, Blencke S, Habenberger P, Kurtenbach A, Dennenmoser J, Wissing J, Ullrich A, Cotten M: Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein. J Virol. 2002 Aug;76(16):8124-37.
12853948	Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
15592455	Rush J, Moritz A, Lee KA, Guo A, Goss VL, Spek EJ, Zhang H, Zha XM, Polakiewicz RD, Comb MJ: Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol. 2005 Jan;23(1):94-101. Epub 2004 Dec 12.
17344846	Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O'Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew YE, DeFazio A, Greaves MF, Green AR, Campbell P, Birney E, Easton DF, Chenevix-Trench G, Tan MH, Khoo SK, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR: Patterns of somatic mutation in human cancer genomes. Nature. 2007 Mar 8;446(7132):153-8.
18669648	Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP: A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7. Epub 2008 Jul 31.
18691976	Daub H, Olsen JV, Bairlein M, Gnad F, Oppermann FS, Korner R, Greff Z, Keri G, Stemmann O, Mann M: Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell. 2008 Aug 8;31(3):438-48.
9472028	Wang HY, Lin W, Dyck JA, Yeakley JM, Songyang Z, Cantley LC, Fu XD: SRPK2: a differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells. J Cell Biol. 1998 Feb 23;140(4):737-50.

# Drug_Target_75_HGNC_ID:
GNC:11306

# Drug_Target_75_HPRD_ID:
Not Available

# Drug_Target_75_ID:
6832

# Drug_Target_75_Locus:
7q22-q31.1

# Drug_Target_75_Molecular_Weight:
77542.1

# Drug_Target_75_Name:
Serine/threonine-protein kinase SRPK2

# Drug_Target_75_Number_of_Residues:
688

# Drug_Target_75_PDB_ID:
Not Available

# Drug_Target_75_Pathway:
Not Available

# Drug_Target_75_Pfam_Domain_Function:
PF00069	Pkinase

# Drug_Target_75_Protein_Sequence:
>Serine/threonine-protein kinase SRPK2
MSVNSEKSSSSERPEPQQKAPLVPPPPPPPPPPPPPLPDPTPPEPEEEILGSDDEEQEDP
ADYCKGGYHPVKIGDLFNGRYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTE
TALDEIKLLKCVRESDPSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKS
NYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQ
KAGAPPPSGSAVSTAPQQKPIGKISKNKKKKLKKKQKRQAELLEKRLQEIEELEREAERK
IIEENITSAAPSNDQDGEYCPEVKLKTTGLEEAAEAETAKDNGEAEDQEEKEDAEKENIE
KDEDDVDQELANIDPTWIESPKTNGHIENGPFSLEQQLDDEDDDEEDCPNPEEYNLDEPN
AESDYTYSSSYEQFNGELPNGRHKIPESQFPEFSTSLFSGSLEPVACGSVLSEGSPLTEQ
EESSPSHDRSRTVSASSTGDLPKAKTRAADLLVNPLDPRARDKIRVKIADLGNACWVHKH
FTEDIQTRQYRSIEVLIGAGYSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIA
HIIELLGSIPRHFALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFT
DFLIPMLEMVPEKRASAGCLCRHPWLNS

# Drug_Target_75_Reaction:
Not Available

# Drug_Target_75_Signals:
None

# Drug_Target_75_Specific_Function:
Phosphorylates RS domain-containing proteins, such as SFRS1 and SFRS2 on serine residues. Role in spliceosome assembly and in mediating the trafficking of splicing factors. Appears to mediate HBV core protein phosphorylation which is a prerequisite for pregenomic RNA encapsidation into viral capsids

# Drug_Target_75_SwissProt_ID:
P78362

# Drug_Target_75_SwissProt_Name:
SRPK2_HUMAN

# Drug_Target_75_Synonyms:
SFRS protein kinase 2
SR-protein-specific kinase 2
Serine/arginine-rich protein-specific kinase 2

# Drug_Target_75_Theoretical_pI:
4.65

# Drug_Target_75_Transmembrane_Regions:
None

# Drug_Target_76_Cellular_Location:
Not Available

# Drug_Target_76_Chromosome_Location:
Not Available

# Drug_Target_76_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_76_Essentiality:
Non-Essential

# Drug_Target_76_GenAtlas_ID:
Not Available

# Drug_Target_76_GenBank_ID_Gene:
L06495

# Drug_Target_76_GenBank_ID_Protein:
146013

# Drug_Target_76_GeneCard_ID:
Not Available

# Drug_Target_76_Gene_Name:
folK

# Drug_Target_76_Gene_Sequence:
>480 bp
ATGACAGTGGCGTATATTGCCATAGGCAGCAATCTGGCCTCTCCGCTGGAGCAGGTCAAT
GCTGCCCTGAAAGCATTAGGCGATATCCCTGAAAGCCACATTCTTACCGTTTCTTCGTTT
TACCGCACCCCACCGCTGGGCCCGCAAGATCAACCCGATTACTTAAACGCAGCCGTGGCG
CTGGAAACCTCTCTTGCACCTGAAGAGCTACTCAATCACACACAGCGTATTGAATTGCAG
CAAGGTCGCGTCCGCAAAGCTGAACGCTGGGGACCACGCACGCTGGATCTCGACATCATG
CTGTTTGGTAATGAAGTGATAAATACTGAACGCCTGACCGTTCCGCACTACGATATGAAG
AATCGTGGATTTATGCTGTGGCCGCTGTTTGAAATCGCGCCGGAGTTGGTGTTTCCTGAT
GGGGAGATGTTGCGTCAAATCTTACATACAAGAGCATTTGACAAATTAAACAAATGGTAA

# Drug_Target_76_General_Function:
Coenzyme transport and metabolism

# Drug_Target_76_General_References:
10378268	Xiao B, Shi G, Chen X, Yan H, Ji X: Crystal structure of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase, a potential target for the development of novel antimicrobial agents. Structure. 1999 May;7(5):489-96.
10452528	Stammers DK, Achari A, Somers DO, Bryant PK, Rosemond J, Scott DL, Champness JN: 2.0 A X-ray structure of the ternary complex of 7,8-dihydro-6-hydroxymethylpterinpyrophosphokinase from Escherichia coli with ATP and a substrate analogue. FEBS Lett. 1999 Jul 30;456(1):49-53.
1325970	Talarico TL, Ray PH, Dev IK, Merrill BM, Dallas WS: Cloning, sequence analysis, and overexpression of Escherichia coli folK, the gene coding for 7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase. J Bacteriol. 1992 Sep;174(18):5971-7.
1657875	Talarico TL, Dev IK, Dallas WS, Ferone R, Ray PH: Purification and partial characterization of 7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase and 7,8-dihydropteroate synthase from Escherichia coli MC4100. J Bacteriol. 1991 Nov;173(21):7029-32.
2537812	Liu JD, Parkinson JS: Genetics and sequence analysis of the pcnB locus, an Escherichia coli gene involved in plasmid copy number control. J Bacteriol. 1989 Mar;171(3):1254-61.
8202364	Fujita N, Mori H, Yura T, Ishihama A: Systematic sequencing of the Escherichia coli genome: analysis of the 2.4-4.1 min (110,917-193,643 bp) region. Nucleic Acids Res. 1994 May 11;22(9):1637-9.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_76_HGNC_ID:
Not Available

# Drug_Target_76_HPRD_ID:
Not Available

# Drug_Target_76_ID:
2644

# Drug_Target_76_Locus:
Not Available

# Drug_Target_76_Molecular_Weight:
18079

# Drug_Target_76_Name:
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase

# Drug_Target_76_Number_of_Residues:
159

# Drug_Target_76_PDB_ID:
1RB0

# Drug_Target_76_Pathway:
Not Available

# Drug_Target_76_Pfam_Domain_Function:
PF01288	HPPK

# Drug_Target_76_Protein_Sequence:
>2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase
MTVAYIAIGSNLASPLEQVNAALKALGDIPESHILTVSSFYRTPPLGPQDQPDYLNAAVA
LETSLAPEELLNHTQRIELQQGRVRKAERWGPRTLDLDIMLFGNEVINTERLTVPHYDMK
NRGFMLWPLFEIAPELVFPDGEMLRQILHTRAFDKLNKW

# Drug_Target_76_Reaction:
ATP + 2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine = AMP + (2-amino-4-hydroxy-7,8-dihydropteridin-6-yl)methyl diphosphate

# Drug_Target_76_Signals:
None

# Drug_Target_76_Specific_Function:
ATP + 2-amino-4-hydroxy-6-hydroxymethyl-7,8- dihydropteridine = AMP + (2-amino-4-hydroxy-7,8-dihydropteridin-6- yl)methyl diphosphate

# Drug_Target_76_SwissProt_ID:
P26281

# Drug_Target_76_SwissProt_Name:
HPPK_ECOLI

# Drug_Target_76_Synonyms:
6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase
7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase
EC 2.7.6.3
HPPK
PPPK

# Drug_Target_76_Theoretical_pI:
5.23

# Drug_Target_76_Transmembrane_Regions:
None

# Drug_Target_77_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_77_Chromosome_Location:
Not Available

# Drug_Target_77_Drug_References:
Not Available

# Drug_Target_77_Essentiality:
Non-Essential

# Drug_Target_77_GenAtlas_ID:
Not Available

# Drug_Target_77_GenBank_ID_Gene:
AE005674

# Drug_Target_77_GenBank_ID_Protein:
Not Available

# Drug_Target_77_GeneCard_ID:
Not Available

# Drug_Target_77_Gene_Name:
ddlB

# Drug_Target_77_Gene_Sequence:
>921 bp
ATGACTGATAAAATCGCGGTCCTGTTGGGCGGGACTTCCGCTGAGCGGGAAGTTTCTCTG
AATTCTGGCGCAGCGGTGTTAGCCGGGCTGCGTGAAGGCGGTATTGATGCGTATCCTGTC
GACCCGAAAGAAGTCGACGTGACGCAACTGAAGTCGATGGGTTTTCAGAAAGTGTTTATC
GCGCTACACGGTCGCGGCGGTGAAGATGGTACGCTGCAGGGCATGCTCGAGCTGATGGGC
TTGCCTTATACCGGCAGCGGAGTGATGGCATCTGCGCTTTCAATAGATAAACTACGCAGC
AAACTTCTGTGGCAAGGTGCCGGTTTACCGGTCGCGCCGTGGGTAGCGTTAACCCGCGCA
GAGTTTGAAAAAGGCCTGAGCGATAAGCAGTTAGCAGAAATTTCTGCTCTGGGTTTGCCG
GTTATCGTTAAGCCGAGCCGCGAAGGTTCCAGTGTGGGAATGTCAAAAGTAGTAGCAGAA
AATGCTCTACAAGATGCATTAAGATTGGCATTTCAGCACGATGAAGAAGTATTGATTGAA
AAATGGCTAAGTGGGCCGGAGTTCACGGTTGCGATACTCGGTGAAGAAATTTTACCGTCA
ATACGTATTCAACCGTCCGGAACCTTCTATGATTATGAGGCGAAGTATCTCTCTGATGAG
ACACAGTATTTCTGCCCCGCAGGTCTGGAAGCGTCACAAGAGGCCAATTTGCAGGCATTA
GTGCTGAAAGCATGGACGACGTTAGGTTGCAAAGGATGGGGACGTATTGACGTTATGCTG
GACAGTGATGGACAGTTTTATCTGCTGGAAGCCAATACCTCACCGGGTATGACCAGCCAC
AGCCTGGTGCCGATGGCGGCACGTCAGGCAGGTATGAGCTTCTCGCAGTTGGTAGTACGA
ATTCTGGAACTGGCGGACTAA

# Drug_Target_77_General_Function:
Involved in catalytic activity

# Drug_Target_77_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_77_HGNC_ID:
Not Available

# Drug_Target_77_HPRD_ID:
Not Available

# Drug_Target_77_ID:
5283

# Drug_Target_77_Locus:
Not Available

# Drug_Target_77_Molecular_Weight:
32822

# Drug_Target_77_Name:
D-alanine--D-alanine ligase B

# Drug_Target_77_Number_of_Residues:
306

# Drug_Target_77_PDB_ID:
1IOV

# Drug_Target_77_Pathway:
Not Available

# Drug_Target_77_Pfam_Domain_Function:
PF01820	Dala_Dala_lig_N
PF07478	Dala_Dala_lig_C

# Drug_Target_77_Protein_Sequence:
>D-alanine--D-alanine ligase B
MTDKIAVLLGGTSAEREVSLNSGAAVLAGLREGGIDAYPVDPKEVDVTQLKSMGFQKVFI
ALHGRGGEDGTLQGMLELMGLPYTGSGVMASALSIDKLRSKLLWQGAGLPVAPWVALTRA
EFEKGLSDKQLAEISALGLPVIVKPSREGSSVGMSKVVAENALQDALRLAFQHDEEVLIE
KWLSGPEFTVAILGEEILPSIRIQPSGTFYDYEAKYLSDETQYFCPAGLEASQEANLQAL
VLKAWTTLGCKGWGRIDVMLDSDGQFYLLEANTSPGMTSHSLVPMAARQAGMSFSQLVVR
ILELAD

# Drug_Target_77_Reaction:
Not Available

# Drug_Target_77_Signals:
None

# Drug_Target_77_Specific_Function:
Cell wall formation (By similarity)

# Drug_Target_77_SwissProt_ID:
Q83MF7

# Drug_Target_77_SwissProt_Name:
DDLB_SHIFL

# Drug_Target_77_Synonyms:
D-Ala-D-Ala ligase B
D-alanylalanine synthetase B
EC 6.3.2.4

# Drug_Target_77_Theoretical_pI:
4.48

# Drug_Target_77_Transmembrane_Regions:
None

# Drug_Target_78_Cellular_Location:
Cytoplasm

# Drug_Target_78_Chromosome_Location:
Not Available

# Drug_Target_78_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_78_Essentiality:
Non-Essential

# Drug_Target_78_GenAtlas_ID:
Not Available

# Drug_Target_78_GenBank_ID_Gene:
AE016958

# Drug_Target_78_GenBank_ID_Protein:
41397305

# Drug_Target_78_GeneCard_ID:
Not Available

# Drug_Target_78_Gene_Name:
recA

# Drug_Target_78_Gene_Sequence:
>1230 bp
TCAGAAGTCGACGGGGGCGGGCAGGACGCCGTCATCGGACAAGTCATCGGTCACGACCGC
GCCAATGCCGAGCTTTTCCTTGATCTTCTTCTCGATCTCGTTGGCGACCTCGTCGTTCTC
CATCAAGAAGGTGCGGGCGTTCTCCTTGCCCTGGCCGAGCTGCTCGCCCTCATAGGTGAA
CCAGGAACCGGACTTGCGGATGAAGCCCTGATCCACACCCATGTCGATCAGCGAGCCCTC
CCGGCTGATCCCGCGGCCGTAGAGGATGTCGAACTCGGCCTGCTTGAACGGCGGCGACAC
CTTGTTCTTGACGATCTTGACCCGGGTGCGGTTGCCGACCGCGTTGGTGCCGTCCTTGAG
CGTCTCGATCCGGCGCACGTCCATGCGCACCGAGGCGTAGAACTTCAACGCCTTGCCACC
CGTCGTGGTCTCCGGGCTGCCGAACATCACCCCGATCTTCTCCCGCAGCTGGTTGATGAA
GATCGCGGTGGTGCCCGAATTGTTCAGCGCGCCAGTCATTTTCCGCAGCGCCTGGCTCAT
CAGCCGGGCCTGCAGCCCGACGTGGCTGTCCCCCATCTCGCCCTCCAGCTCGGCGCGCGG
CACCAGCGCGGCCACCGAGTCGATGACCAGGATGTCCAGCGCGCCGGAGCGGATCAGCAT
GTCGGCGATCTCGAGCGCCTGCTCCCCCGTGTCCGGCTGGCTGACCAGCAGCGAATCGGT
GTCCACGCCGAGCTTCTTGGCGTACTCGGGGTCCAGCGCGTGCTCGGCGTCGATGAACGC
CGCGACACCGCCGGCGGCCTGGGCGTTGGCCACCGCGTGCAGGGCGACGGTGGTCTTACC
CGAGGATTCCGGGCCGTAGATCTCCACGACCCGGCCGCGGGGCAGGCCGCCGATGCCCAG
GGCGACGTCCAGGGCGATGGATCCGGTCGGGATGACCGAGATCGGTTGACGCATCTCGTC
GCCGAGACGCATCACCGAGCCTTTCCCGTAGCTCTTTTCGATCTGGGCCATCGCCAGTTC
GAGAGCCTTCTCGCGGTCGGGGGCTTGCGTCATGGTGCCTCTCCTATAGTCGGTGTGTCT
TCTGACCGGTATCGGTCGGTTGGCGGTGACACTAGAGAAGGCCACCGACAAGTTGACGCT
GCGAACGTCCCCCACAGTAGCCGAACAGGTGTTCGATTCAAGTTCGACACGCCGCGGGCG
TCGCAGCAGCCGCGAAAGGCCGGCCGACAT

# Drug_Target_78_General_Function:
Replication, recombination and repair

# Drug_Target_78_General_References:
Not Available

# Drug_Target_78_HGNC_ID:
Not Available

# Drug_Target_78_HPRD_ID:
Not Available

# Drug_Target_78_ID:
2332

# Drug_Target_78_Locus:
Not Available

# Drug_Target_78_Molecular_Weight:
37465

# Drug_Target_78_Name:
Protein recA

# Drug_Target_78_Number_of_Residues:
350

# Drug_Target_78_PDB_ID:
1G19

# Drug_Target_78_Pathway:
Not Available

# Drug_Target_78_Pfam_Domain_Function:
PF00154	RecA

# Drug_Target_78_Protein_Sequence:
>Protein recA
MTQAPDREKALELAMAQIEKSYGKGSVMRLGDEMRQPISVIPTGSIALDVALGIGGLPRG
RVVEIYGPESSGKTTVALHAVANAQAAGGVAAFIDAEHALDPEYAKKLGVDTDSLLVSQP
DTGEQALEIADMLIRSGALDILVIDSVAALVPRAELEGEMGDSHVGLQARLMSQALRKMT
GALNNSGTTAIFINQLREKIGVMFGSPETTTGGKALKFYASVRMDVRRIETLKDGTNAVG
NRTRVKIVKNKVSPPFKQAEFDILYGRGISREGSLIDMGVDQGFIRKSGSWFTYEGEQLG
QGKENARTFLMENDEVANEIEKKIKEKLGIGAVVTDDLSDDGVLPAPVDF

# Drug_Target_78_Reaction:
Not Available

# Drug_Target_78_Signals:
None

# Drug_Target_78_Specific_Function:
Can catalyze the hydrolysis of ATP in the presence of single-stranded DNA, the ATP-dependent uptake of single-stranded DNA by duplex DNA, and the ATP-dependent hybridization of homologous single-stranded DNAs. It interacts with lexA causing its activation and leading to its autocatalytic cleavage

# Drug_Target_78_SwissProt_ID:
P62219

# Drug_Target_78_SwissProt_Name:
RECA_MYCPA

# Drug_Target_78_Synonyms:
Recombinase A

# Drug_Target_78_Theoretical_pI:
4.87

# Drug_Target_78_Transmembrane_Regions:
None

# Drug_Target_79_Cellular_Location:
Cytoplasmic

# Drug_Target_79_Chromosome_Location:
Not Available

# Drug_Target_79_Drug_References:
Not Available

# Drug_Target_79_Essentiality:
Non-Essential

# Drug_Target_79_GenAtlas_ID:
Not Available

# Drug_Target_79_GenBank_ID_Gene:
X04487

# Drug_Target_79_GenBank_ID_Protein:
Not Available

# Drug_Target_79_GeneCard_ID:
Not Available

# Drug_Target_79_Gene_Name:
dnaX

# Drug_Target_79_Gene_Sequence:
>1932 bp
ATGAGTTATCAGGTCTTAGCCCGAAAATGGCGCCCACAAACCTTTGCTGACGTCGTCGGC
CAGGAACATGTGCTGACCGCACTGGCGAACGGCTTGTCGTTAGGGCGTATTCATCATGCT
TATCTTTTTTCCGGCACCCGTGGCGTCGGAAAAACCTCTATCGCCCGACTGCTGGCGAAG
GGGCTAAACTGCGAAACCGGCATTACCGCGACGCCGTGCGGCGTGTGCGATAACTGTCGT
GAAATCGAGCAGGGGCGCTTTGTCGATCTGATTGAAATCGACGCCGCCTCGCGCACCAAA
GTTGAAGATACCCGCGACCTGCTGGATAACGTCCAGTACGCTCCGGCGCGTGGTCGTTTC
AAAGTTTATCTGATCGACGAAGTGCATATGCTGTCGCGCCACAGCTTTAACGCACTGTTA
AAAACCCTTGAAGAGCCGCCGGAGCACGTTAAGTTTCTGCTGGCGACGACCGATCCACAG
AAATTGCCGGTGACGATTTTGTCACGCTGTCTGCAATTTCATCTCAAGGCGCTGGATGTC
GAGCAAATTCGCCATCAGCTTGAGCACATCCTCAACGAAGAACATATCGCTCACGAGCCG
CGGGCGCTGCAATTGCTGGCACGCGCCGCTGAAGGCAGCCTGCGAGATGCCTTAAGTCTG
ACCGACCAGGCGATTGCCAGCGGTGACGGCCAGGTTTCAACCCAGGCGGTCAGTGCGATG
CTGGGTACGCTTGACGACGATCAGGCGCTGTCGCTGGTTGAAGCGATGGTCGAGGCCAAC
GGCGAGCGCGTAATGGCGCTGATTAATGAAGCCGCTGCCCGTGGTATCGAGTGGGAAGCG
TTGCTGGTGGAAATGCTCGGCCTGTTGCATCGTATTGCGATGGTACAACTTTCGCCTGCT
GCACTTGGCAACGACATGGCCGCCATCGAGCTGCGGATGCGTGAACTGGCGCGCACCATA
CCGCCGACGGATATTCAGCTTTACTATCAGACGCTGTTGATTGGTCGCAAAGAATTACCG
TATGCGCCGGACCGTCGCATGGGCGTTGAGATGACGCTGCTGCGCGCGCTGGCATTCCAT
CCGCGTATGCCGCTGCCTGAGCCAGAAGTGCCACGACAGTCCTTTGCACCCGTCGCGCCA
ACGGCAGTAATGACGCCAACCCAGGTGCCGCCGCAACCGCAATCAGCGCCGCAGCAGGCA
CCGACTGTACCGCTCCCGGAAACCACCAGCCAGGTGCTGGCGGCGCGCCAGCAGTTGCAG
CGCGTGCAGGGAGCAACCAAAGCAAAAAAGAGTGAACCGGCAGCCGCTACCCGCGCGCGG
CCGGTGAATAACGCTGCGCTGGAAAGACTGGCTTCGGTCACCGATCGCGTTCAGGCGCGT
CCGGTGCCATCGGCGCTGGAAAAAGCGCCAGCCAAAAAAGAAGCGTATCGCTGGAAGGCG
ACCACTCCGGTGATGCAGCAAAAAGAAGTGGTCGCCACGCCGAAGGCGCTGAAAAAAGCG
CTGGAACATGAAAAAACGCCGGAACTGGCGGCGAAGCTAGCGGCAGAAGCCATTGAGCGC
GACCCGTGGGCGGCACAGGTGAGCCAACTTTCGCTACCAAAACTGGTCGAACAGGTGGCG
TTAAATGCCTGGAAAGAGGAGAGCGACAACGCAGTATGTCTGCATTTGCGCTCCTCTCAG
CGGCATTTGAACAACCGCGGTGCACAGCAAAAACTGGCTGAAGCGTTGAGCATGTTAAAA
GGTTCAACGGTTGAACTGACTATCGTTGAAGATGATAATCCCGCGGTGCGTACGCCGCTG
GAGTGGCGTCAGGCGATATACGAAGAAAAACTTGCGCAGGCGCGCGAGTCCATTATTGCG
GATAATAATATTCAGACCCTGCGTCGGTTCTTCGATGCGGAGCTGGATGAAGAAAGTATC
CGCCCCATTTGA

# Drug_Target_79_General_Function:
Involved in nucleotide binding

# Drug_Target_79_General_References:
1575709	O'Donnell M: Accessory protein function in the DNA polymerase III holoenzyme from E. coli. Bioessays. 1992 Feb;14(2):105-11.
2181440	Tsuchihashi Z, Kornberg A: Translational frameshifting generates the gamma subunit of DNA polymerase III holoenzyme. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2516-20.
2186364	Blinkowa AL, Walker JR: Programmed ribosomal frameshifting generates the Escherichia coli DNA polymerase III gamma subunit from within the tau subunit reading frame. Nucleic Acids Res. 1990 Apr 11;18(7):1725-9.
2187190	Flower AM, McHenry CS: The gamma subunit of DNA polymerase III holoenzyme of Escherichia coli is produced by ribosomal frameshifting. Proc Natl Acad Sci U S A. 1990 May;87(10):3713-7.
3018672	Yin KC, Blinkowa A, Walker JR: Nucleotide sequence of the Escherichia coli replication gene dnaZX. Nucleic Acids Res. 1986 Aug 26;14(16):6541-9.
3534795	Flower AM, McHenry CS: The adjacent dnaZ and dnaX genes of Escherichia coli are contained within one continuous open reading frame. Nucleic Acids Res. 1986 Oct 24;14(20):8091-101.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_79_HGNC_ID:
Not Available

# Drug_Target_79_HPRD_ID:
Not Available

# Drug_Target_79_ID:
4839

# Drug_Target_79_Locus:
Not Available

# Drug_Target_79_Molecular_Weight:
71139

# Drug_Target_79_Name:
DNA polymerase III subunit tau

# Drug_Target_79_Number_of_Residues:
643

# Drug_Target_79_PDB_ID:
1XXH

# Drug_Target_79_Pathway:
Not Available

# Drug_Target_79_Pfam_Domain_Function:
PF00004	AAA

# Drug_Target_79_Protein_Sequence:
>DNA polymerase III subunit tau
MSYQVLARKWRPQTFADVVGQEHVLTALANGLSLGRIHHAYLFSGTRGVGKTSIARLLAK
GLNCETGITATPCGVCDNCREIEQGRFVDLIEIDAASRTKVEDTRDLLDNVQYAPARGRF
KVYLIDEVHMLSRHSFNALLKTLEEPPEHVKFLLATTDPQKLPVTILSRCLQFHLKALDV
EQIRHQLEHILNEEHIAHEPRALQLLARAAEGSLRDALSLTDQAIASGDGQVSTQAVSAM
LGTLDDDQALSLVEAMVEANGERVMALINEAAARGIEWEALLVEMLGLLHRIAMVQLSPA
ALGNDMAAIELRMRELARTIPPTDIQLYYQTLLIGRKELPYAPDRRMGVEMTLLRALAFH
PRMPLPEPEVPRQSFAPVAPTAVMTPTQVPPQPQSAPQQAPTVPLPETTSQVLAARQQLQ
RVQGATKAKKSEPAAATRARPVNNAALERLASVTDRVQARPVPSALEKAPAKKEAYRWKA
TTPVMQQKEVVATPKALKKALEHEKTPELAAKLAAEAIERDPWAAQVSQLSLPKLVEQVA
LNAWKEESDNAVCLHLRSSQRHLNNRGAQQKLAEALSMLKGSTVELTIVEDDNPAVRTPL
EWRQAIYEEKLAQARESIIADNNIQTLRRFFDAELDEESIRPI

# Drug_Target_79_Reaction:
Not Available

# Drug_Target_79_Signals:
None

# Drug_Target_79_Specific_Function:
The gamma chain seems to interact with the delta subunit to transfer the beta subunit on the DNA

# Drug_Target_79_SwissProt_ID:
P06710

# Drug_Target_79_SwissProt_Name:
DPO3X_ECOLI

# Drug_Target_79_Synonyms:
EC 2.7.7.7

# Drug_Target_79_Theoretical_pI:
6.84

# Drug_Target_79_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
V01547

# Drug_Target_7_GenBank_ID_Protein:
47034

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
aphA

# Drug_Target_7_Gene_Sequence:
>795 bp
ATGGCTAAAATGAGAATATCACCGGAATTGAAAAAACTGATCGAAAAATACCGCTGCGTA
AAAGATACGGAAGGAATGTCTCCTGCTAAGGTATATAAGCTGGTGGGAGAAAATGAAAAC
CTATATTTAAAAATGACGGACAGCCGGTATAAAGGGACCACCTATGATGTGGAACGGGAA
AAGGACATGATGCTATGGCTGGAAGGAAAGCTGCCTGTTCCAAAGGTCCTGCACTTTGAA
CGGCATGATGGCTGGAGCAATCTGCTCATGAGTGAGGCCGATGGCGTCCTTTGCTCGGAA
GAGTATGAAGATGAACAAAGCCCTGAAAAGATTATCGAGCTGTATGCGGAGTGCATCAGG
CTCTTTCACTCCATCGACATATCGGATTGTCCCTATACGAATAGCTTAGACAGCCGCTTA
GCCGAATTGGATTACTTACTGAATAACGATCTGGCCGATGTGGATTGCGAAAACTGGGAA
GAAGACACTCCATTTAAAGATCCGCGCGAGCTGTATGATTTTTTAAAGACGGAAAAGCCC
GAAGAGGAACTTGTCTTTTCCCACGGCGACCTGGGAGACAGCAACATCTTTGTGAAAGAT
GGCAAAGTAAGTGGCTTTATTGATCTTGGGAGAAGCGGCAGGGCGGACAAGTGGTATGAC
ATTGCCTTCTGCGTCCGGTCGATCAGGGAGGATATCGGGGAAGAACAGTATGTCGAGCTA
TTTTTTGACTTACTGGGGATCAAGCCTGATTGGGAGAAAATAAAATATTATATTTTACTG
GATGAATTGTTTTAG

# Drug_Target_7_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_7_General_References:
6313476	Trieu-Cuot P, Courvalin P: Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3'5"-aminoglycoside phosphotransferase type III. Gene. 1983 Sep;23(3):331-41.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
3390

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
30974

# Drug_Target_7_Name:
Aminoglycoside 3'-phosphotransferase

# Drug_Target_7_Number_of_Residues:
264

# Drug_Target_7_PDB_ID:
1J7U

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF01636	APH

# Drug_Target_7_Protein_Sequence:
>Aminoglycoside 3'-phosphotransferase
MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVERE
KDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIR
LFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP
EEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVEL
FFDLLGIKPDWEKIKYYILLDELF

# Drug_Target_7_Reaction:
ATP + kanamycin = ADP + kanamycin 3'-phosphate ALL_REAC (other) R01888

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Resistance to kanamycin and structurally-related aminoglycosides, including amikacin

# Drug_Target_7_SwissProt_ID:
P0A3Y5

# Drug_Target_7_SwissProt_Name:
KKA3_ENTFA

# Drug_Target_7_Synonyms:
APH(3')III
EC 2.7.1.95
Kanamycin kinase, type III
Neomycin-kanamycin phosphotransferase type III

# Drug_Target_7_Theoretical_pI:
4.27

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_80_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_80_Chromosome_Location:
Not Available

# Drug_Target_80_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_80_Essentiality:
Non-Essential

# Drug_Target_80_GenAtlas_ID:
Not Available

# Drug_Target_80_GenBank_ID_Gene:
M36321

# Drug_Target_80_GenBank_ID_Protein:
147780

# Drug_Target_80_GeneCard_ID:
Not Available

# Drug_Target_80_Gene_Name:
coaA

# Drug_Target_80_Gene_Sequence:
>1011 bp
GTGACGCGCCATGGCAAATATCGCTTTGCCGATAGAGCTATGACCGCCAGAAACATGCTT
ATGAGTATAAAAGAGCAAACGTTAATGACGCCTTACCTACAGTTTGACCGCAACCAGTGG
GCAGCTCTGCGTGATTCCGTACCTATGACGTTATCGGAAGATGAGATCGCCCGTCTCAAA
GGTATTAATGAAGATCTCTCGTTAGAAGAAGTTGCCGAGATCTATTTACCTTTGTCACGT
TTGCTGAACTTCTATATAAGCTCGAATCTGCGCCGTCAGGCAGTTCTGGAACAGTTTCTT
GGTACCAACGGGCAACGCATTCCTTACATTATCAGTATTGCTGGCAGTGTCGCGGTGGGG
AAAAGTACAACCGCCCGTGTATTGCAGGCGCTATTAAGCCGTTGGCCGGAACATCGTCGT
GTTGAACTGATCACTACAGATGGCTTCCTTCACCCTAATCAGGTTCTGAAAGAACGTGGT
CTGATGAAGAAGAAAGGCTTCCCGGAATCGTATGATATGCATCGCCTGGTGAAGTTTGTT
TCCGATCTCAAATCCGGCGTGCCAAACGTTACAGCACCTGTTTACTCACATCTTATTTAT
GATGTGATCCCGGATGGAGATAAAACGGTTGTTCAGCCTGATATTTTAATTCTTGAAGGG
TTAAATGTCTTACAGAGCGGGATGGATTATCCACACGATCCACATCATGTATTTGTTTCT
GATTTTGTCGATTTTTCGATATATGTTGATGCACCGGAAGACTTACTTCAGACATGGTAT
ATCAACCGTTTTCTGAAATTCCGCGAAGGGGCTTTTACCGACCCGGATTCCTATTTTCAT
AACTACGCGAAATTAACTAAAGAAGAAGCGATTAAGACTGCCATGACATTGTGGAAAGAG
ATCAACTGGCTGAACTTAAAGCAAAATATTCTACCTACTCGTGAGCGCGCCAGTTTAATC
CTGACGAAAAGTGCTAATCATGCGGTAGAAGAGGTCAGACTACGCAAATAA

# Drug_Target_80_General_Function:
Coenzyme transport and metabolism

# Drug_Target_80_General_References:
1311303	Song WJ, Jackowski S: coaA and rts are allelic and located at kilobase 3532 on the Escherichia coli physical map. J Bacteriol. 1992 Mar;174(5):1705-6.
1328157	Song WJ, Jackowski S: Cloning, sequencing, and expression of the pantothenate kinase (coaA) gene of Escherichia coli. J Bacteriol. 1992 Oct;174(20):6411-7.
3073109	Flamm JA, Friesen JD, Otsuka AJ: The nucleotide sequence of the Escherichia coli rts gene. Gene. 1988 Dec 30;74(2):555-8.
8265357	Blattner FR, Burland V, Plunkett G 3rd, Sofia HJ, Daniels DL: Analysis of the Escherichia coli genome. IV. DNA sequence of the region from 89.2 to 92.8 minutes. Nucleic Acids Res. 1993 Nov 25;21(23):5408-17.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_80_HGNC_ID:
Not Available

# Drug_Target_80_HPRD_ID:
Not Available

# Drug_Target_80_ID:
2371

# Drug_Target_80_Locus:
Not Available

# Drug_Target_80_Molecular_Weight:
36360

# Drug_Target_80_Name:
Pantothenate kinase

# Drug_Target_80_Number_of_Residues:
316

# Drug_Target_80_PDB_ID:
1SQ5

# Drug_Target_80_Pathway:
Not Available

# Drug_Target_80_Pfam_Domain_Function:
PF00485	PRK

# Drug_Target_80_Protein_Sequence:
>Pantothenate kinase
MSIKEQTLMTPYLQFDRNQWAALRDSVPMTLSEDEIARLKGINEDLSLEEVAEIYLPLSR
LLNFYISSNLRRQAVLEQFLGTNGQRIPYIISIAGSVAVGKSTTARVLQALLSRWPEHRR
VELITTDGFLHPNQVLKERGLMKKKGFPESYDMHRLVKFVSDLKSGVPNVTAPVYSHLIY
DVIPDGDKTVVQPDILILEGLNVLQSGMDYPHDPHHVFVSDFVDFSIYVDAPEDLLQTWY
INRFLKFREGAFTDPDSYFHNYAKLTKEEAIKTAMTLWKEINWLNLKQNILPTRERASLI
LTKSANHAVEEVRLRK

# Drug_Target_80_Reaction:
ATP + (R)-pantothenate = ADP + (R)-4'-phosphopantothenate

# Drug_Target_80_Signals:
None

# Drug_Target_80_Specific_Function:
ATP + (R)-pantothenate = ADP + (R)-4'- phosphopantothenate

# Drug_Target_80_SwissProt_ID:
P0A6I3

# Drug_Target_80_SwissProt_Name:
COAA_ECOLI

# Drug_Target_80_Synonyms:
EC 2.7.1.33
Pantothenic acid kinase
Rts protein

# Drug_Target_80_Theoretical_pI:
6.81

# Drug_Target_80_Transmembrane_Regions:
None

# Drug_Target_81_Cellular_Location:
Nucleus

# Drug_Target_81_Chromosome_Location:
Not Available

# Drug_Target_81_Drug_References:
Not Available

# Drug_Target_81_Essentiality:
Non-Essential

# Drug_Target_81_GenAtlas_ID:
Not Available

# Drug_Target_81_GenBank_ID_Gene:
J02400

# Drug_Target_81_GenBank_ID_Protein:
Not Available

# Drug_Target_81_GeneCard_ID:
Not Available

# Drug_Target_81_Gene_Name:
Not Available

# Drug_Target_81_Gene_Sequence:
>2127 bp
ATGGATAAAGTTTTAAACAGAGAGGAATCTTTGCAGCTAATGGACCTTCTAGGTCTTGAA
AGGAGTGCCTGGGGGAATATTCCTCTGATGAGAAAGGCATATTTAAAAAAATGCAAGGAG
TTTCATCCTGATAAAGGAGGAGATGAAGAAAAAATGAAGAAAATGAATACTCTGTACAAG
AAAATGGAAGATGGAGTAAAATATGCTCATCAACCTGACTTTGGAGGCTTCTGGGATGCA
ACTGAGATTCCAACCTATGGAACTGATGAATGGGAGCAGTGGTGGAATGCCTTTAATGAG
GAAAACCTGTTTTGCTCAGAAGAAATGCCATCTAGTGATGATGAGGCTACTGCTGACTCT
CAACATTCTACTCCTCCAAAAAAGAAGAGAAAGGTAGAAGACCCCAAGGACTTTCCTTCA
GAATTGCTAAGTTTTTTGAGTCATGCTGTGTTTAGTAATAGAACTCTTGCTTGCTTTGCT
ATTTACACCACAAAGGAAAAAGCTGCACTGCTATACAAGAAAATTATGGAAAAATATTCT
GTAACCTTTATAAGTAGGCATAACAGTTATAATCATAACATACTGTTTTTTCTTACTCCA
CACAGGCATAGAGTGTCTGCTATTAATAACTATGCTCAAAAATTGTGTACCTTTAGCTTT
TTAATTTGTAAAGGGGTTAATAAGGAATATTTGATGTATAGTGCCTTGACTAGAGATCCA
TTTTCTGTTATTGAGGAAAGTTTGCCAGGTGGGTTAAAGGAGCATGATTTTAATCCAGAA
GAAGCAGAGGAAACTAAACAAGTGTCCTGGAAGCTTGTAACAGAGTATGCAATGGAAACA
AAATGTGATGATGTGTTGTTATTGCTTGGGATGTACTTGGAATTTCAGTACAGTTTTGAA
ATGTGTTTAAAATGTATTAAAAAAGAACAGCCCAGCCACTATAAGTACCATGAAAAGCAT
TATGCAAATGCTGCTATATTTGCTGACAGCAAAAACCAAAAAACCATATGCCAACAGGCT
GTTGATACTGTTTTAGCTAAAAAGCGGGTTGATAGCCTACAATTAACTAGAGAACAAATG
TTAACAAACAGATTTAATGATCTTTTGGATAGGATGGATATAATGTTTGGTTCTACAGGC
TCTGCTGACATAGAAGAATGGATGGCTGGAGTTGCTTGGCTACACTGTTTGTTGCCCAAA
ATGGATTCAGTGGTGTATGACTTTTTAAAATGCATGGTGTACAACATTCCTAAAAAAAGA
TACTGGCTGTTTAAAGGACCAATTGATAGTGGTAAAACTACATTAGCAGCTGCTTTGCTT
GAATTATGTGGGGGGAAAGCTTTAAATGTTAATTTGCCCTTGGACAGGCTGAACTTTGAG
CTAGGAGTAGCTATTGACCAGTTTTTAGTAGTTTTTGAGGATGTAAAGGGCACTGGAGGG
GAGTCCAGAGATTTGCCTTCAGGTCAGGGAATTAATAACCTGGACAATTTAAGGGATTAT
TTGGATGGCAGTGTTAAGGTAAACTTAGAAAAGAAACACCTAAATAAAAGAACTCAAATA
TTTCCCCCTGGAATAGTCACCATGAATGAGTACAGTGTGCCTAAAACACTGCAGGCCAGA
TTTGTAAAACAAATAGATTTTAGGCCCAAAGATTATTTAAAGCATTGCCTGGAACGCAGT
GAGTTTTTGTTAGAAAAGAGAATAATTCAAAGTGGCATTGCTTTGCTTCTTATGTTAATT
TGGTACAGACCTGTGGCTGAGTTTGCTCAAAGTATTCAGAGCAGAATTGTGGAGTGGAAA
GAGAGATTGGACAAAGAGTTTAGTTTGTCAGTGTATCAAAAAATGAAGTTTAATGTGGCT
ATGGGAATTGGAGTTTTAGATTGGCTAAGAAACAGTGATGATGATGATGAAGACAGCCAG
GAAAATGCTGATAAAAATGAAGATGGTGGGGAGAAGAACATGGAAGACTCAGGGCATGAA
ACAGGCATTGATTCACAGTCCCAAGGCTCATTTCAGGCCCCTCAGTCCTCACAGTCTGTT
CATGATCATAATCAGCCATACCACATTTGTAGAGGTTTTACTTGCTTTAAAAAACCTCCC
ACACCTCCCCCTGAACCTGAAACATAA

# Drug_Target_81_General_Function:
Involved in heat shock protein binding

# Drug_Target_81_General_References:
1851875	Loeber G, Stenger JE, Ray S, Parsons RE, Anderson ME, Tegtmeyer P: The zinc finger region of simian virus 40 large T antigen is needed for hexamer assembly and origin melting. J Virol. 1991 Jun;65(6):3167-74.
205802	Fiers W, Contreras R, Haegemann G, Rogiers R, Van de Voorde A, Van Heuverswyn H, Van Herreweghe J, Volckaert G, Ysebaert M: Complete nucleotide sequence of SV40 DNA. Nature. 1978 May 11;273(5658):113-20.
205947	Reddy VB, Thimmappaya B, Dhar R, Subramanian KN, Zain BS, Pan J, Ghosh PK, Celma ML, Weissman SM: The genome of simian virus 40. Science. 1978 May 5;200(4341):494-502.
2160857	Prives C: The replication functions of SV40 T antigen are regulated by phosphorylation. Cell. 1990 Jun 1;61(5):735-8.
2173794	Hoss A, Moarefi IF, Fanning E, Arthur AK: The finger domain of simian virus 40 large T antigen controls DNA-binding specificity. J Virol. 1990 Dec;64(12):6291-6.
2552322	McVey D, Brizuela L, Mohr I, Marshak DR, Gluzman Y, Beach D: Phosphorylation of large tumour antigen by cdc2 stimulates SV40 DNA replication. Nature. 1989 Oct 12;341(6242):503-7.
2555176	Virshup DM, Kauffman MG, Kelly TJ: Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A. EMBO J. 1989 Dec 1;8(12):3891-8.
2838952	Grasser FA, Scheidtmann KH, Tuazon PT, Traugh JA, Walter G: In vitro phosphorylation of SV40 large T antigen. Virology. 1988 Jul;165(1):13-22.
2839300	DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E, Livingston DM: SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell. 1988 Jul 15;54(2):275-83.
6096007	Kalderon D, Roberts BL, Richardson WD, Smith AE: A short amino acid sequence able to specify nuclear location. Cell. 1984 Dec;39(3 Pt 2):499-509.

# Drug_Target_81_HGNC_ID:
Not Available

# Drug_Target_81_HPRD_ID:
Not Available

# Drug_Target_81_ID:
5284

# Drug_Target_81_Locus:
Not Available

# Drug_Target_81_Molecular_Weight:
81583

# Drug_Target_81_Name:
Large T antigen

# Drug_Target_81_Number_of_Residues:
708

# Drug_Target_81_PDB_ID:
1SVO

# Drug_Target_81_Pathway:
Not Available

# Drug_Target_81_Pfam_Domain_Function:
PF00226	DnaJ
PF02217	T_Ag_DNA_bind
PF06431	Polyoma_lg_T_C

# Drug_Target_81_Protein_Sequence:
>Large T antigen
MDKVLNREESLQLMDLLGLERSAWGNIPLMRKAYLKKCKEFHPDKGGDEEKMKKMNTLYK
KMEDGVKYAHQPDFGGFWDATEIPTYGTDEWEQWWNAFNEENLFCSEEMPSSDDEATADS
QHSTPPKKKRKVEDPKDFPSELLSFLSHAVFSNRTLACFAIYTTKEKAALLYKKIMEKYS
VTFISRHNSYNHNILFFLTPHRHRVSAINNYAQKLCTFSFLICKGVNKEYLMYSALTRDP
FSVIEESLPGGLKEHDFNPEEAEETKQVSWKLVTEYAMETKCDDVLLLLGMYLEFQYSFE
MCLKCIKKEQPSHYKYHEKHYANAAIFADSKNQKTICQQAVDTVLAKKRVDSLQLTREQM
LTNRFNDLLDRMDIMFGSTGSADIEEWMAGVAWLHCLLPKMDSVVYDFLKCMVYNIPKKR
YWLFKGPIDSGKTTLAAALLELCGGKALNVNLPLDRLNFELGVAIDQFLVVFEDVKGTGG
ESRDLPSGQGINNLDNLRDYLDGSVKVNLEKKHLNKRTQIFPPGIVTMNEFSVPKTLQAR
FVKQIDFRAKDYLKHCLERSEFLLEKRIIQSGIALLLMLIWYRPVAEFAQSIQSRIVEWK
ERLDKEFSLSVYQKMKFNVAMGIGVLDWLRNSDDDDEDSQENADKNEDGGEKNMEDSGHE
TGIDSQSQGSFQAPQSSQSVHDHNQPYHICRGFTCFKKPPTPPPEPET

# Drug_Target_81_Reaction:
Not Available

# Drug_Target_81_Signals:
None

# Drug_Target_81_Specific_Function:
Initiates DNA unwinding and replication via elaborate interactions with the viral origin of replication. Binds two adjacent sites in the SV40 origin

# Drug_Target_81_SwissProt_ID:
P03070

# Drug_Target_81_SwissProt_Name:
LT_SV40

# Drug_Target_81_Synonyms:
Not Available

# Drug_Target_81_Theoretical_pI:
6.04

# Drug_Target_81_Transmembrane_Regions:
None

# Drug_Target_82_Cellular_Location:
Endoplasmic reticulum
endoplasmic reticulum membrane
multi-pass membrane protein. Peroxisome
pero

# Drug_Target_82_Chromosome_Location:
Not Available

# Drug_Target_82_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_82_Essentiality:
Non-Essential

# Drug_Target_82_GenAtlas_ID:
HMGCR

# Drug_Target_82_GenBank_ID_Gene:
M11058

# Drug_Target_82_GenBank_ID_Protein:
306865

# Drug_Target_82_GeneCard_ID:
HMGCR

# Drug_Target_82_Gene_Name:
HMGCR

# Drug_Target_82_Gene_Sequence:
>2667 bp
ATGTTGTCAAGACTTTTTCGAATGCATGGCCTCTTTGTGGCCTCCCATCCCTGGGAAGTC
ATAGTGGGGACAGTGACACTGACCATCTGCATGATGTCCATGAACATGTTTACTGGTAAC
AATAAGATCTGTGGTTGGAATTATGAATGTCCAAAGTTTGAAGAGGATGTTTTGAGCAGT
GACATTATAATTCTGACAATAACACGATGCATAGCCATCCTGTATATTTACTTCCAGTTC
CAGAATTTACGTCAACTTGGATCAAAATATATTTTGGGTATTGCTGGCCTTTTCACAATT
TTCTCAAGTTTTGTATTCAGTACAGTTGTCATTCACTTCTTAGACAAAGAATTGACAGGC
TTGAATGAAGCTTTGCCCTTTTTCCTACTTTTGATTGACCTTTCCAGAGCAAGCACATTA
GCAAAGTTTGCCCTCAGTTCCAACTCACAGGATGAAGTAAGGGAAAATATTGCTCGTGGA
ATGGCAATTTTAGGTCCTACGTTTACCCTCGATGCTCTTGTTGAATGTCTTGTGATTGGA
GTTGGTACCATGTCAGGGGTACGTCAGCTTGAAATTATGTGCTGCTTTGGCTGCATGTCA
GTTCTTGCCAACTACTTCGTGTTCATGACTTTCTTCCCAGCTTGTGTGTCCTTGGTATTA
GAGCTTTCTCGGGAAAGCCGCGAGGGTCGTCCAATTTGGCAGCTCAGCCATTTTGCCCGA
GTTTTAGAAGAAGAAGAAAATAAGCCGAATCCTGTAACTCAGAGGGTCAAGATGATTATG
TCTCTAGGCTTGGTTCTTGTTCATGCTCACAGTCGCTGGATAGCTGATCCTTCTCCTCAA
AACAGTACAGCAGATACTTCTAAGGTTTCATTAGGACTGGATGAAAATGTGTCCAAGAGA
ATTGAACCAAGTGTTTCCCTCTGGCAGTTTTATCTCTCTAAAATGATCAGCATGGATATT
GAACAAGTTATTACCCTAAGTTTAGCTCTCCTTCTGGCTGTCAAGTACATCTTCTTTGAA
CAAACAGAGACAGAATCTACACTCTCATTAAAAAACCCTATCACATCTCCTGTAGTGACA
CAAAAGAAAGTCCCAGACAATTGTTGTAGACGTGAACCTATGCTGGTCAGAAATAACCAG
AAATGTGATTCAGTAGAGGAAGAGACAGGGATAAACCGAGAAAGAAAAGTTGAGGTTATA
AAACCCTTAGTGGCTGAAACAGATACCCCAAACAGAGCTACATTTGTGGTTGGTAACTCC
TCCTTACTCGATACTTCATCAGTACTGGTGACACAGGAACCTGAAATTGAACTTCCCAGG
GAACCTCGGCCTAATGAAGAATGTCTACAGATACTTGGGAATGCAGAGAAAGGTGCAAAA
TTCCTTAGTGATGCTGAGATCATCCAGTTAGTCAATGCTAAGCATATCCCAGCCTACAAG
TTGGAAACTCTGATGGAAACTCATGAGCGTGGTGTATCTATTCGCCGACAGTTACTTTCC
AAGAAGCTTTCAGAACCTTCTTCTCTCCAGTACCTACCTTACAGGGATTATAATTACTCC
TTGGTGATGGGAGCTTGTTGTGAGAATGTTATTGGATATATGCCCATCCCTGTTGGAGTG
GCAGGACCCCTTTGCTTAGATGAAAAAGAATTTCAGGTTCCAATGGCAACAACAGAAGGT
TGTCTTGTGGCCAGCACCAATAGAGGCTGCAGAGCAATAGGTCTTGGTGGAGGTGCCAGC
AGCCGAGTCCTTGCAGATGGGATGACTCGTGGCCCAGTTGTGCGTCTTCCACGTGCTTGT
GACTCTGCAGAAGTGAAAGCCTGGCTCGAAACATCTGAAGGGTTCGCAGTGATAAAGGAG
GCATTTGACAGCACTAGCAGATTTGCACGTCTACAGAAACTTCATACAAGTATAGCTGGA
CGCAACCTTTATATCCGTTTCCAGTCCAGGTCAGGGGATGCCATGGGGATGAACATGATT
TCAAAGGGTACAGAGAAAGCACTTTCAAAACTTCACGAGTATTTCCCTGAAATGCAGATT
CTAGCCGTTAGTGGTAACTATTGTACTGACAAGAAACCTGCTGCTATAAATTGGATAGAG
GGAAGAGGAAAATCTGTTGTTTGTGAAGCTGTCATTCCAGCCAAGGTTGTCAGAGAAGTA
TTAAAGACTACCACAGAGGCTATGATTGAGGTCAACATTAACAAGAATTTAGTGGGCTCT
GCCATGGCTGGGAGCATAGGAGGCTACAACGCCCATGCAGCAAACATTGTCACCGCCATC
TACATTGCCTGTGGACAGGATGCAGCACAGAATGTTGGTAGTTCAAACTGTATTACTTTA
ATGGAAGCAAGTGGTCCCACAAATGAAGATTTATATATCAGCTGCACCATGCCATCTATA
GAGATAGGAACGGTGGGTGGTGGGACCAACCTACTACCTCAGCAAGCCTGTTTGCAGATG
CTAGGTGTTCAAGGAGCATGCAAAGATAATCCTGGGGAAAATGCCCGGCAGCTTGCCCGA
ATTGTGTGTGGGACCGTAATGGCTGGGGAATTGTCACTTATGGCAGCATTGGCAGCAGGA
CATCTTGTCAAAAGTCACATGATTCACAACAGGTCGAAGATCAATTTACAAGACCTCCAA
GGAGCTTGCACCAAGAAGACAGCCTGA

# Drug_Target_82_General_Function:
Lipid transport and metabolism

# Drug_Target_82_General_References:
10391209	Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet. 1999 Jul;22(3):231-8.
10698924	Istvan ES, Palnitkar M, Buchanan SK, Deisenhofer J: Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis. EMBO J. 2000 Mar 1;19(5):819-30.
2991281	Luskey KL, Stevens B: Human 3-hydroxy-3-methylglutaryl coenzyme A reductase. Conserved domains responsible for catalytic activity and sterol-regulated degradation. J Biol Chem. 1985 Aug 25;260(18):10271-7.

# Drug_Target_82_HGNC_ID:
HGNC:5006

# Drug_Target_82_HPRD_ID:
00836

# Drug_Target_82_ID:
631

# Drug_Target_82_Locus:
5q13.3-q14

# Drug_Target_82_Molecular_Weight:
97477

# Drug_Target_82_Name:
3-hydroxy-3-methylglutaryl-coenzyme A reductase

# Drug_Target_82_Number_of_Residues:
888

# Drug_Target_82_PDB_ID:
1HWL

# Drug_Target_82_Pathway:
Alendronate pathway	SMP00095
Atorvastatin Pathway	SMP00131
Cerivastatin Pathway	SMP00111
Fluvastatin Pathway	SMP00119
Ibandronate Pathway	SMP00079
Lovastatin Pathway	SMP00099
Pamidronate Pathway	SMP00117
Pravastatin Pathway	SMP00089
Risedronate Pathway	SMP00112
Rosuvastatin Pathway	SMP00092
Zoledronate Pathway	SMP00107

# Drug_Target_82_Pfam_Domain_Function:
PF00368	HMG-CoA_red

# Drug_Target_82_Protein_Sequence:
>3-hydroxy-3-methylglutaryl-coenzyme A reductase
MLSRLFRMHGLFVASHPWEVIVGTVTLTICMMSMNMFTGNNKICGWNYECPKFEEDVLSS
DIIILTITRCIAILYIYFQFQNLRQLGSKYILGIAGLFTIFSSFVFSTVVIHFLDKELTG
LNEALPFFLLLIDLSRASTLAKFALSSNSQDEVRENIARGMAILGPTFTLDALVECLVIG
VGTMSGVRQLEIMCCFGCMSVLANYFVFMTFFPACVSLVLELSRESREGRPIWQLSHFAR
VLEEEENKPNPVTQRVKMIMSLGLVLVHAHSRWIADPSPQNSTADTSKVSLGLDENVSKR
IEPSVSLWQFYLSKMISMDIEQVITLSLALLLAVKYIFFEQTETESTLSLKNPITSPVVT
QKKVPDNCCRREPMLVRNNQKCDSVEEETGINRERKVEVIKPLVAETDTPNRATFVVGNS
SLLDTSSVLVTQEPEIELPREPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYK
LETLMETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGV
AGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRAC
DSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMI
SKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREV
LKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITL
MEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLAR
IVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKINLQDLQGACTKKTA

# Drug_Target_82_Reaction:
(R)-mevalonate + CoA + 2 NADP+ = (S)-3-hydroxy-3-methylglutaryl-CoA + 2 NADPH + 2 H+

# Drug_Target_82_Signals:
None

# Drug_Target_82_Specific_Function:
This transmembrane glycoprotein is involved in the control of cholesterol biosynthesis. It is the rate-limiting enzyme of sterol biosynthesis

# Drug_Target_82_SwissProt_ID:
P04035

# Drug_Target_82_SwissProt_Name:
HMDH_HUMAN

# Drug_Target_82_Synonyms:
EC 1.1.1.34
HMG-CoA reductase

# Drug_Target_82_Theoretical_pI:
6.72

# Drug_Target_82_Transmembrane_Regions:
10-39
57-78
90-114
124-149
160-187
192-220
315-339

# Drug_Target_83_Cellular_Location:
Not Available

# Drug_Target_83_Chromosome_Location:
Not Available

# Drug_Target_83_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_83_Essentiality:
Non-Essential

# Drug_Target_83_GenAtlas_ID:
KIF5B

# Drug_Target_83_GenBank_ID_Gene:
X65873

# Drug_Target_83_GenBank_ID_Protein:
Not Available

# Drug_Target_83_GeneCard_ID:
Not Available

# Drug_Target_83_Gene_Name:
KIF5B

# Drug_Target_83_Gene_Sequence:
>2892 bp
ATGGCGGACCTGGCCGAGTGCAACATCAAAGTGATGTGTCGCTTCAGACCTCTCAACGAG
TCTGAAGTGAACCGCGGCGACAAGTACATCGCCAAGTTTCAGGGAGAAGACACGGTCGTG
ATCGCGTCCAAGCCTTATGCATTTGATCGGGTGTTCCAGTCAAGCACATCTCAAGAGCAA
GTGTATAATGACTGTGCAAAGAAGATTGTTAAAGATGTACTTGAAGGATATAATGGAACA
ATATTTGCATATGGACAAACATCCTCTGGGAAGACACACACAATGGAGGGTAAACTTCAT
GATCCAGAAGGCATGGGAATTATTCCAAGAATAGTGCAAGATATTTTTAATTATATTTAC
TCCATGGATGAAAATTTGGAATTTCATATTAAGGTTTCATATTTTGAAATATATTTGGAT
AAGATAAGGGACCTGTTAGATGTTTCAAAGACCAACCTTTCAGTTCATGAAGACAAAAAC
CGAGTTCCCTATGTAAAGGGGTGCACAGAGCGTTTTGTATGTAGTCCAGATGAAGTTATG
GATACCATAGATGAAGGAAAATCCAACAGACATGTAGCAGTTACAAATATGAATGAACAT
AGCTCTAGGAGTCACAGTATATTTCTTATTAATGTCAAACAAGAGAACACACAAACGGAA
CAAAAGCTGAGTGGAAAACTTTATCTGGTTGATTTAGCTGGTAGTGAAAAGGTTAGTAAA
ACTGGAGCTGAAGGTGCTGTGCTGGATGAAGCTAAAAACATCAACAAGTCACTTTCTGCT
CTTGGAAATGTTATTTCTGCTTTGGCTGAGGGTAGTACATATGTTCCATATCGAGATAGT
AAAATGACAAGAATCCTTCAAGATTCATTAGGTGGCAACTGTAGAACCACTATTGTAATT
TGCTGCTCTCCATCATCATACAATGAGTCTGAAACAAAATCTACACTCTTATTTGGCCAA
AGGGCCAAAACAATTAAGAACACAGTTTGTGTCAATGTGGAGTTAACTGCAGAACAGTGG
AAAAAGAAGTATGAAAAAGAAAAAGAAAAAAATAAGATCCTGCGGAACACTATTCAGTGG
CTTGAAAATGAGCTCAACAGATGGCGTAATGGGGAGACGGTGCCTATTGATGAACAGTTT
GACAAAGAGAAAGCCAACTTGGAAGCTTTCACAGTGGATAAAGATATTACTCTTACCAAT
GATAAACCAGCAACCGCAATTGGAGTTATAGGAAATTTTACTGATGCTGAAAGAAGAAAG
TGTGAAGAAGAAATTGCTAAATTATACAAACAGCTTGATGACAAGGATGAAGAAATTAAC
CAGCAAAGTCAACTGGTAGAGAAACTGAAGACGCAAATGTTGGATCAGGAGGAGCTTTTG
GCATCTACCAGAAGGGATCAAGACAATATGCAAGCTGAGCTGAATCGCCTTCAAGCAGAA
AATGATGCCTCTAAAGAAGAAGTGAAAGAAGTTTTACAGGCCCTAGAAGAACTTGCTGTC
AATTATGATCAGAAGTCTCAGGAAGTTGAAGACAAAACTAAGGAATATGAATTGCTTAGT
GATGAATTGAATCAGAAATCGGCAACTTTAGCGAGTATAGATGCTGAGCTTCAGAAACTT
AAGGAAATGACCAACCACCAGAAAAAACGAGCAGCTGAGATGATGGCATCTTTACTAAAA
GACCTTGCAGAAATAGGAATTGCTGTGGGAAATAATGATGTAAAGCAGCCTGAGGGAACT
GGCATGATAGATGAAGAGTTCACTGTTGCAAGACTCTACATTAGCAAAATGAAGTCAGAA
GTAAAAACCATGGTGAAACGTTGCAAGCAGTTAGAAAGCACACAAACTGAGAGCAACAAA
AAAATGGAAGAAAATGAAAAGGAGTTAGCAGCATGTCAGCTTCGTATCTCTCAACATGAA
GCCAAAATCAAGTCATTGACTGAATACCTTCAAAATGTGGAACAAAAGAAAAGACAGTTG
GAGGAATCTGTCGATGCCCTCAGTGAAGAACTAGTCCAGCTTCGAGCACAAGAGAAAGTC
CATGAAATGGAAAAGGAGCACTTAAATAAGGTTCAGACTGCAAATGAAGTTAAGCAAGCT
GTTGAACAGCAGATCCAGAGCCATAGAGAAACTCATCAAAAACAGATCAGTAGTTTGAGA
GATGAAGTAGAAGCAAAAGCAAAACTTATTACTGATCTTCAAGACCAAAACCAGAAAATG
ATGTTAGAGCAGGAACGTCTAAGAGTAGAACATGAGAAGTTGAAAGCCACAGATCAGGAA
AAGAGCAGAAAACTACATGAACTTACGGTTATGCAAGATAGACGAGAACAAGCAAGACAA
GACTTGAAGGGTTTGGAAGAGACAGTGGCAAAAGAACTTCAGACTTTACACAACCTGCGC
AAACTCTTTGTTCAGGACCTGGCTACAAGAGTTAAAAAGAGTGCTGAGATTGATTCTGAT
GACACCGGAGGCAGCGCTGCTCAGAAGCAAAAAATCTCCTTTCTTGAAAATAATCTTGAA
CAGCTCACTAAAGTGCACAAACAGTTGGTACGTGATAATGCAGATCTCCGCTGTGAACTT
CCTAAGTTGGAAAAGCGACTTCGAGCTACAGCTGAGAGAGTGAAAGCTTTGGAATCAGCA
CTGAAAGAAGCTAAAGAAAATGCATCTCGTGATCGCAAACGCTATCAGCAAGAAGTAGAT
CGCATAAAGGAAGCAGTCAGGTCAAAGAATATGGCCAGAAGAGGGCATTCTGCACAGATT
GCTAAACCTATTCGTCCCGGGCAACATCCAGCAGCTTCTCCAACTCACCCAAGTGCAATT
CGTGGAGGAGGTGCATTTGTTCAGAACAGCCAGCCAGTGGCAGTGCGAGGTGGAGGAGGC
AAACAAGTGTAA

# Drug_Target_83_General_Function:
Involved in microtubule motor activity

# Drug_Target_83_General_References:
1607388	Navone F, Niclas J, Hom-Booher N, Sparks L, Bernstein HD, McCaffrey G, Vale RD: Cloning and expression of a human kinesin heavy chain gene: interaction of the COOH-terminal domain with cytoplasmic microtubules in transfected CV-1 cells. J Cell Biol. 1992 Jun;117(6):1263-75.
8606779	Kull FJ, Sablin EP, Lau R, Fletterick RJ, Vale RD: Crystal structure of the kinesin motor domain reveals a structural similarity to myosin. Nature. 1996 Apr 11;380(6574):550-5.

# Drug_Target_83_HGNC_ID:
HGNC:6324

# Drug_Target_83_HPRD_ID:
Not Available

# Drug_Target_83_ID:
5285

# Drug_Target_83_Locus:
10pter-q22.1

# Drug_Target_83_Molecular_Weight:
109686

# Drug_Target_83_Name:
Kinesin heavy chain

# Drug_Target_83_Number_of_Residues:
963

# Drug_Target_83_PDB_ID:
1MKJ

# Drug_Target_83_Pathway:
Not Available

# Drug_Target_83_Pfam_Domain_Function:
PF00225	Kinesin

# Drug_Target_83_Protein_Sequence:
>Kinesin heavy chain
MADLAECNIKVMCRFRPLNESEVNRGDKYIAKFQGEDTVVIASKPYAFDRVFQSSTSQEQ
VYNDCAKKIVKDVLEGYNGTIFAYGQTSSGKTHTMEGKLHDPEGMGIIPRIVQDIFNYIY
SMDENLEFHIKVSYFEIYLDKIRDLLDVSKTNLSVHEDKNRVPYVKGCTERFVCSPDEVM
DTIDEGKSNRHVAVTNMNEHSSRSHSIFLINVKQENTQTEQKLSGKLYLVDLAGSEKVSK
TGAEGAVLDEAKNINKSLSALGNVISALAEGSTYVPYRDSKMTRILQDSLGGNCRTTIVI
CCSPSSYNESETKSTLLFGQRAKTIKNTVCVNVELTAEQWKKKYEKEKEKNKILRNTIQW
LENELNRWRNGETVPIDEQFDKEKANLEAFTVDKDITLTNDKPATAIGVIGNFTDAERRK
CEEEIAKLYKQLDDKDEEINQQSQLVEKLKTQMLDQEELLASTRRDQDNMQAELNRLQAE
NDASKEEVKEVLQALEELAVNYDQKSQEVEDKTKEYELLSDELNQKSATLASIDAELQKL
KEMTNHQKKRAAEMMASLLKDLAEIGIAVGNNDVKQPEGTGMIDEEFTVARLYISKMKSE
VKTMVKRCKQLESTQTESNKKMEENEKELAACQLRISQHEAKIKSLTEYLQNVEQKKRQL
EESVDALSEELVQLRAQEKVHEMEKEHLNKVQTANEVKQAVEQQIQSHRETHQKQISSLR
DEVEAKAKLITDLQDQNQKMMLEQERLRVEHEKLKATDQEKSRKLHELTVMQDRREQARQ
DLKGLEETVAKELQTLHNLRKLFVQDLATRVKKSAEIDSDDTGGSAAQKQKISFLENNLE
QLTKVHKQLVRDNADLRCELPKLEKRLRATAERVKALESALKEAKENASRDRKRYQQEVD
RIKEAVRSKNMARRGHSAQIAKPIRPGQHPAASPTHPSAIRGGGAFVQNSQPVAVRGGGG
KQV

# Drug_Target_83_Reaction:
Not Available

# Drug_Target_83_Signals:
None

# Drug_Target_83_Specific_Function:
Microtubule-dependent motor required for normal distribution of mitochondria and lysosomes (By similarity)

# Drug_Target_83_SwissProt_ID:
P33176

# Drug_Target_83_SwissProt_Name:
KINH_HUMAN

# Drug_Target_83_Synonyms:
UKHC
Ubiquitous kinesin heavy chain

# Drug_Target_83_Theoretical_pI:
6.46

# Drug_Target_83_Transmembrane_Regions:
None

# Drug_Target_84_Cellular_Location:
Not Available

# Drug_Target_84_Chromosome_Location:
Not Available

# Drug_Target_84_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_84_Essentiality:
Non-Essential

# Drug_Target_84_GenAtlas_ID:
GSS

# Drug_Target_84_GenBank_ID_Gene:
L42531

# Drug_Target_84_GenBank_ID_Protein:
886284

# Drug_Target_84_GeneCard_ID:
GSS

# Drug_Target_84_Gene_Name:
GSS

# Drug_Target_84_Gene_Sequence:
>1425 bp
ATGGCCACCAACTGGGGGAGCCTCTTGCAGGATAAACAGCAGCTAGAGGAGCTGGCACGG
CAGGCCGTGGACCGGGCCCTGGCTGAGGGAGTATTGCTGAGGACCTCACAGGAGCCCACT
TCCTCGGAGGTGGTGAGCTATGCCCCATTCACGCTCTTCCCCTCACTGGTCCCCAGTGCC
CTGCTGGAGCAAGCCTATGCTGTGCAGATGGACTTCAACCTGCTAGTGGATGCTGTCAGC
CAGAACGCTGCCTTCCTGGAGCAAACTCTTTCCAGCACCATCAAACAGGATGACTTTACC
GCTCGTCTCTTTGACATCCACAAGCAAGTCCTAAAAGAGGGCATTGCCCAGACTGTGTTC
CTGGGCCTGAATCGCTCAGACTACATGTTCCAGCGCAGCGCAGATGGCTCCCCAGCCCTG
AAACAGATCGAAATCAACACCATCTCTGCCAGCTTTGGGGGCCTGGCCTCCCGGACCCCA
GCTGTGCACCGACATGTTCTCAGTGTCCTGAGTAAGACCAAAGAAGCTGGCAAGATCCTC
TCTAATAATCCCAGCAAGGGACTGGCCCTGGGAATTGCCAAAGCCTGGGAGCTCTACGGC
TCACCCAATGCTCTGGTGCTACTGATTGCTCAAGAGAAGGAAAGAAACATATTTGACCAG
CGTGCCATAGAGAATGAGCTACTGGCCAGGAACATCCATGTGATCCGACGAACATTTGAA
GATATCTCTGAAAAGGGGTCTCTGGACCAAGACCGAAGGCTGTTTGTGGATGGCCAGGAA
ATTGCTGTGGTTTACTTCCGGGATGGCTACATGCCTCGTCAGTACAGTCTACAGAATTGG
GAAGCACGTCTACTGCTGGAGAGGTCACATGCTGCCAAGTGCCCAGACATTGCCACCCAG
CTGGCTGGGACTAAGAAGGTGCAGCAGGAGCTAAGCAGGCCGGGCATGCTGGAGATGTTG
CTCCCTGGCCAGCCTGAGGCTGTGGCCCGCCTCCGCGCCACCTTTGCTGGCCTCTACTCA
CTGGATGTGGGTGAAGAAGGGGACCAGGCCATCGCCGAGGCCCTTGCTGCCCCTAGCCGG
TTTGTGCTAAAGCCCCAGAGAGAGGGTGGAGGTAACAACCTATATGGGGAGGAAATGGTA
CAGGCCCTGAAACAGCTGAAGGACAGTGAGGAGAGGGCCTCCTACATCCTCATGGAGAAG
ATCGAACCTGAGCCTTTTGAGAATTGCCTGCTACGGCCTGGCAGCCCTGCCCGAGTGGTC
CAGTGCATTTCAGAGCTGGGCATCTTTGGGGTCTATGTCAGGCAGGAAAAGACACTCGTG
ATGAACAAGCACGTGGGGCATCTACTTCGAACCAAAGCCATCGAGCATGCAGATGGTGGT
GTGGCAGCGGGAGTGGCAGTCCTGGACAACCCATACCCTGTGTGA

# Drug_Target_84_General_Function:
Involved in catalytic activity

# Drug_Target_84_General_References:
11780052	Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, Bailey J, Barlow KF, Bates KN, Beard LM, Beare DM, Beasley OP, Bird CP, Blakey SE, Bridgeman AM, Brown AJ, Buck D, Burrill W, Butler AP, Carder C, Carter NP, Chapman JC, Clamp M, Clark G, Clark LN, Clark SY, Clee CM, Clegg S, Cobley VE, Collier RE, Connor R, Corby NR, Coulson A, Coville GJ, Deadman R, Dhami P, Dunn M, Ellington AG, Frankland JA, Fraser A, French L, Garner P, Grafham DV, Griffiths C, Griffiths MN, Gwilliam R, Hall RE, Hammond S, Harley JL, Heath PD, Ho S, Holden JL, Howden PJ, Huckle E, Hunt AR, Hunt SE, Jekosch K, Johnson CM, Johnson D, Kay MP, Kimberley AM, King A, Knights A, Laird GK, Lawlor S, Lehvaslaiho MH, Leversha M, Lloyd C, Lloyd DM, Lovell JD, Marsh VL, Martin SL, McConnachie LJ, McLay K, McMurray AA, Milne S, Mistry D, Moore MJ, Mullikin JC, Nickerson T, Oliver K, Parker A, Patel R, Pearce TA, Peck AI, Phillimore BJ, Prathalingam SR, Plumb RW, Ramsay H, Rice CM, Ross MT, Scott CE, Sehra HK, Shownkeen R, Sims S, Skuce CD, Smith ML, Soderlund C, Steward CA, Sulston JE, Swann M, Sycamore N, Taylor R, Tee L, Thomas DW, Thorpe A, Tracey A, Tromans AC, Vaudin M, Wall M, Wallis JM, Whitehead SL, Whittaker P, Willey DL, Williams L, Williams SA, Wilming L, Wray PW, Hubbard T, Durbin RM, Bentley DR, Beck S, Rogers J: The DNA sequence and comparative analysis of human chromosome 20. Nature. 2001 Dec 20-27;414(6866):865-71.
7646467	Gali RR, Board PG: Sequencing and expression of a cDNA for human glutathione synthetase. Biochem J. 1995 Aug 15;310 ( Pt 1):353-8.
8896573	Shi ZZ, Habib GM, Rhead WJ, Gahl WA, He X, Sazer S, Lieberman MW: Mutations in the glutathione synthetase gene cause 5-oxoprolinuria. Nat Genet. 1996 Nov;14(3):361-5.
9215686	Dahl N, Pigg M, Ristoff E, Gali R, Carlsson B, Mannervik B, Larsson A, Board P: Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction. Hum Mol Genet. 1997 Jul;6(7):1147-52.

# Drug_Target_84_HGNC_ID:
HGNC:4624

# Drug_Target_84_HPRD_ID:
03000

# Drug_Target_84_ID:
207

# Drug_Target_84_Locus:
20q11.2

# Drug_Target_84_Molecular_Weight:
52385

# Drug_Target_84_Name:
Glutathione synthetase

# Drug_Target_84_Number_of_Residues:
474

# Drug_Target_84_PDB_ID:
2HGS

# Drug_Target_84_Pathway:
Cyclophosphamide Pathway	SMP00447
Ifosfamide Pathway	SMP00448

# Drug_Target_84_Pfam_Domain_Function:
PF03199	GSH_synthase
PF03917	GSH_synth_ATP

# Drug_Target_84_Protein_Sequence:
>Glutathione synthetase
MATNWGSLLQDKQQLEELARQAVDRALAEGVLLRTSQEPTSSEVVSYAPFTLFPSLVPSA
LLEQAYAVQMDFNLLVDAVSQNAAFLEQTLSSTIKQDDFTARLFDIHKQVLKEGIAQTVF
LGLNRSDYMFQRSADGSPALKQIEINTISASFGGLASRTPAVHRHVLSVLSKTKEAGKIL
SNNPSKGLALGIAKAWELYGSPNALVLLIAQEKERNIFDQRAIENELLARNIHVIRRTFE
DISEKGSLDQDRRLFVDGQEIAVVYFRDGYMPRQYSLQNWEARLLLERSHAAKCPDIATQ
LAGTKKVQQELSRPGMLEMLLPGQPEAVARLRATFAGLYSLDVGEEGDQAIAEALAAPSR
FVLKPQREGGGNNLYGEEMVQALKQLKDSEERASYILMEKIEPEPFENCLLRPGSPARVV
QCISELGIFGVYVRQEKTLVMNKHVGHLLRTKAIEHADGGVAAGVAVLDNPYPV

# Drug_Target_84_Reaction:
ATP + gamma-L-glutamyl-L-cysteine + glycine = ADP + phosphate + glutathione

# Drug_Target_84_Signals:
None

# Drug_Target_84_Specific_Function:
Not Available

# Drug_Target_84_SwissProt_ID:
P48637

# Drug_Target_84_SwissProt_Name:
GSHB_HUMAN

# Drug_Target_84_Synonyms:
EC 6.3.2.3
GSH synthetase
GSH-S
Glutathione synthase

# Drug_Target_84_Theoretical_pI:
5.73

# Drug_Target_84_Transmembrane_Regions:
None

# Drug_Target_85_Cellular_Location:
Not Available

# Drug_Target_85_Chromosome_Location:
Not Available

# Drug_Target_85_Drug_References:
Not Available

# Drug_Target_85_Essentiality:
Non-Essential

# Drug_Target_85_GenAtlas_ID:
Not Available

# Drug_Target_85_GenBank_ID_Gene:
Not Available

# Drug_Target_85_GenBank_ID_Protein:
Not Available

# Drug_Target_85_GeneCard_ID:
Not Available

# Drug_Target_85_Gene_Name:
Not Available

# Drug_Target_85_Gene_Sequence:
Not Available

# Drug_Target_85_General_Function:
Involved in enzyme regulator activity

# Drug_Target_85_General_References:
Not Available

# Drug_Target_85_HGNC_ID:
Not Available

# Drug_Target_85_HPRD_ID:
Not Available

# Drug_Target_85_ID:
5287

# Drug_Target_85_Locus:
Not Available

# Drug_Target_85_Molecular_Weight:
12881

# Drug_Target_85_Name:
Signaling protein

# Drug_Target_85_Number_of_Residues:
116

# Drug_Target_85_PDB_ID:
1V3S

# Drug_Target_85_Pathway:
Not Available

# Drug_Target_85_Pfam_Domain_Function:
PF00543	P-II

# Drug_Target_85_Protein_Sequence:
>Signaling protein
MKLIVAIVRPEKLNEVLKALFQAEVRGLTLSRVQGHGGETERVETYRGTTVKMELHEKVR
LEIGVSEPFVKPTVEAILKAARTGEVGDGKIFVLPVEKVYRIRTGEEDEAAVTPVQ

# Drug_Target_85_Reaction:
Not Available

# Drug_Target_85_Signals:
None

# Drug_Target_85_Specific_Function:
Not Available

# Drug_Target_85_SwissProt_ID:
P83820

# Drug_Target_85_SwissProt_Name:
P83820_THETH

# Drug_Target_85_Synonyms:
Not Available

# Drug_Target_85_Theoretical_pI:
7.70

# Drug_Target_85_Transmembrane_Regions:
None

# Drug_Target_86_Cellular_Location:
Mitochondrion
mitochondrial matrix

# Drug_Target_86_Chromosome_Location:
Not Available

# Drug_Target_86_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_86_Essentiality:
Non-Essential

# Drug_Target_86_GenAtlas_ID:
GLUD1

# Drug_Target_86_GenBank_ID_Gene:
X07674

# Drug_Target_86_GenBank_ID_Protein:
31707

# Drug_Target_86_GeneCard_ID:
GLUD1

# Drug_Target_86_Gene_Name:
GLUD1

# Drug_Target_86_Gene_Sequence:
>1677 bp
ATGTACCGCTACCTGGGCGAAGCGCTGTTGCTGTCCCGGGCCGGGCCCGCTGCCCTGGGC
TCGGCGTCCGCCGACTCGGCCGCGTTGCTGGGCTGGGCCCGGGGACAGCCCGCCGCCGCC
CCGCAGCCGGGGCTGGCATTGGCCGCCCGGCGCCACTACAGCGAGGCGGTGGCCGACCGC
GAGGACGACCCCAACTTCTTCAAGATGGTGGAGGGCTTCTTCGATCGCGGCGCCAGCATC
GTGGAGGACAAGCTGGTGGAGGACCTGAGGACCCGGGAGAGCGAGGAGCAGAAGCGGAAC
CGGGTGCGCGGCATCCTGCGGATCATCAAGCCCTGCAACCATGTGCTGAGTCTCTCCTTC
CCCATCCGGCGCGACGACGGCTCCTGGGAGGTCATCGAAGGCTACCGGGCCCAGCACAGC
CAGCACCGCACGCCCTGCAAGGGAGGTATCCGTTACAGCACTGATGTGAGTGTAGATGAA
GTAAAAGCTTTGGCTTCTCTGATGACATACAAGTGTGCAGTGGTTGATGTGCCGTTTGGG
GGTGCTAAAGCTGGTGTTAAGATCAATCCCAAGAACTATACTGATAATGAATTGGAAAAG
ATCACAAGGAGGTTCACCATGGAGCTAGCAAAAAAGGGCTTTATTGGTCCTGGCATTGAT
GTGCCTGCTCCAGACATGAGCACAGGTGAGCGGGAGATGTCCTGGATCGCTGATACCTAT
GCCAGCACCATAGGGCACTATGATATTAATGCACACGCCTGTGTTACTGGTAAACCCATC
AGCCAAGGGGGAATCCATGGACGCATCTCTGCTACTGGCCGTGGTGTCTTCCATGGGATT
GAAAATTTCATCAATGAAGCTTCTTACATGAGCATTTTAGGAATGACACCAGGGTTTGGA
GATAAAACATTTGTTGTTCAGGGATTTGGTAATGTGGGCCTACACTCTATGAGATATTTA
CATCGTTTTGGTGCTAAATGTATTGCTGTTGGTGAGTCTGATGGGAGTATATGGAATCCA
GATGGTATTGACCCAAAGGAACTGGAAGACTTCAAATTGCAACATGGGTCCATTCTGGGC
TTCCCCAAGGCAAAGCCCTATGAAGGAAGCATCTTGGAGGCCGACTGTGACATACTGATC
CCAGCTGCCAGTGAGAAGCAGTTGACCAAATCCAACGCACCCAGAGTCAAAGCCAAGATC
ATTGCTGAAGGTGCCAATGGGCCAACAACTCCAGAAGCTGACAAGATCTTCCTGGAGAGA
AACATTATGGTTATTCCAGATCTCTACTTGAATGCTGGAGGAGTGACAGTATCTTACTTT
GAGTGGCTGAAGAATCTAAATCATGTCAGCTATGGCCGTTTGACCTTCAAATATGAAAGG
GATTCTAACTACCACTTGCTCATGTCTGTTCAAGAGAGTTTAGAAAGAAAATTTGGAAAG
CATGGTGGAACTATTCCCATTGTACCCACGGCAGAGTTCCAAGACAGGATATCGGGTGCA
TCTGAGAAAGACATCGTGCACTCTGGCTTGGCATACACAATGGAGCGTTCTGCCAGGCAA
ATTATGCGCACAGCCATGAAGTATAACCTGGGATTGGACCTGAGAACAGCTGCCTATGTT
AATGCCATTGAGAAAGTCTTCAAAGTGTACAATGAAGCTGGTGTGACCTTCACATAG

# Drug_Target_86_General_Function:
Replication, recombination and repair

# Drug_Target_86_General_References:
10338089	Meissner T, Beinbrech B, Mayatepek E: Congenital hyperinsulinism: molecular basis of a heterogeneous disease. Hum Mutat. 1999;13(5):351-61.
10636977	Miki Y, Taki T, Ohura T, Kato H, Yanagisawa M, Hayashi Y: Novel missense mutations in the glutamate dehydrogenase gene in the congenital hyperinsulinism-hyperammonemia syndrome. J Pediatr. 2000 Jan;136(1):69-72.
11214910	Santer R, Kinner M, Passarge M, Superti-Furga A, Mayatepek E, Meissner T, Schneppenheim R, Schaub J: Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome. Hum Genet. 2001 Jan;108(1):66-71.
11254391	Smith TJ, Peterson PE, Schmidt T, Fang J, Stanley CA: Structures of bovine glutamate dehydrogenase complexes elucidate the mechanism of purine regulation. J Mol Biol. 2001 Mar 23;307(2):707-20.
11297618	MacMullen C, Fang J, Hsu BY, Kelly A, de Lonlay-Debeney P, Saudubray JM, Ganguly A, Smith TJ, Stanley CA: Hyperinsulinism/hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-binding domain of glutamate dehydrogenase. J Clin Endocrinol Metab. 2001 Apr;86(4):1782-7.
11903050	Fang J, Hsu BY, MacMullen CM, Poncz M, Smith TJ, Stanley CA: Expression, purification and characterization of human glutamate dehydrogenase (GDH) allosteric regulatory mutations. Biochem J. 2002 Apr 1;363(Pt 1):81-7.
12054821	Smith TJ, Schmidt T, Fang J, Wu J, Siuzdak G, Stanley CA: The structure of apo human glutamate dehydrogenase details subunit communication and allostery. J Mol Biol. 2002 May 3;318(3):765-77.
12653548	Banerjee S, Schmidt T, Fang J, Stanley CA, Smith TJ: Structural studies on ADP activation of mammalian glutamate dehydrogenase and the evolution of regulation. Biochemistry. 2003 Apr 1;42(12):3446-56.
1286669	Hochstrasser DF, Frutiger S, Paquet N, Bairoch A, Ravier F, Pasquali C, Sanchez JC, Tissot JD, Bjellqvist B, Vargas R, et al.: Human liver protein map: a reference database established by microsequencing and gel comparison. Electrophoresis. 1992 Dec;13(12):992-1001.
3368458	Mavrothalassitis G, Tzimagiorgis G, Mitsialis A, Zannis V, Plaitakis A, Papamatheakis J, Moschonas N: Isolation and characterization of cDNA clones encoding human liver glutamate dehydrogenase: evidence for a small gene family. Proc Natl Acad Sci U S A. 1988 May;85(10):3494-8.
3377777	Amuro N, Yamaura M, Goto Y, Okazaki T: Molecular cloning and nucleotide sequence of the cDNA for human liver glutamate dehydrogenase precursor. Biochem Biophys Res Commun. 1988 May 16;152(3):1395-400.
3399399	Nakatani Y, Schneider M, Banner C, Freese E: Complete nucleotide sequence of human glutamate dehydrogenase cDNA. Nucleic Acids Res. 1988 Jul 11;16(13):6237.
3426581	Nakatani Y, Banner C, von Herrath M, Schneider ME, Smith HH, Freese E: Comparison of human brain and liver glutamate dehydrogenase cDNAS. Biochem Biophys Res Commun. 1987 Dec 16;149(2):405-10.
3585334	Banner C, Silverman S, Thomas JW, Lampel KA, Vitkovic L, Huie D, Wenthold RJ: Isolation of a human brain cDNA for glutamate dehydrogenase. J Neurochem. 1987 Jul;49(1):246-52.
429360	Julliard JH, Smith EL: Partial amino acid sequence of the glutamate dehydrogenase of human liver and a revision of the sequence of the bovine enzyme. J Biol Chem. 1979 May 10;254(9):3427-38.
8314555	Tzimagiorgis G, Leversha MA, Chroniary K, Goulielmos G, Sargent CA, Ferguson-Smith M, Moschonas NK: Structure and expression analysis of a member of the human glutamate dehydrogenase (GLUD) gene family mapped to chromosome 10p11.2. Hum Genet. 1993 Jun;91(5):433-8.
8486350	Michaelidis TM, Tzimagiorgis G, Moschonas NK, Papamatheakis J: The human glutamate dehydrogenase gene family: gene organization and structural characterization. Genomics. 1993 Apr;16(1):150-60.
9571255	Stanley CA, Lieu YK, Hsu BY, Burlina AB, Greenberg CR, Hopwood NJ, Perlman K, Rich BH, Zammarchi E, Poncz M: Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med. 1998 May 7;338(19):1352-7.

# Drug_Target_86_HGNC_ID:
HGNC:4335

# Drug_Target_86_HPRD_ID:
11748

# Drug_Target_86_ID:
201

# Drug_Target_86_Locus:
10q23.3

# Drug_Target_86_Molecular_Weight:
61399

# Drug_Target_86_Name:
Glutamate dehydrogenase 1, mitochondrial

# Drug_Target_86_Number_of_Residues:
558

# Drug_Target_86_PDB_ID:
1L1F

# Drug_Target_86_Pathway:
Not Available

# Drug_Target_86_Pfam_Domain_Function:
PF00208	ELFV_dehydrog
PF02812	ELFV_dehydrog_N

# Drug_Target_86_Protein_Sequence:
>Glutamate dehydrogenase 1, mitochondrial precursor
MYRYLGEALLLSRAGPAALGSASADSAALLGWARGQPAAAPQPGLALAARRHYSEAVADR
EDDPNFFKMVEGFFDRGASIVEDKLVEDLRTRESEEQKRNRVRGILRIIKPCNHVLSLSF
PIRRDDGSWEVIEGYRAQHSQHRTPCKGGIRYSTDVSVDEVKALASLMTYKCAVVDVPFG
GAKAGVKINPKNYTDNELEKITRRFTMELAKKGFIGPGIDVPAPDMSTGEREMSWIADTY
ASTIGHYDINAHACVTGKPISQGGIHGRISATGRGVFHGIENFINEASYMSILGMTPGFG
DKTFVVQGFGNVGLHSMRYLHRFGAKCIAVGESDGSIWNPDGIDPKELEDFKLQHGSILG
FPKAKPYEGSILEADCDILIPAASEKQLTKSNAPRVKAKIIAEGANGPTTPEADKIFLER
NIMVIPDLYLNAGGVTVSYFEWLKNLNHVSYGRLTFKYERDSNYHLLMSVQESLERKFGK
HGGTIPIVPTAEFQDRISGASEKDIVHSGLAYTMERSARQIMRTAMKYNLGLDLRTAAYV
NAIEKVFKVYNEAGVTFT

# Drug_Target_86_Reaction:
L-glutamate + H2O + NAD(P)+ = 2-oxoglutarate + NH3 + NAD(P)H + H+

# Drug_Target_86_Signals:
None

# Drug_Target_86_Specific_Function:
May be involved in learning and memory reactions by increasing the turnover of the excitatory neurotransmitter glutamate

# Drug_Target_86_SwissProt_ID:
P00367

# Drug_Target_86_SwissProt_Name:
DHE3_HUMAN

# Drug_Target_86_Synonyms:
EC 1.4.1.3
GDH
Glutamate dehydrogenase 1, mitochondrial precursor

# Drug_Target_86_Theoretical_pI:
7.91

# Drug_Target_86_Transmembrane_Regions:
None

# Drug_Target_87_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_87_Chromosome_Location:
Not Available

# Drug_Target_87_Drug_References:
Not Available

# Drug_Target_87_Essentiality:
Non-Essential

# Drug_Target_87_GenAtlas_ID:
Not Available

# Drug_Target_87_GenBank_ID_Gene:
BX842580

# Drug_Target_87_GenBank_ID_Protein:
Not Available

# Drug_Target_87_GeneCard_ID:
Not Available

# Drug_Target_87_Gene_Name:
aroK

# Drug_Target_87_Gene_Sequence:
>531 bp
TCATGTGGCCGCCTCGCTGGGGCTGGGAACCTGCAGCCGCGACAGGATATGGCGGACCAC
CGCCCCGGGGTTGCGGCGATTGGTGTCCACTCGCATGGTCGCGACGCGCCGGTACAGCGG
TGCCCGCTTGGCCATCAGCGCGCGGTATTTTTCGGCGCGGTCGGGGCCGGCCAGCAGTGG
GCGCACGGTGTTGCCGCCGGTGCGGCGCACGCCCTCGGCGGCGCTGATCTCCAGGTAGAC
GACGGTGTGGCCGGCCAGCGCCGCGCGCACACCGGGGCTGGTCACCGCGCCGCCGCCGAG
CGACAGCACACCGTCGTGGTCGGCCAGTGCCGCGCGCACCACGTCCTCCTCGATACGTCG
GAACTCCTGCTCCCCGTCGGTGGCGAAGATGTCGGCGATGCTGCGTCCGGTCCGCTGCTC
GATCGCGACGTCGGTGTCGAGCAGGCCGACCCCGAGCGCCTTGGCCAGCCGGCGCCCGAT
GGTGGACTTGCCGGAGCCCGGCAGGCCGACGAGAACCGCTTTGGGTGCCAT

# Drug_Target_87_General_Function:
Involved in shikimate kinase activity

# Drug_Target_87_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_87_HGNC_ID:
Not Available

# Drug_Target_87_HPRD_ID:
Not Available

# Drug_Target_87_ID:
5288

# Drug_Target_87_Locus:
Not Available

# Drug_Target_87_Molecular_Weight:
18584

# Drug_Target_87_Name:
Shikimate kinase

# Drug_Target_87_Number_of_Residues:
176

# Drug_Target_87_PDB_ID:
1L4Y

# Drug_Target_87_Pathway:
Not Available

# Drug_Target_87_Pfam_Domain_Function:
PF01202	SKI

# Drug_Target_87_Protein_Sequence:
>Shikimate kinase
MAPKAVLVGLPGSGKSTIGRRLAKALGVGLLDTDVAIEQRTGRSIADIFATDGEQEFRRI
EEDVVRAALADHDGVLSLGGGAVTSPGVRAALAGHTVVYLEISAAEGVRRTGGNTVRPLL
AGPDRAEKYRALMAKRAPLYRRVATMRVDTNRRNPGAVVRHILSRLQVPSPSEAAT

# Drug_Target_87_Reaction:
Not Available

# Drug_Target_87_Signals:
None

# Drug_Target_87_Specific_Function:
Catalyzes the specific phosphorylation of the 3-hydroxyl group of shikimic acid using ATP as a cosubstrate

# Drug_Target_87_SwissProt_ID:
P0A4Z2

# Drug_Target_87_SwissProt_Name:
AROK_MYCTU

# Drug_Target_87_Synonyms:
EC 2.7.1.71
SK

# Drug_Target_87_Theoretical_pI:
11.13

# Drug_Target_87_Transmembrane_Regions:
None

# Drug_Target_88_Cellular_Location:
Cytoplasm

# Drug_Target_88_Chromosome_Location:
Not Available

# Drug_Target_88_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_88_Essentiality:
Non-Essential

# Drug_Target_88_GenAtlas_ID:
Not Available

# Drug_Target_88_GenBank_ID_Gene:
X03038

# Drug_Target_88_GenBank_ID_Protein:
40904

# Drug_Target_88_GeneCard_ID:
Not Available

# Drug_Target_88_Gene_Name:
adk

# Drug_Target_88_Gene_Sequence:
>645 bp
ATGCGTATCATTCTGCTTGGCGCTCCGGGCGCGGGGAAAGGGACTCAGGCTCAGTTCATC
ATGGAGAAATATGGTATTCCGCAAATCTCCACTGGCGATATGCTGCGTGCTGCGGTCAAA
TCTGGCTCCGAGCTGGGTAAACAAGCAAAAGACATTATGGATGCTGGCAAACTGGTCACC
GACGAACTGGTGATCGCGCTGGTTAAAGAGCGCATTGCTCAGGAAGACTGCCGTAATGGT
TTCCTGTTGGACGGCTTCCCGCGTACCATTCCGCAGGCAGACGCGATGAAAGAAGCGGGC
ATCAATGTTGATTACGTTCTGGAATTCGACGTACCGGACGAACTGATCGTTGACCGTATC
GTCGGTCGCCGCGTTCATGCGCCGTCTGGTCGTGTTTATCACGTTAAATTCAATCCGCCG
AAAGTAGAAGGCAAAGACGACGTTACCGGTGAAGAACTGACTACCCGTAAAGATGATCAG
GAAGAGACCGTACGTAAACGTCTGGTTGAATACCATCAGATGACAGCACCGCTGATCGGC
TACTACTCCAAAGAAGCAGAAGCGGGTAATACCAAATACGCGAAAGTTGACGGCACCAAG
CCGGTTGCTGAAGTTCGCGCTGATCTGGAAAAAATCCTCGGCTAA

# Drug_Target_88_General_Function:
Nucleotide transport and metabolism

# Drug_Target_88_General_References:
1548697	Muller CW, Schulz GE: Structure of the complex between adenylate kinase from Escherichia coli and the inhibitor Ap5A refined at 1.9 A resolution. A model for a catalytic transition state. J Mol Biol. 1992 Mar 5;224(1):159-77.
2051480	Miyamoto K, Nakahigashi K, Nishimura K, Inokuchi H: Isolation and characterization of visible light-sensitive mutants of Escherichia coli K12. J Mol Biol. 1991 Jun 5;219(3):393-8.
2223776	Reinstein J, Schlichting I, Wittinghofer A: Structurally and catalytically important residues in the phosphate binding loop of adenylate kinase of Escherichia coli. Biochemistry. 1990 Aug 14;29(32):7451-9.
2844237	Reinstein J, Brune M, Wittinghofer A: Mutations in the nucleotide binding loop of adenylate kinase of Escherichia coli. Biochemistry. 1988 Jun 28;27(13):4712-20.
2997739	Brune M, Schumann R, Wittinghofer F: Cloning and sequencing of the adenylate kinase gene (adk) of Escherichia coli. Nucleic Acids Res. 1985 Oct 11;13(19):7139-51.
3299380	Bardwell JC, Craig EA: Eukaryotic Mr 83,000 heat shock protein has a homologue in Escherichia coli. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5177-81.
7937733	Berry MB, Meador B, Bilderback T, Liang P, Glaser M, Phillips GN Jr: The closed conformation of a highly flexible protein: the structure of E. coli adenylate kinase with bound AMP and AMPPNP. Proteins. 1994 Jul;19(3):183-98.
8451239	Muller CW, Schulz GE: Crystal structures of two mutants of adenylate kinase from Escherichia coli that modify the Gly-loop. Proteins. 1993 Jan;15(1):42-9.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.
9600841	Wilkins MR, Gasteiger E, Tonella L, Ou K, Tyler M, Sanchez JC, Gooley AA, Walsh BJ, Bairoch A, Appel RD, Williams KL, Hochstrasser DF: Protein identification with N and C-terminal sequence tags in proteome projects. J Mol Biol. 1998 May 8;278(3):599-608.

# Drug_Target_88_HGNC_ID:
Not Available

# Drug_Target_88_HPRD_ID:
Not Available

# Drug_Target_88_ID:
2296

# Drug_Target_88_Locus:
Not Available

# Drug_Target_88_Molecular_Weight:
23586

# Drug_Target_88_Name:
Adenylate kinase

# Drug_Target_88_Number_of_Residues:
214

# Drug_Target_88_PDB_ID:
2ECK

# Drug_Target_88_Pathway:
Not Available

# Drug_Target_88_Pfam_Domain_Function:
PF00406	ADK
PF05191	ADK_lid

# Drug_Target_88_Protein_Sequence:
>Adenylate kinase
MRIILLGAPGAGKGTQAQFIMEKYGIPQISTGDMLRAAVKSGSELGKQAKDIMDAGKLVT
DELVIALVKERIAQEDCRNGFLLDGFPRTIPQADAMKEAGINVDYVLEFDVPDELIVDRI
VGRRVHAPSGRVYHVKFNPPKVEGKDDVTGEELTTRKDDQEETVRKRLVEYHQMTAPLIG
YYSKEAEAGNTKYAKVDGTKPVAEVRADLEKILG

# Drug_Target_88_Reaction:
ATP + AMP = 2 ADP

# Drug_Target_88_Signals:
None

# Drug_Target_88_Specific_Function:
Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. This small ubiquitous enzyme involved in the energy metabolism and nucleotide synthesis, is essential for maintenance and cell growth

# Drug_Target_88_SwissProt_ID:
P69441

# Drug_Target_88_SwissProt_Name:
KAD_ECOLI

# Drug_Target_88_Synonyms:
AK
ATP-AMP transphosphorylase
EC 2.7.4.3

# Drug_Target_88_Theoretical_pI:
5.45

# Drug_Target_88_Transmembrane_Regions:
None

# Drug_Target_89_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_89_Chromosome_Location:
Not Available

# Drug_Target_89_Drug_References:
Not Available

# Drug_Target_89_Essentiality:
Non-Essential

# Drug_Target_89_GenAtlas_ID:
Not Available

# Drug_Target_89_GenBank_ID_Gene:
Z98682

# Drug_Target_89_GenBank_ID_Protein:
Not Available

# Drug_Target_89_GeneCard_ID:
Not Available

# Drug_Target_89_Gene_Name:
coaD

# Drug_Target_89_Gene_Sequence:
>486 bp
GTGGCGAGTATAGCTGTCTGTCCCGGCAGTTTTGATCCTGTGACCTACGGGCATCTGGAC
ATCATCAAACGCGGGGCGCATATTTTTGAACAAGTGTATGTATGTGTGCTGAATAATTCT
TCAAAAAAGCCTTTGTTCAGTGTGGAAGAACGGTGTGAGCTTCTGAGAGAAGTCACAAAA
GACATTCCGAACATAACAGTTGAAACATCGCAAGGCCTGTTAATTGATTATGCAAAAAGA
AAAAATGCGAAAGCGATTTTAAGAGGCTTGAGAGCTGTATCTGATTTTGAATACGAGATG
CAGGGGACATCAGTAAACCGGGTGCTTGATGAATCTATTGAGACGTTTTTTATGATGACA
AACAATCAATATTCGTTTCTAAGTTCAAGCATCGTAAAAGAAGTGGCAAGATACAACGGC
TCGGTATCAGAGTTTGTACCGCCGGAAGTAGAGTTGGCGCTTCAGCAAAAATTCAGACAA
GGATGA

# Drug_Target_89_General_Function:
Involved in catalytic activity

# Drug_Target_89_General_References:
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_89_HGNC_ID:
Not Available

# Drug_Target_89_HPRD_ID:
Not Available

# Drug_Target_89_ID:
5289

# Drug_Target_89_Locus:
Not Available

# Drug_Target_89_Molecular_Weight:
18179

# Drug_Target_89_Name:
Phosphopantetheine adenylyltransferase

# Drug_Target_89_Number_of_Residues:
161

# Drug_Target_89_PDB_ID:
1O6B

# Drug_Target_89_Pathway:
Not Available

# Drug_Target_89_Pfam_Domain_Function:
PF01467	CTP_transf_2

# Drug_Target_89_Protein_Sequence:
>Phosphopantetheine adenylyltransferase
MASIAVCPGSFDPVTYGHLDIIKRGAHIFEQVYVCVLNNSSKKPLFSVEERCELLREVTK
DIPNITVETSQGLLIDYAKRKNAKAILRGLRAVSDFEYEMQGTSVNRVLDESIETFFMMT
NNQYSFLSSSIVKEVARYNGSVSEFVPPEVELALQQKFRQG

# Drug_Target_89_Reaction:
Not Available

# Drug_Target_89_Signals:
None

# Drug_Target_89_Specific_Function:
Reversibly transfers an adenylyl group from ATP to 4'- phosphopantetheine, yielding dephospho-CoA (dPCoA) and pyrophosphate (By similarity)

# Drug_Target_89_SwissProt_ID:
O34797

# Drug_Target_89_SwissProt_Name:
COAD_BACSU

# Drug_Target_89_Synonyms:
Dephospho-CoA pyrophosphorylase
EC 2.7.7.3
PPAT
Pantetheine- phosphate adenylyltransferase

# Drug_Target_89_Theoretical_pI:
5.81

# Drug_Target_89_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Not Available

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
M18393

# Drug_Target_8_GenBank_ID_Protein:
146220

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
glpK

# Drug_Target_8_Gene_Sequence:
>1509 bp
ATGACTGAAAAAAAATATATCGTTGCGCTCGACCAGGGCACCACCAGCTCCCGCGCGGTC
GTAATGGATCACGATGCCAATATCATTAGCGTGTCGCAGCGCGAATTTGAGCAAATCTAC
CCAAAACCAGGTTGGGTAGAACACGACCCAATGGAAATCTGGGCCACCCAAAGCTCCACG
CTGGTAGAAGTGCTGGCGAAAGCCGATATCAGTTCCGATCAAATTGCAGCTATCGGTATT
ACGAACCAGCGTGAAACCACTATTGTCTGGGAAAAAGAAACCGGCAAGCCTATCTATAAC
GCCATTGTCTGGCAGTGCCGTCGTACCGCAGAAATCTGCGAGCATTTAAAACGTGACGGT
TTAGAAGATTATATCCGCAGCAATACCGGTCTGGTGATTGACCCGTACTTTTCTGGCACC
AAAGTGAAGTGGATCCTCGACCATGTGGAAGGCTCTCGCGAGCGTGCACGTCGTGGTGAA
TTGCTGTTTGGTACGGTTGATACGTGGCTTATCTGGAAAATGACTCAGGGCCGTGTCCAT
GTGACCGATTACACCAACGCCTCTCGTACCATGTTGTTCAACATCCATACCCTGGACTGG
GACGACAAAATGCTGGAAGTGCTGGATATTCCGCGCGAGATGCTGCCAGAAGTGCGTCGT
TCTTCCGAAGTATACGGTCAGACTAACATTGGCGGCAAAGGCGGCACGCGTATTCCAATC
TCCGGGATCGCCGGTGACCAGCAGGCCGCGCTGTTTGGTCAGTTGTGCGTGAAAGAAGGG
ATGGCGAAGAACACCTATGGCACTGGCTGCTTTATGCTGATGAACACTGGCGAGAAAGCG
GTGAAATCAGAAAACGGCCTGCTGACCACCATCGCCTGCGGCCCGACTGGCGAAGTGAAC
TATGCGTTGGAAGGTGCGGTGTTTATGGCAGGCGCATCCATTCAGTGGCTGCGCGATGAA
ATGAAGTTGATTAACGACGCCTACGATTCCGAATATTTCGCCACCAAAGTGCAAAACACC
AATGGTGTGTATGTGGTTCCGGCATTTACCGGGCTGGGTGCGCCGTACTGGGACCCGTAT
GCGCGCGGGGCGATTTTCGGTCTGACTCGTGGGGTGAACGCTAACCACATTATACGCGCG
ACGCTGGAGTCTATTGCTTATCAGACGCGTGACGTGCTGGAAGCGATGCAGGCCGACTCT
GGTATCCGTCTGCACGCCCTGCGCGTGGATGGTGGCGCAGTAGCAAACAATTTCCTGATG
CAGTTCCAGTCCGATATTCTCGGCACCCGCGTTGAGCGCCCGGAAGTGCGCGAAGTCACC
GCATTGGGTGCGGCCTATCTCGCAGGCCTGGCGGTTGGCTTCTGGCAGAACCTCGACGAG
CTGCAAGAGAAAGCGGTGATTGAGCGCGAGTTCCGTCCAGGCATCGAAACCACTGAGCGT
AATTACCGTTACGCAGGCTGGAAAAAAGCGGTTAAACGCGCGATGGCGTGGGAAGAACAC
GACGAATAA

# Drug_Target_8_General_Function:
Energy production and conversion

# Drug_Target_8_General_References:
10090737	Bystrom CE, Pettigrew DW, Branchaud BP, O'Brien P, Remington SJ: Crystal structures of Escherichia coli glycerol kinase variant S58-->W in complex with nonhydrolyzable ATP analogues reveal a putative active conformation of the enzyme as a result of domain motion. Biochemistry. 1999 Mar 23;38(12):3508-18.
1372899	Weissenborn DL, Wittekindt N, Larson TJ: Structure and regulation of the glpFK operon encoding glycerol diffusion facilitator and glycerol kinase of Escherichia coli K-12. J Biol Chem. 1992 Mar 25;267(9):6122-31.
2544860	Muramatsu S, Mizuno T: Nucleotide sequence of the region encompassing the glpKF operon and its upstream region containing a bent DNA sequence of Escherichia coli. Nucleic Acids Res. 1989 Jun 12;17(11):4378.
2826434	Pettigrew DW, Ma DP, Conrad CA, Johnson JR: Escherichia coli glycerol kinase. Cloning and sequencing of the glpK gene and the primary structure of the enzyme. J Biol Chem. 1988 Jan 5;263(1):135-9.
8170944	Feese M, Pettigrew DW, Meadow ND, Roseman S, Remington SJ: Cation-promoted association of a regulatory and target protein is controlled by protein phosphorylation. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3544-8.
8346018	Plunkett G 3rd, Burland V, Daniels DL, Blattner FR: Analysis of the Escherichia coli genome. III. DNA sequence of the region from 87.2 to 89.2 minutes. Nucleic Acids Res. 1993 Jul 25;21(15):3391-8.
8430315	Hurley JH, Faber HR, Worthylake D, Meadow ND, Roseman S, Pettigrew DW, Remington SJ: Structure of the regulatory complex of Escherichia coli IIIGlc with glycerol kinase. Science. 1993 Jan 29;259(5095):673-7.
8631672	Pettigrew DW, Liu WZ, Holmes C, Meadow ND, Roseman S: A single amino acid change in Escherichia coli glycerol kinase abolishes glucose control of glycerol utilization in vivo. J Bacteriol. 1996 May;178(10):2846-52.
8899705	Gonzalez-Gil G, Bringmann P, Kahmann R: FIS is a regulator of metabolism in Escherichia coli. Mol Microbiol. 1996 Oct;22(1):21-9.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9817843	Feese MD, Faber HR, Bystrom CE, Pettigrew DW, Remington SJ: Glycerol kinase from Escherichia coli and an Ala65-->Thr mutant: the crystal structures reveal conformational changes with implications for allosteric regulation. Structure. 1998 Nov 15;6(11):1407-18.
9843423	Ormo M, Bystrom CE, Remington SJ: Crystal structure of a complex of Escherichia coli glycerol kinase and an allosteric effector fructose 1,6-bisphosphate. Biochemistry. 1998 Nov 24;37(47):16565-72.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
2922

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
56231

# Drug_Target_8_Name:
Glycerol kinase

# Drug_Target_8_Number_of_Residues:
502

# Drug_Target_8_PDB_ID:
1BOT

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF00370	FGGY_N
PF02782	FGGY_C

# Drug_Target_8_Protein_Sequence:
>Glycerol kinase
MTEKKYIVALDQGTTSSRAVVMDHDANIISVSQREFEQIYPKPGWVEHDPMEIWATQSST
LVEVLAKADISSDQIAAIGITNQRETTIVWEKETGKPIYNAIVWQCRRTAEICEHLKRDG
LEDYIRSNTGLVIDPYFSGTKVKWILDHVEGSRERARRGELLFGTVDTWLIWKMTQGRVH
VTDYTNASRTMLFNIHTLDWDDKMLEVLDIPREMLPEVRRSSEVYGQTNIGGKGGTRIPI
SGIAGDQQAALFGQLCVKEGMAKNTYGTGCFMLMNTGEKAVKSENGLLTTIACGPTGEVN
YALEGAVFMAGASIQWLRDEMKLINDAYDSEYFATKVQNTNGVYVVPAFTGLGAPYWDPY
ARGAIFGLTRGVNANHIIRATLESIAYQTRDVLEAMQADSGIRLHALRVDGGAVANNFLM
QFQSDILGTRVERPEVREVTALGAAYLAGLAVGFWQNLDELQEKAVIEREFRPGIETTER
NYRYAGWKKAVKRAMAWEEHDE

# Drug_Target_8_Reaction:
ATP + glycerol = ADP + sn-glycerol 3-phosphate

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Key enzyme in the regulation of glycerol uptake and metabolism

# Drug_Target_8_SwissProt_ID:
P0A6F3

# Drug_Target_8_SwissProt_Name:
GLPK_ECOLI

# Drug_Target_8_Synonyms:
ATP:glycerol 3-phosphotransferase
EC 2.7.1.30
GK
Glycerokinase

# Drug_Target_8_Theoretical_pI:
5.18

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_90_Cellular_Location:
Cytoplasm

# Drug_Target_90_Chromosome_Location:
Not Available

# Drug_Target_90_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_90_Essentiality:
Non-Essential

# Drug_Target_90_GenAtlas_ID:
Not Available

# Drug_Target_90_GenBank_ID_Gene:
J04423

# Drug_Target_90_GenBank_ID_Protein:
145427

# Drug_Target_90_GeneCard_ID:
Not Available

# Drug_Target_90_Gene_Name:
bioD

# Drug_Target_90_Gene_Sequence:
>660 bp
GTGAGTAAACGTTATTTTGTCACCGGAACGGATACCGAAGTGGGGAAAACTGTCGCCAGT
TGTGCACTTTTACAAGCCGCAAAGCGAGCAGGCTACCGGACGGCAGGTTATAAACCGGTC
GCCTCTGGCAGCGAAAAGACCCCGGAAGGTTTACGCAATAGCGACGCGCTGGCGTTACAG
CGCAACAGCAGCCTGCAGCTGGATTACGCAACAGTAAATCCTTACACCTTCGCAGAACCC
ACTTCGCCGCACATCATCAGCGCGCAAGAGGGCAGACCGATAGAATCATTGGTAATGAGC
GCCGGATTACGCGCGCTTGAACAACAGGCTGACTGGGTGTTAGTGGAAGGTGCTGGCGGC
TGGTTTACGCCGCTTTCTGACACTTTCACTTTTGCAGATTGGGTAACACAGGAACAACTG
CCGGTGATACTGGTAGTTGGTGTGAAACTCGGCTGTATTAATCACGCGATGTTGACTGCA
CAGGTAATACAACACGCCGGACTGACTCTGGCGGGTTGGGTGGCGAACGATGTTACGCCT
CCGGGAAAACGTCACGCTGAATATATGACCACGCTCACCCGCATGATTCCGCGCCGCTGC
TGGGAGAGATCCCCTGGCTTGCAGAAAATCCAGAAAATGCGGCAACCGGAAAGTACATAA

# Drug_Target_90_General_Function:
Coenzyme transport and metabolism

# Drug_Target_90_General_References:
10089457	Sandalova T, Schneider G, Kack H, Lindqvist Y: Structure of dethiobiotin synthetase at 0.97 A resolution. Acta Crystallogr D Biol Crystallogr. 1999 Mar;55(Pt 3):610-24.
3058702	Otsuka AJ, Buoncristiani MR, Howard PK, Flamm J, Johnson C, Yamamoto R, Uchida K, Cook C, Ruppert J, Matsuzaki J: The Escherichia coli biotin biosynthetic enzyme sequences predicted from the nucleotide sequence of the bio operon. J Biol Chem. 1988 Dec 25;263(36):19577-85.
7881906	Alexeev D, Baxter RL, Sawyer L: Mechanistic implications and family relationships from the structure of dethiobiotin synthetase. Structure. 1994 Nov 15;2(11):1061-72.
8081756	Huang W, Lindqvist Y, Schneider G, Gibson KJ, Flint D, Lorimer G: Crystal structure of an ATP-dependent carboxylase, dethiobiotin synthetase, at 1.65 A resolution. Structure. 1994 May 15;2(5):407-14.
8289297	Alexeev D, Bury SM, Boys CW, Turner MA, Sawyer L, Ramsey AJ, Baxter HC, Baxter RL: Sequence and crystallization of Escherichia coli dethiobiotin synthetase, the penultimate enzyme of biotin biosynthesis. J Mol Biol. 1994 Jan 14;235(2):774-6.
9125495	Yang G, Sandalova T, Lohman K, Lindqvist Y, Rendina AR: Active site mutants of Escherichia coli dethiobiotin synthetase: effects of mutations on enzyme catalytic and structural properties. Biochemistry. 1997 Apr 22;36(16):4751-60.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9576910	Kack H, Gibson KJ, Lindqvist Y, Schneider G: Snapshot of a phosphorylated substrate intermediate by kinetic crystallography. Proc Natl Acad Sci U S A. 1998 May 12;95(10):5495-500.
9865950	Kack H, Sandmark J, Gibson KJ, Schneider G, Lindqvist Y: Crystal structure of two quaternary complexes of dethiobiotin synthetase, enzyme-MgADP-AlF3-diaminopelargonic acid and enzyme-MgADP-dethiobiotin-phosphate; implications for catalysis. Protein Sci. 1998 Dec;7(12):2560-6.

# Drug_Target_90_HGNC_ID:
Not Available

# Drug_Target_90_HPRD_ID:
Not Available

# Drug_Target_90_ID:
2334

# Drug_Target_90_Locus:
Not Available

# Drug_Target_90_Molecular_Weight:
24140

# Drug_Target_90_Name:
Dethiobiotin synthetase

# Drug_Target_90_Number_of_Residues:
225

# Drug_Target_90_PDB_ID:
1DAM

# Drug_Target_90_Pathway:
Not Available

# Drug_Target_90_Pfam_Domain_Function:
PF01656	CbiA

# Drug_Target_90_Protein_Sequence:
>Dethiobiotin synthetase
MSKRYFVTGTDTEVGKTVASCALLQAAKAAGYRTAGYKPVASGSEKTPEGLRNSDALALQ
RNSSLQLDYATVNPYTFAEPTSPHIISAQEGRPIESLVMSAGLRALEQQADWVLVEGAGG
WFTPLSDTFTFADWVTQEQLPVILVVGVKLGCINHAMLTAQVIQHAGLTLAGWVANDVTP
PGKRHAEYMTTLTRMIPAPLLGEIPWLAENPENAATGKYINLALL

# Drug_Target_90_Reaction:
ATP + 7,8-diaminononanoate + CO2 = ADP + phosphate + dethiobiotin

# Drug_Target_90_Signals:
None

# Drug_Target_90_Specific_Function:
ATP + 7,8-diaminononanoate + CO(2) = ADP + phosphate + dethiobiotin

# Drug_Target_90_SwissProt_ID:
P13000

# Drug_Target_90_SwissProt_Name:
BIOD_ECOLI

# Drug_Target_90_Synonyms:
DTB synthetase
DTBS
Dethiobiotin synthase
EC 6.3.3.3

# Drug_Target_90_Theoretical_pI:
5.64

# Drug_Target_90_Transmembrane_Regions:
None

# Drug_Target_91_Cellular_Location:
Secreted protein

# Drug_Target_91_Chromosome_Location:
Not Available

# Drug_Target_91_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_91_Essentiality:
Non-Essential

# Drug_Target_91_GenAtlas_ID:
RNASE1

# Drug_Target_91_GenBank_ID_Gene:
D26129

# Drug_Target_91_GenBank_ID_Protein:
Not Available

# Drug_Target_91_GeneCard_ID:
Not Available

# Drug_Target_91_Gene_Name:
RNASE1

# Drug_Target_91_Gene_Sequence:
>471 bp
ATGGCTCTGGAGAAGTCTCTTGTCCGGCTCCTTCTGCTTGTCCTGATACTGCTGGTGCTG
GGCTGGGTCCAGCCTTCCCTGGGCAAGGAATCCCGGGCCAAGAAATTCCAGCGGCAGCAT
ATGGACTCAGACAGTTCCCCCAGCAGCAGCTCCACCTACTGTAACCAAATGATGAGGCGC
CGGAATATGACACAGGGGCGGTGCAAACCAGTGAACACCTTTGTGCACGAGCCCCTGGTA
GATGTCCAGAATGTCTGTTTCCAGGAAAAGGTCACCTGCAAGAACGGGCAGGGCAACTGC
TACAAGAGCAACTCCAGCATGCACATCACAGACTGCCGCCTGACAAACGGCTCCAGGTAC
CCCAACTGTGCATACCGGACCAGCCCGAAGGAGAGACACATCATTGTGGCCTGTGAAGGG
AGCCCATATGTGCCAGTCCACTTTGATGCTTCTGTGGAGGACTCTACCTAA

# Drug_Target_91_General_Function:
Involved in nucleic acid binding

# Drug_Target_91_General_References:
1741299	Haugg M, Schein CH: The DNA sequences of the human and hamster secretory ribonucleases determined with the polymerase chain reaction (PCR). Nucleic Acids Res. 1992 Feb 11;20(3):612.
2049798	Sakakibara R, Hashida K, Tominaga N, Sakai K, Ishiguro M, Imamura S, Ohmatsu F, Sato E: A putative mouse oocyte maturation inhibitory protein from urine of pregnant women: N-terminal sequence homology with human nonsecretory ribonuclease. Chem Pharm Bull (Tokyo). 1991 Jan;39(1):146-9.
2383019	Mizuta K, Awazu S, Yasuda T, Kishi K: Purification and characterization of three ribonucleases from human kidney: comparison with urine ribonucleases. Arch Biochem Biophys. 1990 Aug 15;281(1):144-51.
3202829	Beintema JJ, Blank A, Schieven GL, Dekker CA, Sorrentino S, Libonati M: Differences in glycosylation pattern of human secretory ribonucleases. Biochem J. 1988 Oct 15;255(2):501-5.
6201087	Beintema JJ, Wietzes P, Weickmann JL, Glitz DG: The amino acid sequence of human pancreatic ribonuclease. Anal Biochem. 1984 Jan;136(1):48-64.
7649283	Russo N, de Nigris M, Ciardiello A, Di Donato A, D'Alessio G: Expression in mammalian cells, purification and characterization of recombinant human pancreatic ribonuclease. FEBS Lett. 1995 Aug 7;369(2-3):352.
8049276	Seno M, Futami J, Kosaka M, Seno S, Yamada H: Nucleotide sequence encoding human pancreatic ribonuclease. Biochim Biophys Acta. 1994 Aug 2;1218(3):466-8.
8588814	Kochetov AV, Lukasheva VV, Filipenko ML, Mertvetsov NP, Rivkin MI: [Primary structure of the coding part of the gene for human pancreatic ribonuclease and its chromosomal location] Bioorg Khim. 1995 Sep;21(9):691-4.

# Drug_Target_91_HGNC_ID:
HGNC:10044

# Drug_Target_91_HPRD_ID:
Not Available

# Drug_Target_91_ID:
5682

# Drug_Target_91_Locus:
14q11.2

# Drug_Target_91_Molecular_Weight:
17644

# Drug_Target_91_Name:
Ribonuclease pancreatic

# Drug_Target_91_Number_of_Residues:
156

# Drug_Target_91_PDB_ID:
1E21

# Drug_Target_91_Pathway:
Not Available

# Drug_Target_91_Pfam_Domain_Function:
PF00074	RnaseA

# Drug_Target_91_Protein_Sequence:
>Ribonuclease pancreatic
MALEKSLVRLLLLVLILLVLGWVQPSLGKESRAKKFQRQHMDSDSSPSSSSTYCNQMMRR
RNMTQGRCKPVNTFVHEPLVDVQNVCFQEKVTCKNGQGNCYKSNSSMHITDCRLTNGSRY
PNCAYRTSPKERHIIVACEGSPYVPVHFDASVEDST

# Drug_Target_91_Reaction:
Not Available

# Drug_Target_91_Signals:
1-28

# Drug_Target_91_Specific_Function:
Endonuclease that catalyzes the cleavage of RNA on the 3' side of pyrimidine nucleotides. Acts on single stranded and double stranded RNA

# Drug_Target_91_SwissProt_ID:
P07998

# Drug_Target_91_SwissProt_Name:
RNAS1_HUMAN

# Drug_Target_91_Synonyms:
EC 3.1.27.5
HP-RNase
RIB-1
RNase 1
RNase A
RNase UpI-1
Ribonuclease pancreatic precursor

# Drug_Target_91_Theoretical_pI:
8.94

# Drug_Target_91_Transmembrane_Regions:
None

# Drug_Target_92_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_92_Chromosome_Location:
Not Available

# Drug_Target_92_Drug_References:
Not Available

# Drug_Target_92_Essentiality:
Non-Essential

# Drug_Target_92_GenAtlas_ID:
Not Available

# Drug_Target_92_GenBank_ID_Gene:
L42023

# Drug_Target_92_GenBank_ID_Protein:
Not Available

# Drug_Target_92_GeneCard_ID:
Not Available

# Drug_Target_92_Gene_Name:
hslU

# Drug_Target_92_Gene_Sequence:
>1335 bp
ATGTCTGAAATGACTCCTCGCGAAATAGTTTCTGAATTAGATCAACATATTATTGGTCAA
GCCGATGCAAAACGTGCTGTGGCGATTGCGTTGCGTAACCGTTGGCGTCGTATGCAGCTT
CAAGAACCTTTGCGTCATGAAGTAACTCCAAAAAATATTTTAATGATTGGCCCAACTGGT
GTGGGTAAAACTGAAATTGCGCGCCGTTTAGCAAAATTAGCTAACGCACCATTTATCAAA
GTGGAAGCAACGAAATTTACTGAAGTAGGTTACGTGGGGAAAGAGGTGGATTCCATTATT
CGTGATTTAACGGATAGTGCGATGAAACTTGTTCGCCAACAAGAAATTGCGAAGAACAGA
GCAAGAGCTGAAGACGTGGCTGAAGAGCGTATTTTGGATGCTTTACTTCCTCCAGCAAAA
AATCAGTGGGGCGAAGTTGAAAACCATGATAGTCACAGCAGTACTCGCCAAGCGTTCCGT
AAAAAATTACGTGAAGGTCAATTAGATGATAAAGAAATCGAAATTGATGTGTCTGCTGGC
GTATCTATGGGGGTTGAAATTATGGCTCCTCCAGGCATGGAAGAAATGACAAATCAACTG
CAATCATTGTTCCAAAATTTGGGTTCAGACAAAACGAAAAAACGCAAAATGAAAATTAAA
GATGCGTTGAAAGCGTTGATTGATGATGAAGCAGCGAAATTAATTAACCCTGAAGAACTT
AAACAAAAAGCCATTGATGCTGTGGAACAAAATGGTATCGTCTTTATCGATGAAATCGAC
AAAATTTGTAAGAAAGGTGAATACAGTGGTGCTGATGTATCGCGTGAAGGTGTGCAACGT
GATTTACTTCCGTTAGTAGAAGGCTCGACAGTTAGCACCAAGCACGGAATGGTTAAAACT
GATCATATCTTATTTATTGCATCTGGTGCATTCCAAGTTGCTCGCCCTTCAGATTTAATT
CCTGAACTACAAGGGCGTTTGCCGATTCGTGTTGAACTTACCGCATTAAGTGCGGCGGAT
TTTGAGCGTATTTTAACAGAGCCACATGCTTCTTTAACCGAACAATATAAAGCGTTGATG
GCAACAGAAGGGGTGAATATTGCATTCACAACAGATGCAGTGAAGAAAATTGCTGAGGCG
GCATTCCGAGTGAATGAAAAAACGGAAAATATCGGTGCACGCCGTTTGCATACGGTAATG
GAGCGTTTGATGGATAAAATTTCTTTCAGCGCAAGCGACATGAATGGTCAAACGGTCAAT
ATTGATGCAGCTTATGTTGCGGATGCACTTGGCGAAGTGGTTGAAAATGAAGATTTGAGC
CGTTTTATTCTTTAA

# Drug_Target_92_General_Function:
Involved in nucleotide binding

# Drug_Target_92_General_References:
10693812	Bochtler M, Hartmann C, Song HK, Bourenkov GP, Bartunik HD, Huber R: The structures of HsIU and the ATP-dependent protease HsIU-HsIV. Nature. 2000 Feb 17;403(6771):800-5.
11106733	Sousa MC, Trame CB, Tsuruta H, Wilbanks SM, Reddy VS, McKay DB: Crystal and solution structures of an HslUV protease-chaperone complex. Cell. 2000 Nov 10;103(4):633-43.
7542800	Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, et al.: Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science. 1995 Jul 28;269(5223):496-512.

# Drug_Target_92_HGNC_ID:
Not Available

# Drug_Target_92_HPRD_ID:
Not Available

# Drug_Target_92_ID:
5290

# Drug_Target_92_Locus:
Not Available

# Drug_Target_92_Molecular_Weight:
49372

# Drug_Target_92_Name:
ATP-dependent hsl protease ATP-binding subunit hslU

# Drug_Target_92_Number_of_Residues:
444

# Drug_Target_92_PDB_ID:
1KYI

# Drug_Target_92_Pathway:
Not Available

# Drug_Target_92_Pfam_Domain_Function:
PF07724	AAA_2

# Drug_Target_92_Protein_Sequence:
>ATP-dependent hsl protease ATP-binding subunit hslU
MSEMTPREIVSELDQHIIGQADAKRAVAIALRNRWRRMQLQEPLRHEVTPKNILMIGPTG
VGKTEIARRLAKLANAPFIKVEATKFTEVGYVGKEVDSIIRDLTDSAMKLVRQQEIAKNR
ARAEDVAEERILDALLPPAKNQWGEVENHDSHSSTRQAFRKKLREGQLDDKEIEIDVSAG
VSMGVEIMAPPGMEEMTNQLQSLFQNLGSDKTKKRKMKIKDALKALIDDEAAKLINPEEL
KQKAIDAVEQNGIVFIDEIDKICKKGEYSGADVSREGVQRDLLPLVEGSTVSTKHGMVKT
DHILFIASGAFQVARPSDLIPELQGRLPIRVELTALSAADFERILTEPHASLTEQYKALM
ATEGVNIAFTTDAVKKIAEAAFRVNEKTENIGARRLHTVMERLMDKISFSASDMNGQTVN
IDAAYVADALGEVVENEDLSRFIL

# Drug_Target_92_Reaction:
Not Available

# Drug_Target_92_Signals:
None

# Drug_Target_92_Specific_Function:
Chaperone subunit of a proteasome-like degradation complex

# Drug_Target_92_SwissProt_ID:
P43773

# Drug_Target_92_SwissProt_Name:
HSLU_HAEIN

# Drug_Target_92_Synonyms:
Not Available

# Drug_Target_92_Theoretical_pI:
5.59

# Drug_Target_92_Transmembrane_Regions:
None

# Drug_Target_93_Cellular_Location:
Not Available

# Drug_Target_93_Chromosome_Location:
Not Available

# Drug_Target_93_Drug_References:
Not Available

# Drug_Target_93_Essentiality:
Non-Essential

# Drug_Target_93_GenAtlas_ID:
Not Available

# Drug_Target_93_GenBank_ID_Gene:
AF033856

# Drug_Target_93_GenBank_ID_Protein:
Not Available

# Drug_Target_93_GeneCard_ID:
Not Available

# Drug_Target_93_Gene_Name:
glgA1

# Drug_Target_93_Gene_Sequence:
>1443 bp
ATGAATGTCCTTTCGGTTTCATCCGAAATTTATCCCCTGATCAAGACCGGAGGGCTCGCC
GACGTTGTCGGCGCGCTCCCCATCGCGCTCGAAGCCCATGGCGTCAGAACGCGGACATTG
ATACCCGGCTATCCGGCGGTGAAAGCCGCCGTGACGGACCCCGTCAAATGTTTTGAGTTC
ACCGACCTGCTTGGCGAAAAGGCCGATCTGCTCGAAGTCCAACACGAGAGGCTAGACCTT
TTGATCCTCGACGCGCCCGCCTATTACGAGCGTTCCGGCGGCCCCTATCTCGGCCAGACC
GGCAAGGATTATCCTGATAACTGGAAGCGTTTTGCGGCGCTGTCACTGGCGGCGGCGCGG
ATCGGCGCCGGTGTGCTCCCCGGCTGGCGGCCGGATATGGTGCACGCGCATGACTGGCAG
GCCGCCATGACGCCTGTCTATATGCGTTACGCCGAAACACCGGAAATTCCGAGCCTTCTC
ACCATCCACAACATTGCCTTTCAGGGCCAGTTCGGCGCAAACATCTTCAGCAAACTTGCC
CTGCCCGCCCACGCCTTCGGCATGGAGGGCATCGAATATTACAACGACGTCAGCTTCCTC
AAGGGCGGCTTGCAGACGGCAACCGCGCTCAGCACGGTCAGCCCATCCTATGCGGAAGAA
ATCCTGACCGCGGAATTCGGCATGGGGCTTGAAGGGGTGATCGGCAGCCGCGCCCATGTG
CTGCACGGCATCGTCAACGGCATCGACGCCGATGTCTGGAACCCGGCCACCGACCATCTG
ATCCACGACAATTATTCCGCCGCCAATCTCAAGAACCGTGCCCTGAACAAGAAGGCGGTC
GCCGAACATTTCCGTATCGATGATGATGGCAGCCCGCTATTCTGCGTCATCTCCCGCCTC
ACCTGGCAGAAGGGCATCGACCTCATGGCGGAAGCCGTGGATGAGATCGTTTCCCTCGGC
GGCCGCCTGGTCGTGCTGGGCGCGGGCGATGTGGCACTGGAAGGCGCGCTTCTTGCGGCG
GCATCCCGCCACCATGGACGCGTCGGTGTTGCCATCGGTTACAACGAGCCGCTGTCGCAT
CTCATGCAGGCGGGTTGCGACGCGATCATCATTCCCTCTCGCTTCGAGCCCTGCGGCCTG
ACCCAGCTTTACGCGTTGCGTTACGGCTGCATTCCGGTCGTCGCCCGCACCGGCGGCCTT
GCCGACACCGTGATTGACGCCAACCATGCCGCCCTCGCCAGCAAGGCGGCAACTGGCGTA
CAATTTTCACCCGTCACACTTGACGGTCTGAAACAGGCGATCCGCCGGACCGTCCGTTAT
TATCACGACCCGAAACTGTGGACACAAATGCAGAAACTCGGAATGAAATCCGATGTTTCC
TGGGAAAAAAGCGCCGGTCTCTACGCCGCGCTTTATAGCCAGCTTATTTCGAAAGGCCAT
TGA

# Drug_Target_93_General_Function:
Involved in starch synthase activity

# Drug_Target_93_General_References:
7959036	Uttaro AD, Ugalde RA: A chromosomal cluster of genes encoding ADP-glucose synthetase, glycogen synthase and phosphoglucomutase in Agrobacterium tumefaciens. Gene. 1994 Dec 2;150(1):117-22.

# Drug_Target_93_HGNC_ID:
Not Available

# Drug_Target_93_HPRD_ID:
Not Available

# Drug_Target_93_ID:
5291

# Drug_Target_93_Locus:
Not Available

# Drug_Target_93_Molecular_Weight:
51710

# Drug_Target_93_Name:
Glycogen synthase 1

# Drug_Target_93_Number_of_Residues:
480

# Drug_Target_93_PDB_ID:
1RZU

# Drug_Target_93_Pathway:
Not Available

# Drug_Target_93_Pfam_Domain_Function:
PF00534	Glycos_transf_1
PF08323	Glyco_transf_5

# Drug_Target_93_Protein_Sequence:
>Glycogen synthase 1
MNVLSVSSEIYPLIKTGGLADVVGALPIALEAHGVRTRTLIPGYPAVKAAVTDPVKCFEF
TDLLGEKADLLEVQHERLDLLILDAPAYYERSGGPYLGQTGKDYPDNWKRFAALSLAAAR
IGAGVLPGWRPDMVHAHDWQAAMTPVYMRYAETPEIPSLLTIHNIAFQGQFGANIFSKLA
LPAHAFGMEGIEYYNDVSFLKGGLQTATALSTVSPSYAEEILTAEFGMGLEGVIGSRAHV
LHGIVNGIDADVWNPATDHLIHDNYSAANLKNRALNKKAVAEHFRIDDDGSPLFCVISRL
TWQKGIDLMAEAVDEIVSLGGRLVVLGAGDVALEGALLAAASRHHGRVGVAIGYNEPLSH
LMQAGCDAIIIPSRFEPCGLTQLYALRYGCIPVVARTGGLADTVIDANHAALASKAATGV
QFSPVTLDGLKQAIRRTVRYYHDPKLWTQMQKLGMKSDVSWEKSAGLYAALYSQLISKGH

# Drug_Target_93_Reaction:
Not Available

# Drug_Target_93_Signals:
None

# Drug_Target_93_Specific_Function:
Synthesizes alpha-1,4-glucan chains using ADP-glucose

# Drug_Target_93_SwissProt_ID:
P0A3F3

# Drug_Target_93_SwissProt_Name:
GLGA1_RHIRD

# Drug_Target_93_Synonyms:
EC 2.4.1.21
Starch [bacterial glycogen] synthase 1

# Drug_Target_93_Theoretical_pI:
6.46

# Drug_Target_93_Transmembrane_Regions:
None

# Drug_Target_94_Cellular_Location:
Nucleus

# Drug_Target_94_Chromosome_Location:
Not Available

# Drug_Target_94_Drug_References:
Not Available

# Drug_Target_94_Essentiality:
Non-Essential

# Drug_Target_94_GenAtlas_ID:
DCK

# Drug_Target_94_GenBank_ID_Gene:
M60527

# Drug_Target_94_GenBank_ID_Protein:
Not Available

# Drug_Target_94_GeneCard_ID:
Not Available

# Drug_Target_94_Gene_Name:
DCK

# Drug_Target_94_Gene_Sequence:
>783 bp
ATGGCCACCCCGCCCAAGAGAAGCTGCCCGTCTTTCTCAGCCAGCTCTGAGGGGACCCGC
ATCAAGAAAATCTCCATCGAAGGGAACATCGCTGCAGGGAAGTCAACATTTGTGAATATC
CTTAAACAATTGTGTGAAGATTGGGAAGTGGTTCCTGAACCTGTTGCCAGATGGTGCAAT
GTTCAAAGTACTCAAGATGAATTTGAGGAACTTACAATGTCTCAGAAAAATGGTGGGAAT
GTTCTTCAGATGATGTATGAGAAACCTGAACGATGGTCTTTTACCTTCCAAACATATGCC
TGTCTCAGTCGAATAAGAGCTCAGCTTGCCTCTCTGAATGGCAAGCTCAAAGATGCAGAG
AAACCTGTATTATTTTTTGAACGATCTGTGTATAGTGACAGGTATATTTTTGCATCTAAT
TTGTATGAATCTGAATGCATGAATGAGACAGAGTGGACAATTTATCAAGACTGGCATGAC
TGGATGAATAACCAATTTGGCCAAAGCCTTGAATTGGATGGAATCATTTATCTTCAAGCC
ACTCCAGAGACATGCTTACATAGAATATATTTACGGGGAAGAAATGAAGAGCAAGGCATT
CCTCTTGAATATTTAGAGAAGCTTCATTATAAACATGAAAGCTGGCTCCTGCATAGGACA
CTGAAAACCAACTTCGATTATCTTCAAGAGGTGCCTATCTTAACACTGGATGTTAATGAA
GACTTTAAAGACAAATATGAAAGTCTGGTTGAAAAGGTCAAAGAGTTTTTGAGTACTTTG
TGA

# Drug_Target_94_General_Function:
Involved in ATP binding

# Drug_Target_94_General_References:
1996353	Chottiner EG, Shewach DS, Datta NS, Ashcraft E, Gribbin D, Ginsburg D, Fox IH, Mitchell BS: Cloning and expression of human deoxycytidine kinase cDNA. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1531-5.
2013338	Eriksson S, Cederlund E, Bergman T, Jornvall H, Bohman C: Characterization of human deoxycytidine kinase. Correlation with cDNA sequences. FEBS Lett. 1991 Mar 25;280(2):363-6.
9342341	Johansson M, Brismar S, Karlsson A: Human deoxycytidine kinase is located in the cell nucleus. Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):11941-5.

# Drug_Target_94_HGNC_ID:
HGNC:2704

# Drug_Target_94_HPRD_ID:
Not Available

# Drug_Target_94_ID:
4773

# Drug_Target_94_Locus:
4q13.3-q21.1

# Drug_Target_94_Molecular_Weight:
30519

# Drug_Target_94_Name:
Deoxycytidine kinase

# Drug_Target_94_Number_of_Residues:
260

# Drug_Target_94_PDB_ID:
1P62

# Drug_Target_94_Pathway:
Gemcitabine Pathway	SMP00446

# Drug_Target_94_Pfam_Domain_Function:
PF01712	dNK

# Drug_Target_94_Protein_Sequence:
>Deoxycytidine kinase
MATPPKRSCPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLCEDWEVVPEPVARWCN
VQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAE
KPVLFFERSVYSDRYIFASNLYESECMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQA
TPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNE
DFKDKYESLVEKVKEFLSTL

# Drug_Target_94_Reaction:
Not Available

# Drug_Target_94_Signals:
None

# Drug_Target_94_Specific_Function:
Required for the phosphorylation of several deoxyribonucleosides and certain nucleoside analogs widely employed as antiviral and chemotherapeutic agents

# Drug_Target_94_SwissProt_ID:
P27707

# Drug_Target_94_SwissProt_Name:
DCK_HUMAN

# Drug_Target_94_Synonyms:
EC 2.7.1.74
dCK

# Drug_Target_94_Theoretical_pI:
4.88

# Drug_Target_94_Transmembrane_Regions:
None

# Drug_Target_95_Cellular_Location:
Cytoplasmic

# Drug_Target_95_Chromosome_Location:
Not Available

# Drug_Target_95_Drug_References:
Not Available

# Drug_Target_95_Essentiality:
Non-Essential

# Drug_Target_95_GenAtlas_ID:
Not Available

# Drug_Target_95_GenBank_ID_Gene:
AE017221

# Drug_Target_95_GenBank_ID_Protein:
Not Available

# Drug_Target_95_GeneCard_ID:
Not Available

# Drug_Target_95_Gene_Name:
TT_C1605

# Drug_Target_95_Gene_Sequence:
>750 bp
CTAGGCTTCCTGGACACGGGCCATCACCTCCTCTGCCAGGCGGCGGTAGGCGTGGGCCCC
GGGGGAGGTGGGGGCGTGCTGGGCGATGGTCTTGCCAAAGCTCGGGGCCTCCGCCAGGCG
GACGTTCCTGGGGATCACCGTCCAAAACACCTTCTCCCCGAAGTGGGCGCGGAGCTGGGC
CTCCACCTGCTGGGCGAGCAGGGTGCGGCCGTCGTACATGGTCACCAGGATGCCGAGGAG
GCGGAGCCTGGGGTTGAGGCCCGCCCGCACCTCCTCCAGGGTGGCGAGGAGGCCCGCCAC
CCCCTCCAGGGCGTAGTACTCGGCCTGGACCGGGACCACCACCCCTTCCGCCGCGGCCAG
GGCGTTGAGGGTAAGAGGGGAAAGGCTCGGGGGCGCGTCCAGGAGGACGAGGTCGTAGCC
CTCATCCCGCAGGGCCTCCCGCAGGGCGGTGGGGGCCCCGGCCAACTCCACCGTGGCCCC
CACCAGGTCCGGGGTGGCGGGCAGGAGGTGGAAGCCGTCCACGGGGTGCACGAGCCCCTC
CAGGGGCTCCCCCTGGAGGAGGTGGTACACCCCCCGCTCCGCCCGCACCCCGAGGCCGCT
CGTGGCGTTCCCCTGAGGGTCCAGGTCCACCAGGAGCACCCGCTTGCCCAGGCGGGCCAG
GTAGGCCGCGAGGTTGATGGCCGTGGTGGTCTTGCCCACCCCGCCCTTCTGGTTGGCCAA
GGCGATGCGCCGCACCTTGGCCCTTAGCAT

# Drug_Target_95_General_Function:
Involved in cobyrinic acid a,c-diamide synthase activity

# Drug_Target_95_General_References:
Not Available

# Drug_Target_95_HGNC_ID:
Not Available

# Drug_Target_95_HPRD_ID:
Not Available

# Drug_Target_95_ID:
5292

# Drug_Target_95_Locus:
Not Available

# Drug_Target_95_Molecular_Weight:
26563

# Drug_Target_95_Name:
Putative partitioning protein

# Drug_Target_95_Number_of_Residues:
249

# Drug_Target_95_PDB_ID:
2BEJ

# Drug_Target_95_Pathway:
Not Available

# Drug_Target_95_Pfam_Domain_Function:
PF01656	CbiA

# Drug_Target_95_Protein_Sequence:
>Putative partitioning protein
MLRAKVRRIALANQKGGVGKTTTAINLAAYLARLGKRVLLVDLDPQGNATSGLGVRAERG
VYHLLQGEPLEGLVHPVDGFHLLPATPDLVGATVELAGAPTALREALRDEGYDLVLLDAP
PSLSPLTLNALAAAEGVVVPVQAEYYALEGVAGLLATLEEVRAGLNPRLRLLGILVTMYD
GRTLLAQQVEAQLRAHFGEKVFWTVIPRNVRLAEAPSFGKTIAQHAPTSPGAHAYRRLAE
EVMARVQEA

# Drug_Target_95_Reaction:
Not Available

# Drug_Target_95_Signals:
None

# Drug_Target_95_Specific_Function:
Not Available

# Drug_Target_95_SwissProt_ID:
Q72H90

# Drug_Target_95_SwissProt_Name:
Q72H90_THET2

# Drug_Target_95_Synonyms:
Not Available

# Drug_Target_95_Theoretical_pI:
7.91

# Drug_Target_95_Transmembrane_Regions:
None

# Drug_Target_96_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_96_Chromosome_Location:
Not Available

# Drug_Target_96_Drug_References:
Not Available

# Drug_Target_96_Essentiality:
Non-Essential

# Drug_Target_96_GenAtlas_ID:
Not Available

# Drug_Target_96_GenBank_ID_Gene:
X14777

# Drug_Target_96_GenBank_ID_Protein:
Not Available

# Drug_Target_96_GeneCard_ID:
Not Available

# Drug_Target_96_Gene_Name:
aroL

# Drug_Target_96_Gene_Sequence:
>522 bp
ATGACAGAACCCATTTTTATGGTCGGCGCCAGAGGGTGCGGAAAAACCACCGTCGGCCGT
GAGCTGGCGCGGGCGCTTGGCTATGAGTTTGTCGATACGGATATTTTTATGCAGCACACC
AGCGGCATGACAGTGGCGGACGTGGTGGCAGCGGAAGGCTGGCCGGGGTTTCGCCGCCGT
GAAAGCGAGGCCTTGCAGGCTGTCGCGACACCGAATCGTGTGGTGGCGACCGGTGGCGGC
ATGGTGTTGTTGGAGCAAAACCGCCAGTTTATGCGTGCGCACGGAACGGTCGTCTATTTG
TTCGCGCCAGCCGAGGAGCTGGCGTTACGCTTGCAGGCAAGCCCACAGGCACACCAGCGA
CCGACACTGACCGGGCGGCCTATTGCTGAGGAAATGGAGGCGGTGCTCCGTGAACGCGAA
GCGTTGTATCAGGATGTAGCGCACTATGTGGTCGATGCGACCCAACCGCCCGCCGCGATT
GTCTGCGAATTGATGCAGACGATGCGTCTGCCTGCGGCCTGA

# Drug_Target_96_General_Function:
Involved in shikimate kinase activity

# Drug_Target_96_General_References:
2537963	Minton NP, Whitehead PJ, Atkinson T, Gilbert HJ: Nucleotide sequence of an Erwinia chrysanthemi gene encoding shikimate kinase. Nucleic Acids Res. 1989 Feb 25;17(4):1769.
9600856	Krell T, Coggins JR, Lapthorn AJ: The three-dimensional structure of shikimate kinase. J Mol Biol. 1998 May 22;278(5):983-97.

# Drug_Target_96_HGNC_ID:
Not Available

# Drug_Target_96_HPRD_ID:
Not Available

# Drug_Target_96_ID:
5293

# Drug_Target_96_Locus:
Not Available

# Drug_Target_96_Molecular_Weight:
18956

# Drug_Target_96_Name:
Shikimate kinase 2

# Drug_Target_96_Number_of_Residues:
173

# Drug_Target_96_PDB_ID:
2SHK

# Drug_Target_96_Pathway:
Not Available

# Drug_Target_96_Pfam_Domain_Function:
PF01202	SKI

# Drug_Target_96_Protein_Sequence:
>Shikimate kinase 2
MTEPIFMVGARGCGKTTVGRELARALGYEFVDTDIFMQHTSGMTVADVVAAEGWPGFRRR
ESEALQAVATPNRVVATGGGMVLLEQNRQFMRAHGTVVYLFAPAEELALRLQASPQAHQR
PTLTGRPIAEEMEAVLREREALYQDVAHYVVDATQPPAAIVCELMQTMRLPAA

# Drug_Target_96_Reaction:
Not Available

# Drug_Target_96_Signals:
None

# Drug_Target_96_Specific_Function:
Catalyzes the specific phosphorylation of the 3-hydroxyl group of shikimic acid using ATP as a cosubstrate

# Drug_Target_96_SwissProt_ID:
P10880

# Drug_Target_96_SwissProt_Name:
AROL_ERWCH

# Drug_Target_96_Synonyms:
EC 2.7.1.71
SK 2
SKII
Shikimate kinase II

# Drug_Target_96_Theoretical_pI:
5.65

# Drug_Target_96_Transmembrane_Regions:
None

# Drug_Target_97_Cellular_Location:
Not Available

# Drug_Target_97_Chromosome_Location:
Not Available

# Drug_Target_97_Drug_References:
Not Available

# Drug_Target_97_Essentiality:
Non-Essential

# Drug_Target_97_GenAtlas_ID:
Not Available

# Drug_Target_97_GenBank_ID_Gene:
AE000512

# Drug_Target_97_GenBank_ID_Protein:
Not Available

# Drug_Target_97_GeneCard_ID:
Not Available

# Drug_Target_97_Gene_Name:
TM_0857

# Drug_Target_97_Gene_Sequence:
>882 bp
ATGGTTGTCAGCATCGGAGTTTTCGATGGAGTTCACATCGGGCATCAGAAGGTCTTGAGG
ACCATGAAGGAAATAGCATTTTTCAGGAAGGACGATAGCCTTATCTACACCATATCTTAT
CCCCCCGAATATTTCTTACCGGATTTTCCCGGTCTTCTCATGACGGTAGAAAGCAGGGTG
GAGATGCTTTCTCGTTACGCCAGAACCGTTGTTCTGGATTTTTTCAGAATAAAAGATCTC
ACCCCAGAAGGGTTCGTCGAGAGGTATCTATCTGGAGTATCGGCTGTTGTTGTTGGAAGG
GATTTCAGATTTGGCAAGAACGCGAGCGGAAACGCGTCTTTTCTCAGAAAGAAAGGTGTG
GAAGTCTATGAAATTGAAGATGTCGTTGTTCAGGGAAAAAGAGTGAGCAGTTCTCTGATC
AGAAACCTCGTTCAGGAGGGAAGAGTGGAGGAAATTCCTGCATATCTCGGCAGATATTTC
GAAATCGAAGGAATCGTCCACAAAGATAGGGAATTTGGAAGAAAACTGGGATTTCCAACT
GCCAACATCGATAGAGGAAATGAAAAACTCGTAGATCTGAAAAGAGGAGTTTATCTGGTG
AGAGTTCATCTGCCGGATGGAAAGAAAAAATTCGGTGTTATGAACGTGGGTTTCAGGCCC
ACCGTGGGTGATGCGAGAAACGTGAAGTACGAGGTGTACATCCTGGATTTCGAAGGGGAT
CTTTACGGGCAGAGACTGAAACTGGAAGTATTGAAATTCATGAGGGATGAGAAGAAATTT
GATTCAATCGAGGAGCTGAAGGCTGCTATTGACCAGGATGTAAAGAGCGCCAGAAACATG
ATAGATGATATAATCAATTCGAAGTTCGAAAAAGAGGGGTGA

# Drug_Target_97_General_Function:
Involved in FMN adenylyltransferase activity

# Drug_Target_97_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.
12910462	Wang W, Kim R, Jancarik J, Yokota H, Kim SH: Crystal structure of a flavin-binding protein from Thermotoga maritima. Proteins. 2003 Sep 1;52(4):633-5.

# Drug_Target_97_HGNC_ID:
Not Available

# Drug_Target_97_HPRD_ID:
Not Available

# Drug_Target_97_ID:
4366

# Drug_Target_97_Locus:
Not Available

# Drug_Target_97_Molecular_Weight:
33614

# Drug_Target_97_Name:
Riboflavin kinase/FMN adenylyltransferase

# Drug_Target_97_Number_of_Residues:
293

# Drug_Target_97_PDB_ID:
1T6Z

# Drug_Target_97_Pathway:
Not Available

# Drug_Target_97_Pfam_Domain_Function:
PF01687	Flavokinase
PF06574	FAD_syn

# Drug_Target_97_Protein_Sequence:
>Riboflavin kinase/FMN adenylyltransferase
MVVSIGVFDGVHIGHQKVLRTMKEIAFFRKDDSLIYTISYPPEYFLPDFPGLLMTVESRV
EMLSRYARTVVLDFFRIKDLTPEGFVERYLSGVSAVVVGRDFRFGKNASGNASFLRKKGV
EVYEIEDVVVQGKRVSSSLIRNLVQEGRVEEIPAYLGRYFEIEGIVHKDREFGRKLGFPT
ANIDRGNEKLVDLKRGVYLVRVHLPDGKKKFGVMNVGFRPTVGDARNVKYEVYILDFEGD
LYGQRLKLEVLKFMRDEKKFDSIEELKAAIDQDVKSARNMIDDIINSKFEKEG

# Drug_Target_97_Reaction:
Not Available

# Drug_Target_97_Signals:
None

# Drug_Target_97_Specific_Function:
Not Available

# Drug_Target_97_SwissProt_ID:
Q9WZW1

# Drug_Target_97_SwissProt_Name:
Q9WZW1_THEMA

# Drug_Target_97_Synonyms:
Not Available

# Drug_Target_97_Theoretical_pI:
9.26

# Drug_Target_97_Transmembrane_Regions:
None

# Drug_Target_98_Cellular_Location:
Not Available

# Drug_Target_98_Chromosome_Location:
Not Available

# Drug_Target_98_Drug_References:
Not Available

# Drug_Target_98_Essentiality:
Non-Essential

# Drug_Target_98_GenAtlas_ID:
Not Available

# Drug_Target_98_GenBank_ID_Gene:
X03007

# Drug_Target_98_GenBank_ID_Protein:
Not Available

# Drug_Target_98_GeneCard_ID:
Not Available

# Drug_Target_98_Gene_Name:
pseT

# Drug_Target_98_Gene_Sequence:
>906 bp
ATGAAAAAGATTATTTTGACTATTGGCTGTCCTGGTTCTGGTAAGAGTACTTGGGCTCGT
GAATTTATTGCTAAGAATCCCGGGTTTTATAATATCAATCGTGATGACTATCGCCAATCT
ATTATGGCGCATGAAGAACGCGATGAGTACAAGTATACCAAAAAGAAAGAAGGTATCGTA
ACTGGTATGCAGTTTGATACAGCTAAAAGTATTCTGTACGGTGGCGATTCTGTTAAGGGA
GTAATCATTTCAGATACTAACCTGAATCCTGAACGTCGCCTAGCATGGGAAACTTTTGCC
AAAGAATACGGCTGGAAAGTTGAACATAAAGTGTTTGATGTTCCTTGGACTGAATTGGTT
AAACGTAACTCAAAACGCGGAACTAAAGCAGTACCAATTGATGTTTTACGTTCAATGTAT
AAAAGCATGCGAGAGTATCTCGGTCTTCCAGTATATAATGGGACTCCTGGTAAACCAAAA
GCAGTTATTTTTGATGTTGATGGTACACTAGCTAAAATGAATGGTCGTGGTCCTTATGAC
CTTGAAAAATGCGATACCGATGTTATCAATCCTATGGTTGTTGAACTGTCTAAGATGTAT
GCTCTTATGGGTTATCAAATCGTAGTCGTTTCAGGTCGTGAAAGTGGAACTAAAGAAGAC
CCAACGAAATATTATCGTATGACCCGTAAATGGGTTGAGGACATTGCTGGCGTTCCATTA
GTTATGCAATGTCAGCGCGAACAAGGCGATACCCGTAAAGACGATGTAGTTAAAGAAGAA
ATTTTCTGGAAACACATTGCACCGCATTTTGACGTGAAATTAGCTATTGATGACCGAACT
CAAGTAGTTGAAATGTGGCGTCGTATCGGTGTTGAATGCTGGCAAGTCGCTTCGGGAGAT
TTTTAA

# Drug_Target_98_General_Function:
Not Available

# Drug_Target_98_General_References:
12220496	Galburt EA, Pelletier J, Wilson G, Stoddard BL: Structure of a tRNA repair enzyme and molecular biology workhorse: T4 polynucleotide kinase. Structure. 2002 Sep;10(9):1249-60.
12626685	Miller ES, Kutter E, Mosig G, Arisaka F, Kunisawa T, Ruger W: Bacteriophage T4 genome. Microbiol Mol Biol Rev. 2003 Mar;67(1):86-156, table of contents.
2996886	Midgley CA, Murray NE: T4 polynucleotide kinase; cloning of the gene (pseT) and amplification of its product. EMBO J. 1985 Oct;4(10):2695-703.

# Drug_Target_98_HGNC_ID:
Not Available

# Drug_Target_98_HPRD_ID:
Not Available

# Drug_Target_98_ID:
4346

# Drug_Target_98_Locus:
Not Available

# Drug_Target_98_Molecular_Weight:
34620

# Drug_Target_98_Name:
Polynucleotide kinase

# Drug_Target_98_Number_of_Residues:
301

# Drug_Target_98_PDB_ID:
1RRC

# Drug_Target_98_Pathway:
Not Available

# Drug_Target_98_Pfam_Domain_Function:
Not Available

# Drug_Target_98_Protein_Sequence:
>Polynucleotide kinase
MKKIILTIGCPGSGKSTWAREFIAKNPGFYNINRDDYRQSIMAHEERDEYKYTKKKEGIV
TGMQFDTAKSILYGGDSVKGVIISDTNLNPERRLAWETFAKEYGWKVEHKVFDVPWTELV
KRNSKRGTKAVPIDVLRSMYKSMREYLGLPVYNGTPGKPKAVIFDVDGTLAKMNGRGPYD
LEKCDTDVINPMVVELSKMYALMGYQIVVVSGRESGTKEDPTKYYRMTRKWVEDIAGVPL
VMQCQREQGDTRKDDVVKEEIFWKHIAPHFDVKLAIDDRTQVVEMWRRIGVECWQVASGD
F

# Drug_Target_98_Reaction:
Not Available

# Drug_Target_98_Signals:
None

# Drug_Target_98_Specific_Function:
Acts as a 5'-hydroxyl kinase, a 3'-phosphatase and a 2',3'-cyclic phosphodiesterase. Catalyzes the transfer of the terminal phosphate of ATP to the 5'-hydroxyl termini of ribo- and deoxyribonucleotides. In the presence of ADP the enzyme also catalyzes an exchange reaction. In the exchange reaction, an excess ADP causes the enzyme to transfer the 5' terminal phosphate from phosphorylated DNA to ADP. These activities modify the ends of nicked tRNA generated by a bacterial response to infection and facilitate repair by T4 RNA ligase

# Drug_Target_98_SwissProt_ID:
P06855

# Drug_Target_98_SwissProt_Name:
KIPN_BPT4

# Drug_Target_98_Synonyms:
EC 2.7.1.78
PNK
Polynucleotide 5'-hydroxy- kinase

# Drug_Target_98_Theoretical_pI:
8.96

# Drug_Target_98_Transmembrane_Regions:
None

# Drug_Target_99_Cellular_Location:
Cytoplasm. Nucleus

# Drug_Target_99_Chromosome_Location:
Not Available

# Drug_Target_99_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_99_Essentiality:
Non-Essential

# Drug_Target_99_GenAtlas_ID:
NME1

# Drug_Target_99_GenBank_ID_Gene:
X75598

# Drug_Target_99_GenBank_ID_Protein:
Not Available

# Drug_Target_99_GeneCard_ID:
Not Available

# Drug_Target_99_Gene_Name:
NME1

# Drug_Target_99_Gene_Sequence:
>459 bp
ATGGCCAACTGTGAGCGTACCTTCATTGCGATCAAACCAGATGGGGTCCAGCGGGGTCTT
GTGGGAGAGATTATCAAGCGTTTTGAGCAGAAAGGATTCCGCCTTGTTGGTCTGAAATTC
ATGCAAGCTTCCGAAGATCTTCTCAAGGAACACTACGTTGACCTGAAGGACCGTCCATTC
TTTGCCGGCCTGGTGAAATACATGCACTCAGGGCCGGTAGTTGCCATGGTCTGGGAGGGG
CTGAATGTGGTGAAGACGGGCCGAGTCATGCTCGGGGAGACCAACCCTGCAGACTCCAAG
CCTGGGACCATCCGTGGAGACTTCTGCATACAAGTTGGCAGGAACATTATACATGGCAGT
GATTCTGTGGAGAGTGCAGAGAAGGAGATCGGCTTGTGGTTTCACCCTGAGGAACTGGTA
GATTACACGAGCTGTGCTCAGAACTGGATCTATGAATGA

# Drug_Target_99_General_Function:
Involved in nucleoside diphosphate kinase activity

# Drug_Target_99_General_References:
10512675	Manda R, Kohno T, Matsuno Y, Takenoshita S, Kuwano H, Yokota J: Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display. Genomics. 1999 Oct 1;61(1):5-14.
11835509	Min K, Song HK, Chang C, Kim SY, Lee KJ, Suh SW: Crystal structure of human nucleoside diphosphate kinase A, a metastasis suppressor. Proteins. 2002 Feb 15;46(3):340-2.
12628186	Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J: Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell. 2003 Mar 7;112(5):659-72.
12972261	Chen Y, Gallois-Montbrun S, Schneider B, Veron M, Morera S, Deville-Bonne D, Janin J: Nucleotide binding to nucleoside diphosphate kinases: X-ray structure of human NDPK-A in complex with ADP and comparison to protein kinases. J Mol Biol. 2003 Sep 26;332(4):915-26.
1851158	Gilles AM, Presecan E, Vonica A, Lascu I: Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem. 1991 May 15;266(14):8784-9.
2056128	Hailat N, Keim DR, Melhem RF, Zhu XX, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Strahler JR, et al.: High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest. 1991 Jul;88(1):341-5.
2509941	Rosengard AM, Krutzsch HC, Shearn A, Biggs JR, Barker E, Margulies IM, King CR, Liotta LA, Steeg PS: Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature. 1989 Nov 9;342(6246):177-80.
7916650	Wang L, Patel U, Ghosh L, Chen HC, Banerjee S: Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res. 1993 Feb 15;53(4):717-20.
8270257	Dooley S, Seib T, Engel M, Theisinger B, Janz H, Piontek K, Zang KD, Welter C: Isolation and characterization of the human genomic locus coding for the putative metastasis control gene nm23-H1. Hum Genet. 1994 Jan;93(1):63-6.

# Drug_Target_99_HGNC_ID:
HGNC:7849

# Drug_Target_99_HPRD_ID:
Not Available

# Drug_Target_99_ID:
5294

# Drug_Target_99_Locus:
17q21.3

# Drug_Target_99_Molecular_Weight:
17149

# Drug_Target_99_Name:
Nucleoside diphosphate kinase A

# Drug_Target_99_Number_of_Residues:
152

# Drug_Target_99_PDB_ID:
1JXV

# Drug_Target_99_Pathway:
Adefovir Dipivoxil Pathway	SMP00418
Gemcitabine Pathway	SMP00446
Methotrexate Pathway	SMP00432
Tenofovir Pathway	SMP00419

# Drug_Target_99_Pfam_Domain_Function:
PF00334	NDK

# Drug_Target_99_Protein_Sequence:
>Nucleoside diphosphate kinase A
MANCERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVGLKFMQASEDLLKEHYVDLKDRPF
FAGLVKYMHSGPVVAMVWEGLNVVKTGRVMLGETNPADSKPGTIRGDFCIQVGRNIIHGS
DSVESAEKEIGLWFHPEELVDYTSCAQNWIYE

# Drug_Target_99_Reaction:
Not Available

# Drug_Target_99_Signals:
None

# Drug_Target_99_Specific_Function:
Major role in the synthesis of nucleoside triphosphates other than ATP

# Drug_Target_99_SwissProt_ID:
P15531

# Drug_Target_99_SwissProt_Name:
NDKA_HUMAN

# Drug_Target_99_Synonyms:
EC 2.7.4.6
GAAD
Granzyme A-activated DNase
Metastasis inhibition factor nm23
NDK A
NDP kinase A
Tumor metastatic process-associated protein
nm23-H1

# Drug_Target_99_Theoretical_pI:
6.11

# Drug_Target_99_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
M21446

# Drug_Target_9_GenBank_ID_Protein:
145334

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
argB

# Drug_Target_9_Gene_Sequence:
>777 bp
ATGATGAATCCATTAATTATCAAACTGGGCGGCGTACTGCTGGATAGTGAAGAGGCGCTG
GAACGTCTGTTTAGCGCACTGGTGAATTATCGTGAGTCACATCAGCGTCCGCTGGTGATT
GTGCACGGCGGCGGTTGCGTGGTGGATGAGCTGATGAAAGGGCTGAATCTGCCGGTGAAA
AAGAAAAACGGCCTGCGGGTGACGCCTGCTGATCAGATAGACATTATCACCGGAGCACTG
GCGGGAACGGCAAATAAAACCCTGTTGGCATGGGCGAAGAAACATCAGATTGCGGCCGTA
GGTTTGTTTCTCGGTGACGGCGACAGCGTCAAAGTGACCCAGCTTGATGAAGAGTTAGGT
CATGTTGGACTGGCGCAGCCAGGTTCGCCTAAGCTTATCAACTCCTTGCTGGAGAACGGT
TATCTGCCGGTGGTCAGCTCCATTGGCGTAACAGACGAAGGGCAACTGATGAACGTCAAT
GCCGACCAGGCGGCAACGGCGCTGGCGGCAACGCTGGGCGCGGATCTGATTTTGCTCTCC
GACGTCAGCGGCATTCTCGACGGCAAAGGGCAACGCATTGCCGAAATGACCGCCGCGAAA
GCAGAACAACTGATTGAGCAGGGCATTATTACTGACGGCATGATAGTGAAAGTGAACGCG
GCGCTGGATGCGGCCCGCACGCTGGGCCGTCCGGTAGATATCGCCTCCTGGCGTCATGCG
GAGCAGCTTCCGGCACTGTTTAACGGTATGCCGATGGGTACGCGGATTTTAGCTTAA

# Drug_Target_9_General_Function:
Amino acid transport and metabolism

# Drug_Target_9_General_References:
10393305	Gil F, Ramon-Maiques S, Marina A, Fita I, Rubio V: N-Acetyl-L-glutamate kinase from Escherichia coli: cloning of the gene, purification and crystallization of the recombinant enzyme and preliminary X-ray analysis of the free and ligand-bound forms. Acta Crystallogr D Biol Crystallogr. 1999 Jul;55(Pt 7):1350-2.
12005432	Ramon-Maiques S, Marina A, Gil-Ortiz F, Fita I, Rubio V: Structure of acetylglutamate kinase, a key enzyme for arginine biosynthesis and a prototype for the amino acid kinase enzyme family, during catalysis. Structure. 2002 Mar;10(3):329-42.
2851495	Parsot C, Boyen A, Cohen GN, Glansdorff N: Nucleotide sequence of Escherichia coli argB and argC genes: comparison of N-acetylglutamate kinase and N-acetylglutamate-gamma-semialdehyde dehydrogenase with homologous and analogous enzymes. Gene. 1988 Sep 7;68(2):275-83.
8265357	Blattner FR, Burland V, Plunkett G 3rd, Sofia HJ, Daniels DL: Analysis of the Escherichia coli genome. IV. DNA sequence of the region from 89.2 to 92.8 minutes. Nucleic Acids Res. 1993 Nov 25;21(23):5408-17.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
2892

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
27160

# Drug_Target_9_Name:
Acetylglutamate kinase

# Drug_Target_9_Number_of_Residues:
258

# Drug_Target_9_PDB_ID:
1OHB

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF00696	AA_kinase

# Drug_Target_9_Protein_Sequence:
>Acetylglutamate kinase
MMNPLIIKLGGVLLDSEEALERLFSALVNYRESHQRPLVIVHGGGCVVDELMKGLNLPVK
KKNGLRVTPADQIDIITGALAGTANKTLLAWAKKHQIAAVGLFLGDGDSVKVTQLDEELG
HVGLAQPGSPKLINSLLENGYLPVVSSIGVTDEGQLMNVNADQAATALAATLGADLILLS
DVSGILDGKGQRIAEMTAAKAEQLIEQGIITDGMIVKVNAALDAARTLGRPVDIASWRHA
EQLPALFNGMPMGTRILA

# Drug_Target_9_Reaction:
ATP + N-acetyl-L-glutamate = ADP + N-acetyl-L-glutamyl 5-phosphate

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
ATP + N-acetyl-L-glutamate = ADP + N-acetyl-L- glutamate 5-phosphate

# Drug_Target_9_SwissProt_ID:
P0A6C8

# Drug_Target_9_SwissProt_Name:
ARGB_ECOLI

# Drug_Target_9_Synonyms:
AGK
EC 2.7.2.8
N-acetyl-L- glutamate 5-phosphotransferase
NAG kinase

# Drug_Target_9_Theoretical_pI:
5.32

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB03431
